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Abstract 
Prodiginines are a large family of red-pigmented antibiotics produced by a range of actinomycetes 
and other eubacteria that contain the highly-conjugated 4-methoxypyrrolyldipyrromethene core.  
It has recently been shown that the Rieske oxygenase-like non-haem iron-dependent enzyme 
RedG is responsible for catalysing the oxidative carbocyclisation of undecylprodigiosin to form the 
carbocyclic derivative streptorubin B, via functionalisation of an unactivated C-H bond.    
Figure 1: The oxidative carbocyclisation of undecylprodigiosin to streptorubin B catalysed by the 
Rieske oxygenase-like non-haem iron-dependent enzyme RedG 
The mechanism of this chemically challenging reaction has been investigated using a 
mutasynthesis approach, employing analogues of key biosynthetic intermediates that bear specific 
functional groups, designed to probe different aspects of the proposed catalytic mechanism.  
Analogues of the biosynthetic intermediate 2-undecylpyrrole bearing sulphides, ethers, 
cyclopropanes, methyl substituents and deuterium labels in the undecyl chain have been 
synthesised and fed to Streptomyces coelicolor mutants blocked in the biosynthesis of 
2-undecylpyrrole.   
These 2-undecylpyrrole analogues have also been fed along with synthetic 4-methoxy-2,2’-
bipyrrole carboxaldehyde to Streptomyces albus expressing redH and redG.  The results of these 
feeding experiments have confirmed that RedG utilises molecular oxygen, is capable of catalysing 
dealkylation of an ether and revealed that the pro-R hydrogen atom from C-7’ of the undecyl chain 
is specifically abstracted during the oxidative carbocyclisation.  The results also showed that RedG 
is not able to tolerate substrate analogues with increase steric bulk close to the site of cyclisation. 
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1.1 Introduction to prodiginines 
Prodiginines are a large class of antibiotics produced by actinomycetes and other eubacteria.  
This family of compounds contains a common highly conjugated 
4-methoxypyrrolyldipyrromethene that is responsible for their intense red colour, Figure 1.1.  
The different members of this family of compounds differ depending on the extent and 
position of the substitution pattern for R1 to R5. 
Figure 1.1: The 4-methoxypyrrolyldipyrromethene core common to all prodiginines (left) and 
a plate with Streptomyces coelicolor growing showing the intense red colour (right) 
Prodigiosin 1, the first member of the prodiginine family to be discovered, was isolated from 
the bacterium Serratia marcescens in 1902.1  However, the structure of this unusual pigment 
was initially unclear, with a number of potential structures proposed, Figure 1.2.  It was not 
until 1960 when the structure was confirmed as 1.2 
Figure 1.2: The structure of prodigiosin 1 and the initially proposed structures 2 and 3 
Since the discovery of prodigiosin 1, a large number of other prodiginines have been isolated 
from a range of microorganisms, with the majority coming from actinomycetes.  A selection of 
prodiginines are shown below in Figure 1.3, including the linear undecylprodigiosin 4 originally 
isolated from Streptomyces sp. Y-42 and several macrocyclic derivatives such as 
metacycloprodigiosin 5, streptorubin B 6 and nonylprodigiosin 7, isolated from Actinomadura 
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madurae.3  In addition to these cyclic derivatives, other prodiginine-like compounds have 
been observed including prodigiosin R1 8 and roseophilin 9 isolated from Streptomyces 
griseoviridis. 
Figure 1.3: The structure of a selection of prodiginines including undecylprodigiosin 4, 
metacycloprodigiosin 5, streptorubin B 6, nonylprodigiosin 7, prodigiosin R1 8 and the related 
compound roseophilin 9 
Prodiginines have received a lot of attention in recent years due to their wide range of 
biological activities.  In addition to their antibacterial properties, prodiginines have also been 
shown to demonstrate immunosuppressant, anti-malarial and anti-cancer properties.4,5,6,7,8    
Indeed, a synthetic analogue of streptorubin B 6, Obatoclax 10, has undergone Phase II clinical 
trials for the treatment of chronic lymphocytic leukemia (CLL), Figure 1.4.9  It has been shown 
that CLL cells, in addition to a number of other cancer cell lines, over-express the Bcl-2 family 
of anti-apoptotic proteins, thus preventing the normal cell death process from occurring.10  
This family of proteins contain a conserved binding site that ordinarily binds pro-apoptotic 
proteins, such as Bax and Bak, preventing them from triggering the apoptotic pathway.  It has 
been shown that Obatoclax 10 binds to this conserved binding site, resulting in the release of 
the pro-apoptotic proteins, restoring normal apoptotic processes.  
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Figure 1.4: The structure of Obatoclax 10 
In addition to their anti-cancer properties, prodiginines have shown promise as anti-malarial 
agents.  When screened against chloroquine-resistant Plasmodium falciparum, the parasite 
that causes malaria, undecylprodigiosin 4, metacycloprodiginine 5 and streptorubin B 6 
(IC50 7.7, 1.7 and 7.8 nM respectively) were found to be more potent than chloroquine 
(IC50 11 nM), although the mechanism of action is unknown.
8  Furthermore, several synthetic 
analogues of these prodiginines demonstrated even greater potency and were even shown to 
cure malaria in several mice studies.11  
1.2 Streptomyces coelicolor A3(2) 
Streptomyces are the largest genus of actinobacteria with over 500 different species currently 
known.12  Streptomyces reside in soil and water and play a major role in the decomposition of 
organic matter in the environment.  In addition, Streptomyces are known to produce a wide 
range of structurally diverse antibiotics, with 80% of the clinically used antibiotics originating 
from Streptomyces species including viomycin 11, isolated from Streptomyces puniceus, 
chloramphenicol 12, isolated from Streptomyces venezuelae, fosfomycin 13, isolated from 
Streptomyces fradiae and streptomycin 14, isolated from Streptomyces griseus, Figure 1.5. 
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Figure 1.5: A selection of clinically utilised antibiotics produced by a variety of Streptomyces 
species 
Streptomyces coelicolor A3(2) is a known producer of prodiginine antibiotics, specifically 
undecylprodigiosin 4 and streptorubin B 6.  In 2002, the complete genome sequence was 
reported making it an ideal model strain for the study of the biosynthesis of secondary 
metabolites such as the prodiginines.13 In addition to prodiginines, S. coelicolor A3(2) 
produces a range of other antibiotics including methylenomycin A 15, actinorhodin 16, an 
intensely blue coloured compound from which the species name of this strain derives, and 
coelimycin P1 17, Figure 1.6. 
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Figure 1.6: Undecylprodigiosin 4, methylenomycin A 15, actinorhodin 16, streptorubin B 6 and 
coelimycin 17, antibiotics produced by S. coelicolor A3(2) 
1.3 Early studies of prodiginine biosynthesis 
Early studies of the biosynthesis of prodiginines focused on prodigiosin 1 in Serratia 
marcescens, with later studies focusing on undecylprodigiosin 4 and metacycloprodigiosin 5 in 
Streptomyces longispororuber.  A combination of feeding experiments utilising carbon-13 
labelled precursors and isolation of putative biosynthetic intermediates lead to the hypothesis 
that the prodginines are formed via the condensation of two late stage intermediates.  Given 
the structural similarities between prodigiosin 1 and undecylprodigiosin 4, it was expected 
that they would share a common biosynthetic intermediate, namely 4-methoxy-2,2’-bipyrrole-
carboxaldehyde (MBC) 19, Figure 1.7.  Condensation of MBC 19 with either 2-methyl-3-
pentylpyrrole 18 or 2-undecylpyrrole (2-UP) 20 would provide prodigiosin 1 and 
undecylprodigiosin 4, respectively.14,15,16,17,18 
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Figure 1.7: The proposed biosynthetic route to prodigiosin 1 and undecylprodigiosin 4 with 
the results of feeding experiments using carbon-13 labelled precursors 
It was demonstrated from the feeding of isotopically labelled precursors that MBC 19, in both 
systems, is biosynthesised from one unit of L-proline, carbons-2 and -3 of L-serine, the methyl 
group of L-methionine and one unit of acetate.  In the case of prodigiosin 1, 2-methyl-5-
pentylpyrrole 18 is biosynthesised from carbons-2 and -3 of L-alanine and several units of 
acetate whereas 2-UP 20 is derived from glycine and several units of acetate.18,19,20,21   
In addition to the linear prodiginine undecylprodigiosin 4, S. longispororuber is known to 
produce the carbocyclic derivative, metacycloprodigiosin 5.  The results of feeding 
experiments with isotopically labelled precursors revealed an identical incorporation pattern 
to that of undecylprodigiosin 4.  As a result, it was proposed that metacycloprodigiosin 5 is 
formed from undecylprodigiosin 4 via an oxidative carbocyclisation reaction, Figure 1.8.  Since 
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metacycloprodigiosin 5 and streptorubin B 6 only differ by the size of their macrocycles, it was 
proposed by Challis et al that streptorubin B 6 was formed in an analogous manner. 
Figure 1.8: The identical isotope labelling patterns for undecylprodigiosin 4 and 
metacycloprodigiosin 5 (see Figure 1.7 for colour code) suggests metacycloprodigiosin 5 is 
derived from undecylprodigiosin 4 via an oxidative carbocyclisation reaction 
1.4 The undecylprodigiosin 4 and streptorubin B 6 biosynthetic 
gene cluster 
In 2002, the entire S. coelicolor A3(2) genome sequence was published and the gene cluster 
responsible for the biosynthesis of undecylprodigiosin 4 and streptorubin B 6 was identified, 
Figure 1.9.13  This gene cluster, known as the red cluster, contains twenty three genes 
arranged in four transcription units.  Sequence comparisons of the encoded proteins with 
proteins of known function allowed a role for each gene within the cluster to be proposed.  
Since then, these enzymes have been studied extensively and the functions of the majority 
are now known.   
Figure 1.9: The red gene cluster; green arrows represent genes involved in MBC 19 
biosynthesis; blue arrows represent genes involved in 2-UP 20 biosynthesis; the black arrow 
represents a gene involved in the condensation of MBC 19 and 2-UP 20; the orange arrow 
represents a gene involved in the oxidative cyclisation of 4 into 6; white arrows represent 
genes of unknown function; grey arrows represent regulatory genes 
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Of the twenty three genes in the red gene cluster, nine have been shown to be required for 
the biosynthesis of MBC 19 (redI, M – N, T – W, Y)22,23 while six are required for the 
biosynthesis of 2-UP 20 (redJ – L, P – R).24,25  Of the remaining genes, two are known to 
encode pathway specific regulators (redD and redZ),26 one encodes the enzyme that catalyses 
the condensation of the two late stage intermediates MBC 19 and 2-UP 2027 (redH) and the 
other encodes the enzyme that catalyses the oxidative carbocyclisation which converts 
undecylprodigiosin 4 to streptorubin B 6 (redG).  The remaining genes (red S, F and E) do not 
appear to be required for the biosynthesis of prodiginines.   
1.5 4-Methoxy-2,2’-bipyrrole-carboxaldehyde (MBC, 19) 
biosynthesis 
As discussed in Section 1.3, MBC 19 is a common intermediate in the biosynthesis of 
prodigiosin 1 and undecylprodigiosin 4 in Serratia and Streptomyces species, respectively.  In 
both cases, MBC 19 is biosynthesised from one unit of L-proline, L-serine, L-methionine and 
acetate.  The mechanism for the biosynthesis of MBC 19 in S. coelicolor was initially proposed 
by Cerdeño et al and was later revised by Stanley et al.23 28 
The first step in the biosynthesis of MBC 19 involves the post-translational 
phosphopantetheinylation of the peptidyl carrier protein (PCP) RedO catalysed by RedU, a 
phosphopantetheinyl transferase (PPTase), Figure 1.10.  Adenylation of the carboxyl group of 
L-proline, catalysed by RedM, activates it for loading onto the phosphopantethene thiol of 
RedO.  Subsequent dehydrogenation, catalysed by the flavin adenine dinucleotide (FAD) 
dependent enzyme RedW, converts the pyrrolidine to a pyrrole ring.29 Transfer of the 
resulting pyrrole-2-carboxyl intermediate to the C-terminal keto-synthase (KS) domain of RedX 
occurs directly and not via release and subsequent reloading of pyrrole-2-carboxylic acid.  
Subsequent decarboxylative condensation with a malonyl unit, attached to one of the acyl 
carrier protein (ACP) domains of RedN yields a β-keto-ACP-thioester.  Condensation of 
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L-serine with this β-keto-ACP-thioester followed by loss of the serine carboxylate group as 
carbon dioxide, catalysed by the pyridoxal-5’-phosphate (PLP) dependent α-oxoamine 
synthase (OAS) domain, results in product release from the RedN enzyme.  Subsequent 
cyclisation and dehydration provides the bipyrrole moiety.  Oxidation of the primary alcohol 
to the corresponding aldehyde, catalysed by RedV,30 and methylation of the pyrrole hydroxyl 
group, catalysed by RedI, completes the biosynthesis of MBC 19.  The roles of RedT and RedY 
are currently unknown, however, mutant strains lacking these enzymes produce significantly 
less prodiginines which can be restored by feeding chemically synthesised MBC 19 to the 
mutants. 
Figure 1.10: The biosynthetic pathway to MBC 19; PCP – peptidyl carrier protein, ACP – acyl 
carrier protein, KS – ketosynthase domain, OAS – α-oxoamine synthase domain 
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1.6 2-Undecylpyrrole (2-UP, 20) biosynthesis 
As discussed in Section 1.3, it was demonstrated that 2-UP 20 is biosynthesised from one unit 
of glycine and several units of acetate.  The initial steps in the biosynthesis of 2-UP 20 involve 
the formation of dodecanoic acid via the actions of RedP, RedQ, RedR and fatty acid 
biosynthetic enzymes in S. coelicolor, Figure 1.11.24  RedP, a homologue of the fatty acid 
biosynthetic enzyme FabH, initiates the biosynthesis of dodecanoic acid by catalysing the 
decarboxylative condensation of acetyl-CoA with a malonyl extender unit bound to the ACP 
RedQ.25  Subsequent keto-reduction, dehydration and enoyl-reduction catalysed by fatty acid 
biosynthetic enzymes yields a butylanoyl thioester attached to RedQ.  This butylanoyl 
thioester then undergoes several rounds of chain elongation, dehydrations and reductions 
catalysed by RedR, a homologue of FabF, and fatty acid biosynthetic enzymes, ultimately 
resulting in the formation of a dodecanoyl thioester bound to RedQ.   
Transfer of the dodecanoyl chain to N-terminal ACP domains of RedL has been shown to occur 
via hydrolysis of the thioester, catalysed by RedJ, to afford dodecanoic acid.31  This free 
carboxylic acid is then loaded onto the RedL N-terminal ACP domain, after activation by 
adenylation catalysed by the adenylation (A) domain of RedL.  A final decarboxylative 
condensation with a malonyl group bound to the C-terminal ACP, catalysed by the KS domain, 
affords β-ketomyristoyl-ACP.  In an analogous process to that in the biosynthesis of MBC 19, 
condensation with glycine followed by decarboxylation catalysed by the OAS domain of RedL, 
releases the chain to yield 4-keto-2-undecylpyrroline after cyclisation and elimination of 
water.  Finally, reduction of the resulting ketone by the NAD(P)H dependent enzyme RedK, 
followed by aromatisation via elimination of water provides 2-UP 20. 
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Figure 1.11: The biosynthetic pathway to 2-UP 20; ACP – acyl carrier protein domain, A –
 adenylation domain, KS – ketosynthase domain, AT – acetyl transferase domain, OAS – 
α-oxoamine synthase domain 
1.7 Condensation of MBC 19 and 2-UP 20 
As discussed in Section 1.3, undecylprodigiosin 4 is proposed to be assembled via the 
condensation of the two late stage intermediates MBC 19 and 2-UP 20.  Initially, it was 
proposed that no enzyme was required to catalyse this reaction, since the reaction occurs 
spontaneously in the presence of a Brønsted acid.  However, mutant strains of S. coelicolor 
lacking the redH gene produce no undecylprodigiosin 4 or streptorubin B 6, but accumulate 
both MBC 19 and 2-UP 20, indicating that RedH catalyses the condensation of MBC 19 and 
2-UP 20.32  Indeed, feeding of chemically synthesised MBC 19 and 2-UP 20 to the heterologous 
host Streptomyces venezaelae expressing redH results in the production of 
undecylprodigiosin 4 but not streptorubin B 6, indicating that RedH is only responsible for 
catalysing the condensation of MBC 19 and 2-UP 20.33 
Comparison of the sequence of RedH to proteins of known function predicted that it contains 
three functional domains, two of which show sequence similarity to the ATP-binding and 
13 
 
phosphotransferase domains of phosphoenol pyruvate synthase (PEPS) and 
pyruvate-phosphate dikinase (PPDK).24 The third domain of RedH does not show sequence 
similarity to any proteins of known function and was therefore proposed to be the MBC 19 
and 2-UP 20 binding site.   
It has been proposed that RedH activates the carbonyl group of MBC 19 by phosphorylation of 
the oxygen atom in an analogous manner to the phosphorylation of pyruvate by PEPS and 
PPDK, Figure 1.12.  Subsequent nucleophilic attack of 2-UP 20, followed by elimination of 
phosphate and rearomatisation yields undecylprodigiosin 4. 
Figure 1.12: The condensation of MBC 19 and 2-UP 20 catalysed by RedH 
1.8 Oxidative carbocyclisation  
The final step in the biosynthesis of streptorubin B 6 is the oxidative carbocyclisation of 
undecylprodigiosin 4, which yields the 10-membered ansa-bridged carbocycle.  RedG was 
implicated in this chemically challenging reaction because a mutant of S. coelicolor lacking the 
redG gene produces undecylprodigiosin 4 but not streptorubin B 6.  Indeed, feeding of 
chemically synthesised MBC 19 and 2-UP 20 to the heterologous host Streptomyces 
venezuelae expressing both redH and redG results in the production of undecylprodigiosin 4 
and streptorubin B 6, indicating that RedG is responsible for catalysing the oxidative 
carbocyclisation of undecylprodigiosin 4 into streptorubin B 6.33 
Sequence comparison of RedG with proteins of known function revealed a strong similarity to 
the Rieske non-haem iron-dependent enzyme, naphthalene dioxygenase (NDO), Figure 1.13.  
Indeed, McpG, a homologue of RedG from Streptomyces longispororuber that converts 
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undecylprodigiosin 4 to metacycloprodigiosin 5, also exhibited a high sequence similarity to 
RedG and NDO. 
Figure 1.13: The sequence comparison of RedG (S. coelicolor), McpG (S. longispororuber) and 
the Rieske non-haem iron dependent enzyme naphthalene dioxygenase (NDO); residues 
highlighted in yellow are proposed to ligate the [2Fe-2S] cluster and the non-haem iron atom; 
a mutation from aspartate in NDO to glutamate in RedG and McpG is highlighted in green 
Figure 1.14: The proposed [2Fe-2S] Rieske cluster (blue), the non-haem iron catalytic site (red) 
and the bridging glutamate residue in RedG 
As shown in Figure 1.13 and 1.14, the N-terminal domain of RedG contains the CXH and CX2H 
motifs for [2Fe-2S] Rieske cluster binding in NDO.  In the C-terminal domain, RedG contains an 
EX2HX4H motif that exhibits a strong similarity with the DX2HX4H motif in the substrate binding 
region of NDO.  These two conserved histidine residues, in addition to an unidentified 
aspartate or glutamate residue, are proposed to bind the catalytic iron atom.  The aspartate 
residue proposed to be involved in the transfer of electrons from the Rieske cluster to the 
non-haem iron centre during the catalytic cycle of NDO appears to be mutated to a glutamate 
residue in RedG.  Since the side chains of aspartate and glutamate differ only in the length of 
the side chain, it is expected that this alteration has no impact on function. 
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Rieske enzymes, including NDO, are typically multicomponent enzymes with a dedicated 
reductase to accept electrons from NAD(P)H and a ferredoxin to transfer the electrons from 
the reductase to the oxygenase where substrate oxidation occurs.  However, there are no 
genes within the red cluster that encode either a reductase or a ferredoxin protein.  However, 
elsewhere in the S. coelicolor genome, there are six ferredoxin and three reductase encoding 
genes that could potentially be involved in mediating electron transfer to RedG.34 
While Rieske enzymes typically catalyse dihydroxylation reactions, other non-haem 
iron-dependent enzymes have previously been shown to catalyse oxidative cyclisation 
reactions in the biosynthesis of a variety of natural products.  In the case of fosfomycin 13, the 
epoxide ring essential for the observed antibacterial properties is installed by the non-haem 
iron-dependent enzyme HppE, Figure 1.15.  Another example of a non-haem iron-dependent 
enzyme involved in the biosynthesis of a clinically important natural products is isopenicillin N 
synthase (IPNS).  It has been demonstrated that IPNS is responsible for catalysing the 
formation of the β-lactam and thiazolidine rings of the penicillins.  
Figure 1.15: The oxidative cyclisation reactions catalysed by non-haem iron-dependent 
enzymes in the biosynthesis of fosfomycin and the penicillins; the hydrogen atoms lost are 
highlighted in red while the new bonds formed are highlighted in green 
While a range of non-haem iron-dependent enzymes are known to catalyse oxidative 
cyclisation reactions at unactivated carbon centres, prior to the discovery of RedG, no such 
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enzyme was known that could catalyse the formation of a carbon-carbon bond.  Moreover, no 
other Rieske oxygenase-like enzyme is known to catalyse an oxidative cyclisation reaction.   
1.9 Proposed RedG catalytic mechanism 
At present, there is no experimental evidence for the mechanism by which RedG catalyses the 
oxidative carbocyclisation of undecylprodigiosin 4 to streptorubin B 6.  However, the catalytic 
mechanisms of several other Rieske oxygenases, including NDO, have been studied.35,36,37  
Thus, a plausible catalytic mechanism for RedG can be proposed based on what is known 
about these other enzymes, Figure 1.16. 
Figure 1.16: The proposed catalytic mechanism of RedG based on the studied catalytic 
mechanism of NDO; A – substrate binds to the active site; B – an electron is transferred from 
the Rieske cluster to the non-haem iron centre, dioxygen binds and undergoes protonation; 
C – the resulting bridged iron(III) hydroperoxy species abstracts a hydrogen atom from the 
17 
 
undecyl chain followed by cyclisation of the resulting radical; D – or the bridged iron(III) 
hydroperoxy species rearranges to a the iron(V) oxo-hydroxo species; E – and the iron(V) oxo-
hydroxo species abstracts a hydrogen atom from the undecyl chain followed by cyclisation of 
the resulting radical; F – abstraction of a second hydrogen atom regenerates the aromatic 
pyrrole ring; G – regeneration of the resting enzyme by transfer of a second electron from the 
Rieske cluster 
The catalytic cycle is initiated by undecylprodigiosin 4 binding to the active site, promoting 
loss of one of the water ligands, resulting in a vacant binding site on the non-haem iron atom, 
step A.  A molecule of oxygen then binds to this vacant site and is subsequently reduced to 
the corresponding bridged hydroperoxo species utilising an electron from the non-haem iron 
atom and another electron from NAD(P)H transferred via the [2Fe-2S] Rieske cluster which is 
then protonated and displaces the second water ligand, step B.  From here two pathways are 
possible.  One involves abstraction of a hydrogen atom from C-7’ of undecylprodigiosin 4 by 
the iron(III) bridged hydroperoxo species, generating a carbon-centred radical that 
subsequently cyclises onto the pyrrole ring, step C.  The other involves heterolysis of the 
oxygen-oxygen bond of the bridged hydroperoxo complex to afford the corresponding iron(V) 
oxo-hydroxo species, step D.  This iron(V) oxo-hydroxo species is then proposed to abstract a 
hydrogen atom from C-7’ of undecylprodigiosin 4 to form a radical that adds to the pyrrole, 
step E.  Abstraction of a second hydrogen atom regenerates the pyrrole, yielding the product 
streptorubin B 6, step F.  Transfer of a second electron from NAD(P)H via the Rieske cluster 
regenerates the resting state of RedG, step G. 
1.10 Relative and absolute stereochemistry of streptorubin B 6 
The structure of streptorubin B 6 presents several interesting stereochemical features.  In 
addition to the stereocentre at C-7’ and the geometry of the exocyclic double bond, molecular 
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models indicate that free rotation of the methoxypyrrolidipyrromethene core through the 
ansa-bridged 10-membered carbocycle is likely to be highly restricted. 
1.10.1 Geometrical isomerism about the exocyclic double bond in prodiginine 
alkaloids 
D’Alessio and coworkers demonstrated that prodiginines generally exist as an equilibrium 
mixture of cis- and trans-isomers about the exocyclic double bond.38 Such isomers are often 
observed during reverse-phase HPLC analysis.  Broad peaks that exhibit extensive ‘tailing’ are 
typically observed, resulting from interconversion of isomers during passage through the 
column.  The position of equilibrium is strongly dependent on the pH of the sample; at low 
pH, protonation of the central nitrogen atom occurs allowing an appropriate counter ion 
(e.g. chloride) to hydrogen bond with all three N-H groups, thus favouring the cis-isomer, 
Figure 1.17.  At high pH, a greater proportion of the trans-isomer is present.  In the case of 
streptorubin B 6, steric interactions between the n-butyl group and the 
methoxypyrrolidipyrromethene core also favour the cis-isomer. 
Figure 1.17: The equilibrium between cis- and trans-isomers of streptorubin B 6 indicating the 
unfavourable steric interaction between the n-butyl side chain and the 
methoxypyrrolidipyrromethene core 
1.10.2 Atropisomerism of streptorubin B 6 
Since rotation of the methoxypyrrolidipyrromethene core through the ansa-bridged 
10-membred carbocycle is restricted, the n-butyl side chain and the 
methoxypyrrolidipyrromethene core are forced to adopt defined relative configurations, 
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namely anti and syn, Figure 1.18.  Indeed, even at 120 oC, no signal broadening was observed 
in the 1H-NMR spectrum of streptorubin B 6, indicating it is conformationally stable at room 
temperature.   
Figure 1.18: The atropisomeric anti and syn configurations of streptorubin B 6 
This conformational stability has a peculiar effect on the protons attached to C-4’, Figure 1.19.  
One of the protons is held directly above the π-faces of a pyrrole resulting in a chemical shift 
of -1.54 ppm in the 1H-NMR spectrum, while the other proton has a typical methylene 
chemical shift of 1.16 ppm.  By measuring NOESY NMR spectra experiments of 
streptorubin B 6 isolated from Streptomyces coelicolor M511, Challis et al were able to 
demonstrate that the major atropisomer of streptorubin B 6 in solution is anti, Figure 1.19.39 
Correlation between H-7’ and H-1’’ in addition to a correlations between the protons attached 
to C-8’ and H-3C indicated that the n-butyl and C-1’’ have an anti relationship as expected for 
the anti conformer.  Correlations between H-7’ and H-1’’, H-1’’ and H-1’’’, H-1’’’ and H-4B and 
H-4B and H-3A also confirmed the cis-geometry of the exocyclic double bond.  In addition to 
the peak at -1.54 ppm, a peak at -1.48 ppm with approximately 5% the intensity was 
observed, indicating a small amount of the syn conformer also present in solution. 
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Figure 1.19: NOESY correlations observed for streptorubin B 6 
1.10.3 Absolute stereochemistry of streptorubin B 6 
Challis et al elucidated the absolute stereochemistry of streptorubin B 6 via a mutasynthesis 
approach, involving feeding of stereoselective deuterium-labelled 2-UP 25 to a mutant of 
S. coelicolor that is blocked in 2-UP 20 biosynthesis, to produce stereoselectively labelled 
streptorubin B 6.39  The large difference in chemical shift of the diastereotopic C-4’ protons 
was exploited to assign the configuration of C-7’.  Stuart Haynes, a previous PhD student in 
the Challis group, synthesised 2-UP analogues (4’R)-25 and (4’S)-25 with either the pro-S or 
pro-R hydrogen at C-4’ replaced with a deuterium atom, Scheme 1.1 and Figure 1.20.  Feeding 
of (4’S)-25 resulted in streptorubin B 6 containing approximately 70% of the label in the 
position directly over the pyrrole π-face, whereas feeding of (4’R)-25 resulted in 
approximately 30% labelling of the position directly over the pyrrole π-face as determined by 
1H-NMR spectroscopy.  These data indicated that streptorubin B 6 has the 7’S configuration. 
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Scheme 1.1: The synthetic route utilised by Stuart Haynes for the stereoselective synthesis of 
deuterium-labelled 2-UP analogues (4’R)-25 and (4’S)-25; a. n-C6H13Li, CuCN; b. TMSI, MeOH; 
c. NaBD4; d. NaOH; e. i. (PyS)2, PPh3 ii. EtMgBr, pyrrole; f. NaBH4; g. AlMe3, Me2NH.HCl; h. TsCl, 
Pyridine 
Figure 1.20: The mutasynthetic strategy utilised to biochemically confirm the stereochemistry 
of streptorubin B 6 
The observation that only 70% of the deuterium labelled occupied the position directly above 
the pyrrole π-face when (4’S)-25 was fed implied that either partial racemisation during the 
synthesis had occurred or natural streptorubin B 6 is produced as a mixture of enantiomers.  
To probe this, Challis et al analysed streptorubin B 6 isolated from S. coelicolor via HPLC on a 
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homochiral stationary phase.  From this, they were able to deduce that partial racemisation 
during the synthesis of (4’R)- and (4’S)-25 was the main reason for the scrambling of the label.  
However, a small amount of (7’R)-streptorubin B 6 was detected in the natural material, 
indicating that the RedG-catalysed oxidative carbocyclisation reaction proceeds without 
complete stereocontrol.  
1.11 Total synthesis of prodiginine antibiotics 
As a result of their interesting biological properties, the total synthesis of prodiginine 
antibiotics has been of particular interest.  In addition, those prodiginines containing 
macrocycles have attracted considerable attention due to the synthetic challenge they 
present.  Typically, the total synthesis of these compounds focuses on the synthesis of a 
macrocyclic monopyrrole moiety which is subsequently coupled with a bipyrrole moiety. 
1.11.1 Undecylprodigiosin 4 total synthesis 
Undecylprodigiosin 4 has proved very amenable to total synthesis due to the simplicity of its 
structure.  Indeed, Wasserman et al published a synthetic route to undecylprodigiosin 4 in 
1966 that mimics the biosynthetic route in which MBC 19 is condensed with 2-UP 20 in an 
acidic ethanol solution.40   
An alternative synthetic route for the synthesis of undecylprodigiosin 4 that is more amenable 
to scale-up was reported in 1996 by D’Alessio et al.41  This is not dependent on the 
condensation of MBC 19 and 2-UP 20, Scheme 1.2.  Beginning from 2-UP 20, D’Alessio utilised 
the Vilsmeier-Haack reaction to install an aldehyde group, yielding 26, which was 
subsequently condensed with lactam 27 to provide 28.  Treatment of 28 with triflic anhydride 
afforded the corresponding triflate 29 which was subsequently cross-coupled with Boc-
protected pyrroleboronic acid 30 using the Suzuki cross-coupling reaction to yield 
undecylprodigiosin 4. 
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Scheme 1.2: The synthetic route developed by D’Alessio et al for undecylprodigiosin 4; 
a. POCl3, DMF; b. NaOH, 60 
oC; c. Tf2O; d. Pd(PPh3)4, K2CO3, 90 
oC 
1.11.2 Total synthesis of metacycloprodigiosin 5 
The first total synthesis of racemic metacycloprodigiosin rac-5 was reported by Wasserman 
et al in 1969, Scheme 1.3.42 The enolate of cyclododecanone 31 was alkylated with ethyl 
bromide and subsequently protected as ketal 32.  Regioselective bromination of ketal 32, 
followed by a high temperature elimination and ketal deprotection provided enone 33.  
Epoxidation of this enone, followed by Wharton fragmentation of the resulting epoxide gave 
alcohol 34.  Oxidation and subsequent cyanation provided nitrile 35, which was reduced, 
following ketone protection, and hydrolysed to give 1,4-dicarbonyl compound 36.  This was 
converted to the pyrrole 37 utilising the Paal-Knorr pyrrole synthesis.  Coupling of the 
resulting pyrrole with MBC 19, in an analogous manner to that used in the synthesis of 
undecylprodigiosin 4, provided racemic metacycloprodigiosin rac-5 in an overall yield of 0.02% 
over twelve linear steps. 
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Scheme 1.3: The synthetic route utilised by Wasserman for the total synthesis of racemic 
metacycloprodigiosin rac-5; a. NaNH2, EtBr; b. HO(CH2)2OH, p-TsOH; c. H5C5NH
+Br3
-; d. DBN, 
110 oC; e. p-TsOH; f. H2O2, NaOH; g. N2H4; h. Na2Cr2O7; i. KCN; j. p-TsOH, MeOH; k. DIBAL-H; 
l. (NH4)2CO3 
Since this pioneering work by Wasserman et al was published, several other synthetic routes 
have been developed for the synthesis of racemic metacycloprodigiosin rac-5, including two 
by Furstner et al.43,44  However, it was not until 2009 that the first enantioselective total 
synthesis of metacycloprodigiosin 5 was reported by Thomson et al, Scheme 1.4.45   In their 
synthesis, the enantioselective 1,4-conjugate addition of ethyl cuprate to enone 38, followed 
by trapping of the resulting enolate with a chlorosilyl enol ether 39 and oxidative C-C bond 
formation by treatment with cerium(IV) ammonium nitrate and 2,6-di-t-butylpyridine, 
afforded 1,4-diketone 41.  The stereochemistry of addition of the cuprate to the enone was 
controlled by addition of 6% (R, S)-JosiPhos and provided a 93:7 mixture of enantiomers.  A 
ring-closing metathesis reaction utilising Grubbs second generation catalyst followed by 
hydrogenation afforded a macrocyclic 1,4-diketone, which was converted to the 
corresponding pyrrole 42 via the Paal-Knorr pyrrole synthesis.  Oxidation of the methyl group 
in pyrrole 42 to an aldehyde 43 was achieved by treatment with DDQ.  The synthesis was 
completed via a modification of the route developed by D’Alessio for the synthesis of 
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undecylprodigiosin 4, Scheme 1.2.  Comparison of the synthetic material with natural 
metacycloprodigiosin 5 confirmed the absolute stereochemistry as R.  
Scheme 1.4: The route utilised by Thomson and co-workers for the enantioselective total 
synthesis of metacycloprodigiosin 5; a. EtMgBr, CuBr, (R, S)-JosiPhos; b. CAN, 2,6-di-t-Bu-Py; 
c. Grubbs II generation; d. Pd(OAc)2, H2; e. NH4OAc; f. DDQ, H2O; g. i-Pr2Net, TMSOTf; h. HCl; 
i. Tf2O; j. Pd(PPh3)4, 30, Na2CO3; k. NaOMe 
1.11.3 Total synthesis of streptorubin B 6 
The first total synthesis of racemic streptorubin B rac-6 was not reported until 1998 by 
Furstner et al, Scheme 1.5.46 This is presumably due to the fact that the 10-membered ansa-
bridged carbocycle in streptorubin B 6 is much more strained than the corresponding 
12-membered ring in metacycloprodigioisn 5.  In their synthetic route, Furstner and 
co-workers utilised an enyne metathesis reaction as a key step. 
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Treatment of cyclooctene 45 with elemental selenium and chloramine-T provided an amine 
which was alkyated with propargyl bromide to afford a tosylated alkyne 46 that was acylated 
to afford ketone 47.  An enyne metathesis skeletal rearrangement catalysed by palladium(II) 
chloride yielded the azabicyclododecane 48.  Reduction of the alkene and ketone followed by 
deoxygenation and removal of the N-tosyl protecting group gave pyrrole rac-50.   
Scheme 1.5: The route utilised by Furstner and coworkers for the total synthesis of racemic 
streptorubin B rac-6; a. Se, Chloramine-T; b. NaH, Propargul bromide; c. BuLi, ZnCl, MeCOCl; 
d. PtCl2; e. Bu3SnH, Pd(PPh3)4; f. LiAlH4; g. PhOC(S)Cl; h. Bu3SnH, AIBN; i. Potassium 
1,3-diaminopropane 
More recently, Thomson et al reported the first enatioselective total synthesis of 
streptorubin B 6.47  Their initial attempts to synthesise streptorubin B 6 focused on an 
analogous route to that already devised for the total synthesis of metacycloprodigiosin 5, in 
which a ring-closing metathesis reaction was utilised to form the macrocycle.  However, in the 
case of streptorubin B 6, the corresponding ring-closing metathesis reaction was unsuccessful, 
presumably due to the increased transannular strain of the 10-membered ring relative to the 
12-membered ring.  Thus an anionic oxy-Cope rearrangement was used to form the macrocyle 
instead, Scheme 1.6.  Thus, heptanedial 51 was treated with (S)-proline resulting in an 
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enantioselective exo-enol-6-exo-trig aldol reaction that gave aldehyde 52, which was trapped 
in situ by exposure to the ylide 53, yielding alkene 54.  Swern oxidation of the hydroxyl group 
in 54 to the corresponding ketone, followed by addition of organolithium 55 afforded 
dienol 56.  Treatment of the dienol with potassium hexamethyldisilazide resulted in the 
expected anionic oxy-Cope rearrangement.  Subsequent simultaneous hydrogenation of the 
alkene and removal of the benzyl protecting group, followed by a Dess-Martin oxidation and 
Paal-Knorr pyrrole synthesis provided pyrrole 50.  An acid-catalysed coupling of pyrrole 50 
with Boc-protect MBC provided streptorubin B 6.  This synthetic route yielded 
streptorubin B 6 in nine steps with an overall yield of 20%. 
Scheme 1.6: The route utilised by Thomson for the enantioselective total synthesis of 
streptorubin B 6; a. (S)-Proline; b. (COCl)2, DMSO, i-Pr2Et; c. 55; d. KHMDS; e. H2, Pd/C; 
f. Dess-Martin periodinane; g. NH4OAc 
Using this synthetic material, Thomson et al independently arrived at the same conclusion 
regarding the major atropisomer of streptorubin B 6 (see Section 1.10.2).  Analysis of the 
product resulting from the condensation of dialkylpyrrole 50 and Boc-protected MBC revealed 
a 10:1 mixture of isomers, the major of which had different spectroscopic properties to 
natural streptorubin B 6.  However, after standing for ten days, reanalysis of the sample 
revealed that the mixture had completely converted to natural streptorubin B 6.  Thomson 
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et al were able to demonstrate that the initially formed product of the condensation reaction 
was actually the syn isomer of streptorubin B 6 which slowly isomerised to the more stable 
anti isomer over the course of ten days.  Using the equilibrium ratio of 10:1 at room 
temperature, they were able to demonstrate that the anti isomer is approximately 1.4 kcal 
mol-1 more stable than the syn isomer, presumably due to steric interactions between the 
n-butyl chain and the methoxypyrrolodipyrromethene core in the syn isomer. 
Using CD spectroscopy, comparison of synthetic (7’R)-streptorubin B 6 prepared by Thomson 
et al, Scheme 1.6, with that isolated from S. coelicolor confirmed that natural streptorubin B 6 
has 7’S absolute stereochemistry.  This was further confirmed by X-ray crystallography.47 
1.12 Mutasynthesis of undecylprodigiosin and streptorubin B 
analogues  
During his investigation of RedH, Stuart Haynes, a previous PhD student in the Challis group, 
employed a mutasynthesis approach in which MBC analogues were fed to a mutant blocked in 
the biosynthesis of MBC 19.48 He was able to demonstrate that RedH has a relatively relaxed 
substrate specificity with regard to the monosubstituted pyrrole with a number of other 
aromatic rings being tolerated, resulting in a range of novel undecylprodigiosin analogues, 
Figure 1.21.  However, alterations to the central pyrromethene were not tolerated. 
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Figure 1.21: Undecylprodigiosin analogues produced via a mutasynthetic approach by Stuart 
Haynes 
Through a similar set of experiments, Stuart Haynes was able to probe the substrate tolerance 
of RedG.  Of the undecylprodigiosin analogues shown in Figure 1.21, only indole analogue 61 
was further converted to the corresponding streptorubin B analogue.  Stuart Haynes also 
investigated the ability of RedG to tolerate changes to the length of the hydrocarbon chain, 
Figure 1.22.  While a n-decyl and n-dodecyl chains were tolerated by both RedH and RedG, 
resulting in the formation of streptorubin B analogues 62, 63 and 64 respectively, an n-octyl 
chain was not tolerated by RedG and only undecylprodigiosin analogue 65 was produced, 
Figure 1.22.  Interestingly, when feeding 2-UP analogue bearing a n-dodecyl chain, a second 
oxidative carbocyclised product 64 was produced containing a larger carbocyclic ring, 
presumably formed as a result of a loss in regiocontrol of RedG.   
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Figure 1.22: Streptorubin B and undecylprodigiosin analogues detected produced in 
mutasynthesis experiments utilising 2-UP analogues with altered hydrocarbon chain lengths 
To further probe the substrate tolerance of RedG, Stuart Haynes synthesised a number of 
2-UP analogues bearing additional functional groups within the undecyl chain.  Analogues of 
2-UP containing a methyl group at C-9’ or C-10’, an oxygen atom in place of C-3’ and a double 
bond across C-10’ / C-11’ were all tolerated by RedG and yielded the corresponding 
streptorubin B analogues 66-69, Figure 1.23. 
Figure 1.23: Streptorubin B analogues detected produced by mutasynthesis with 2-UP 
analogues bearing alterations to the hydrocarbon chain 
In the case of the analogue with a methyl group at C-9’, a second compound with the same 
m/z as streptorubin B analogue 68 was detected in LC-MS analyses of culture extracts.  
Isolation of this compound using reverse-phase HPLC and analysis by 1H-NMR spectroscopy 
revealed proton signals at approximately 5.2 ppm, characteristic of alkene protons.  It is 
proposed that this product results from a desaturation reaction that competes with oxidative 
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carbocyclisation; the regio- and stereochemistry of the alkene could not be determined 
unambiguously, Figure 1.24.   
Figure 1.24: The streptorubin B analogue 68 resulting from oxidative carbocyclisation of 
undecylprodigiosin analogue 70 (route B) and the mixture of desaturated undecylprodigiosin 
analogues 71 and 72 proposed to result from a competing desaturation reaction (route A) 
As discussed in Section 1.9, the iron(V) oxo-hydroxo species is proposed to abstract a 
hydrogen atom from C-7’ resulting in a carbon-centred radical that subsequently attacks the 
pyrrole resulting in formation of the 10-membered ansa-bridged carbocycle.  In the case of 
analogue 70, it was hypothesised that the increased steric bulk at C-9’ slows the rate of attack 
of the carbon-centred radical on the pyrrole.  A second hydrogen abstraction from either C-6’ 
or C-8’ would result in the formation of the observed unsaturated undecylprodigiosin 
analogues 71 and/or 72, Figure 1.25. 
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Figure 1.25: The proposed mechanism for the RedG-catalysed desaturation reaction observed 
for the undecylprodigiosin analogue 70 
Another interesting result was obtained when a 2-UP analogue containing an oxygen in place 
of C-6’ was fed to mutants blocked in the biosynthesis of 2-UP 20.  In this case, no compound 
with the m/z corresponding to streptorubin B analogue 75 was detected.  Instead, another 
prodiginine-like compound was detected by LC-MS that had a m/z corresponding to 
dealkylated undecylprodigiosin analogue 76, Figure 1.26.  However, due to the small quantity 
produced, it was no possible to purify and fully characterise this compound. 
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Figure 1.26: The proposed structure of the dealkyation product resulting from mutasynthesis 
with undecylprodigiosin analogue 74.  The streptorubin B 75 analogue was not observed 
A plausible mechanism for the dealkylation process is shown in Figure 1.27.  Initial abstraction 
of a hydrogen atom from C-7’ would result in carbon-centred radical 77.  It was hypothesised 
that stabilisation of this radical by the adjacent oxygen atom lone pairs would slow down the 
addition of the radical to the pyrrole.  Instead, hydroxylation occurs resulting in unstable 
hemiacetal 78, which collapses to eliminate n-pentanal resulting in dealkylated product 76.  
Attempts to detect n-pentanal as a by-product of this reaction failed, presumably due to its 
high volatility. 
Figure 1.27: The proposed mechanism for the formation of dealkylated product 76 
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1.13 Aims and objectives 
The aim of this research project was to investigate the unusual oxidative carbocyclisation 
reaction catalysed by the non-haem iron-dependent Rieske oxygenase-like enzyme RedG.  It 
was envisaged that a mutasynthesis approach could be employed involving feeding of 
chemically synthesised analogues of 2-UP 20, bearing specific functional groups designed to 
probe various aspects of the proposed RedG catalytic cycle, to mutants of S. coelicolor blocked 
in the biosynthesis of 2-UP 20, Figure 1.28. 
Figure 1.28: A schematic representation of the mutasynthesis strategy envisaged for 
investigating the oxidative carbocyclisation reaction catalysed by RedG 
The resulting undecylprodigiosin and/or streptorubin B analogues would be extracted from 
the mutant strains and analysed using a variety of techniques including HR-LCMS and NMR 
spectroscopy. 
 
 
 
35 
 
 
 
 
 
2. Results and discussion: Synthesis of 4-methoxy-2,2’-
bipyrrole-5-carboxaldehyde, 2-undecylpyrrole and analogues 
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As discussed in Section 1.9, there are several interesting aspects of the proposed RedG 
catalytic cycle that could be probed using synthetic 2-UP analogues.  These probes could be 
used to answer specific questions about the proposed catalytic cycle, e.g. does RedG utilise 
molecular oxygen, does RedG generate a carbon-centred radical or a carbocation, what is the 
stereochemical course of the RedG-catalysed reaction? 
Before these analogues were synthesised, it was necessary to develop an efficient synthetic 
route to both late stage intermediates in the biosynthetic pathway, namely MBC 19 and 
2-UP 20.  These synthetic intermediates would be required as positive controls in feeding 
experiments to ensure synthetic analogues can penetrate bacterial cells.  In addition, it was 
desired that the synthetic route for 2-UP 20 was tolerant of a variety of functional groups to 
aid in the synthesis of the desired mechanistic probes. 
2.1 Synthesis of 4-methoxy-2,2’-bipyrrole-5-carboxaldehyde 
(MBC, 19) 
Stuart Haynes, a previous PhD student in the Challis group, utilised a synthetic route originally 
reported in a patent relating to the synthesis of Obatoclax 10 for the synthesis of MBC 19, 
Scheme 2.1.49 More recently, this route has also been used in a number of papers detailing 
the total synthesis of several members of the prodiginine family.11,50,51 
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Scheme 2.1: The synthetic route to MBC 19 utilizing a palladium catalysed cross coupling to 
install the biaryl bond; a. n-BuLi, 2,2,6,6-Tetramethylpiperidine, B(OMe)3,THF, -78 
oC, 54%; 
b. POBr3, Et2NCHO, CH2Cl2, 40 
oC, 73%; c. i. Pd(OAc)2, PPh3, Na2CO3 ii. NaOMe, iii. HCl, 76% 
The first step in the synthesis of MBC 19 involved the conversion of N-Boc-pyrrole 79 to 
N-Boc-pyrrole-2-boronic acid 30 via regiospecific lithiation at the 2-position using lithium 
2,2,6,6-tetramethylpiperidide, Scheme 2.2.52  The presence of the t-butyloxycarbonyl group is 
essential to achieve regioselectivity for a number of reasons.  Firstly, the electron-withdrawing 
properties of the t-butyloxycarbonyl group increases the acidity of the hydrogen atoms α to 
the pyrrole nitrogen atom, allowing efficient deprotonation.  Secondly, the t-butyloxycarbonyl 
group ensures the regiospecific lithiation by co-ordination of the carbonyl oxygen atom with 
the lithium ion.53 This directing effect has been observed in a variety of aromatic systems 
containing a variety of different directing groups.   
Scheme 2.2: The synthesis of N-Boc-pyrrol-2-boronic acid 30 via a directed lithiation using 
lithium 2,2,6,6-tetramethylpiperidide 
Haloformylation of commercially available 4-methoxy-3-pyrrolin-2-one 27 with two 
equivalents of the Vilsmeier-Haack salt, generated in situ from diethylformamide and 
phosphorus(V) oxybromide, yielded the desired bromo-enamine in 73% yield.  This reaction 
involves several separate steps, Scheme 2.3.  After initial formation of the Vilsmeier-Haack 
salt, nucleophilic attack by the electron rich oxygen atom of the amide occurs, followed by 
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several addition-elimination and tautomerisation steps to provide 2-bromo-4-
methoxypyrrole 81.  This electron rich aromatic ring can then react with another equivalent of 
Vilsmeier-Haack salt to provide the desired bromo-enamine 80.  It is important to ensure that 
the product is not exposed to aqueous acidic conditions because this would lead to rapid 
hydrolysis of the enamine, resulting in formation of the corresponding aldehyde. 
Scheme 2.3: The mechanism of the Vilsmeier-Haack reaction initially forming 2-bromo-4-
methoxypyrrole 81 and subsequent formylation to yield the desired bromo-enamine 80 
The final step in the synthesis of MBC 19 was the palladium-catalysed Suzuki coupling 
between the boronic acid 30 and bromo-enamine 80.  Reduction of palladium(II) acetate 
in situ by heating with triphenylphosphine under anaerobic conditions provided the active 
palladium(0) species required for the coupling reaction.  Methanolysis of the 
t-butyloxycarbonyl group and hydrolysis of the enamine was achieved during the work up to 
give MBC 19 as a precipitate.  Washing of this insoluble product with cold acetone removed 
residual palladium and triphenylphosphine impurities. 
 2.2 Synthesis of 2-undecylpyrrole (2-UP, 20) 
A route devised by Stuart Haynes in which undecanoic acid 82 is activated as the 
pyridylthioester 83 and is subsequently treated with pyrrylmagnesium bromide to provide the 
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2-ketopyrrole 84 was utilised for the synthesis of 2-UP 20.54,55,56  Reduction of the resulting 
ketone to the corresponding methylene would then yield 2-UP 20, Scheme 2.4. 
Scheme 2.4: The synthetic route to 2-UP 20; a. (PyS)2, PPh3, toluene, 25 
oC; b. EtMgBr, pyrrole, 
toluene, -78 oC, 83%; c. NaBH4, IPA, 85 
oC, 83% 
Thus, undecanoic acid 82 was activated as the pyridylthioester 83 by treatment with 
2,2’-dipyridyldisulphide and triphenylphosphine.  This pyridylthioester 83 was then converted 
to the 2-ketopyrrole 84 by reaction with pyrrylmagnesium bromide, generated in situ from 
freshly distilled pyrrole and ethylmagnesium bromide.  It was necessary to distil the pyrrole 
immediately prior to use to remove polymeric pyrrole-derived impurities, in addition to 
removing any water present, which would quench the ethylmagnesium bromide during the 
reaction.  Subsequent reduction of the ketone using excess sodium borohydride in refluxing 
reagent grade isopropanol provided 2-UP 20 in excellent yield of 83%. 
This relatively simple method 2-UP 20 synthesis was shown by Stuart Haynes to be useful for 
the synthesis of a range of 2-UP analogues.  It was therefore envisaged that this chemistry 
could be utilised to synthesise the desired mechanistic probes.   
It should be noted that alkyl pyrroles are unstable, especially under acidic conditions and 
often degrade when allowed to stand for protracted periods of time.  Typically, after 
purification, 2-UP 20 was a white waxy solid.  However, after a week stored at 4 oC, the white 
solid began to turn brown and additional signals appeared in the 1H-NMR spectrum.  As a 
result, compounds were stored as the 2-ketopyrrole until required because the carbonyl 
group withdraws electron density from the pyrrole and thus prevents polymerisation.  Indeed, 
2-ketopyrrole 84 can be stored at 4 oC for several months without apparent degradation. 
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In order for the final reduction of the ketone to proceed efficiently, it was essential that the 
sodium borohydride was refluxed in reagent grade isopropanol prior to the addition of the 
2-ketopyrrole.  If the reduction was performed in dry isopropanol, or below reflux 
temperature, substantial amounts of pyrrole and 1-undecanol by products were generated.  
These presumably arise via a retro-aldol type reaction, involving the elimination of pyrrole to 
give undecanal which in the presence of excess sodium borohydride, is further reduced to the 
corresponding alcohol, Scheme 2.5. 
Scheme 2.5: The two competing pathways observed for final reduction of 2-ketopyrrole, 
illustrating the desired product and the undesired retro-aldol cleavage products and 
subsequent reduction 
Protonation of the pyrrole appears to be required for the retro-aldol side reaction to occur.  
However, trace amounts of water present in the reagent grade isopropanol, would react with 
the sodium borohydride to produce sodium hydroxide in addition to sodium isopropoxide 
resulting from the reaction between the isopropanol and sodium borohydride. This increase in 
basicity would prevent the initial protonation required for the undesired reto-aldol side 
reaction to occur. 
 2.3 Synthesis of ether containing 2-UP analogues 
Previous work by Stuart Haynes, as discussed in Section 1.12, indicated that RedG is not only 
capable of catalysing an oxidative carbocyclisation, but also a dealkylation reaction.  However, 
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due to the small quantity produced, it was not possible to purify and fully characterise this 
compound.  In order to further investigate this process, the 2-UP analogue 85 was 
resynthesised, in addition to an authentic standard of the putative dealkylation product 76, 
Scheme 2.6.  
This dealkyation process is proposed to occur via the formation of an unstable hemiacetal 
which, under acidic conditions, collapses with loss of n-pentanal, which is not detected due to 
its high volatility Scheme 1.27.  It was therefore decided to synthesise an additional ether 
analogue with an oxygen atom replacing C-8’ 86.  In this case, collapse of the hemiacetal 
formed by hydroxylation at C-7’ would yield propanol and the corresponding aldehyde 
undecylprodigiosin analogue 88, Scheme 2.6. 
Scheme 2.6: The undecylprodigiosin analogue 74 and dealkylated product 76 expected to 
result from feeding 2-UP analogue 85 to the redL mutant and the undecylprodigiosin 
analogue 87 and dealkylated product 88 predicted to result from feeding 2-UP analogue 86 to 
the redL mutant 
 2.3.1 2-(5-Pentoxypentyl)-pyrrole 85 
Initial attempts to resynthesise 2-UP analogue 85 followed the route developed by 
Stuart Haynes, Scheme 2.7.   This route utilised the Williamson ether synthesis in which 
sodium n-pentoxide is generated in situ and alkylated with ethyl 5-bromopentanoate 89.  
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Hydrolysis of the ethyl ester would generate the desired carboxylic acid 90, which could then 
be converted to 2-UP analogue 85 via the route already outlined for the synthesis of 2-UP 20. 
Scheme 2.7: Stuart Haynes’ synthetic route to 2-UP analogue 85; a. CH3(CH2)4OH, NaH, THF, 
<10% desired product; b. NaOH, THF:Water, 75 oC; c. (PyS)2, PPh3, toluene, 25 
oC then EtMgBr, 
pyrrole, toluene, -78 oC; d. NaBH4, IPA, 85 
oC 
In practice, the yield of the initial alkylation reaction was very poor and resulted in a complex 
mixture of products.  The undesired side products arose from a competing transesterifcation 
process, in which the sodium n-pentoxide attacks the carbonyl group of the ester resulting in 
the displacement of ethoxide.  As a result, a mixture of ethoxide and pentoxide alkylation 
products was formed.  Consequently, an alternative route was devised that avoids this 
problematic alkyation reaction, Scheme 2.8. 
Scheme 2.8: The alternative synthetic route to 2-UP analogue 85; a. NaH, t-BDMSCl, THF, 70%; 
b. NaH, 1-bromopentane, DMF, 80%; c. TBAF, THF, 0 oC, 97%; d. IBX, DMSO, 25 oC, 80%; 
e. Oxone, DMF, 25 oC, 88%; f. (PyS)2, PPh3, toluene, 25 
oC then EtMgBr, pyrrole, toluene, 
-78 oC, 40%; g. NaBH4, IPA, 85 
oC, 85% 
The first step in this new synthetic route to 85 was the monosilylation of 1,5-pentanediol 92 
with t-butyldimethylsilyl chloride.  Typically, monoprotection of symmetrical diols is very 
difficult and usually results in a statistical distribution of the unprotected, mono- and 
diprotected products.  However, work by McDougal et al showed that the yield of the desired 
monoprotected product could be improved if the monosodium salt is initially formed using 
one equivalent of sodium hydride, prior to the addition of the silylating reagent.57 Since the 
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monosodium salt of the diol is insoluble in THF and precipitates out of solution, it is proposed 
that this prevents deprotonation of the alkoxide, which would lead to the diprotected species, 
from occurring.  Upon addition of the silylating reagent, the small amount of monosodium salt 
in solution reacts, thus drawing some of the precipitate into solution.  Using this procedure, a 
70% yield of the monoprotected diol was obtained.  
Alkylation of the alkoxide derived from the monoprotected alcohol with 1-bromopentane 
provided the protected ether 93.  Removal of the silyl protecting group with 
tetrabutylammonium fluoride afforded the corresponding alcohol.  
Oxidation of this alcohol would provide the desired carboxylic acid 90 that could be used to 
complete the synthesis of 2-UP analogue 85.   Methods for oxidation of alcohols directly to 
carboxylic acids, for example the Jones oxidation, typically require the use of harsh reaction 
conditions, in addition to extensive purification procedures to isolate the pure carboxylic acid.  
While it is possible to purify carboxylic acids using a variety of techniques, including 
recrystalisation, flash column chromatography and HPLC, these can often prove problematic.  
Due to the length of the chain in carboxylic acid 90, it was expected that it would be an oil and 
that recystallisation would therefore not be applicable.  While it is possible to purify carboxylic 
acids using silica flash chromatography, the procedure is often complicated by the fact that 
the acid ‘streaks’, becoming very diffuse and difficult to detect in the fractions leading to a 
reduced yield.  While reverse-phase HPLC could be used to purify the carboxylic acid 90, this is 
often a laborious and time consuming procedure and was thus avoided. 
To circumvent such potential problems, an alternative method for oxidising the alcohol to the 
carboxylic acid was required.  A search of the literature revealed a method for oxidising 
aldehydes to the corresponding carboxylic acids using Oxone (potassium 
peroxymonosulphate).58 One advantage of this method is that a simple aqueous workup 
provides the pure carboxylic acid.  It is proposed that this reaction proceeds via a Baeyer-
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Villiger type mechanism in which a peroxyacetal 94 is formed, which undergoes 
rearrangement resulting in the elimination of sulphate, Scheme 2.9.59 
Scheme 2.9: The proposed mechanism for the oxidation of an aldehyde to the corresponding 
carboxylic acid using Oxone 
Thus, a suitable method for oxidising the alcohol to the corresponding aldehyde was required.  
Several methods are available, including the Swern oxidation and the use of hypervalent 
iodine reagents such as 2-iodoxybenzoic acid (IBX).60,61,62  Treatment of the alcohol with IBX 
followed by oxidation of the aldehyde with Oxone provided the desired carboxylic acid 90 in a 
yield of 71% over two steps.  Through subsequent work it was discovered that, provided the 
starting aldehyde was clean, the Oxone oxidation yielded the pure carboxylic acid.  The 
synthesis of 2-UP analogue 85 was completed by coupling of carboxylic acid 90 with pyrrole 
and reduction of the resulting 2-ketopyrrole as described previously.   
 2.3.2 2-(7-Propoxyheptyl)-pyrrole 86 
The synthetic route to 2-UP analogue 86 is shown in Scheme 2.10.  It is analogous to the route 
used for the synthesis of 2-UP analogue 85. 
Scheme 2.10: The synthetic route to 2-UP analogue 86; a. NaH, t-BDMSCl, THF, 45%; b. NaH, 
1-bromopropane, DMF, 84%; c. TBAF, THF, 0 oC, 93%; d. IBX, DMSO, 25 oC, 67%; e. Oxone, 
DMF, 25 oC, 94%; f. (PyS)2, PPh3, toluene, 25 
oC then EtMgBr, pyrrole, toluene, -78 oC, 40%; 
g. NaBH4, IPA, 85 
oC, 85% 
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An interesting point to note is the difference in yields for the initial monosilyation reaction.  In 
the case of 1,5-pentandiol 92 a yield of 70% was achieved.  However, when 1,7-heptandiol 95 
was used, the yield was only 45%. This is proposed to be due to the decreased polarity of the 
monosodium salt of 1,7-heptandiol, resulting from the increased alkyl chain length.  As a 
result, a greater proportion remains in solution than the monosodium salt of 1,4-pentandiol.  
This allows more double deprotonation to occur, leading to more of the diprotected product. 
Alkylation of the resulting primary alcohol with bromopropane provided the desired silyl 
protected ether 96 in 84% yield.  Subsequent deprotection, oxidation to carboxylic acid 97, 
coupling with pyrrole and reduction provided the desired 2-UP analogue 86. 
 2.4 Synthesis of sulphur containing 2-UP analogues 
It is proposed that RedG belongs to the non-haem iron-dependent oxygenase family of 
enzymes, more specifically the Rieske subfamily, which utilize molecular oxygen as the 
oxidant.  To probe whether RedG utilises molecular oxygen as an oxidant, it was decided to 
synthesise a 2-UP analogue with a sulphur atom at C-7’.  A sulphur atom placed at the site of 
C-H functionalisation would be expected to intercept the proposed iron(V)-oxo-hydroxy.  This 
would be expected to result in formation of the corresponding sulphoxide.  Indeed, it is 
known that sulphides react with metal-oxo species because such complexes have been 
utilized in the asymmetric oxidation of sulphides.  For example, Fujita et al demonstrated that 
methyl phenyl sulphide 98 can be enantioselectively oxidised to a sulphoxide using 
oxovanadium(IV) complex 99 in the presence of hydrogen peroxide, Figure 2.1.63 
46 
 
Figure 2.1: The use of a metal-oxo species capable of enantioselective oxidation of sulphides 
to the corresponding sulphoxides 
The use of sulphides to trap reactive oxidants has been used to probe other non-haem iron-
dependent enzymes.  For example, Burzlaff et al utilised a sulphide analogue of δ-(L-α-
aminoadipoyl)-L-cysteinyl-D-valine (ACV, 100) to probe the mechanism of isopenicillin N 
synthase (IPNS), which is responsible for the formation of the β-lactam and thiazolidine rings 
of the penicillins, Figure 2.2.64 
Figure 2.2: The reaction catalysed by the non-haem iron-dependent enzyme IPNS, resulting in 
the formation of the β-lactam and thiazolidine rings of the penicillins 
To resolve the question of which of the two rings was formed first, they utilized X-ray 
crystallography and an analogue of ACV in which the D-valine residue is replaced with D-S-
methyl-cysteine, B in Figure 2.3.  They were able to demonstrate that the reaction proceeds 
with initial formation of the β-lactam, which gives rise to an iron-(IV)-oxo species that was 
trapped by reaction with the sulphide in the ACV analogue for form the corresponding 
sulphoxide, B in Figure 2.3.  While they were unable to observe the iron(IV)-oxo species 
directly, but they were able to observe the sulphoxide product bound to the enzyme’s active 
site using X-ray crystallography. 
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Figure 2.3: A. The proposed mechanisms for β-lactam and thiazolidine formation catalysed by 
IPNS; B. The proposed mechanism for the formation of the β-lactam formed in the active site 
of IPNS upon incubation with a sulphide containing analogue of ACV 
It was therefore hypothesised that feeding a sulphide containing 2-UP analogue 101 to a 
mutant of S. coelicolor blocked in 2-UP biosynthesis would result in the formation of the 
corresponding undecylprodigiosin analogue 102, which could trap the reactive oxidant formed 
by RedG to produce the corresponding sulphoxide 103, Scheme 2.11.  
Scheme 2.11: The expected undecylprodigiosin analogues 102 and 103 expected to result 
from the feeding of 2-UP analogue 101 to a mutant of S. coelicolor blocked in the biosynthesis 
of 2-UP 20 
 2.4.1 2-(6-Butylsulphanylhexyl)-pyrrole 101 
Sulphides are typically synthesised via the displacement of halides by thiolates.11  Alkylation of 
lithium n-butylthiolate, generated in situ by treatment of n-butanthiol with n-butyllithium, 
with ethyl 6-bromohexanoate 104 followed by ester hydrolysis, generated carboxylic acid 105 
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in high yields, Scheme 2.12.  Carboxylic acid 105 was converted to 2-UP analogue 101 using 
the methodology described for the synthesis of 2-UP 20.     
Scheme 2.12: The synthetic route to 2-UP analogue 101; a. CH3(CH2)3SH, n-BuLi, THF, 0 
oC, 
98%; b. NaOH, THF:Water, 75 oC, 96%; c. i. (PyS)2, PPh3, toluene, 25 
oC ii. EtMgBr, pyrrole, 
toluene, -78 oC, 81%; d. NaBH4, IPA, 85 
oC, 71% 
During the synthesis of 101, it was noticed that storage of the sulphide-containing 
intermediates in air resulted in partial oxidation to the corresponding sulphoxides.  To prevent 
this unwanted oxidation process, all intermediates were stored under an inert atmosphere of 
argon.  However, even with these measures in place, small amounts of the corresponding 
sulphoxide could be detected in the mass spectrum of the final 2-UP analogue 101.  As a 
result, purification by column chromatography was performed immediately before the 
feeding experiments to remove the sulphoxide. 
 2.5 Synthesis of cyclopropane containing 2-UP analogues 
As discussed in Section 1.9, it is proposed that the RedG-catalysed reaction involves 
abstraction of a hydrogen atom from C-7’ of undecylprodigiosin 4 to generate a carbon-
centred radical.  This radical is then proposed to attack the pyrrole resulting in the formation 
of the 10-membered carbocycle present in streptorubin B 6, after rearomatisation via 
abstraction of a second hydrogen atom. 
Probes that undergo a characteristic skeletal rearrangement upon formation of a radical have 
been widely used to investigate the involvement of radical intermediates in a range of 
enzymatic and non-enzymatic reactions.  One such species that undergoes such a skeletal 
rearrangement is the cyclopropylcarbinyl radical.  Thus, cyclopropane-containing mechanistic 
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probes are commonly used to detect radical intermediates.  Depending on the ratio of 
unrearranged to rearranged products obtained using such probes, an estimate of the radical 
lifetime can be obtained.65 
The rearrangement of cyclopropylcarbinyl radicals has been used extensively in organic   
synthesis.  One example, reported recently by Danishefsky et al in the total synthesis of the 
natural product spirotenuipesines A and B, is the synthesis of dienophile 107, Scheme 2.13.66  
Cyclopropane 108 was converted to the [3.2.1]bicyclolactone 107 by a skeletal rearrangement  
of radical 110 generated from the corresponding xanthate 109. 
Scheme 2.13: The synthetic route to dienophile 107 used by Danishefsky et al. The 
cyclopropane is highlighted in red.  Only half of the curly arrows are shown for clarity 
In addition to their use in organic synthesis, cyclopropanes have been used in a number of 
enzyme mechanism studies.  While studying the enzyme α-methyleneglutarate mutase, a 
coenzyme-B12 dependent enzyme, Golding et al investigated a model cobalt complex 
chloro(pyridine)cobaloxime 111 as an enzyme mimic.  Using 111 and the cyclopropane 
containing substrate 112, they aimed to investigate whether the cobalt atom remained 
attached to the substrate throughout the rearrangement, or whether a discreet carbon-
centred radical was formed, Scheme 2.14.67  They were able to demonstrate that the only 
observable product was 115 that resulting from rearrangement of cyclopropylcarbinyl 
radical 114. 
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Scheme 2.14: The cobalt complex and cyclopropane substrate used by Golding et al to study 
the mechanism of α-methyleneglutarate mutase.  The cyclopropane is highlighted in red 
More recently, work conducted by Lipscomb et al on naphthalene dioxygenase (NDO), a 
Rieske oxygenase showing sequence similarity to RedG, used norcarane 116 and 
bicyclohexane 117 as mechanistic probes.68  In each case, substantial amounts of products 
resulting from rearrangement of a cyclopropylcarbinyl radical were observed, Figure 2.4.   
Figure 2.4: Products obtained from incubation of cyclopropane containing probes for radical 
intermediates with naphthalene dioxygenase 
Thus, we decided to investigate feeding of cyclopropane containing 2-UP analogues E-and 
Z-118 to a mutant of S. coelicolor blocked in the biosynthesis of 2-UP 20.  These would be 
expected to be converted to the corresponding undecylprodigiosin analogues E-and Z-119 via 
the action of RedH, Scheme 2.15.  Subsequent hydrogen atom abstraction at C-7’ by RedG 
should trigger a skeletal rearrangement of the resulting cyclopropylcarbinyl radicals to one of 
the homoallylic radicals 120 or 121.  The fate of these homoallylic radicals is difficult to predict 
but in principal, they could undergo hydroxylation, desaturation of carbocyclisation. 
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Scheme 2.15: The two potential homoallylic radicals 120 and 121 expected to result from the 
feeding of E-and/or Z-118 to a mutant of S. coelicolor blocked in 2-UP biosynthesis 
Cyclopropanes are commonly prepared from the corresponding alkene using the Simmons-
Smith reaction.69 This involves the treatment of an alkene with an organozinc carbenoid 
generated in situ from diethylzinc and diiodomethane.  Since the carbenoid is delivered to 
both carbon atoms of the alkene simultaneously, the stereochemistry of the starting alkene is 
preserved.70 Thus, the cis- and trans-cyclopropane-containing 2-UP analogues E-and Z-118 can 
be obtained from the corresponding cis- and trans-alkenes.  A synthetic route to both alkene 
isomers was therefore devised, Scheme 2.16. 
Scheme 2.16: The synthetic route to Z- and E-118; a. Ethylene diamine, NaH, 60 oC, 67%; 
b. TBDMSCl, Imadazole, CH2Cl2, 94%; c. n-BuLi, EtI, DMPU, -40 
oC to RT, 88%; d. H2, Lindlar’s 
catalyst, quinoline, THF, 98%; e. Na, NH3 (l), -78 
oC, 89%; f. ZnEt2, CH2I2, CH2Cl2, used in next 
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step without purification; g. TBAF, THF, 0 oC to RT, Z 89%, E 58%; h. IBX, DMSO, 25 oC, Z 87%, 
E 70%; i. Oxone, DMF, 25 oC, Z 91%, E 95%; j. i. (PyS)2, PPh3, toluene, 25
oC ii. EtMgBr, pyrrole, 
toluene, -78 oC, Z 69%, E 44%; k. NaBH4, IPA, 85 
oC, Z 60%, E 65% 
The first step in the synthesis of the two cyclopropanes analogues Z- and E-118 involves the 
isomerisation of commercially available 3-nonyn-1-ol 122 to the terminal alkyne isomer 123 in 
a 67% yield, utilising the ‘alkyne zipper’ reaction.71 The proposed mechanism for this 
isomerisation reaction is shown in Scheme 2.17.   
Scheme 2.17: The proposed mechanism of the ‘alkyne zipper’ reaction 
The monoanion of ethylene diamine deprotonates the methylene adjacent to the alkyne, with 
protonation of the alkyne itself, resulting in the formation of allene 130.  Deprotonation of the 
allene 130 concomitant with protonation regenerates an alkyne 131 that has migrated one 
carbon along the chain.  This reaction is unusual because it converts the more stable internal 
alkyne to the less stable terminal alkyne.  Presumably, reversible alkyne migration occurs 
continuously until the terminal alkyne is formed, at which point, under the highly basic 
conditions, it is deprotonated, trapping it as the acetylide anion.  It should be noted that no 
intermediate allene or internal alkyne products were observed.  Protection of the hydroxyl 
group in 123 with a t-butyldimethylsilyl group followed by alkylation of the terminal alkyne 
with iodoethane generated the desired alkyne 124 in excellent yield.   
With silyl protected alkyne 124 in hand, a divergent synthetic route to the cis- and trans-125 
was envisaged.  Stereoselective reduction of alkyne 124 would provide the required cis- and 
trans-alkenes required for the Simmons-Smith cyclopropanation.  It is well known in organic 
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chemistry that treatment of an alkyne with sodium dissolved in liquid ammonia will provide 
the corresponding trans-alkene, whereas hydrogenation of an alkyne over Lindlar’s catalyst 
affords the corresponding cis-alkene.72  Thus, alkyne 124 was converted to Z- and E-125 in 
excellent yields of 98% and 89% respectively. 
During the formation of cis-125, it was discovered that commercial Lindlar’s catalyst was too 
active and substantial over-reduction to the corresponding alkane was observed.  In order to 
prevent this, the catalyst was further deactivated by addition of quinoline.  Lόpez et al have, 
on the basis of DFT calculations, hypothesised that quinoline absorbs to the surface of the 
catalyst blocking some hydrogen and alkyne binding sites.73 This, in addition to the effect of 
the lead poisoning, which disfavours alkene binding, improves the product selectivity of the 
catalyst.  Indeed, when quinoline was added to the reaction, no over-reduction to the 
corresponding alkane was observed. It was not possible to unambiguously confirm the 
stereochemistry of the products of the reduction reactions employing Lindlar’s catalyst and 
sodium in liquid ammonia due to signal overlap in the 1H-NMR spectra, even at 700 MHz.  
However, GC-MS analysis indicated they are stereoisomers due to a small difference in their 
retention times. 
Cyclopropanation of the alkenes was achieved by reaction with the organozinc carbenoid 
generated in situ from diethylzinc and diiodomethane.  The product of these reactions were 
difficult to visualise on TLC plates and so the reactions were monitored using GC-MS.  Thus, 
once the reaction had gone to completion, sodium hydroxide was cautiously added to quench 
them and precipitate the zinc-containing by-products, which could be easily removed via 
filtration.  The t-butyldimethylsilyl groups were removed directly from the crude products 
using tetrabutylammonium fluoride, yielding E- and Z-126 in yields of 58% and 89%, 
respectively, over the two steps.   
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Comparison of the 1H-NMR of E- and Z-126 revealed some subtle differences, Figure 2.5.  In 
the case of E-126 (top spectra in Figure 2.5) the multiplet at 0.08 ppm corresponds to H-9, the 
two diastereotopic methylene protons of the cyclopropane.  However, in the case of Z-126 
(bottom spectra in Figure 2.5) the two multiplets at 0.52 ppm and -0.38 ppm correspond to 
the two diastereotopic methylene protons of the cyclopropane.  In addition, singals for the 
two terminal methyl groups have substantially different chemical shifts; 0.87 ppm in the case 
of E-126 and 0.98 ppm in Z-126.   
 Figure 2.5: A comparison of the 1H-NMR spectrum in CDCl3 at 700 MHz of E-126 (top 
spectrum) and Z-126 (bottom spectrum).  The two singlets present in the bottom spectra at 
0.92 ppm and 0.10 ppm are due to residual t-butyldimethyl silyl fluoride impurities 
This significant difference in the 1H-NMR spectrum can be explained by the stereochemistry of 
the cyclopropane, Figure 2.6.  In the case of E-126, the diastereotopic methylene protons 
(highlighted in green) are each syn to one alkyl chain and one proton, as highlighted by the 
red and blue arrows.  Thus, they occupy similar chemical environments and their resonances 
therefore have similar chemical shifts in the 1H-NMR spectrum.  However, in the case of 
Z-126, the diastereotopic methylene protons of the cyclopropyl (highlighted in green) occupy 
very different chemical environments.  One of these protons is syn to two alkyl groups, 
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indicated by the red arrows, whereas the other proton is syn to two protons, indicated by the 
blue arrows.  As a result, the resonances due to these two diastereotopic protons have 
significantly different chemical shifts.  These significant differences in the 1H-NMR spectrum of 
E-and Z-126 are consistent with the expected stereochemical outcomes of the alkyne 
reduction reactions. 
Figure 2.6: Stereochemical relationships of diastereotopic methylene protons (highlighted in 
green) with cyclopropane substituents, illustrating why the two sets of diastereotopic protons, 
give rise to significantly different 1H-NMR signals 
With primary alcohols E- and Z-126 in hand, the synthesis of the 2-UP analogues E- and Z-118 
could be completed.  Oxidation of the primary alcohols to the corresponding carboxylic acids, 
via the aldehydes, using the chemistry previously outlined for the synthesis of 2-UP analogue 
85 provided E- and Z-127 in good yields.  Coupling of the carboxylic acids E- and Z-127 with 
pyrrole and reduction of the resulting 2-ketopyrroles using the methodology described for the 
synthesis of 2-UP 20, afforded 2-UP analogues E- and Z-118. 
 2.6 Attempted synthesis of fluorine containing 2-UP analogues 
As discussed in Section 1.9, the proposed RedG catalytic mechanism involves the formation of 
a carbon-centred radical at C-7’ which attacks the pyrrole to form the carbocycle.  However, 
an alternative mechanism involves formation of a carbocation at C-7’ which the pyrrole ring 
then nucleophilically attacks resulting in the macrocycle.  To probe this, it was decided to 
synthesise 2-UP analogues with one or two fluorine atoms adjacent to C-7’.  Due to its high 
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electronegativity, fluorine should destabilise formation of a carbocation and slow its rate of 
formation.   
A similar approach has been used previously by Liu et al when studying the mechanism of 
UDP-galactopyranose mutase (UDP-Galp mutase), an enzyme present in several bacteria 
responsible for the isomerisation of UDP-galactopyranose 132 to UDP-galactofuranose 135.  
One proposed mechanism for this isomerisation involves the formation of oxocarbenium 
intermediate 134, Scheme 2.18.  To probe this possibility, the kinetics of the reactions using 
132 and two fluorinated analogues, [2-F]-136 and [3-F]-137, as substrates was were 
compared, demonstrating that the rate constant for both fluorinated analogues was 
significantly smaller than for the natural substrate (kcat for natural substrate 132 = 27s
-1, kcat 
for [2-F]-136 = 0.033s-1 and kcat for [3-F]-137 = 5.7s
-1).  This dramatic rate reduction was 
attributed to the electron withdrawing properties of the fluoro substituents, which destabilise 
the proposed oxocarbenium intermediate 134. 
Scheme 2.18: The proposed mechanism for the isomerisation of 132 to 135 catalysed by 
UDP-galp mutase and the two fluorinated substrate analogues used to probe the mechanism 
It was therefore hypothesised that feeding of 2-UP analogues 138 and 139 with one or two 
fluorine atoms at C-8’ to a mutant of S. coelicolor blocked in the biosynthesis of 2-UP 20 would 
result in the formation of the corresponding undecylprodigiosin analogues 140 and 141 via 
the action of RedH, but that little or none of the corresponding streptorubin B analogues 142 
or 143 would be formed, Scheme 2.19.  
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Scheme 2.19: The undecylprodigiosin analogues 140 and 141 expected to result from feeding 
of 2-UP analogue 138 and 139 to a mutant of S. coelicolor blocked in the biosynthesis of 2-UP.  
Little or none of the corresponding streptorubin B analogues would be expected to be formed 
if the RedG-catalysed oxidative carbocyclisation reaction proceeds via a C-7’ carbocation 
intermediate 
Deoxy-fluorination is commonly employed for the incorporation of fluorine atoms into organic 
molecules.  Such reactions typically activate an alcohol or carbonyl compound towards 
nucleophilic attack by fluoride, resulting in the replacement of the hydroxyl group / oxygen 
atom with one or two fluorine atoms, generating mono-fluoro or gem-difluoro products, 
respectively.  One commercially-available deoxy-fluorination reagent is diethylaminosulphur 
tetrafluoride (DAST) 144.  The generally-accepted mechanism for the fluorination of alcohols 
and carbonyl compounds by DAST 144 is shown in Scheme 2.20.74 In the case of an alcohol, 
the initial nucleophilic displacement of a fluoride ion from DAST 144 by the hydroxyl group 
results in the alkyloxyaminosulphur difluoride intermediate 145.  Elimination of a second 
fluoride ion from this intermediate, followed by nucleophilic attack of fluoride on the 
activated carbon atom generates the monofluorinated product 147.  The mechanism for 
gem-difluorination of a carbonyl group is similar, Scheme 2.20. 
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Scheme 2.20: The generally-accepted mechanisms for the fluorination of alcohols and 
carbonyl compounds using DAST 144 
A synthetic route to 1-benzyloxy-8-undecan-ol 151 was designed that could to provide access 
to mono-fluorinated 2-UP analogue 138 and 1-benzyloxy-2-undecananone 152 to provide 
access to the gem-difluorinated 2-UP analogue 139, Scheme 2.21. 
Scheme 2.21: The proposed synthetic route to mono-fluorinated and di-fluorinated 2-UP 
analogues 138 and 139; a. Ag2O, BnBr, CH2Cl2, 74%; b. (COCl)2, DMSO, Et3N, CH2Cl2, -78 
oC, 
81%; c. n-PrMgBr, THF, -78 oC, 91%; d. DAST, CH2Cl2; e. (COCl)2, DMSO, Et3N, CH2Cl2, -78 
oC, 
82% 
The first step in the synthesis was the mono-protection of 1,8-octandiol 153.  As shown in 
Scheme 2.20, the use of DAST 144 as a fluorination agent results in the formation of fluoride 
ions in situ.  Thus, a silyl protecting group was not suitable.  Monobenzylation was attempted 
using a similar approach to that described in Section 2.3.1 for the selective monosilylation of 
diols.  However, the yield of the monobenzylated product 154 was only 50%; a significant 
amount of the unprotected and dibenzylated products were also formed.  Examination of the 
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literature revealed an alternative method for the monobenzylation of symmetrical diols 
utilising silver(I) oxide.75  Thus, treatment of 1,8-octandiol 153 with benzyl bromide in the 
presence of silver(I) oxide provided the desired monobenzylated alcohol 154 in 74% yield. 
Sauvé et al have proposed that the selectivity of this reaction arises from the co-ordination of 
the diol to the silver(I) ion, which acts as a Lewis acid, Figure 2.7.  As a result, the acidity of the 
diol proton not involved in hydrogen bonding is increased, resulting in selective 
deprotonation, leading to benzylation. 
Figure 2.7: The proposed co-ordination of 1,8-octandiol to the silver(I) ion resulting in 
selective mono-benzylation 
Swern oxidation of the primary alcohol 154 to the corresponding aldehyde 155 followed by 
addition of propylmagnesium bromide afforded secondary alcohol 151 in 74% yield over two 
steps.  It was anticipated that this secondary alcohol could be converted to the corresponding 
mono-fluorinated compound 156 by treatment with DAST 144.  Oxidation of the secondary 
alcohol 151 would yield the corresponding ketone 152, which could then also be converted to 
the corresponding gem-difluoro compound 157 by treatment with DAST 144. 
Initial attempts to convert secondary alcohol 151 and ketone 152 to mono-156 and 
gem-difluorinated 157, respectively, using DAST 144 were unsuccessful.  Only 3% of the 
desired monofluorinated product 156 was isolated along with 15% of a byproduct when 
secondary alcohol 151 was used (75% of the unreacted starting material was recovered).  
Moreover, it proved difficult to separate the monofluorinated product from the byproduct; 
several rounds of flash column chromatography were required.  The 1H-NMR spectrum of the 
byproduct is shown in Figure 2.8.   
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Figure 2.8: The 1H-NMR spectrum in CDCl3 at 300 MHz of the byproduct resulting from the 
attempted fluorination of alcohol 151 
Examination of the 1H-NMR spectrum of this unknown byproduct revealed a signal typical of 
alkene protons at 5.30 ppm.  Thus, it was hypothesised that the byproduct results from a 
competing elimination reaction, in which fluoride ions act as a base, resulting in the formation 
of an alkene 159, Scheme 2.22.  Since the starting material is a secondary alcohol, fluoride 
ions could deprotonate at either C-7 or C-9.  This would give rise to two regioisomeric alkene 
byproducts 159-C7 and 150-C9, respectively, Scheme 2.22.  The observation of two triplets at 
0.87 ppm and 0.79 ppm in the two products is consistent with this hypothesis. 
Scheme 2.22: The mechanism for the nucleophilic displacement of activated alcohol 158 
(pathway a, blue arrows) and the competing fluoride-promoted elimination reactions 
resulting in the formation of alkene side products 159-C7 and 159-C9 (pathway b, red arrows) 
Elimination reactions are a known problem when attempting to use fluoride ion as a 
nucleophile.  Indeed, fluoride can be utilised as a mild base in organic synthesis.76,77  In an 
effort to overcome the problem of the competing elimination reaction, a range of other 
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fluorinating agents were investigated, Figure 2.9.  These included the other commercially 
available aminosulphur trifluorides Morpho-DAST 160 and Deoxo-Fluor 161 in addition to 
XtalFluor-E 162 and XtalFluor-M 163, which were prepared from the corresponding 
aminosulphur trifluorides by treatment with boron trifluoride.78 The results of these 
investigations are summarised in Table 2.1. 
Figure 2.9: Alternative fluorinating agents investigated in attempts to overcome competing 
elimination in the conversion of secondary alcohol 151 to fluoride 156 
Reagent 
Starting material Fluorinated product Elimination product 
151 152 156 157   
144 75% 89% 3% 0% 15% 3% 
160 95% 94% 1% 0% 4% 0% 
161 83% 90% 5% 0% 10% 0% 
162 50% - 2% - 38% - 
163 70% - 6% - 20% - 
Table 2.1: Yields of products isolated from various fluorination reactions  
As can be seen from Table 2.1, none of the alternative methods investigated provided the 
mono- or gem-difluorinated products in acceptable yields.  Thus, an alternative strategy for 
synthesis of the target compounds was investigated.  Kim et al recently reported activation of 
a hydroxyl group as the corresponding triflate followed by displacement of the triflate with 
tetrabutylammonium bifluoride.  Tetrabutylammonium fluoride and tetrabutylammonium 
dihydrogentrifluoride were also screened investigated as fluorinating agents using the triflate 
derivative of alcohol 164, Scheme 2.23. 
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Scheme 2.23: An alternative approach investigated for the synthesis of the corresponding 
triflate and subsequent treatment with a variety of fluoride sources 
The major products in each case resulted from elimination.  Only trace amounts of desired 
fluorinated product was formed.  As a consequence, a new strategy for the synthesis of 
fluorinated 2-UP analogues 138 and 139 was devised. 
 2.6.1 2-(8-Fluoroundecyl)-pyrrole 138 
Examination of the literature indicated that opening of an epoxide with fluoride could be used 
to install the fluorine atom.  For example, Haufe et al used the regioselective ring opening of 
epoxide 165 with Olah’s reagent79 in their synthesis of fluorinated lactone 167, Scheme 2.24.80 
Thus, a synthetic route to epoxide 168 was devised, Scheme 2.25.   
Scheme 2.24: Opening of epoxide 165 with fluoride used by Haufe et al to install a fluorine 
atom in the synthesis of lactone 167 
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Scheme 2.25: Alternative route investigated for the synthesis of fluorinated 2-UP analogue 
138; a. MeLi, Toluene, 0 oC, 98%; b. THF, 85 oC, 57%; c. m-CPBA, CH2Cl2, 0 
oC, 84%; d. Py.xHF, 
CH2Cl2, 0 
oC, 48%; e. TsCl, DMAP, Et3N, CH2Cl2, 59%; f. EtMgBr, CuI, THF, 0 
oC, 
Aldehyde 155, as described in Scheme 2.21, was converted to epoxide 168 via alkene 171 by 
treatment with dimethyltitanocene 17081,82 followed by m-chloroperbenzoic acid.  
Regioselective opening of epoxide 168 using Olah’s reagent afforded fluorinated product 172 
in 40% yield.  Large coupling constants for the H-13 and H-14 signals in the 1H-NMR spectrum 
confirmed the presence of a fluorine atom, Figure 2.10. 
Figure 2.10: The 1H-NMR spectrum in CDCl3 at 400 MHz of monofluro alcohol 172 showing the 
large coupling constant for the geminal proton H-13 and adjacent protons H-14 
The displacement of tosylates by alkyl cuprates is well-precedented.83  Thus, fluorinated 
alcohol 172 was converted to the corresponding tosylate 173 and subsequently reacted with 
the cuperate generated in situ from ethylmagnesium bromide and copper(I) iodide.  
13 
14 
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Surprisingly, the sole product of this reaction was alkene 171 resulting from loss of both the 
tosyl and fluoro groups, Figure 2.11.  A possible mechanism for this unexpected reaction is 
shown in Scheme 2.26 involving single electron transfers from the cuprate. 
Figure 2.11: A comparison of the 1H-NMR spectrum in CDCl3 at 400 MHz of alkene 171 
prepared from aldehyde 155 (top spectrum) and the 1H-NMR spectrum in CDCl3 at 250 MHz of 
the product resulting reaction of tosylate 173 with ethylmagnesium bromide and copper(I) 
iodide (bottom spectrum) 
Scheme 2.26: A possible mechanism for the conversion of tosylate 173 to alkene 171 involving 
single electron transfer (SET) reactions 
Due to the lack of success encountered with the synthetic approaches described above, as 
well as several other approaches that are not discussed here, it was decided to abandon the 
synthesis of monofluorinated 2-UP analogue 138 and focus our efforts on the 
gem-difluorinated 2-UP analogue 139 instead. 
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 2.6.2 2-(8, 8-Difluoroundecyl)-pyrrole 139 
Due to the failure of DAST to convert ketone 152 to its gem-difluoro derivative, an alternative 
route was devised for the synthesis of gem-difluorinated 2-UP analogue 139, Scheme 2.27.84   
Scheme 2.27: The new synthetic route to gem-difluorinated intermediate 179; a. TMS-CH2N2, 
20% HBr in acetic acid, CH3CN, 94%; b. DAST, CH2Cl2, 0 
oC, 42%; c. BnBr, NaH, DMF, 65 oC, 85%; 
d. n-BuLi, THF, 65 oC 
Thus, butanoylchloride 174 was converted to the corresponding bromoketone 175 by 
treatment with TMS-diazomethane and hydrobromic acid.85 While it was anticipated that the 
bromide would be the exclusive product, a 3:1 ratio of bromide:chloride was isolated, as 
estimated from the 1H-NMR spectrum, Figure 2.12.   
Figure 2.12: The 1H-NMR spectrum in CDCl3 at 400 MHz showing the ratio of brominated to 
chlorinated 175 
Treatment of the mixture of bromo- and chloro-175 with DAST 144 yielded gem-difluoro 
bromide 176 as the sole product in 42% yield.  Presumably gem-difluoro chloride 176 was lost 
5 Cl 
5 Br 
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during the workup due to its greater volatility.  Examination of the 1H-NMR spectrum of 176 
revealed a triplet at 3.44 ppm with a large coupling constant (J = 13Hz), consistent with a 
methylene group adjacent to a difluor methylene group, Figure 2.13. 
Figure 2.13: The 1H-NMR spectrum in CDCl3 at 400 MHz of gem-difluoro bromide 176 
With gem-difluoro bromide 176 in hand, alkylation of the acetylide resulting from 
deprotonation of alkyne 178 was investigated.  Analysis of the reaction mixture by TLC and 
mass spectrometry after 16 hours stirring at room temperature revealed that no reaction had 
occurred.  The reaction was repeated at 65 oC overnight.  Analysis of the reaction mixture by 
TLC and mass spectrometry indicated that it contained a complex, inseparable mixture of 
compounds.  Due to time constraints, the synthesis of the gem-difluoro 2-UP analogue 139 
was not investigated further. 
 2.7 Synthesis of methyl-branched 2-UP analogues 
Previous work by Stuart Haynes, as discussed in Section 1.12, indicated that RedG catalyses 
the desaturation of a 2-UP analogue bearing a methyl substituent at C-9’.  This desaturation 
reaction was proposed to result from increased steric bulk at C-9’, due to the methyl group, 
which slows down the rate of cyclisation.  To probe the generability of this desaturation 
reaction, a 2-UP analogue bearing a methyl substituent at C-8’ 180 was synthesised.  It was 
hypothesised that a greater proportion of desaturation to carbocyclisation would occur with 
5 
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the C-8’ methylated analogue than the C-9’ methylated analogue due to the increased steric 
bulk in the vicinity of C-7’, Scheme 2.28. 
Scheme 2.28: The undecylprodigiosin analogue 181 and three potential oxidation products 
expected to result from the feeding of 2-UP analogue 180 to a mutant of S. coelicolor blocked 
in the biosynthesis of 2-UP 
It proved necessary to resynthesis 2-UP analogue 185 bearing a methyl substituent at C-9’ 
since the material provided by Stuart Haynes had degraded. 
2.7.1 2-(9-Methylundecyl)-pyrrole 185 
The synthetic route employed by Stuart Haynes for the synthesis of 2-UP analogue 185 is 
shown in Scheme 2.29.  Ethyl 7-bromoheptanoate 186 was converted to the corresponding 
phosphonium salt and used in a Wittig reaction with isovaleraldehyde to yield alkene 187.  
However, he observed a side reaction in which n-BuLi acted as a nucleophile, adding to the 
ester carbonyl group, rather than acting as a base.  This resulted resulting in a mixture of 
products. 
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Scheme 2.29: The synthetic used by Stuart Haynes for the synthesis of 2-UP analogue 185; 
a. i. PPh3, Toluene, 120 
oC ii. n-BuLi, Isovaleraldehyde, THF, -78 oC; b. H2, Pd/C, THF; c. NaOH, 
THF; d. (PyS)2, PPh3, toluene, 25 
oC then EtMgBr, pyrrole, toluene, -78 oC; d. NaBH4, IPA, 85 
oC 
In an attempt to eliminate the side reaction observed by Stuart Haynes, the more sterically 
hindered base LDA was used to generate the ylide.  Unfortunately, this resulted in a complex 
mixture of inseparable products.  Lithium bis(trimethylsilyl)amide was also used, but this also 
resulted in a complex mixture of products.  Thus, an alternative synthetic route was devised, 
Scheme 2.30.   
Scheme 2.30: The alternative synthetic route to 2-UP analogue 185; a. TsCl, DMAP, Et3N, 
CH2Cl2, 85%; b. KI, Acetone, 65 
oC, 100%; c. i. PPh3, Toluene, 120 
oC ii. n-BuLi, Butanone, THF, 
-78 oC, 85%; d. i. Li, naphthalene, THF, 50 oC, ii. H2, Pd/C, THF, 96%; e. IBX, DMSO, 73%; 
f. Oxone, DMF, 99%; g. i. (PyS)2, PPh3, toluene, 25 
oC ii. EtMgBr, pyrrole, toluene, -78 oC, 83%; 
h. NaBH4, IPA, 85 
oC, 66% 
Monobenzyl protected alcohol 154, Scheme 2.21, was converted to the corresponding iodide 
189, via the tosylate, in 85% overall yield. Conversion of iodide 189 to phosphonium salt and 
subsequent Wittig reaction with butanone yielded alkene 190 as an inseparable mixture of 
stereoisomers.  The ratio of stereoisomers was ~2:3, as estimated by 1H-NMR spectroscopy.  
Alkene 190 proved difficult to purify due to co-purification of the triphenylphosphine oxide 
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byproduct, which was eventually removed by repeated silica gel column chromatography and 
precipitation/filtration. 
Subsequent hydogenolysis of the benzyl protecting group with concurrent reduction of the 
alkene should have provided alcohol 191.  However, even after 14 days, only 15% 
debenzylation was observed, although complete reduction of the alkene had occurred.  In an 
attempt to improve the hydrogenolysis rate, a range of solvents, palladium catalysts and 
additives were screened, Table 2.2.  Addition of Amberlyst-15 as an acid catalyst improved the 
conversion rate to 35% after 7 days.  However, this was still not practical and alternative 
methods for debenzylation were sought. 
Solvent Catalysts Additives 
THF 10% Pd/C Silica gel 
Methanol 45% Pd/C Trifluoroacetic acid 
Ethyl acetate Pd(OAc)2 Amberlyst-15 
Hexane - - 
Table 2.2: The range of solvents, catalysts and additives screened in an attempt to improve 
the debenzylation of 190 
Examination of the literature revealed several alternative reagents for the deprotection of 
benzyl ethers, including concentrated hydrobromic acid86, triphenylphosphine 
hydrobromide87, chlorosulfonyl isocyanate-sodium hydroxide88 and lithium naphthalenide.89 
Lithium naphthalenide was selected because it appeared to be the mildest and simplest 
method to implement.  Thus, benzyl protected 190 was treated with lithium naphthalenide 
and subsequent hydrogenation of the alkene provided alcohol 191 in 96% overall yield.  
Oxidation of alcohol 191 to the corresponding carboxylic acid 188, followed by coupling with 
pyrrole and reduction of the resulting 2-ketopyrrole, using the methodology described for the 
synthesis of 2-UP 20, yielded 2-UP analogue 185. 
70 
 
While this synthetic route provided the desired 2-UP analogue 185, there were significant 
issues associated with several steps that required substantial amounts of time and effort to 
resolve.  In addition, the synthesis of monobenzyl protected alcohol 154 requires 
stoichiometric amounts of expensive silver(I) oxide.  Thus, an alternative synthetic route was 
developed in parallel that avoided the problematic steps and required less expensive 
reagents, Scheme 2.31. 
Scheme 2.31: The second generation synthetic route to 2-UP analogue 185; a. TsCl, DMAP, 
Et3N, CH2Cl2, 90%; b. KI, Acetone, 60 
oC, 100%; c. NaH, PMBCl, THF, 95%; d. n-BuLi, THF, -78 oC 
up to 75 oC, 75%; e. H2, Pd/C, THF, 71%; f. IBX, DMSO, 73%; g. Oxone, DMF, 99%; 
h. 2,2’dipyridyl disulphide, PPh3, toluene, 25 
oC then EtMgBr, pyrrole, toluene, -78 oC, 83%; 
i. NaBH4, IPA, 85 
oC, 66%  
In this alternative synthetic route, 3-methylpentan-1-ol 192 was converted to 1-iodo-3-
methylpentane 193 via the corresponding tosylate in 90% yield of over the two steps.  
Protection of 5-hexyn-1-ol 177 with 4-methoxybenzyl chloride provided protected alkyne 178 
in 85% yield.  The 4-methoxybenzyl group was selected because of its greater reactivity under 
hydrogenation conditions and is thus easier to remove.  Alkylation of alkyne 178 with iodide 
193 followed by hydrogenation provided alcohol 191.  Oxidation of alcohol 191 to the 
corresponding carboxylic acid 188 followed by coupling with pyrrole and reduction of the 
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resulting 2-ketopyrrole using the methodology described for the synthesis of 2-UP 20 
provided 2-UP analogue 188. 
2.7.2 2-(8-Methylundecyl)-pyrrole 180 
The route employed for the synthesis of the 2-UP analogue 180 with a methyl group at C-8’ is 
shown in Scheme 2.32.  It is analogues to the second generation synthesis of the 2-UP 
analogue 185 with a methyl group at C-9’, see Section 2.7.1. 
Scheme 2.32: The synthetic route to 2-UP analogue 180; a. TsCl, DMAP, Et3N, CH2Cl2, 98%; 
b. KI, Acetone, 60 oC, 80%; c. NaH, THF, 85%; d. n-BuLi, THF, -78 oC upto 75 oC, 65%; e. H2, 
Pd/C, THF, 79%; f. IBX, DMSO, 68%; g. Oxone, DMF, 95%; h. (PyS)2, PPh3, toluene, 25 
oC then 
EtMgBr, pyrrole, toluene, -78 oC, 71%; i. NaBH4, IPA, 85 
oC, 59% 
 2.8 Synthesis of 2-UP analogues with a methyl group on the 
pyrrole 
As discussed in Section 1.9, the proposed RedG catalytic mechanism involves the formation of 
a carbon-centred radical at C-7’, which attacks the pyrrole.  Subsequent abstraction of the 
hydrogen atom at the 4-position of the resulting intermediate regenerates the aromatic 
system.  Thus, it was decided to replace the hydrogen atom at the 4-position of the pyrrole 
with a methyl group 200, to investigate whether the intermediate radical 202 can be trapped, 
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Scheme 2.33.  While it is difficult to predict the fate of the trapped radical, one possibility 
would be reaction with the Fe(IV)=O(OH) intermediate to form a hydroxylated product 203. 
Scheme 2.33: The expected undecylprodigiosin analogue 201 and a possible hydroxylation 
product 203 resulting from feeding 2-UP analogue 200 to a mutant of S. coelicolor blocked in 
the biosynthesis of 2-UP 
It was expected that 2-UP analogue 200 could be synthesised in an analogues manner to that 
utilised for 2-UP 20 using 3-methylpyrrole 204 instead of pyrrole, Scheme 2.34  It was 
anticipated that steric interaction between the methyl group and the acylating agent would 
facilitate selective acylation of 3-methylpyrrole 204 at the 5-position. 
Scheme 2.34: Initially investigated synthetic route to 2-UP analogue 200; a. i. (PyS)2, PPh3, 
toluene, 25 oC ii. EtMgBr, pyrrole, toluene, -78 oC, 53%; b. NaBH4, IPA, 85 
oC, 68% 
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The aromatic region of the 1H-NMR spectrum of the product resulting from acylation of 
3-methylpyrrole with the thioester derived from reaction of undecanoic acid with 
(2,2’)-dipyridyldisulphide and triphenylphosphine, revealed two multiplets, in contrast to the 
two singlets expected for 205.  In addition, a correlation between the two aromatic protons 
was observed in the COSY spectrum, indicating that they are adjacent to each other.  This 
implied that acylation had occurred at the 2-position, yielding the regioisomer 206 of the 
desired product, Figure 2.14.  To confirm the regiochemistry of the product of the acylation 
reaction, a series of NOE experiments was performed.  For the desired regioisomer 205, it was 
expected that correlations would be observed between each of the aromatic protons and the 
methyl group, but not between the aromatic protons themselves.  Conversely, for regioisomer 
206, it was expected that correlations between the two aromatic protons and one of the 
aromatic protons and the methyl group would be observed, Figure 2.15. 
Figure 2.14: Correlations between protons expected to be observed in the NOE spectra of 
4-methyl-2-acyl pyrrole 205 and 3-methyl-2-acyl pyrrole 206 
74 
 
Figure 2.15: NOE difference spectra for 206 in CDCl3 at 600 MHz with no irradiation (top 
spectrum), irradiation at the frequency corresponding to the signal at 2.42 ppm (second 
spectrum), irradiation at the frequency corresponding to the signal at 6.10 ppm (third 
spectrum) and irradiation at the frequency corresponding to the signal at 6.89 ppm (bottom 
spectrum) 
Irradiation at the frequency corresponding to the signal at 2.42 ppm, resulting from the 
pyrrole methyl group, resulted in enhancement of the signals due to one of the aromatic 
protons and protons α to the keto group.  Conversely, irradiation at the frequency 
corresponding to the signal at 6.10 ppm resulted in enhancement of the signal at 6.89 ppm 
and vice versa.  Thus, the product of the acylation reaction was confirmed as the 3-methyl-2-
acyl pyrrole 206.  This unexpected result can be explained by considering the electronic 
properties of the two intermediates resulting from acylation of the Grignard reagent 208 
derived from 3-methylpyrrole at the 2- and 5-position, Scheme 2.35. 
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Scheme 2.35: Intermediates resulting from acylation of the Grignard reagent 208 derived 
from 3-methylpyrrole at the 2- (black arrows) and 5- (red arrows) positions 
The presence of the electronegative nitrogen atom polarises the π-system of intermediates 
209 and 210.  Acylation at the 2-position allows the partial positive charge to be stabilised by 
hyperconjugation from the methyl group, whereas acylation at the 5-position does not.  Thus, 
the energy of the transition state for 2-acylation is lower and regioisomer 206 is formed. 
It was decided to reduce the keto group of 206 to provide the 2-UP analogue 207.  This 
analogue could be used to probe the steric ability of RedG to tolerate additional substituent’s 
on the pyrrole involved in the oxidative carbocyclisation reaction, Scheme 2.36. 
Scheme 2.36: The expected undecylprodigiosin analogue 211 and streptorubin B analogue 
212 from feeding 2-UP analogue 207 to a mutant of S. coelicolor blocked in the biosynthesis of 
2-UP 
An alternative synthetic route was devised for the synthesis of 2-UP analogue 200, 
Scheme 2.37.   This route involves the Paal-Knorr pyrrole synthesis, a reaction that converts 
1,4-dicarbonyl compounds upon heating with an amine to the corresponding pyrrole. 90,91     
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Scheme 2.37: The alternative route to 2-UP analogue 200;  a. Ag2O, BnBr, CH2Cl2, 90%; b. TsCl, 
DMAP, Et3N, CH2Cl2, 95%; c. LiBr, acetone, 65 
oC, 87%; d. i. Mg (s), THF, 50 oC ii. Dodecanal, 
THF, 60%; e. H2 (g), Pd/C, THF, 89%; f. (COCl)2, DMSO, Et3N, CH2Cl2, -78 
oC, 75%; g. Nitrogen 
source, THF, 70 oC 
Monobenzylation of 2-methyl-1,3-propandiol 213 in the presence of silver(I) oxide, as 
discussed previously, and conversion of the resulting monoprotected alcohol to the 
corresponding bromide 214 via the tosylate was achieved in 74% overall yield.  Treatment of 
bromide 214 with magnesium turnings afforded the corresponding Grignard reagent in situ 
which was reacted with dodecanal to yield diol 215, after hydrogenolytic debenzylation.  The 
diastereoisomeric mixture of diols was not separated because both stereocentres are absent 
from the final product.  Swern oxidation of diol 215 yielded 1,4-dicarbonyl 216 in 75% yield. 
Attempts to convert 1,4-dicarbonyl 215 to the desired 2-UP analogue 200 using Paal-Knorr 
chemistry proved unsuccessful.  Heating with a range of nitrogen sources including 
ammonium acetate, ammonium hydroxide and ammonium chloride resulted in the 
consumption of starting material but yielded complex mixtures of inseparable products.  
These complex mixtures of products presumably arise due to the instability of the initially-
formed dialkylpyrrole.  Indeed, during the total synthesis of the roseophillin macrocycle, Trost 
et al reported that the trialkylated pyrrole 218 was unstable and prone to degradation during 
its formation under Paal-Knorr conditions, Scheme 2.38.92 
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Scheme 2.38: Attempted conversion of 1,4-diketone 217 to pyrrole 218 reported by Trost 
et al 
The instability of the dialkylpyrrole is most likely due to its electron-rich nature resulting from 
the electron-donating effects of the additional methyl group.  Addition of an electron-
withdrawing group to the pyrrole nitrogen would therefore be expected to stabilise the 
dialkylpyrrole product.  Unfortunately, placing an electron withdrawing substituent on the 
nitrogen source in the Paal-Knorr reaction would also reduce its nucleophilicity, thus it would 
be expected not to react.  An alternative synthetic route was therefore sought. 
Urabe et al have recently reported the use of sulphonamides and bromoacetylenes as building 
blocks for pyrrole rings.93 They demonstrated that sulphonamides were able to act as 
nucleophiles towards electron-deficient halo-alkynes, resulting in functionalised alkenes that 
can be converted to N-sulphonyl-dialkyl pyrroles using a palladium catalyst, Scheme 2.39.   
Scheme 2.39: A generalised scheme for the synthesis of N-sulphonyl-dialkyl pyrroles from a 
sulphonamide and a bromoalkyne 
Thus, an alternative synthetic route to the desired 2-UP analogue 200 could be envisaged that 
utilises this chemistry, Scheme 2.40. 
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Scheme 2.40: The alternative synthetic route to 2-UP analogue 200; a. K2CO3, NaI, Acetone, 60 
oC, 32%; b. AgNO3, NBS, Acetone, 82%; c. i. K3PO4, DMF, 120 
oC ii. Bu4NBr, Pd(OAc)2, 120 
oC, 
30%; d. KOH, MeOH, 60 oC 
Sulphonamide 200 was alkylated with potassium carbonate and allyl bromide 219 to give a 
1:1:1 mixture of unalkylated, monoalkylated and dialkylated products, from which the 
monoalklyated product 221 was isolated by flash column chromatography in 32% yield.  
Reaction of alkyne 222 with N-bromosuccinimide and silver nitrate yielded bromoalkyne 223 
in 82% yield.  Treatment of sulphonamide 221 and bromoalkyne 223 with K3PO4 resulted in 
the formation of bromoalkene 224, which was converted to pyrrole 225 via a Heck reaction.   
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To confirm the regiochemistry of the methyl group in 225, NOE experiments where 
performed.  It was expected that correlations between each of the pyrrole protons and the 
methyl group, but not the pyrrole protons themselves would be observed, Figure 2.16. 
Figure 2.16: NOE difference spectra for 225 in CDCl3 at 600 MHz with no irradiation (top 
spectrum), irradiation at the frequency corresponding to the signal at 2.02 ppm (second 
spectrum), irradiation at the frequency corresponding to the signal at 5.86 ppm (third 
spectrum) and irradiation at the frequency corresponding to the signal at 7.01 ppm (bottom 
spectrum) 
Irradiation at the frequency corresponding to the signal at 2.02 ppm due to the methyl group 
of the pyrrole, resulted in enhancement of the signals for the two aromatic protons.  In 
addition, no correlation between the pyrrole protons is observed.  It was anticipated that 
removal of the tosyl group using potassium hydroxide would provide 2-UP analogue 200.  
However, prolonged elevated temperatures were required which resulted in substantial 
degradation of the product.  Due to time constraints, alternative methods for the 
deprotection were not investigated. 
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2.9  Synthesis of stereoselectively deuterium-labelled 2-UP 
analogues 
As discussed in Section 1.10.3, RedG catalyses the stereoselective oxidative carbocyclisation of 
undecylprodigiosin 4 to streptorubin B 6, to give an 9:1 mixture of S:R stereoisomers.  There 
are several possible stereochemical courses for this reaction.  Firstly, RedG could 
stereoselectively abstract the pro-S hydrogen atom from C-7’, followed by attack of the 
resulting carbon-centred radical on the pyrrole with retention of stereochemistry (i.e. 
abstraction of the pro-S hydrogen atom leads to the S stereochemistry), route A Scheme 2.41. 
Alternatively, RedG could stereoselectively abstract the pro-R hydrogen atom from C-7’ 
followed by attack of the resulting carbon-centred radical on the pyrrole with inversion of 
stereochemistry (i.e. abstraction of pro-R hydrogen atom leads to S stereochemistry), route B 
Scheme 2.41.  A third possibility is non-stereoselective abstraction of either pro-S or pro-R 
hydrogen atoms from C-7’ resulting in carbocyclisation via a mixture of routes A and B, 
Scheme 2.41.  Presumably, restricted rotation of the undecyl chain, when bound to the RedG 
active site, prevents a mixture of pro-R and pro-S hydrogen atom abstraction. 
Scheme 2.41: Different possible stereochemical courses for the RedG catalysed oxidative 
carbocyclisation, which could occur via primarly route A or route B, or via a mixture of routes 
A and B 
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The stereochemical course of several other reactions catalysed by non-haem iron-dependent 
oxidative cyclases has been studied in detail.  These include: the conversion of 226 to 13, 
catalysed by HppE, in fosfomycin biosynthesis94,95; the conversion of L, L, D-ACV 100 to 
isopenicillin, catalysed by IPNS96,97; and the conversion of 227 to 228 catalysed by clavaminate 
synthase in clavulanic acid biosynthesis.98,99  In the HppE catalysed reaction, the pro-R 
hydrogen atom is removed from C-1 of the substrate resulting in inversion of configuration at 
the newly-formed stereocentre, Figure 2.17 A.  However, this proposed inversion of 
stereochemistry is based on an X-ray crystal structure and no stereoselectively labelled 
substrate investigations has been undertaken.  In contrast, it has been shown that both the 
IPNS and clavaminate synthase-catalysed reactions proceed with retention of configuration at 
the carbon atom undergoing functionalisation via the use of stereoselectively labelled 
substrates, B and C respectively in Figure 2.17. 
Figure 2.17: Stereochemical course of the oxidative cyclisation reactions catalysed by HppE, 
IPNS and clavaminate synthase.  Only half of the curly arrows are shown for clarity 
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To investigate the stereochemical course of the clavaminate synthase-catalysed oxidative 
cyclisation, Townsend et al synthesised two stereoselectively deuterium-labelled substrates 
pro-R 229 and pro-S 229, Figure 2.18.  Incubation of the substrate in which the pro-R 
hydrogen atom attached to C-3 was labelled with clavaminate synthase resulted in 94% 
retention of the label.  However, incubation of the substrate in which the pro-S hydrogen 
atom attached to C-3 has been labelled with clavaminate synthase resulted in only 12% 
retention of the label.  Thus, Townsend et al concluded that clavaminate synthase 
stereoselectively abstracts the pro-S hydrogen atom and that oxidative cyclisation proceeds 
with retention of configuration. 
Figure 2.18: Use of stereoselectivly deuterium-labelled substrates by Townsend et al to 
determine that the clavaminate synthase-catalysed oxidative cyclisation occurs with retention 
of configuration 
It was envisaged that a similar approach could be employed to investigate the stereochemical 
course of the RedG-catalysed oxidative carbocyclisation.  By synthesising 2-UP analogues 
stereoselectively deuterium-labelled at C-7’, R- and S-232, it would be possible to distinguish 
between the three possible scenarios outlined in Scheme 2.41.  If RedG stereoselectively 
abstracts the pro-S hydrogen atom from C-7’, feeding of 2-UP analogue S-232 would result in 
predominat loss of the deuterium label, 6 C-7’H.  Alternatively, if RedG stereoselectively 
abstracts the pro-R hydrogen atom from C-7’, then feeding of 2-UP analogue S-232 should 
result in predominant retention of the deuterium label, 6 C-7’D.  In the third scenario outlined 
in Scheme 2.41, about 50% of the deuterium label would be retained, Scheme 2.42. 
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Scheme 2.42: Possible products resulting from feeding of 2-UP S-232 in which the pro-S 
hydrogen atom at C-7’ has been stereospecifically labelled with deuterium to a mutant of 
S. coelicolor blocked in 2-UP biosynthesis 
Thus, a synthetic method for the stereoselective incorporation of deuterium into C-7’ of 2-UP 
was required.  Examination of the literature revealed surprisingly few methods for the 
stereoselective incorporation of deuterium into hydrocarbons.  One method that has been 
demonstrated to be stereoselective is reductive displacement of certain leaving groups with 
lithium aluminium deuteride.  One of the first uses of this method was reported by Chickos 
et al.100 More recently, Ashby et al undertook a rigorous investigation of the mechanism for 
the reduction of organic halides with lithium aluminium hydride.101 Using a variety of 
techniques and mechanistic probes, they demonstrated that the lithium aluminium hydride 
reduction of alkyl chlorides and tosylates occurs exclusively via an SN2 process with 
concomitant inversion of configuration.  This chemistry has been utilised by Abad et al for the 
synthesis of several stereoselectively deuterium-labelled fatty acids.102,103  For example, during 
their study of the biosynthesis of (Z)-13-hexadecene-11-inyl acetate 234, stereoselective 
deuterium labelled (Z)-11-hexadecanoic acid 236 was required, Scheme 2.43.  This was 
synthesised via lithium aluminium deuteride reduction of enantioenriched mesylate 235. 
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Scheme 2.43: The route used by Abad et al for the stereospecific incorporation of a deuterium 
label into hexadecanoic acid 236 by reduction of mesylate 235 with lithium aluminium 
deuteride 
Thus, we designed a stereoselective synthetic route to tosylates R- and S-248, Scheme 2.44.  
Commercially available enatiomerically enriched R-(+)- and S-(-)-glycidol R- and S-237 (98% ee) 
were used as starting materials for the synthesis. 
Scheme 2.44: The synthetic route to 2-UP stereoselectively deuterium-labelled at C-7’; 
a. TBDMSCl, DMAP, Et3N, CH2Cl2, R 91%, S 86%; b. NaH, PMBCl, DMF, 70 
oC, 83%; c. n-BuLi, 
BF3.Et2O, THF, -78 
oC, R 63%, S 89%; d. H2, Pd/C, THF, R 67%, S 52%; e. PivCl, Pyridine, CH2Cl2, 
-20 oC, R 80%, S 77%; f. TsCl, DMAP, Et3N, CHCl3, 70 
oC, R 79%, S 81%; g. TBAF, THF, R 86%, 
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S 72%; h. Li, Hexane, 0 oC; i. CuCN, BF3.Et2O, Et2O, -78 
oC, R 75%, S 50%; j. TsCl, DMAP, Et3N, 
CHCl3, 70 
oC, R 25%, S 24%  k. LiAlD4, THF, R 56%, S 24%; l. (COCl)2, DMSO, Et3N, CH2Cl2, -78 
oC, 
R 67%, S 59%; m. Oxone, DMF, R 75%, S 74%; n. 2,2’dipyridyl disulphide, PPh3, toluene, 25 
oC 
then EtMgBr, pyrrole, toluene, -78 oC, R 63%, S 87%; o. NaBH4, IPA, 85 
oC, R 99%, S 54% 
t-Butyldimethyl silyl ether protection of glycidol 237 and 4-methoxybenzyl ether protection of 
alkyne 239 proceeded in excellent yields.  Boron trifluoride promoted regioselective ring 
opening at the least hindered end of epoxide 238 with lithium acetylide 240 yielded alcohol 
241.  Simultaneous hydrogenation of the alkyne and hydrogenolysis of the 4-methoxybenzyl 
protecting group was achieved with hydrogen and a palladium on carbon catalyst yielding diol 
242.  Selective protection of the primary alcohol as the pivaloyl ester was achieved by 
treatment with pivaloyl chloride, giving 88% and 77% yields for the R and S enantiomers, 
respectively.  Tosylation of this secondary alcohol required prolonged reaction times and 
elevated temperatures for complete conversion of the starting material. 
Initial attempts at the one-pot silyl ether deprotection and intramolecular displacement of the 
tosylate to provide epoxide 244 were performed in the presence of sodium bicarbonate 
because commercially available tetrabutylammonium fluoride is sold as a trihydrate.  Thus, it 
was assumed that protonation of the intermediate alkoxide 251 would occur and that a base 
would be required to deprotonate alcohol 252 prior to displacement of the tosylate to form 
epoxide 244, Scheme 2.45.  However, a substantial amount of an unknown byproduct was 
isolated from the reaction mixture.  The 1H-NMR spectrum of this unknown byproduct is 
shown in Figure 2.19. 
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Scheme 2.45: The assumed mechanism for the one-pot silyl ether deprotection and 
intramolecular cyclisation to convert tosylate 243 into epoxide 244 
Figure 2.19: The 1H-NMR spectrum in CDCl3 at 400 MHz of the unknown side product resulting 
from the treatment of tosylate 243 with tetrabutylammonium fluoride and sodium 
bicarbonate 
Examination of the 1H-NMR, 13C-NMR, mass and IR spectra of this byproduct lead to structural 
assignment as the cyclic carbonate 254, Scheme 2.46.  While the carbonyl carbon signals were 
not visible in the 13C-NMR spectrum, correlations were observed in the HMBC spectrum 
consistent with two separate carbonyl groups.  The IR spectrum also supported the cyclic 
carbonate 254, due to the presence of two absorbances at 1794cm-1 and 1720cm-1, indicative 
of two carbonyl groups.  HRMS of the byproduct provided a molecular formula of C14H24O5, 
which is also consistent with the cyclic carbonate structure 254. 
With hindsight, the use of sodium bicarbonate as a base was ill-judged, due to the equilibrium 
that exists between the bicarbonate anion and carbon dioxide in solution, Scheme 2.46.  It 
was hypothesised that the cyclic carbonate byproduct results from nucleophilic attack of the 
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intermediate alkoxide 253 onto carbon dioxide.  Subsequent intramolecular displacement of 
the tosylate by the carbonate anion would generate the cyclic carbonate 254. 
Scheme 2.46: The proposed mechanism for formation of the unexpected cyclic carbonate 
byproduct 254 
The one-pot silyl deprotection and intramolecular elimination reaction was repeated without 
addition of bicarbonate to provide epoxide 244 in 82% and 72% yields for the R and S 
enantiomers, respectively.  In neither case was any trace of the deprotected alcohol observed, 
presumably because protonation by water is a reversible process. 
To complete the synthesis of the undecyl chain, regioselective ring opening of epoxide 244 
with a propyl anion was required.  This ring opening reaction was complicated by the 
presence of the pivaloyl ester protecting group.  Examination of the literature revealed that 
higher order mixed metal organocuprates, R2Cu(CN)Li2, selectively react with epoxides in the 
presence of esters and can be  readily prepared from copper(I) cyanide and two equivalents of 
the desired alkyl lithium. 104,105 
Unfortunately, n-propyllithium 246 is not commercially available and therefore it needed to 
be synthesised.106 Thus, n-propyl chloride 245 was treated with two equivalents of lithium 
dust to yield a solution of n-propyllithium 245 in hexane.  The concentration of 
n-propyllithium 246 was determined using the titration method described in the Experimental 
section for n-butyllithium. 
With n-propyllithium in hand, epoxide 244 was treated with the higher order organocuprate 
prepared in situ.  Initially, poor conversion of the starting epoxide 244 was observed, but 
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addition of boron trifluoride vastly increased the rate of the reaction yielding alcohol 247 in 
75% and 50% yields for the R and S enantiomers, respectively. 
To determine their enantiopurity, both of the secondary alcohols 247 were derivatised with 
both enatiomers of α-methoxy-α-trifluoromethylphenyl acetic acid to yield (R, R)-, (R, S)-, 
(S, R)- and (S, S)-255 were synthesised, Scheme 2.47.107,108  A comparison of the 1H-NMR 
spectrum of the four diastereoisomers is shown in Figures 2.20 and 2.21. 
Scheme 2.47: Synthesis of the Mosher esters of alcohols R- and S-255; Acid, DCC, DMAP, 
CHCl3, 50 
oC; a. (R)-α-methoxy-α-trifluorophenylacetic acid (R, R)- 50%, (R, S)-255 44%; 
b. (S)-α-methoxy-α-trifluorophenylacetic acid(S, R)-255 50%, (S, S)-255 56% 
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Figure 2.20: A comparison of the 1H-NMR spectra in CDCl3 at 700 MHz of (S, R)-255 (top 
spectrum), (S, S)-255 (second from top spectrum), (R, R)-255 (third from top spectrum) and 
(R, S)-255 (bottom spectrum) 
Figure 2.21: A comparison between 4.20 – 3.90 ppm and 1.80 – 0.70 ppm of the 1H-NMR 
spectra in CDCl3 at 700 MHz of (S, R)-255 (top spectrum), (S, S)-255 (second from top 
spectrum), (R, R)-255 (third from spectrum) and (R, S)-255 (bottom spectrum) 
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As expected, the pairs of enantiomers (R, R)- and (S, S)- and (R, S)- and (S, R)-255 have 
identical 1H-NMR spectra but the spectra of diastereoisomers exhibit subtle differences.  
These differences are most profound for the two triplets observed between 4.10 – 4.00 ppm 
and 0.90 – 0.85 ppm, corresponding to the protons adjacent to the pivalyl ester and of the 
terminal methyl group respectively, Figure 2.21.  In the case of the (R, R)- and (S, S)-255 pair, 
the triplets resonate at 4.04 ppm and 0.82 ppm, whereas for the (R, S)- and (S, R)-255 pair, 
these signals are at 4.02 ppm and 0.88 ppm.  Thus, utilising these chemical shift differences 
between the diasteroisomers, the expected absolute stereochemistry of the major 
components was confirmed. 
For (R, R)- and (S, S)-255, there appears to be significant signal broadening, most notably for 
the terminal methyl group triplet at 0.88pm.  This indicated presence of rotamers that are 
interchanging conformation on the timescale of the NMR experiment.  To investigate this 
hypothesis, the 1H-NMR experiments for these two samples were repeated at 40 oC, 
Figure 2.22 and 2.23. At 40 oC, the signal broadening was significantly reduced, confirming the 
presence of rotamers.   
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 Figure 2.22: A comparison of the 1H-NMR spectra in CDCl3 at 700 MHz of (S, R)-255 (top 
spectrum) and (R, S)-255 (third from top spectrum) at 25 oC and (S, R)-255 (second from top 
spectrum) and (R, S)-255 (bottom spectrum) at 40 oC 
Figure 2.23: A comparison between 4.20 – 3.90 ppm and 1.80 – 0.70 ppm of the 1H-NMR 
spectrum in CDCl3 at 700 MHz of (S, R)-255 (top spectrum) and (R, S)-255 (third from top 
spectrum) at 25 oC and (S, R)-255 (second from top spectrum) and (R, S)-255 (bottom 
spectrum) at 40 oC  
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While the absolute stereochemistry of the major component of R- and S-247 was confirmed, it 
was not possible determine the exact ratio of enatiomers because, even at 700 MHz, the 
triplets at 0.88 ppm and 0.82 ppm are not completly resolved.  Thus, the four 
diastereoisomers were analysed via HPLC using a variety of achiral and homochiral stationary 
phases.  Unfortunately, it was not possible to resolve the minor diastereoisomer for any of the 
Mosher esters.  It was therefore assumed that R- and S-247 had an optical purity of no greater 
than 97% ee. 
With the absolute stereochemistry of 247 confirmed, secondary alcohol 247 was converted to 
the corresponding tosylate 248.  Treatment with lithium aluminium deuteride simultaneously 
stereospecifically substituted the tosyl group and cleaved the pivalyl ester protecting group to 
yield alcohol 249.  Attempts to obtain a molecular formula to confirm the presence of a 
deuterium atom using high-resolution mass spectrometry proved unsuccessful, presumably 
due to low ionisation of 249. As such, the 13C-NMR spectra of R- and S-249 were compared to 
undecanol, Figure 2.24. 
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Figure 2.24: A comparison of the 13C-NMR spectrum in CDCl3 at 400 MHz of undecanol (top 
spectrum), S-249 (middle spectrum) and R-249 (bottom spectrum) 
Comparison of the 13C-NMR spectrum of S- and R-249 with undecanol revealed the presence 
of additional signals at approximately 30 ppm, as a result of signal splitting caused by the 
deuterium atom. 
Oxidation of alcohols S- and R-249 to the corresponding carboxylic acids S- and R-250 was 
achieved using the methodology previously described.  Ionisation of both S- and R-250 in the 
electrospray mass spectrometer was more efficient and molecular formulae were obtained 
that confirmed the presence of a deuterium atom.  The synthesis of 2-UP analogues S- and 
R-232 was completed by coupling with pyrrole followed by reduction of the 2-ketopyrrole 
using the methodology previously described for the synthesis of 2-UP 20. 
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3. Results and discussion: Feeding of 2-undecylpyrrole 
analogues to Streptomyces coelicolor mutants blocked in the 
biosynthesis of 2-undecylpyrrole 
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With the synthesis of a selection of 2-UP analogues bearing specific functional groups 
complete, the mutasynthetic approach to probe the oxidative carbocyclisation catalysed by 
RedG was investigated.  A typical feeding experiment involved inoculating an agar plate 
containing R5 medium with 10 μl of the redL mutant spore stock and incubating for three days 
at 30 oC.  3 mg of a 2-UP analogue was then added to the plate as a suspension in 200 μl of 
methanol and 2 ml of water and the culture was incubated for a further three days at 30 oC. 
3.1 Feeding 2-UP 20 to Streptomyces coelicolor redL mutant 
During Stuart Haynes preliminary investigations of RedG, he used a mutant constructed by 
Anna Stanley, a previous member of the Challis group, in which the redL gene was replaced 
with an apramycin resistance cassette.109 Since RedL is involved in the biosynthesis of 2-UP 20, 
Section 1.6, this mutant does not produce either undecylprodigiosin 4 or streptorubin B 6.  
However, feeding this mutant with chemically synthesised 2-UP 20 restores the production of 
both undecylprodigiosin 4 and streptorubin B 6.   
When feeding 2-UP 20 to this mutant, Stuart Haynes observed that the ratio of 
streptorubin B 6 to undecylprodigiosin 4 was much lower than in the wild type and in many 
cases, streptorubin B 6 was barely detectable.  In an effort to increase the amount of 
streptorubin B 6 produced, Paulina Sydor, a previous member of the Challis group, introduced 
a plasmid containing an additional copy of both redH and redG into the redL mutant.110 For 
clarity, this strain will henceforth be referred to as the redL mutant. 
As shown in Figure 3.1, the redL mutant expressing additional copies of both redH and redG 
does not produce either undecylprodigiosin 4 or streptorubin B 6 (blue chromatogram).  
Supplementing this mutant with chemically synthesised 2-UP 20 restored the production of 
both undecylprodigiosin 4 and streptorubin B 6 (yellow chromatogram) to levels approaching 
the wild type (red chromatogram).   
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Figure 3.1: A533 chromatograms from LC-MS analyses of mycelial extracts from Streptomyces 
coelicolor wild type (red), the redL mutant (blue) and the redL mutant supplemented with 
chemically synthesised 2-UP 20 
3.2 Feeding of sulphur containing 2-UP analogues to the 
Streptomyces coelicolor redL mutant 
3.2.1 Feeding of sulphur containing 2-UP analogue 101 
As discussed in Section 2.4, feeding of a 2-UP analogue bearing a sulphur atom at the site of 
cyclisation was expected to trap the reactive oxygen species generated by RedG as the 
corresponding sulphoxide, Scheme 3.1. 
Scheme 3.1: The expected undecylprodigiosin analogues 102 and 103 expected to result from 
the feeding of 2-UP analogue 101 to the redL mutant 
LC-MS analysis of the mycelial extract resulting from feeding the redL mutant with 2-UP 
analogue 101 gave a surprising result.  As shown in Figure 3.2, three distinct peaks were 
4 6 
97 
 
observed in the A533 chromatogram, the characteristic λmax of prodiginine hydrochloride 
salts.111   
Figure 3.2: A533 chromatogram from LC-MS analysis of the mycelial extracts of the redL mutant 
fed with 2-UP analogue 101  
Examination of the mass spectrum for the peak with a retention time of 8.3 min revealed the 
expected m/z = 412, corresponding to the undecylprodigiosin sulphide analogue 102.  
Likewise, examination of the mass spectrum for the peak with a retention time of 5.5 min 
revealed the expected m/z = 428, corresponding to the undecylprodigiosin sulphoxide 
analogue 103.  High-resolution mass spectrometry confirmed the molecular formulae of these 
compounds as C24H34N3OS and C24H34N3O2S, respectively. 
Examination of the mass spectrum for the remaining unexpected peak with a retention time 
of 5.2 min revealed an m/z = 444, 32 mass units higher than the corresponding sulphide 102 
and 16 mass units higher than the corresponding sulphoxide 103.  It was therefore proposed 
that RedG not only catalyses the oxidation of sulphide 102 to sulphoxide 103 as anticipated, 
but further converts sulphide 102 to sulphone 256, Scheme 3.2 and Figure 3.3.  The molecular 
formula obtained from high-resolution mass spectrometry, C24H34N3O3S, was consistent with 
sulphone 256. 
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Scheme 3.2: Products resulting from the feeding of 2-UP analogue 101 to the redL mutant 
Figure 3.3: A533 chromatogram (black) and extracted ion chromatograms at m/z = 412 (red), 
m/z = 428 (blue) and m/z = 444 (yellow) from LC-MS analysis of the mycelial extracts of the 
redL mutant fed with 2-UP analogue 101  
During the synthesis of 2-UP analogue 101, it was noticed that exposure of the sulphide to air 
resulted in partial oxidation to the corresponding sulphoxide (see Section 2.4.1).  Since these 
feeding experiments were performed under aerobic conditions, it was possible that the 
observed sulphoxide 103 was produced as a result of non-enzymatic oxidation by air.  To 
confirm that RedG was responsible for the oxidation of the sulphide, the feeding experiment 
was repeated with a mutant lacking the redG gene in addition to the redL gene, Figure 3.4. 
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Figure 3.4: Extracted ion chromatograms at m/z = 412 (red), m/z = 428 (blue) and m/z = 444 
(yellow) from LC-MS analysis of the mycelial extracts of the redL mutant (solid lines) and redLG 
double mutant (dashed lines) fed with 2-UP analogue 101 
As shown in Figure 3.4, the amount of both oxidised products is substantially reduced in the 
redLG double mutant (dashed line chromatograms), indicating that RedG was indeed 
responsible for the majority of the oxidation observed.  As shown by the yellow dashed 
extracted ion chromatogram (m/z = 444), a reasonable amount of sulphone 256 was still 
observed in the redLG double mutant.  While no oxidation to the sulphone was observed 
during the synthesis of 2-UP analogue 101, the reduced levels observed in the feeding 
experiment with the redLG double mutant may result from the action of a non-specific 
oxidative enzyme in Streptomyces coelicolor. 
As expected, feeding of 2-UP analogue 101 bearing a sulphur atom at the site of cyclisation 
resulted in the formation of the corresponding sulphoxide 103 in addition to the unexpected 
sulphone 256.  To confirm that the oxygen atoms incorporated into these oxidised products 
originate from molecular oxygen, the feeding experiments were repeated under an 18O2 
atmosphere.  If the oxygen atoms present in the oxidised products originate from molecular 
oxygen, a shift of two mass units for the sulphoxide 18O-101 and four mass units for the 
sulphone 218O-256 would be observed, Scheme 3.3 and Figure 3.5 and 3.6. 
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Scheme 3.3: The expected pattern of isotope labelling for sulphoxide 18O-103 and sulphone 
218O-256 resulting from the feeding of 2-UP analogue 101 to the redL mutant under an 
atmosphere of 18O2 
Figure 3.5: Extracted ion chromatograms at m/z = 428 (red) and m/z = 430 (blue) from LC-MS 
analysis of mycelial extracts of the redL mutant fed with 2-UP analogue 101  under an 
atmosphere of 18O2 
Figure 3.6: Extracted ion chromatograms at m/z = 444 (red),  m/z = 446 (blue) and m/z = 448 
(yellow) from LC-MS analysis of mycelial extracts of the redL mutant fed with 2-UP analogue 
101  under an atmosphere of 18O2 
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As shown in both Figure 3.5 and 3.6, a significant amount of 18O was incorporated into both 
oxidised products, in addition to 16O, presumably resulting from atmospheric oxygen.  
Interestingly, significant amounts of sulphone 256 were observed that contain one 16O atom 
and one 18O atom, as highlighted by the blue chromatogram in Figure 3.6.  This result implies 
that the oxidation of sulphide 102 to sulphone 256 occurs in two distinct steps.   
3.2.2 Feeding of sulphur containing 2-UP analogue 257 
With the successful trapping of the reactive oxygen species generated by RedG using 2-UP 
analogue 101, it was decided to investigate another sulphur containing 2-UP analogue, this 
time with the sulphur atom replacing C-6’ 257.  As discussed in Section 1.12, feeding of 2-UP 
analogue 85 bearing an ether linkage resulted in a RedG catalysed dealkylation process.  Since 
sulphur is much larger than oxygen, it was hypothesised that there would be less efficient 
overlap between the sulphur lone pairs and the carbon-centred radical resulting in less of the 
dealkylation product 259 and more carbocyclised product 260, Scheme 3.4.  2-UP 
analogue 257 was synthesised via an analogue route to that described in Section 2.4.1 for 
2-UP analogue 101, Scheme 3.5. 
Scheme 3.4: The expected undecylprodigiosin analogues 258, along with the dealkylated 
product 259 (pathway a) and carbocyclised product 260 (pathway b), expected to result from 
feeding 2-UP analogue 257 to the redL mutant  
102 
 
Scheme 3.5: The synthetic route to 2-UP analogue 257; a. CH3(CH2)4SH, n-BuLi, THF, 0 
oC, 96%; 
b. NaOH, THF:Water, 75 oC, 91%; c. i. (PyS)2, PPh3, toluene, 25 
oC ii. EtMgBr, pyrrole, toluene, 
-78 oC, 81%; d. NaBH4, IPA, 85 
oC, 81% 
LC-MS analysis of the mycelial extract resulting from feeding the redL mutant with 2-UP 
analogue 257 revealed a surprising result.  As shown in Figure 3.7, the A533 chromatogram 
bears a striking similarity with that resulting from feeding the redL mutant with 2-UP 
analogue 101. 
Figure 3.7: A533 chromatogram resulting from LC-MS analysis of the mycelial extracts of the 
redL mutant fed with 2-UP analogue 257  
Examination of the mass spectrum for each peak revealed m/z values corresponding to the 
sulphide, sulphoxide and sulphone, as seen for feeding 2-UP analogue 101.  Extracted ion 
chromatograms for m/z = 410 and m/z = 342, the m/z values for [M+H]+ derived from 260 and 
259 respectively, revealed neither was present, Figure 3.8. 
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Figure 3.8: A533 chromatogram (black) and extracted ion chromatograms at m/z = 412 (red), 
m/z = 428 (blue), m/z = 444 (yellow), m/z = 410 (green) and m/z = 342 (brown) from LC-MS 
analysis of the mycelial extracts of the redL mutant fed with 2-UP analogue 257 
To confirm that RedG was responsible for the oxidation products observed, the experiments 
were repeated with the redLG double mutant, Figure 3.9. 
Figure 3.9: Extracted ion chromatograms at m/z = 412 (red), m/z = 428 (blue) and m/z = 444 
(yellow) from LC-MS analysis of the mycelial extracts of the redL mutant (solid lines) and redLG 
double mutant (dashed lines) fed with 2-UP analogue 257 
The observation of only sulphoxide 264 and sulphone 265 products, while unexpected, can be 
explained by the ease with which sulphur can be oxidised compared to carbon.  In the case of 
undecylprodigiosin analogue 258, the sulphur atom that replaced C-6’ presumably remains in 
close proximity to the activated oxygen species generated at the non-haem iron active site.  
Thus, the sulphur atom is oxidised more rapidly than the adjacent carbon atom, Scheme 3.6.   
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Scheme 3.6: The observed products resulting from feeding of 2-UP analogue 257 to the redL 
mutant 
3.2.3 Feeding of sulphur containing 2-UP analogues 266 – 270 
To further probe this unexpected oxidation process, 2-UP analogues bearing a sulphur atom at 
other positions of the undecyl chain were synthesised, Scheme 3.7 and Table 3.1.  In addition 
to the sulphur oxidation process catalysed by RedG, it was predicted that the typical oxidative 
carbocyclisation reaction would occur when the sulphur atom was far enough removed from 
C-7’, resulting in the formation of novel streptorubin B analogues bearing a sulphur atom in 
the macrocycle, Scheme 3.8. 
Scheme 3.7: The synthetic route to 2-UP analogues 266 – 271; a. CH3(CH2)YSH, n-BuLi, THF, 
0 oC; or, NaSCH3, DMF, 80 
oC; b. NaOH, THF:Water, 75 oC; c. i. (PyS)2, PPh3, toluene, 25 
oC 
ii. EtMgBr, pyrrole, toluene, -78 oC; d. NaBH4, IPA, 85 
oC 
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Table 3.1: The yields for the synthesis of 2-UP analogues 266 – 271 as outlined in Scheme 3.7; 
step A for S-10’ 266 resulted in 44% of the corresponding carboxylic acid 
Scheme 3.8: The expected undecylprodigiosin analogue 272 and possible oxidation products 
that might result from feeding 2-UP analogue 269 to the redL mutant as a representative 
example 
The 2-UP analogues 266 – 271 were synthesised using an analogues route to that described in 
Section 2.4.1.  In the synthesis of 2-UP analogue 271 that had C-3’ replaced with a sulphur 
atom, no product was isolated from the final reduction, due to extensive degradation via an 
unknown mechanism.  In the case of 2-UP analogue 266 that had C-10’ replaced with a 
Position of 
sulphur atom 
Step A Step B Step C Step D 
10’ 266 24% (44%) 90% 49% 95% 
9’ 267 99% 100% 89% 69% 
8’ 268 97% 99% 76% 80% 
5’ 269 99% 99% 76% 83% 
4’ 270 100% 99% 60% 63% 
3’ 271 87% 94% 53% - 
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sulphur atom, the sodium salt of methanthiol was utilised in place of methanthiol, which is a 
gas at room temperature and pressure.  Interestingly, 44% of the corresponding carboxylic 
acid was isolated, presumably resulting from a competing transthioesterification reaction or 
via a direct displacement of the carboxylate anion using the sodium methanthiolate. 
The results of feeding sulphur containing 2-UP analogues 101, 257 and 266 – 270 to the redL 
mutant is summarised in Table 3.2 (see Appendix for chromatograms). 
Table 3.2: The observed products resulting from feeding of 2-UP analogues 101, 257 and 
266 – 270 to the redL mutant;  compound was observed; ? inconclusive;  compound was 
not observed 
In the case of 2-UP analogues 269 and 270, with C-5’ and C-4’ replaced with sulphur atoms 
respectively, the corresponding sulphoxides 273 and 289 along with sulphones 274 and 290 
were observed.  For 2-UP analogue 270, a trace amount of a compound with the expected 
m/z for the corresponding streptorubin B analogue 291 was barely detected.  However, there 
was no significant difference between the control experiment when 2-UP analogue 270 was 
fed to the redLG double mutant.  Interestingly, the amount of sulphur oxidation product 
observed appeared to decrease as the sulphur atom was moved further from C-7’.  This 
Position of 
sulphur atom 
Sulphide 
analogue 
Sulphoxide 
analogue 
Sulphone 
analogue 
Streptorubin B 
analogue 
10’ 266 276 ? 277 ? 278 ? 279 ? 
9’ 267 280 ? 281 ? 282 ? 283 ? 
8’ 268 284 ? 285 ? 286 ? 287 ? 
7’ 101 102  103  256  - 
6’ 257 258  264  265  260  
5’ 269   272  273  274  275  
4’ 270 288  289  290  291? 
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decrease in sulphur atom oxidation is presumably due to the sulphur atom being too far from 
the activated oxygen non-haem iron to react. 
It was expected that feeding of 2-UP analogues 266, 267 and 268 to the redL mutant would 
provide analogous results to 270, 269 and 257, respectively, since the sulphur atom is the 
same distance from C-7’ except on the other side.  Indeed, it was also hypothesised that 
feeding of 2-UP analogue 266 might result in the formation of a streptorubin B analogue, this 
time with an exocyclic sulphur atom.  However, feeding of these 2-UP analogues yielded 
unexpected results, Figure 3.10. 
Figure 3.10: A533 chromatogram from LC-MS analysis of the mycelial extracts of the redL 
mutant fed with 2-UP analogue 268 as a representative example 
As shown in Figure 3.10, only trace amounts of the expected sulphur oxidised products 285 
and 286 were detected.  Indeed, comparison with the control experiment in which 2-UP 
analogue 268 was fed to the redLG double mutant revealed that these products were barely 
attributable to RedG.   
Feeding of 2-UP analogue 268 to the redL mutant was repeated with 2-UP 20 and 2-UP 
analogue 101 performed in parallel as a positive control.  However, neither feeding 
experiment provided the expected result.  Attempts to reproduce the results of feeding 2-UP 
analogues 101, 257, 269 or 270 were unsuccessful; this will be discussed in more detail in 
Section 3.4. 
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3.3 Feeding of ether containing 2-UP analogue to the 
Streptomyces coelicolor redL mutant 
As discussed in Section 1.12, feeding of a 2-UP analogue 85 containing an ether linkage 
adjacent C-7’ resulted in the apparent formation of a dealkylated undecylprodgiosin 
analogue 76, Scheme 3.9.  Prior to confirming the exact nature of the predicted dealkylated 
product, it was decided to ensure that the results observed by Stuart Haynes could be 
reproduced. 
Scheme 3.9: The undecylprodigiosin analogue 74 and dealkylated product 76 expected to 
result from feeding 2-UP analogue 85 to the redL mutant 
LC-MS analysis of the mycelial extract resulting from feeding the redL mutant with 2-UP 
analogue 85 revealed a surprising result, Figure 3.11.  Examination of the A533 chromatogram 
revealed the presence of only one peak with a retention time of 7 min.  This was surprising 
because two peaks were expected, corresponding to the undecylprodigiosin analogue 74 and 
the dealkylated product 76, respectively. 
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Figure 3.11: A533 chromatogram from LC-MS analysis of the mycelial extracts of the redL 
mutant fed with 2-UP analogue 85 
Examination of the mass spectrum corresponding to the single peak in the A533 chromatogram 
showed that it has the m/z value expected for the [M+H]+ ion of undecylprodigiosin 
analogue 74.  Extracted ion chromatograms for m/z = 326 and m/z = 394, corresponding to 
[M+H]+ for the dealkylated product 76 and cyclised product 75, respectively, did not reveal 
any additional peaks, Figure 3.12.   
Figure 3.12: A533 chromatogram (black) and extracted ion chromatograms at m/z = 396 (red), 
m/z = 326 (blue) and m/z = 394 (yellow) from LC-MS analysis of the mycelial extracts of the 
redL mutant fed with 2-UP analogue 85 
This failure to reproduce the results reported by Stuart Haynes may have been due to 
problems with the activity of RedG, as previously observed in the feeding of the sulphur 
analogues, Section 3.2.4. 
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3.4 Problems with feeding to the Streptomyces coelicolor redL 
mutant 
As shown in both Section 3.2 and 3.3, the reproducibility of the feeding experiments with the 
redL mutant was poor.  Indeed, it was noticed that over the course of several months, the 
apparent activity of RedG decreased, even when the redL mutant strains were fed with the 
natural substrate 2-UP 20.  This reduced activity of RedG would explain why feeding of ether 
containing 2-UP analogue 85 did not result in the dealkylated product 76 previously observed 
by Stuart Haynes. 
A possible explanation for this reduced RedG activity could be instability of the plasmid 
introduced by Paulina Sydor containing the additional copies of redH and redG.  To confirm 
that the redL mutants still contained this plasmid, spores of the redL mutant were grown on 
SFM agar plates containing hygromycin.  Since the plasmid containing the additional copies of 
redH and redG also contained a hygromycin resistance gene, only spores that still contained 
the plasmid should survive.  A single colony was subsequently picked and used to generate a 
new spore stock.  However, feeding of 2-UP 20 to cultures derived from this fresh spore stock 
did not result in the ratio of streptorubin B 6 to undecylprodigiosin 4 originally observed when 
this strain was created. 
In a further effort to improve the ratio of streptorubin B 6 to undecylprodigiosin 4, a range of 
alternative experimental conditions were investigated, including: 
 Changing the growth medium 
 Changing the amount of 2-UP / 2-UP analogue fed 
 Changing the amount of time the culture was grown for before commencing feeding 
 Changing the method of feeding 
 Changing the source of water used to make the culture medium112 
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None of these factors had a significant impact on the ratio of streptorubin B 6 to 
undecylprodigiosin 4 observed.  Thus, an alternative approach for utilising the mechanistic 
probes to investigate the catalytic mechanism of RedG was pursued. 
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4. Results and discussion: Feeding of 2-undecypyrrole 
analogues to Streptomyces albus expressing redHG 
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 4.1 Streptomyces albus as a heterologous host for expression of 
redHG 
Due to the poor and inconsistent activity of RedG in the redL mutant, resulting in a poor ratio 
of streptorubin B 6 to undecylprodigiosin 4, an alternative method was required to investigate 
the oxidative carbocyclisation catalysed by RedG.   
Paulina Sydor, a previous member of the Challis group, reported that Streptomyces albus 
expressing redHG under the control of the constitutive ermE* promoter produces an 
approximate 1:1 ratio of streptorubin B 6 to undecylprodigiosin 4 when fed with chemically 
synthesised 2-UP 20 and MBC 19.113 Fresh transconjugants of S. albus expressing redH and 
redHG were prepared as described by Paulina Sydor.110 
After similar optimisation experiments to those undertaken for S. coelicolor, as discussed in 
Section 3.4, it was found that feeding 2 mg of MBC 19 and 2-UP 20 to S. albus + redHG on the 
third day after inoculation provided the best yield and ratio of streptorubin B 6 to 
undecylprodigiosin 4.  It was established that premixing a DMSO solution of MBC 19 and a 
methanol solution of 2-UP 20, followed by direct addition to the bacterial culture as small 
droplets, without the addition of water, was essential to achieve good levels of production. 
Feeding of chemically synthesised 2-UP 20 and MBC 19 to wild type S. albus, S. albus + redH 
and S. albus + redHG, showed that almost no red pigment is produced in the absence of redH, 
Figure 4.1. 
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Figure 4.1: A photograph of wild type S. albus (left), S. albus + redH (middle) and S. albus + 
redHG (right) after two days incubation at 30 oC fed with chemically synthesised 2-UP 20 and 
MBC 19 
LC-MS analyses of the mycelial extracts resulting from feeding chemically synthesised 2-UP 20 
and MBC 19 to S. albus, S. albus + redH and S. albus + redHG, Figure 4.2, revealed that wild 
type S. albus (red chromatogram) only produces a trace amount of undecylprodigiosin 4, 
presumably due to non-enzymatic acid-catalysed condensation of 2-UP 20 and MBC 19 during 
extraction of the mycelia.  In contrast, S. albus + redH produces a substantial amount of 
undecylprodigiosin 4 (blue chromatogram), and S. albus + redHG produces a 1:1 ratio of 
streptorubin B 6 to undecylprodigiosin 4 (yellow chromatogram). 
Figure 4.2: A comparison of A533 chromatograms resulting from LC-MS analysis of the mycelial 
extracts of S. albus (red), S. albus + redH (blue) and S. albus + redHG (yellow) fed with 
chemically synthesised 2-UP 20 and MBC 19 
4 6 
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Previously, Paulina Sydor had noticed that the ratio of streptorubin B 6 to 
undecylprodigiosin 4 was improved when RedH and RedG were present.  It was not obvious 
why the ratio of streptorubin B 6 to undecylprodigiosin 4 should be affected by RedH, since it 
has no direct role in the oxidative carbocyclisation reaction.  One possible explanation for this 
observation is that RedH and RedG form a complex in vivo, in which undecylprodigiosin 4 is 
‘passed’ directly from RedH to RedG, preventing undecylprodigiosin 4 from becoming trapped 
in the cell membrane by its lipophilic undecyl chain, thus preventing RedG from accessing its 
substrate.   
During the feeding of chemically synthesised 2-UP 20 and MBC 19 to S. albus + redHG, it was 
noticed that red pigment was visible much sooner than in S. albus + redH, Figure 4.3.  As 
shown in Figure 4.3, after two hours incubation at 30 oC, S. albus + redHG (top right) has 
produced more red pigment than S. albus + redH (bottom right).  Since RedG is not involved in 
the condensation of 2-UP 20 and MBC 19, this observation was unexpected.  A possible 
explanation for this unexpected observation could be that the catalytic efficiency of RedH is 
improved by forming a complex in vivo with RedG; thus, undecylprodigiosin 4 is produced 
more rapidly. 
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Figure 4.3: A comparison of S. albus + redHG (top plates) and S. albus + redH (bottom plates) 
immediately after feeding chemically synthesised 2-UP 20 and MBC 19 (left) and after two 
hours incubation at 30 oC (right) 
Feeding of MBC 19 and 2-UP analogues was reinvestigated using S. albus + redHG.  However, 
it was noticed that over the course of several weeks, the level of RedG activity reduced 
dramatically, Figure 4.4.  
Figure 4.4: A comparison of A533 chromatogram resulting from LC-MS analysis of the mycelial 
extracts of S. albus + redHG fed with chemically synthesised 2-UP 20 and MBC 19 immediately 
after conjugation (red) and after spores had been stored at -80 oC for one week (blue), three 
weeks (yellow) and five weeks (green) 
4 6 
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Immediately after conjugation, a 1:1 ratio of streptorubin B 6 to undecylprodigiosin 4 was 
observed (red chromatogram).  However, after one week of storage at -80 oC, this ratio had 
reduced slightly and after five weeks, only trace amounts of streptorubin B 6 were detected 
(green chromatogram).  During this same time period, undecylprodigiosin 4 production 
remained constant.  Since undecylprodigiosin 4 was still produced, the plasmid containing 
redH and redG must still be present in the S. albus stain. 
A possible explanation for this marked decrease in activity could be a result of an unforeseen 
toxic effect of RedG on S. albus.  Since redG is constitutively expressed, for large periods of 
time when no substrate is present in the cells, reactive oxygen species, such as superoxide or 
hydrogen peroxide, could be generated by RedG, resulting in cell damage.  Indeed, it is well 
known that many iron-containing enzymes that activate molecular oxygen often self-
inactivate due to reactions with the reactive oxygen species.114,115  It is therefore possible that 
strains containing mutant redG alleles, which no longer express active enzyme are selected for 
during storage.  Due to time constraints, sequencing of the redG gene from the samples that 
had lost enzymatic activity to investigate this hypothesis was not undertaken.  
Whatever the cause of this observed decrease in RedG activity, it proved necessary to use 
freshly conjugated S. albus + redHG for the feeding experiments with 2-UP analogues. 
4.2 Feeding of sulphur containing 2-UP analogues to 
Streptomyces albus + redHG 
With this new feeding method developed, it was decided to repeat the feeding of the sulphide 
analogues to confirm the results obtained from feeding in S. coelicolor.   
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4.2.1. Feeding of sulphur containing 2-UP analogue 101 
As discussed in Section 3.2.1, feeding of 2-UP analogue 101 with C-7’ replaced with a sulphur 
atom resulted in oxidation of the sulphide to the corresponding sulphoxide 103 and sulphone 
256, Scheme 4.1.  This was repeated using S. albus + redHG to confirm the previous 
observations, Figure 4.5. 
Scheme 4.1: The observed undecylprodigiosin analogue 102 and sulphur oxidation products 
103 and 256 resulting from feeding 2-UP analogue 101 to the S. coelicolor redL mutant 
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Figure 4.5: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue) and 
m/z = 444.23 (yellow) from LC-MS analysis of the mycelial extracts of S. albus + redHG (solid 
lines) and S. albus + redH (dashed lines) fed with 2-UP analogue 101 and MBC 19 
As shown in Figure 4.5, both of the expected sulphur oxidation products 103 and 256 were 
observed in addition to large amounts of the corresponding sulphide 102.  As a control 
experiment, 2-UP analogue 101 and MBC 19 were also fed to the S. albus + redH strain 
(dashed lines).  As expected, a significant decrease in the amount of sulphur oxidation 
products 103 and 256 was observed. 
To confirm the identity of the undecylprodigiosin analogues produced in these experiments, it 
was decided to synthesise authentic standards of sulphide 102, sulphoxide 103 and sulphone 
256.  Comparison of the retention times and fragmentation patterns of the authentic 
standards with the compounds produced in the feeding experiment would confirm their 
structures.  
As discussed in Section 1.11.3, Thomson et al completed their enantioselective total synthesis 
of streptorubin B 6 by an acid-catalysed condensation of BOC-protected MBC 292 and 
monopyrrole 50.  It was envisaged that this procedure could be utilised in the synthesis of the 
authentic standards with an additional sulphur oxidation step, Scheme 4.2 and Table 4.1. 
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Scheme 4.2: The synthetic route to the authentic standards of 102, 103 and 256; a. n-BuLi, 
2,2,6,6-tetramethylpiperidine, B(OMe)3,THF, -78 
oC, 54%; b. POBr3, Et2NCHO, CH2Cl2, 40 
oC, 
73%; c. i. Pd(OAc)2, PPh3, Na2CO3, ii. HCl, 54%; d. i. 2M HCl, MeOH, ii. Oxidant, iii. NaOMe 
 Oxidant Yield 
Sulphide 102 - 38% 
Sulphoxide 103 m-CPBA 58% (33%) 
Sulphone 256 Oxone 54% (13%) 
Table 4.1: The oxidant used for the sulphur oxidation; the yield of different sulphur oxidation 
products are shown in brackets 
After the initial Suzuki coupling reaction, careful addition of 2M HCl to hydrolyse the enamine 
afforded BOC-protected MBC 292.  Acid-catalysed condensation of BOC-protected MBC 292 
and 2-UP analogue 101, followed by oxidation, deprotection and purification by HPLC 
provided the authentic standards 102, 103 and 256. For sulphoxide 103, m-CPBA was used to 
oxidise the sulphide to the corresponding sulphoxide, with approximately 33% of sulphide 102 
remaining.  For sulphone 256, Oxone was used to oxidise the sulphide to the corresponding 
sulphone, with approximately 13% of sulphoxide 103 also isolated.  
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As shown in Figure 4.6, the chemically synthesised authentic standards had the same 
retention times as the compounds from the mycelial extract.  In addition, the authentic 
standards had identical fragmentation patterns to the corresponding metabolites in the 
mycelial extract, Figure 4.7. 
Figure 4.6: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue) and 
m/z = 444.23 (yellow) from LC-MS analysis of the mycelial extracts of S. albus + redHG (solid 
lines) fed with 2-UP analogue 101 and MBC 19 and solutions of the chemically synthesised 
authentic standards 102, 103 and 256 (dashed lines) 
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Figure 4.7: A comparison of the MS/MS spectrum observed for the authentic standards (top 
spectra) and the mycelial extract of sulphide 102 (A), sulphoxide 103 (B) and sulphone 256 (C) 
4.2.2 Feeding of other sulphur containing 2-UP analogues  
With the successful reproduction of the results observed for the feeding experiments in 
S. coelicolor utilising S. albus + redHG, feeding of the remaining sulphur containing 2-UP 
analogues 257 and 266 – 270 was repeated.  The results of these feeding experiments are 
summarised in Table 4.2. 
A 
B 
C 
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Scheme 4.3: The undecylprodigiosin analogue 288 and oxidised expected to result from 
feeding S. albus + redHG with 2-UP analogue 270 and MBC 19, as a representative example 
Table 4.2: The observed products resulting from feeding of 2-UP analogues 101, 257 and 
266 – 270 with MBC 19 to S. albus + redHG ;  compound was observed;  compound was 
not observed; * other RedG-derived products were observed 
As shown in Table 4.2, feeding of 2-UP analogues 257 and 266 – 270 with chemically 
synthesised MBC 19 to S. albus + redHG resulted in the corresponding sulphoxides and 
Position of 
sulphur atom 
Sulphide 
analogue 
Sulphoxide 
analogue 
Sulphone 
analogue 
Streptorubin B 
analogue 
10’ 266 276  277  278  279 * 
9’ 267 280  281  282  283  
8’ 268 284  285  286  287  
7’ 101 102  103  256  - 
6’ 257 258  264  265  260  
5’ 269   272  273  274  275  
4’ 270 288  289  290  291  
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sulphones in all cases.  For each oxidation product, HRMS provided molecular formulae 
consistent with the expected sulphur oxidised products.  Control experiments were performed 
by feeding each 2-UP analogue, along with chemically synthesised MBC 19, to the S. albus + 
redH strain, resulting in substantially reduced levels of sulphur oxidation products.  It should 
be noted that, as in the case of the redL mutant, trace amounts of the corresponding 
sulphoxides and sulphones were detected in the control experiments, presumably due to non-
enzymatic oxidation by air and/or the actions of a non-specific oxidative enzyme in 
Streptomyces albus.  The observation that the amount of sulphur oxidised product observed 
decreased as the sulphur atom was moved further away from C-7’ was confirmed using 
S. albus + redHG, with 2-UP analogues 266  and 270 producing the least. 
When feeding 2-UP analogue 270 to the S. coelicolor redL mutant, trace amounts of the 
corresponding oxidative cyclised product 291 may have been produced.  Repeating this 
experiment in the S. albus + redHG strain, resulted in a substantial amount of the putative 
oxidative carbocyclised 291 product being observed, Figure 4.8 and 4.9. 
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Figure 4.8: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue), 
m/z = 444.23 (yellow) and m/z = 410.22 (green) from LC-MS analysis of the mycelial extracts 
of S. albus + redHG fed with 2-UP analogue 270 and MBC 19 
Figure 4.9: A comparison of the HRMS for the compound eluting after 21.7 min in the LC-MS 
analysis of S. albus + redHG fed with 2-UP analogue 270 and MBC 19 (top spectrum) and the 
predicted mass spectrum for C24H32N3OS (bottom spectrum) 
Since the peak at 21.7 min has the correct molecular formula and a similar retention time 
relative to streptorubin B 6, its seems likely that this compound is indeed the streptorubin B 
analogue 291.  However, due to time constraints, this analogue was not isolated to confirm 
the structure via NMR spectroscopy. 
Initial analysis of the LC-MS data resulting from the mycelial extracts of S. albus + redHG fed 
with 2-UP analogue 266 and chemically synthesised MBC 19 indicated that only a trace 
amount of the corresponding streptorubin B analogue 279 was produced.  This was 
126 
 
unexpected, since the analogous 2-UP analogue 270, with the sulphur atom the same number 
of atoms from C-7’ but on the other side, resulted in a substantial amount of the 
corresponding oxidative carbocyclised product 291.  However, examination of the A533 
chromatogram revealed the presence of an additional broad peak with a retention time of 
19.2 min, Figure 4.10. 
Figure 4.10: A533 chromatogram (black) and extracted ion chromatograms at m/z = 412.24 
(red), m/z = 428.23 (blue), m/z = 444.23 (yellow) and m/z = 410.21 (green) from LC-MS 
analysis of the mycelial extracts of S. albus + redHG fed with 2-UP analogue 266 and MBC 19 
Examination of the high resolution mass spectrum for the peak with retention time of 
19.2 min revealed the presence of m/z = 426.2214 and m/z = 442.2166, Figure 4.11 and 4.12.   
Figure 4.11: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue) and 
m/z = 444.23 (yellow) from LC-MS analysis of the mycelial extracts of S. albus + redHG fed with 
2-UP analogue 266 and MBC 19 
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Figure 4.12: A comparison of the HRMS for the compounds eluting after 19.0 min and 
19.3 min in the LC-MS analysis (A and B, respectively, top spectrum) and the predicted mass 
spectrum for C24H32N3O2S and C24H32N3O3S (A and B, respectively, bottom spectrum) 
Given that these two unexpected peaks differ from sulphoxide 277 and sulphone 278 by two 
mass units, it seems plausible that this broad peak was a result of the corresponding 
streptorubin B sulphoxide 293 and sulphone 294 analogues, respectively, Scheme 4.4.  To 
confirm these compounds were RedG-derived, 2-UP analogue 266 was fed with MBC 19 to S. 
albus + redH.   LC-MS analysis indicated that neither of these putative streptorubin B 
analogues were observed, in addition to reduced levels of the sulphur oxidised products 277 
and 278. 
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Scheme 4.4: The observed undecylprodigiosin analogue 276, sulphur oxidation products 277 
and 278 and streptorubin B analogues 279, 293 and 294 resulting from LC-MS analysis of the 
mycelial extract of S. albus + redHG fed with 2-UP analogue 266 and MBC 19  
A number of possible explanations can be proposed for the formation of these unexpected 
sulphur oxidised streptorubin B analogues 293 and 294.  Firstly, sulphoxide 277 and sulphone 
278 may be substrates for RedG, in which case sulphur oxidation could occur prior to the 
oxidative carbocyclisation reaction.  Alternatively, oxidative carbocyclisation could occur first 
followed by sulphur oxidation either catalysed by RedG or a non-specific enzyme present in S. 
albus.  To discriminate between these possibilities, chemically synthesised sulphoxide 277, 
produced via an analogous route to that shown in Scheme 4.2, could be fed to S. albus + 
redHG to determine whether oxidative carbocyclisation occurs.  However, due to time 
constraints, this was not pursued further. 
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4.3 Feeding of ether containing 2-UP analogues to 
Streptomyces albus + redHG 
4.3.1 Feeding of ether containing 2-UP analogue 85 
As discussed in Section 3.3, feeding of 2-UP analogue 85 with an oxygen atom in the 6’ 
position to the S. coelicolor redL mutant did not replicate the dealkylation reaction observed 
by Stuart Haynes.  This was therefore reinvestigated by feeding 2-UP analogue 85 with MBC 
19 to S. albus + redHG, Scheme 4.5.  2-UP analogue 85 and MBC 19 were also fed to S. albus + 
redH as a control, Scheme 4.5. 
Scheme 4.5: The undecylprodigiosin analogue 74 and dealkylated product 76 expected to 
result from feeding 2-UP analogue 85 and MBC 19 to S. albus + redHG 
The results of the LC-MS analysis of the mycelial extracts resulting from this experiment are 
shown in Figure 4.13. As shown in Figure 4.13, a large amount of the corresponding 
undecylprodigiosin analogue 74 was produced (red chromatogram).  Examination of the high 
resolution mass spectrum for this peak provided a molecular formula of C24H34N3O2, 
consistent with the expected analogue 74.  In addition, a small peak was observed with the 
expected m/z = 326.18 for the dealkylated product 76 (blue chromatogram).  Indeed, 
examination of the high resolution mass spectrum for this peak provided a molecular formula 
of C19H24N3O2, consistent with the expected dealkylated product 76, Figure 4.14.  This 
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dealkylated product 76, but not the undecylprodigiosin analogue 74, was absent from the 
control experiment employing S. albus + redH. 
Figure 4.13:  Extracted ion chromatograms at m/z = 396.26 (red) and m/z = 326.18 (blue) from 
LC-MS analysis of the mycelial extract of S. albus + redHG (solid lines) and S. albus + redH 
(dashed lines) fed with 2-UP analogue 85 and MBC 19 
Figure 4.14: A comparison of the HRMS for the compound eluting after 18.5 min in the LC-MS 
analysis (top spectrum) and the predicted mass spectrum for C19H24N3O2 (bottom spectrum) 
Only small amounts of the putative dealkylated product 76 were produced, thus it was not 
practical to isolate it from the bacterial culture for NMR spectroscopic analysis.  An authentic 
standard of the proposed dealkylated product was therefore synthesised to confirm the 
identity of this product, Scheme 4.6. 
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Scheme 4.6: The synthetic route to the authentic standard of dealkylated product 76; 
a. (COCl)2, DMSO, CH2Cl2, Et3N, -78 
oC, 79%; b. NaClO2, NaH2PO4, 2-Methyl-2-butene, t-BuOH, 
water, 64%; c. i. (PyS)2, PPh3, toluene, 25 
oC ii. EtMgBr, pyrrole, toluene, -78 oC, 47%; d. NaBH4, 
IPA, 85 oC, 90%; e. TBAF, THF, 70%; f. i. HCl, MeOH, ii. NaOMe, 80% 
Oxidation of monosilyl protected alcohol 92 under Swern conditions, yielded the 
corresponding aldehyde in 79% yield.  It was expected that treatment of this aldehyde with 
Oxone, as discussed previously, would provide the desired carboxylic acid 295.  However, 
upon addition of Oxone, a complex mixture of products was obtained, presumably due to the 
instability of the silyl ether protecting group to the strongly oxidising reaction conditions.  
Thus, a milder method for the oxidation was required.  The Pinnick oxidation was selected due 
to the wide range of functional groups tolerated by this procedure and provided carboxylic 
acid 295 in 64% yield.116,117 Coupling of carboxylic acid 295 with pyrrole, followed by reduction 
of the resulting 2-ketopyrrole and silyl deprotection, yielded the corresponding alcohol 296, 
which was condensed under acidic conditions with BOC-protected MBC 292 to provide the 
authentic standard of the dealkylated product 76 in 80% yield after reverse-phase HPLC 
purification.  With the authentic standard of the dealkylated product 76 in hand, an LC-MS 
comparison with the putative dealkylated product in the mycelial extract was undertaken, 
Figure 4.15. 
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Figure 4.15: Extracted ion chromatograms for m/z = 326.18 from LC-MS analysis of the 
mycelial extracts of S. albus + redHG fed with 2-UP analogue 85 and MBC 19 (red) and the 
chemically synthesised authentic standard 76 (blue) 
As shown in Figure 4.15, the authentic standard has an identical retention time to that of the 
putative dealkylated product 76 in the mycelial extract.  In addition, the putative dealkylated 
product in the mycelial extract and the authentic standard give identical high resolution mass 
spectra and MS/MS fragmentation patterns, Figures 4.16 and 4.17. 
Figure 4.16: A comparison of the HRMS for the compound eluting after 18.5 min in LC-MS 
analysis of the mycelial extract of S. albus + redHG fed with 2-UP analogue 85 and MBC 19 
(top spectrum), HRMS of the authentic standard 76 (middle spectrum) and the predicted mass 
spectrum for C19H24N3O2 (bottom spectrum) 
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Figure 4.17: A comparison of the MS/MS spectrum observed for the authentic standard of 76 
(top spectrum) and 76 in the mycelial extract of S. albus + redHG fed with MBC 19 and 2-UP 
analogue 85 (bottom spectrum) 
The authentic standard was mixed with the mycelial extract and reanalysed by LC-MS to 
confirm that the retention time of the authentic standard and 76 in the mycelial extract were 
identical.  Together, these data confirmed that the compound with a retention time of 
18.5 min observed in the LC-MS analysis when 2-UP analogue 85 and MBC 19 are fed to 
S. albus + redHG is indeed the dealkylated product 76. 
4.3.2 Feeding of ether containing 2-UP analogue 86 
As discussed in Section 2.3, it was hypothesised that undecylprodigiosin analogue 87 would 
result in the formation of dealkylated aldehyde 88 by the actions of RedG, Scheme 4.7.  
Scheme 4.7: The undecylprodigiosin analogue 87 and dealkylated aldehyde product 88 
expected to result from feeding 2-UP analogue 86 and MBC 19 to S. albus + redHG 
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Unfortunately, analysis of the A533 chromatogram from LC-MS analysis of the mycelial extracts 
of S. albus + redHG fed with 2-UP analogue 86 and MBC 19 indicated the presence of only one 
peak, Figure 4.18.  Analysis of the HRMS for this peak indicated that the only observed 
product was the corresponding undecylprodigiosin analogues 87. LC-MS analysis of did not 
reveal any RedG-derived products. 
Figure 4.18: A533 chromatogram from LC-MS analysis of the mycelial extracts of S. albus + 
redHG fed with 2-UP analogue 86 and MBC 19 showing the single peak  
This lack of RedG products was surprising since 2-UP analogue 85 had been shown to undergo 
dealkylation catalysed by RedG.  A possible explanation for this lack of observed product could 
be the instability of the resulting aldehyde 88 in vivo.  It is well known that aldehyde 
functional groups are reactive species and, if only trace amounts were generated, the 
expected aldehyde could have degraded and therefore would not be detected.  It is also 
possible that undecylprodigiosin analogue 87 is not a substrate for RedG. 
4.4 Feeding of stereoselectively deuterated 2-UP to 
Streptomyces albus + redHG 
As discussed in Section 2.9, feeding of 2-UP bearing a deuterium-label at either the pro-R or 
pro-S position of C-7’ would allow the stereochemical course of the RedG-catalysed oxidative 
carbocyclisation reaction to be probed. If RedG stereospecifically abstracts the pro-S hydrogen 
atom from C-7’,  then feeding of 2-UP analogue S-232 should result in a loss of the deuterium 
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label, in keeping with other non-haem iron-dependent oxidative cyclases that proceed with 
retention of configuration (route A, Scheme 4.8).  Alternatively, if RedG stereospecifically 
abstracts the pro-R hydrogen atom from C-7’, then feeding of 2-UP analogue S-232 should 
result in retention of the deuterium label (route B, Scheme 4.8).  On the other hand, a 
non-stereoselective process would result in approximately 50% retention of the deuterium 
label in both experiments. 
Scheme 4.8: The undecylprodigiosin analogue S-233 expected to result from feeding of 
stereoselectively deuterium-labelled 2-UP 232 with MBC 19 to S. albus + redHG and two 
possible outcomes for the conversion of 233 to streptorubin B 6 
A comparison of the A533 chromatograms resulting from LC-MS analysis of the mycelial 
extracts of S. albus + redHG fed with either 2-UP 20, S-232 and R-232 and MBC 19 is shown in 
Figure 4.19. 
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Figure 4.19: A comparison of the A533 chromatograms from LC-MS analysis of the mycelial 
extracts of S. albus + redHG fed with pro-S labelled 2-UP S-232 (red) and pro-R labelled 2-UP 
R-232 (blue) with MBC 19, respectively  
As shown in Figure 4.19, feeding of R-232 and MBC 19 to S. albus + redHG resulted in a lower 
ratio of unlabelled streptorubin B 6 C-7’H than the ratio of labelled streptorubin B 6 C-7’D 
produced when S-232 was fed.  This difference in ratio of streptorubin B 6 to 
undecylprodigiosin 232 is consistent with a primary kinetic isotope effect.  If RedG abstracts 
the pro-R hydrogen atom from C-7’, the position of the deuterium atom in R-232 would slow 
this reaction, reducing the ratio of streptorubin B 6 to undecylprodigiosin 4 produced.  On the 
other hand, the position of the deuterium atom in S-233 would be expected to have little or 
no effect on the rate of abstraction of the pro-R hydrogen atom.  It should be noted that, due 
to time constraints, this experiment was only performed once. 
Consistent with the ratio of streptorubin B 6 to undecylprodigiosin 233 produced, feeding of 
S-232 resulted in almost complete retention of the deuterium label, whereas feeding of R-232 
appeared to result in an approximately 2:1 mixture of unlabelled to labelled streptorubin B 6, 
Figure 4.20.   
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Figure 4.20: A comparison of the HRMS for the compounds with a retention time of at 
22.0 min in the LC-MS analyses of the mycelial extract of S. albus + redHG fed with MBC 19 
and either 2-UP 20 (top), S-232 (middle) or R-232 (bottom)  
The small peak at m/z = 392.2702 in the spectrum of streptorubin B 6 arising from feeding of 
S-232 to S. albus + redHG presumably results from the small amount of R-232 present in the 
sample.  By calculating the area under each peak in the mass spectrum, it was concluded that 
92% of the deuterium label is retained when S-232 is fed to S. albus + redHG. 
A more detailed analysis of the mass spectrum resulting from feeding of R-232 to S. albus + 
redHG was complicated by the inability of the mass spectrometer to distinguish compounds 
containing a carbon-13 atom from those containing a deuterium atom.  The peak at 
m/z = 393.2750 presumably appears more intense than expected because it is a combination 
of the 13C-isotopomer of unlabelled streptorubin B 6 and the oxidative carbocyclisation 
product of the small amounts of S-232 present in the starting material.  Using Equation 4.1, it 
was possible to calculate the proportion of the m/z = 393.2750 peak that is due to the 
13C-isotopomer. 
   
      
      
 
Equation 4.1: Nc is the number of carbon atoms in the molecule, X13 is the area of the 
carbon-13 isotopomer peak and X12 is the area of the carbon-12 isotopomer peak 
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Thus, it was determined that 48% of the m/z = 393.2750 peak is due to the 13C-isotopomer 
and that 77% of the deuterium label is lost when R-232 is fed to S. albus + redHG.  The larger 
than expected level of deuterium retention resulting in streptorubin B 6 presumably results 
from consumption of the small amount of S-232 present in the R-232 sample, due to the 
absence of a primary kinetic isotope effect. 
From the results of these feeding experiments, it was determined that the RedG-catalysed 
oxidative carbocyclisation reactions proceeds via preferential abstraction of the pro-R 
hydrogen atom from C-7’ and proceeds with inversion of configuration at C-7’.  Thus, RedG 
differs from the majority of non-haem iron-dependent oxidative cyclases for which retention 
of configuration is observed, see Section 2.9.  In the case of these other oxidative cyclases, the 
retention of configuration can be explained by the fact that the incoming heteroatom is 
bound to the non-haem iron centre, thus is delivered to the same face of the carbon atom 
that hydrogen atom abstraction occurred from (route A Figure 4.21).  However, in the case of 
RedG, the incoming pyrrole carbon atom is not bound to the non-haem iron centre and so the 
carbon-centred radical undergoes inversion prior to cyclisation as a result of the specific 
substrate orientation in the RedG active site (route B Figure 4.21).   
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Figure 4.21: An explanation for why most non-haem iron-dependent oxidative cyclases 
proceed with retention of configuration (route A), whereas the RedG-catalysed 
carbocyclisation proceeds with inversion of configuration (route B). Only half of the curly 
arrows are shown for clarity 
As discussed in Section 1.10.3, natural streptorubin B 6 is produced as a 9:1 mixture of 
enantiomers.  The mechanism by which the minor enantiomer is produced is not known, but 
it could be formed either by abstractions of the pro-S hydrogen atom from C-7’ or by 
cyclisation of the intermediate carbon-centred radical with retention of configuration.  If 
R-streptorubin B R-6 is generated via abstraction of the pro-S hydrogen atom from C-7’, it 
would be expected that much less of this enantiomer of the product would have been 
produced when S-232 was fed along with MBC 19 to S. albus + redHG, due to the primary 
kinetic isotope effect.  A preliminary analysis of the mycelial extract from this experiment 
using a homochiral HPLC column indicated that the ratio of S-streptorubin B 6 to 
R-streptorubin B R-6 is unchanged, suggesting that abstraction of the pro-S hydrogen atom is 
not responsible for the formation of R-streptorubin B R-6.  However, only small amounts of 
material were available for this analysis and it is not conclusive, because the observed peaks 
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were very small.  This experiment will need to be repeated using more material to provide a 
definitive answer. 
  4.5 Feeding of cyclopropyl containing 2-UP analogues to 
Streptomyces albus + redHG 
As discussed in Section 2.5, feeding of 2-UP analogue Z- and E-118 containing a cyclopropane 
adjacent to the site of cyclisation was synthesised to probe the possibility that a carbon-
centred radical was generated via the actions of RedG.  If RedG abstracts a hydrogen atom 
from C-7’, it would be expected that the resulting cyclopropylcarbinyl radicals would undergo 
a skeletal rearrangement, yielding a homoallylic radical.  The fate of this homoallylic radical is 
difficult to predict but in principal, they could undergo hydroxylation, desaturation of 
carbocyclisation, Scheme 4.9. 
Scheme 4.9: The undecylprodigiosin analogues E- and Z-119 and possible hydroxylated and 
desaturated products 297 and 298 expected to from feeding 2-UP analogues Z- and E-118 to 
S. albus + redHG.  Any streptorubin B analogues would have the same expected m/z and 
chemical formula as the desaturated product 
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Unfortunately, analysis of the A533 chromatogram from LC-MS analysis of the mycelial extracts 
of S. albus + redHG fed with either Z- or E-188 and MBC 19 indicated the presence of only one 
peak in each case, Figure 4.22 and 4.23.  Analysis of the HRMS for these two peaks indicated 
that the two observed peaks were the corresponding undecylprodigiosin analogues Z- and 
E-119, respectively. LC-MS analysis of did not reveal any RedG derived products. 
Figure 4.22: A533 chromatogram from LC-MS analysis of the mycelial extracts of S. albus + 
redHG fed with 2-UP analogue Z-118 and MBC 19  
Figure 4.23: A533 chromatogram from LC-MS analysis of the mycelial extracts of S. albus + 
redHG fed with 2-UP analogue E-118 and MBC 19 
A number of possibilities can be proposed to explain the lack of any RedG derived products 
resulting from feeding S. albus + redHG with either 2-UP analogues Z- or E-118.  One possible 
explanation for the lack of RedG derived products could be that neither 2-UP analogues Z- or 
E-118 are substrates for RedG, potentially as a result of the increased steric bulk of the 
cyclopropane ring at C-8’.  Another possibility is that both 2-UP analogues Z- and E-118 are 
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toxic to S. albus + redHG and effect the growth and development of the cells.  It was noticed 
that during the mycelial extraction after feeding 2-UP analogue Z-118 and MBC 19, removal of 
the biomass from the membrane overlay proved problematic.  Typically, the biomass was 
easily removed from the overlay membrane using a scalpel.  However, after feeding with 2-UP 
analogue Z-118, the bacteria had become ‘watery’ and less red pigment was present, 
Figure 4.24.  
Figure 4.24: A comparison of ‘typical’ S. albus + redHG fed with 2-UP 20 and MBC 19 (left) and 
the unusual effect resulting from feeding 2-UP analogue Z-118 and MBC 19 (right) 
As shown in Figure 4.24, it appears that feeding of 2-UP analogue Z-118 had a negative effect 
on the growth of the S. albus + redHG bacteria.  One possible reason for this could be due to 
the effect that 2-UP analogue Z-118 has on the cell membrane as a result of embedding in the 
cell membrane.  Since 2-UP analogue Z-118 is locked in the cis configuration, this could lead to 
structural changes within the membrane affecting the membrane fluidity. 
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4.6 Feeding of branched methyl analogues to Streptomyces 
albus + redHG 
4.6.1 Feeding of branched methyl 2-UP analogue 185 
As discussed in Section 1.12, feeding of 2-UP analogue 185 bearing a methyl substituent at 
C-9’ had previously been shown to result in a mixture of the corresponding streptorubin B 
analogue 68 in addition to a desaturated product 71 and/or 72, Scheme 4.10. 
Scheme 4.10: The streptorubin B analogue 68 resulting from oxidative carbocyclisation 
(route A) and the mixture of desaturated undecylprodigiosin analogues 71 and 72 resulting 
from a competing desaturation reaction (route B) from feeding S. albus + redHG with 2-UP 
analogue 185 and MBC 19 
However, due to the unforeseen problems in developing an efficient and reproducible feeding 
method, 2-UP analogue 185 had degraded and there was insufficient time available to 
synthesise more. 
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4.6.2 Feeding of branched methyl 2-UP analogue 180 
As discussed in Section 2.7, feeding of 2-UP analogue 180 bearing a methyl substituent at C-8’ 
was proposed to increase the amount of desaturated products relative to the oxidative 
carbocylised product due to the increase in steric bulk, Scheme 4.11.   
Scheme 4.11: The undecylprodigiosin analogue 181 with the proposed desaturated products 
182 and 183 in addition to the oxidative carbocyclised product 184 to result from feeding 
S. albus + redHG with 2-UP analogue 180 and MBC 19 
Unfortunately, analysis of the A533 chromatogram from LC-MS analysis of the mycelial extracts 
of S. albus + redHG fed with 2-UP analogue 180 and MBC 19 indicated the presence of only 
one peak, Figure 4.25.  Analysis of the HRMS for this peak indicated that it was the 
corresponding undecylprodigiosin analogue 181.  
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Figure 4.25: A533 chromatogram from LC-MS analysis of the mycelial extracts of S. albus + 
redHG fed with 2-UP analogue 180 and MBC 19 
The lack of any RedG-derived products is presumably a result of substrates with extra bulk at 
the C-8’ position are not tolerated by RedG.  This is consistent with that observation for 2-UP 
analogues Z- and E-118 to S. albus + redHG. 
4.7 Feeding of a methyl-substituted pyrrole analogue to 
Streptomyces albus + redHG 
As discussed in Section 2.8, feeding of 2-UP analogue 207 containing an additional methyl 
group on the dialkylpyrrole would probe the steric tolerance of the RedG-catalysed oxidative 
carbocylisation.  If the additional methyl group on the pyrrole ring prevents cyclisation, it is 
possible that the undecyl chain could undergo desaturation or hydroxylation as a shunt 
product, Scheme 4.12. 
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Scheme 4.12: The undecylprodigiosin analogue 211 and proposed desaturated product 299, 
hydroxylated product 300 in addition to the oxidative carbocyclised product 212 to result 
from feeding S. albus + redHG with 2-UP analogue 207 and MBC 19 
During the feeding of 2-UP analogue 207, it was noticed that the biomass had a much more 
intense red colour when compared to the natural substrate 2-UP 20.  Comparison of the A533 
chromatograms from LC-MS analysis of the mycelial extract of S. albus + redHG fed with MBC 
19 and either 2-UP 20 or 2-UP analogue 207 revealed that substantially more of the 
corresponding undecylprodigiosin analogue 211 was produced, Figure 4.26. 
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Figure 4.26: A comparison of the A533 chromatograms from the LC-MS analysis of the mycelial 
extracts of S. albus + redHG fed with MBC 19 and either 2-UP 20 (blue) or 2-UP analogue 207 
(red) 
Presumably, this increase in production of undecylprodigiosin analogue 211 is a result of the 
additional electron-donating methyl group increasing the nucleophilicity of the pyrrole, 
causing the condensation with MBC 19 to occur much more rapidly.  To confirm that the 
additional undecylprodigiosin analogue 211 production was a result of RedH and not non-
enzymatic acid-condensation of 2-UP analogue 207 and MBC 18, the feeding experiment was 
repeated with wild type S. albus and S. albus + redH, Figure 4.27 
Figure 4.27: A comparison of the extracted ion chromatograms at m/z = 403.30 from LC-MS 
analysis of the mycelial extracts of S. albus + redHG (red), S. albus + redH (blue) and S. albus 
wild type (yellow) fed with 2-UP analogue 207 and MBC 19 
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As shown in Figure 4.27, significantly more undecylprodigiosin analogue 211 is formed in the 
presence of RedH.  However, even with this substantial increase in substrate, no RedG-derived 
products were observed. 
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5. Conclusion and Future Work 
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In the course of this research, a range of 2-UP analogues bearing specific functional groups 
have been synthesised in an effort to probe the remarkable oxidative carbocyclisation 
reaction catalysed by RedG.   
Initial feeding experiments were performed in a mutant of S. coelicolor blocked in the 
biosynthesis of 2-UP.  During the course of these experiments, it became apparent that the 
activity of both RedH and RedG decreased over the course of several months.  It remains 
unclear why the activity of this mutant decreased; perhaps mutations accumulated in the 
redH and redG gene resulting in inactivation of the corresponding enzyme.  Whatever the 
cause for this decrease in activity, an alternative feeding method was developed in which 
redH and redG were heterologously expressed in S. albus.   
Feeding of 2-UP 20 and MBC 19 to the S. albus + redHG strain resulted in a 1:1 ratio of 
streptorubin B 6 to undecylprodigiosin 4, as previously observed by Paulina Sydor.  It was 
noticed that, over the course of several weeks, the activity of RedG decreased while RedH 
activity remained constant.  The most likely explanation for this decrease in activity is 
unforeseen toxic effects of redG expression on S. albus, leading to an accumulation of 
mutations in the redG gene, resulting in inactivation of RedG.  To explore this hypothesis 
further, the redG gene from S. albus + redHG samples that lost activity could be sequenced to 
determine if any of the codons for catalytically-essential amino acid residues have been 
mutated. 
5.1 Sulphur containing 2-UP analogues 
Feeding of 2-UP analogue 101 that replaced the C-7’ with a sulphur atom trapped the 
proposed reactive oxygen species as a sulphoxide.  The origin of the sulphoxide oxygen atom 
was confirmed to originate from molecular oxygen by incorporation of an 18O atom when the 
experiment was repeated under an atmosphere of 18O2.  Interestingly, oxidation to the 
sulphone, via the sulphoxide as shown by the 18O2 incorporation experiment, was also 
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observed.  It is not clear at the moment whether RedG is responsible for this second oxidation 
reaction, or whether it is a result of another enzyme present in S. albus.  To discriminate 
between these possibilities, feeding of sulphoxide 103 to S. albus + redHG and S. albus + redH 
could be undertaken to investigate if sulphone production is RedG-dependent. 
Several other sulphur-containing 2-UP analogues were synthesised, in which the sulphur atom 
was moved away from C-7’.   Oxidation of the sulphide to the corresponding sulphoxide and 
sulphone was observed in each case, with the extent of sulphur oxidation decreasing as the 
sulphur atom was moved away from C-7’.  It was not until C-4’ and C-10’ were replaced with 
sulphur atoms that putative streptorubin B analogue were detected.  To confirm the 
structures of these putative streptorubin B analogues, isolation via HPLC and structure 
elucidation using NMR spectroscopy would be required. 
  5.2 Ether containing 2-UP analogues 
Previous work by Stuart Haynes indicated that feeding of 2-UP analogue 85, in which C-6’ is 
replaced with an oxygen atom, results in dealkyation of the corresponding undecylprodigiosin 
analogue.  Repeating this experiment in S. albus + redHG resulted in the detection of a 
compound with the expected m/z for the dealkylated product.  The identity of this compound 
was confirmed as the dealkylated undecylprodigiosin analogue 76 by comparison with a 
synthetic authentic standard. 
 Feeding of 2-UP analogue 86, in which C-8’ had been replaced with an oxygen atom, resulted 
in the formation of the corresponding undecylprodigiosin analogue via the action of RedH.  
However, none of the expected dealkylated aldehyde product was observed.  This is 
presumably due to the instability of the aldehyde functional group in vivo resulting in 
degradation of the expected product.  It is also possible that the corresponding 
undecylprodigiosin analogue 87 is not a substrate for RedG. 
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5.3 Cyclopropane containing 2-UP analogues 
Feeding of 2-UP analogues Z- and E-118 bearing cyclopropanes between C-8/9’ resulted in the 
production of the corresponding undecylprodigiosin analogues via the action of RedH.  
However, no products resulting from the action of RedG were detected.  It was noticed that 
feeding of Z-118 had a detrimental effect on the growth of the S. albus + redHG strain.  This 
may be responsible for the lack of products of RedG-catalysis.  This toxic effect was most 
probably due to changes in cell membrane fluidity as a result Z-118 embedding in the 
membrane.  Alternatively, RedG may not tolerate substrates containing extra bulk C-8’. 
5.4 Branched methyl containing 2-UP analogues 
Feeding of 2-UP analogue 180 bearing a methyl substituent at C-8’ resulted in the production 
of the corresponding undecylprodigiosin analogue 181 via the action of RedH.  However, no 
products resulting from the action of RedG were detected, presumably because substrates 
with extra bulk at C-8’ are not tolerated by RedG.   
5.5 Methyl-substituted pyrrole containing 2-UP analogue 
Feeding of 2-UP analogue 207 resulted in a substantial increase in the amount of 
undecylprodigiosin analogue produced relative to the natural substrate 2-UP 20.  This increase 
in activity of RedH is presumably a result of the increased nucleophilicity of the pyrrole ring 
due to the electron-donating properties of the additional methyl group.  However, no 
products resulting from the actions of RedG were detected.   
5.6 Stereoselectively deuterium-labelled 2-UP  
Feeding of 2-UP analogues S- and R-232 containing a deuterium-label in place of one of the 
prochiral hydrogen atoms attached to C-7’ resulted in productions of the corresponding 
undecylprodigiosin analogues via the action of RedH.  RedG-catalysed oxidative 
carbocyclisation of pro-S labelled undecylprodigiosin resulted in 92% retention of the 
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deuterium label, whereas 77% loss of the deuterium label was observed for the pro-R labelled 
undecylprodigiosin.  This indicates that the RedG-catalysed oxidative carbocyclisation 
proceeds via stereoselective abstraction the pro-R hydrogen atom from C-7’, followed by 
inversion of the resulting carbon-centred radical and attack on the pyrrole.  This inversion of 
configuration at the carbon atom undergoing functionalisation is in contrast with the majority 
of reactions catalysed by other non-haem iron-dependent oxidative cyclases, for which 
retention of configuration is the norm.  In these other non-haem iron-dependent oxidative 
cyclases, the group that traps the carbon-centred radical tends to be ligated to the non-haem 
iron atom and so is delivered to the same face of the carbon atom that the hydrogen atom is 
abstracted from.   In the case of RedG, the carbon-centred radical does not react with a ligand 
of the non-haem iron atom but reacts with a pyrrole carbon, which needs to be shielded from 
the reactive oxygen species generated at the iron-centre to prevent pyrrole oxidation. 
5.7 Implications for RedH 
RedH appears to exhibit relatively relaxed substrate specificity with regard to the undecyl 
chain of 2-UP 20.  All of the 2-UP analogues synthesised in this project, bearing heteroatoms, 
methyl groups and cyclopropanes were substrates for RedH and resulted in substantial 
production of the corresponding undecylprodigiosin analogues.  RedH was also able to utilise 
2-UP analogue 207 bearing a methyl group on the pyrrole, resulting in an increased 
production of the corresponding undecylprodigiosin analogue 211. 
Comparison of the feeding of 2-UP 20 and MBC 19 to S. albus + redH and S. albus + redHG 
revealed that the RedH-catalysed condensation reaction occurs more rapidly in the presence 
of RedG.  A possible explanation for this increased rate of condensation could be that RedH 
and RedG form a catalytic complex in vivo enhancing the activity of both enzymes.  Indeed, 
previous work by Paulina Sydor had revealed that RedG is more active in the presence of 
RedH.   
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5.8 Implications for the RedG mechanism 
At the beginning of this work, little was known regarding the mechanism by which RedG 
converts undecylprodigiosin 4 to streptorubin B 6.  A proposed mechanism, based on another 
Rieske non-haem iron-dependent enzyme NDO, predicted that RedG would utilise molecular 
oxygen as the oxidant and would proceed via abstraction of a hydrogen atom from C-7’ to 
generate a carbon-centred radical that subsequently cyclises onto the pyrrole, furnishing the 
macrocycle.  Based on other non-haem iron-dependent oxidative cyclases, it was also 
expected that oxidative carbocyclisation would proceed with retention of configuration at 
C-7’. 
Evidence that RedG does indeed utilise molecular oxygen as the oxidant during the oxidative 
carbocyclisation has been obtained using sulphur-containing analogues.  It has also been 
demonstrated that RedG stereoselectively abstracts the pro-R hydrogen atom from C-7’ and 
that functionalisation of this carbon atom proceeds with inversion of configuration.  This 
stereochemical course contrasts with the majority of reactions catalysed by other oxidative 
cyclases, which typically proceed with retention of configuration at the carbon atom 
undergoing functionalisation. 
It has also been demonstrated that RedG is capable of catalysing a dealkylation reaction of 
ether containing substrate analogues.   A summary of the insight into the catalytic mechanism 
of RedG obtained through this work is shown in Figure 5.1. 
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Figure 5.1: A summary of the insight into the catalytic mechanism of RedG obtained through 
this work 
 5.9 Future work 
To aid in further investigation of the catalytic mechanism of RedG, it would be advantageous if 
a method to provide functional recombinant RedG could be developed to allow for in vitro 
investigations.  The use of recombinant RedG would overcome several of the problems 
encountered during this work with inconsistent reproducibility and loss of RedG-activity over 
time.  However, efforts to purify recombinant RedG has been unsuccessful because, like many 
other Rieske non-haem iron-dependent enzymes, recombinant RedG is unstable under 
aerobic conditions, resulting in rapid loss of the Rieske iron-sulphur cluster, essential for 
activity.  A method that provides recombinant RedG could potentially allow for X-ray 
crystallographic investigation into the structure of RedG.  Such investigations could reveal the 
orientation of substrate binding within the active site, to help explain why the RedG-catalysed 
oxidative carbocyclisation proceeds with inversion of configuration at the carbon atom being 
functionalised. 
Very recently, Rebin Salih, a current PhD student in the Challis group, has expressed mcpH and 
mcpG, homologues of redH and redG involved in the biosynthesis of metacycloprodigiosin 5, 
in Streptomyces albus.  He has demonstrated that feeding of chemically synthesised 2-UP 20 
and MBC 19 results in the production of undecylprodigiosin 4 and metacycloprodigiosin 5.  
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Since McpG is proposed to catalyse the oxidative carbocyclisation of undecylprodigiosin 4 into 
metacycloprodigiosin 5 via an analogous mechanism to that of RedG, several of the 2-UP 
analogues synthesised in this work could be used to investigate this reaction (e.g. the sulphur-
containing 2-UP analogues).  The origin of the opposite stereochemistry of 
metacycloprodigiosin 5 at C-9’ could be investigated via an analogous stereoselective labelling 
experiment to that performed for RedG, Scheme 5.1.  McpG may yield the opposite 
stereochemistry to RedG by either stereoslectively abstracting the pro-S hydrogen atom from 
C-9’ with subsequent inversion of configuration, or by stereoselectively abstracting the pro-R 
hydrogen atom from C-9’ with subsequent rentention of configuration.  McpG may also 
tolerate a 2-UP analogue bearing a cyclopropane at C-10’/11’ better than RedG to investigate 
the possibility that a carbon-centred radical is formed. 
Scheme 5.1: The analogous stereoselectively deuterium-labelled 2-UP 301 experiment to 
investigate the stereochemical course of the McpG-catalysed oxidative carbocyclisation in 
metacycloprodigiosin 5 biosynthesis 
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6. Experimental  
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6.1 Chemistry experimental 
All reagents were purchased from Sigma Aldrich, Alfa Aesar, Acros Organic, TCI, FluoroChem 
or VWR and used without further purification unless otherwise stated. 
All solvents were purchased from Fischer Scientific and used without further purification 
unless otherwise stated. 
Flash chromatography was conducted on Fluka silica gel (40-63 μm, 60Å).  TLC was performed 
on aluminium backed plates pre-coated with Merck silica gel 60 F254 and was visualised with 
UV radiation, potassium permanganate, bromocresol or 2,4-DNP stains. 
All 1H-NMR spectra were obtained using a Bruker DPX400 spectrometer at 400 MHz equipped 
with a Proton Carbon Dual Probe.  600 MHz and 700 MHz 1H-NMR spectra were obtained by 
the University of Warwick NMR service using Bruker AVIII600 or 700 instrument equipped 
with a BBO probe and TCI cryoprobe respectively.  Deuterated solvents were purchased from 
Sigma Aldrich and used as supplied. 
IR spectra were recorded using a Perkin Elmer Avatar 320 Fourier Transformation spectromer.  
Selected absorptions are recorded and given in units of wave numbers. 
Low resolution ESI mass spectra were recorded using a Bruker Esquire 2000 spectrometer or 
an Agilent 6130B single quad mass spectrometer.  HRMS spectra were measured by the 
University of Warwick mass spectrometry service on Bruker MaXis or MicroTOF mass 
spectrometers.  GC-MS spectra were obtained using a Varian 4000 instrument fitted with a 
Varian CP8944 VF (5 µm 30 x 0.25 mm) column. 
Melting points were measured using a Stuart Scientific SMP10 melting point apparatus and 
were uncorrected. 
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Acetone distillation 
Acetone was heated to 50 oC over activated 4Å molecular sieves for 3 hours before being 
collected by distillation at 65 oC.  The dry acetone was stored over activated 4 Å molecular 
sieves under argon. 
Acetonitrile distillation 
Acetonitrile was heated to 70 oC over calcium hydride for 2 hours before being collected by 
distillation at 105 oC.  The dry acetonitrile was stored over activated 4 Å molecular sieves 
under argon. 
Dichloromethane distillation 
CH2Cl2 was heated to 35 
oC over calcium hydride for 3 hours before being collected by 
distillation at 65 oC.  The dry CH2Cl2 was stored over activated 4 Å molecular sieves under 
argon. 
Diisopropyl amine distillation 
Diisopropyl amine was heated to 80 °C over calcium hydride for 2 hours before being collected 
by distillation at 100 oC.  The dry diisoprpylamine was stored under argon. 
Pyridine distillation 
Pyridine was heated to 110 oC over calcium hydride for 2 hours before being collected by 
distillation at 130 oC.  The dry pyridine was stored over dried KOH pellets under argon.  
2,2,6,6-Tetramethyl piperidine distillation 
2,2,6,6-Tetramethyl piperidine was heated to 100 oC over calcium hydride for 2 hours before 
being collected by distillation at 155 oC.  The dry 2,2,6,6-tetramethyl piperidine was used 
immediately for reactions.    
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n-Butyl lithium titration119 
To a solution of diphenyl acetic acid (100 mg, 0.50 mmol) in THF (2 ml), under argon, was 
added enough n-butyl lithium solution to give a persistent yellow colour.  This was repeated 
three times and the average titre used to calculate the initial n-butyl lithium concentration.  
IBX synthesis120 
To a solution of Oxone (32.50 g, 52.42 mmol) in water (130 ml) was added 2-iodobenzoic acid 
(10.00 g, 40.32 mmol) and the resulting thick slurry vigorously stirred for 3 hours while being 
heated to 75 oC.  The reaction mixture was cooled to 0 oC and stirred for an additional 
1.5 hours before the solid was collected via filtration.  The solid was washed with water and 
acetone to give IBX as a bright white solid.  1H-NMR of this material was identical to that 
reported in the literature. 
p-Toluenesulphonyl chloride recrystalisation 
To a solution of commercially available p-toluenesulphonyl chloride (25.00 g) in chloroform 
(100 ml) was added pet ether (500 ml) and the resulting mixture stirred for 15 mins.  The 
resulting mixture was filtered through celite and solvent removed under vacuum to leave the 
purified p-toluenesulphonyl chloride as a bright white solid. 
General procedure for sulphide synthesis121 
To a solution of n-butyl lithium (1.25 eq) in THF, under argon cooled to 0 oC, was added the 
required thiol (1.2 eq) in THF.  The resulting white precipitate was stirred for 10 mins before 
the required bromo ester (1 eq) in THF was added and allowed to warm to RT over 30 mins.  
Water was added to the reaction mixture and it was extracted with Et2O.  The combined 
organics were washed with brine, dried (MgSO4) and concentrated under vacuum to give the 
desired sulphide.  
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General procedure for ester hydrolysis 
To a solution of the required sulphide ester in THF, under argon, was added 2.35 M sodium 
hydroxide and the reaction was heated to 75 oC for 16 hours.  The THF was removed under 
vacuum and the aqueous layer acidifed with conc HCl to pH 1 before being extracted with 
EtOAc.  The combined organic layers were washed with brine, dried (MgSO4) and 
concentrated under vacuum to give the desired carboxylic acid. 
General procedure for coupling of carboxylic acid with pyrrole122 
A solution of carboxylic acid, 2,2’-dipyridyl disulphide (2 eq) and triphenyl phosphine (2 eq) in 
toluene, under argon, was stirred for 16 hours.  This solution was cooled to -78 oC and pyrryl 
magnesium bromide (3 eq), prepared by adding ethyl magnesium bromide to freshly distilled 
pyrrole in toluene at -40 oC, was added and stirred vigorously for 45 mins.   Saturated NH4Cl 
solution was added and extracted with EtOAc.  The combined organics were washed with 5% 
K2CO2, 2M HCl, brine, dried (MgSO4) and concentrated under vacuum.  The crude product was 
purified by flash column chromatography. 
General procedure for the reduction of acyl ketone 
A suspension of sodium borohydride (6 eq) in propan-2-ol (under argon for sulphides), was 
heated to 85 oC for 60 mins before the acyl ketone in propan-2-ol was added and stirred for 
16 hours.  Water was added to dissolve the solid and the aqueous layer extracted with EtOAc.  
The combined organics were washed with brine, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified by flash column chromatography. 
General procedure for Swern Oxidation123 
To a solution of oxalyl chloride (1.7 eq) in CH2Cl2, cooled to -78 
oC under argon, was added 
DMSO (2.5 eq) in CH2Cl2 dropwise and allowed to stir for 10 mins.  The desired alcohol (1 eq) 
in CH2Cl2 was added and the reaction stirred for an additional 45 mins.  Triethylamine (5 eq) 
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was added and the reaction mixture allowed to warm to RT over 20 mins.  Water was added 
to dissolve the white solid and extracted with CH2Cl2.  The combined organics were washed 
with 2M HCl, sat NaCO3, brine, dried (MgSO4) and concentrated under vacuum to give the 
desired aldehyde. 
General procedure for Oxone Oxidation124 
To a solution of aldehyde in DMF was added Oxone (1.5 eq) and the resulting suspension 
stirred for 30 mins.  2M HCl was added and the aqueous layer extracted with EtOAc.  The 
combined organics were dried (MgSO4) and concentrated under vacuum.  The residue was left 
under high vacuum for 24 hours to remove residual DMF. 
 6.1.1 Synthesis of sulphur containing 2-UP analogues 
Ethyl (8-ethylsulfanyl)octanoate 
Following the general sulphide procedure, work up gave ethyl (8-ethylsulfanyl)octanoate 
(2.76 g, 99% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.05 (q, 2H, H-2, J=7.2Hz), 2.49 – 2.43 (m, 4H, H-10 and 11), 2.22 
(t, 2H, H-4, J=7.5Hz), 1.59 – 1.47 (m, 4H, H-5 and 9), 1.31 (m, 2H, H-8), 1.25 (m, 4H, H-6 and 7), 
1.18 (m, 6H, H-1 and 12) 
13C-NMR (CDCl3, 100 MHz) δ: 172.83 (C-3), 59.16 (C-2), 33.32 (C-4), 30.61, 28.55, 27.89, 27.87, 
27.72, 24.92, 23.89, 13.79 (C-1 or 12), 13.25 (C-1 or 12) 
IR (cm-1): 1733 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1395 
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Ethyl (7-propylsulfanyl)heptanoate 
Following the general sulphide procedure, work up gave ethyl (7-propylsulfanyl)heptanoate 
(2.84 g, 97% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.06 (q, 2H, H-2, J=7.1Hz), 2.45 – 2.30 (m, 4H, H-9 and 10), 2.22 
(t, 2H, H-4, J=7.4Hz), 1.60 – 1.48 (m, 6H, H-5, 8 and 11), 1.37 – 1.23 (m, 4H, H-6 and 7), 1.19 (t, 
3H, H-1, J=7.2Hz), 0.92 (t, 3H, H-12, J=7.7Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 173.80 (C-3), 60.21 (C-2), 34.30 (C-4), 34.25, 32.03, 29.54, 28.76, 
28.56, 24.86, 23.02, 14.27 (C-1), 13.55 (C-12) 
IR (cm-1): 1733 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1390 
Ethyl (6-butylsulfanyl)hexanoate  
Following the general sulphide procedure, work up gave ethyl (6-butylsulfanyl)hexanoate 
(1.02 g, 98% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.11 (q, 2H, H-2, J=7.1Hz), 2.48 (m, 4H, H-8 and 9), 2.29 (t, 2H, 
H-4, 7.3Hz), 1.59 (m, 6H, H-5, 7 and 10),  1.40 (m, 4H, H-6 and 11), 1.24 (t, 3H, H-1, 7.0Hz), 
0.90 (t, 3H, H-12, 7.3Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 173.67 (C-3), 60.24 (C-2), 34.23 (C-4), 31.94 (C-8), 31.86 (C-9), 
31.82 (C-10), 29.36 (C-7), 28.40 (C-6), 24.61 (C-5), 22.05 (C-11), 14.27 (C-1), 13.71 (C-12) 
IR (cm-1): 1733 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1389 
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Ethyl (5-pentylsulfanyl)pentanoate 
Following the general sulphide procedure, work up gave ethyl (5-pentylsulfanyl)pentanoate 
(1.07 g, 96% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.06 (q, 2H, H-2, J=7.0Hz), 2.44 (m, 4H, H-7 and 8), 2.25 (t, 3H, 
H-4, J=7.4Hz), 1.70 (m, 2H, H-5), 1.63 – 1.59 (m, 4H, H-6 and 9), 1.31 – 1.23 (m, 4H, H-10 and 
11), 1.10 (t, 3H, H-1, J=7.6Hz), 0.83 (t, 3H, H-12, J=7.2Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 173.80 (C-3), 60.21 (C-2), 34.30 (C-4), 34.25 (C-10), 32.03 (C-9), 
29.54 (C-8), 28.76 (C-7), 28.56 (C-6), 24.86 (C-5), 23.02 (C-11), 14.27 (C-1), 13.55 (C-12) 
IR (cm-1): 1735 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1385 
Ethyl (4-hexylsulfanyl)butanoate 
Following the general sulphide procedure, the crude product was purified on silica gel (3% 
EtOAc in pet ether) to give ethyl (4-hexylsulfanyl)butanoate (1.18 g, 99% yield) as a colourless 
oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.06 (q, 2H, H-2, J=7.1Hz), 2.45 (m, 4H, H-6 and 7), 2.36 (t, 2H, 
H-4, J=7.3Hz), 1.84 (m, 2H, H-5), 1.50 (m, 2H, H-8), 1.31 (m, 2H, H-9), 1.25 – 1.17 (m, 7H, H-1, 
10 and 11), 0.81 (t, 3H, H-12, J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 173.10 (C-3), 60.39 (C-2), 33.16 (C-4), 32.00 (C-7), 31.46 (C-10), 
31.36 (C-6), 29.61 (C-8), 28.61 (C-9), 24.80 (C-5), 22.57 (C-11), 14.25 (C-1), 14.05 (C-11) 
IR (cm-1): 1732 (C=O stretch) 
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HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1387 
Ethyl (3-heptylsulfanyl)propanoate 
Following the general sulphide procedure, the crude product was purified on silica gel (4% 
EtOAc in pet ether) to give ethyl (3-heptylsulfanyl)propanoate (1.28 g, 100% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.09 (q, 2H, H-2, J=7.2Hz), 2.71 (t, 2H, H-4), 2.51 (m, 4H, H-5 and 
6), 1.51 (m, 2H, H-7), 1.31 (m, 2H, H-8), 1.26 – 1.18 (m, 9H, H-1, 9, 10 and 11), 0.81 (t, 3H, 
H-12, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 172.07 (C-3), 60.64 (C-2), 35.00 (C-5), 32.19 (C-6), 31.74 (C-10), 
29.58 (C-7), 28.90 (C-8), 28.84 (C-9), 27.02 (C-4), 22.61 (C-11), 14.22 (C-1), 14.08 (C-12) 
IR (cm-1): 1735 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1391 
Ethyl (2-octylsulfanyl)ethanoate 
Following the general sulphide procedure, the crude product was purified on silica gel (4% 
EtOAc in pet ether) to give ethyl (2-octylsulfanyl)ethanoate (2.43 g, 87% yield) as a colourless 
oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.12 (q, 2H, H-2, J=7.2Hz), 3.14 (s, 2H, H-4), 2.56 (t, 2H, H-5, 
J=7.2Hz), 1.53 (m, 2H, H-6), 1.27 – 1.20 (m, 11H, H-1, 8, 9, 10 and 11), 0.81 (t, 3H, H-12, 
J=7.5Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 170.66 (C-3), 61.28 (C-2), 33.76 (C-4), 32.73 (C-5), 31.81 (C-10), 
29.17, 29.15, 29.03 (C-6), 28.78 (C-7), 22.65 (C-11), 14.19 (C-1), 14.10 (C-12) 
IR (cm-1): 1732 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1392 
Ethyl (9-methylsulfanyl)nonanoate 
To a suspension of sodium thiomethoxide (1.59 g, 22.62 mmol) in DMF (20 ml), heated to 
80 oC under argon, was added ethyl 9-bromononanoate (2.00 g, 7.75 mmol) and the reaction 
stirred for 32 hours.  The reaction mixture was poured into 2M HCl and extracted with EtOAc.  
The combined organics were dried (MgSO4) and concentrated under vacuum.  The crude 
product was purified on silica gel (10% EtOAC increasing to 50% EtOAc in pet ether) to give 
ethyl (9-methylsulfanyl)nonanoate (411 mg, 24% yield) as a colourless oil and 
(9-methylsulfanyl)nonanoic acid (684 mg, 44 % yield) as a white solid.   
1H-NMR (CDCl3, 400 MHz) δ: 4.05 (q, 2H, H-2, J=7.0Hz), 2.41 (t, 2H, H-1, J=7.0Hz), 2.22 (t, 2H, 
H-4, J=7.2Hz), 2.03 (s, 3H, H-12), 1.58 – 1.48 (m, 4H, H-5 and 10), 1.34 – 1.24 (m, 8H, H-6 to 9), 
1.19 (t, 3H, H-1, J=7.2Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 172.86 (C-3), 59.15 (C-2), 33.45, 33.27, 28.13, 28.03, 27.72, 
23.93, 14.53 (C-12), 13.25 (C-1).  2 signals missing. 
IR (cm-1): 1733 (C=O stretch) 
HRMS: m/z calculated for C12H24O2SNa = 255.1395 [M+Na]
+; Found 255.1392 
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(9-Methylsulfanyl)nonanoic acid 
Following the general ester hydrolysis procedure, work up gave (9-methylsulfanyl)nonanoic 
acid (241 mg, 90% yield) as a brown solid. 
1H-NMR (CDCl3, 400 MHz) δ: 2.42 (t, 2H, H-9, J=7.0 Hz), 2.28 (t, 2H, H-2, J=7.0 Hz), 2.03 (s, 3H, 
H-10), 1.60 – 1.48 (m, 4H, H-3 and 8), 1.34 – 1.19 (m, 8H, H-4 to 7) 
13C-NMR (CDCl3, 100 MHz) δ: 179.82 (C-1), 34.28 (C-9), 33.98 (C-2), 29.13, 29.03, 28.98, 28.73, 
24.64 (C-3), 15.55 (C-10).  1 signal missing. 
IR (cm-1): 3037 (H-O stretch), 1705 (C=O stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1076 [M+Na]
+; Found 277.1075 
Melting point (oC): 35 – 36 
(8-Ethylsulfanyl)octanoic acid) 
Following the general ester hydrolysis procedure, work up gave (8-ethylsulfanyl)octanoic acid 
(2.42 g, 100% yield) as a white waxy solid. 
1H-NMR (CDCl3, 400 MHz) δ: 2.49 (m, 4H, H-8 and 9), 2.28 (t, 2H, H-2, J=7.5 Hz), 1.57 (m, 2H, 
H-3), 1.51 (m, 2H, H-7), 1.34 – 1.28 m, 6H, H-4 to 6), 1.19 (t, 3H, H-10, J=7.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.90 (C-1), 33.82 (C-2), 31.63, 29.56, 28.93, 28.87, 28.71, 
25.95, 24.61 (C-3), 14.94 (C-10) 
IR (cm-1): 3035 (H-O stretch), 1703 (C=O stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1076 [M+Na]
+; Found 277.1075 
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Melting point (oC): 34 – 36 
(7-Propylsulfanyl)heptanoic acid 
Following the general ester hydrolysis procedure, work up gave (7-propylsulfanyl)heptanoic 
acid (2.48 g, 99% yield) as a dark yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.45 – 2.30 (m, 4H, H-7 and 8), 2.29 (t, 2H, H-2, J=7.6Hz), 1.61 – 
1.48 (m, 6H, H-3, 6 and 9), 1.38 – 1.26 (m, 4H, H-4 and 5), 0.92 (t, 3H, H-10, J=7.3Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 180.08 (C-1), 34.25 (C-8), 33.98 (C-2), 32.00 (C-7), 29.49 (C-6), 
28.66 (C-5), 28.51 (C-4), 24.53 (C-3), 23.01 (C-9), 13.54 (C-10) 
IR (cm-1): 3037 (H-O stretch), 1703 (C= stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1073 [M+Na]
+; Found 277.1075 
(6-Butylsulfanyl)hexanoic acid 105 
Following the general ester hydrolysis procedure, work up gave (6-butylsulfanyl)hexanoic acid 
(788 mg, 88% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.51 (m, 4H, H-6 and 7), 2.36 (t, 2H, H-2, J=7.6Hz), 1.61 (m, 6H, 
H-3, 5 and 8), 1.43 (m, 4H, H-4 and 9), 0.91 (t, 3H, H-10, J=7.3Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 179.85 (C-1), 34.00 (C-2), 32.02 (C-6), 32.00 (C-7), 31.93 (C-8), 
29.44 (C-5), 28.42 (C-4), 22.17 (C-9), 24.42 (C-3), 13.83 (C-10) 
IR (cm-1): 3214 (H-O stretch), 1705 (C=O stretch) 
HRMS: m/z calculated for C10H19O2S = 203.1111 [M-H]
-; Found 203.1104 
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(5-Pentylsulfanyl)pentanoic acid 262 
Following the general ester hydrolysis procedure, work up gave (5-pentylsulfanyl)pentanoic 
acid (859 mg, 91% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.47 – 2.41 (m, 4H, H-5 and 6), 2.31 (t, 2H, H-2, J=7.0Hz), 1.72 (m, 
2H, H-3), 1.64 – 1.61 (m, 4H, H-4 and 7), 1.31 – 1.23 (m, 4H, H-8 and 9), 0.83 (t, 3H, H-10, 
J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 179.82 (C-1), 33.59 (C-2), 32.14 (C-6), 31.64 (C-5), 31.10 (C-8), 
29.36 (C-7), 28.95 (C-4), 23.83 (C-3), 22.31 (C-9), 13.98 (C-10) 
IR (cm-1): 3216 (H-O stretch), 1706 (C=O stretch) 
HRMS: m/z calculated for C10H19O2S = 203.1111 [M-H]
-; Found 203.1103 
(4-Hexylsulfanyl)butanoic acid 
Following the general ester hydrolysis procedure, work up gave (4-hexylsulfanyl)butanoic acid 
(1.18 g, 99% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.50 (m, 2H, H-4), 2.43 (m, 4H, H-2 and 5), 1.85 (qu, 2H, H-3, 
J=7.3Hz), 1.50 (qu, 2H, H-6, J=7.3Hz), 1.29 (m, 2H, H-7), 1.25 – 1.17 (m, 4H, H-8 and 9), 0.82 (t, 
3H, H-10, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 179.21 (C-1), 32.73 (C-2), 31.98 (C-5), 31.45 (C-8), 31.21 (C-4), 
29.59 (C-6), 28.59 (C-7), 24.80 (C-3), 22.56 (C-9), 14.05 (C-10) 
IR (cm-1): 1705 (C=O stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1076 [M+Na]
+; Found 227.1076 
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(3-Heptylsulfanyl)propanoate 
Following the general ester hydrolysis procedure, work up gave (3-heptylsulfanyl)propanoic 
acid (1.12 g, 99% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.71 (t, 2H, H-2, J=6.5Hz), 2.59 (t, 2H, H-3, J=6.5Hz), 2.47 (t, 2H, 
H-4, J=7.4Hz), 1.52 (m, 2H, H-5), 1.29 (m, 2H, H-6), 1.24 – 1.18 (m, 6H, H- 7, 8 and 9), 0.81 (t, 
3H, H-10, J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 177.90 (C-1), 34.67 (C-3), 32.23 (C-4), 31.73 (C-8), 29.54 (C-5), 
28.89 (C-7), 28.83 (C-6), 26.61 (C-2), 22.61 (C-9), 14.08 (C-10) 
IR (cm-1): 1684 (C=O stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1076 [M+Na]
+; Found 227.1073 
(2-Octylsulfanyl)ethanoic acid 
Following the general ester hydrolysis procedure, work up gave (2-octylsulfanyl)ethanoic acid 
(2.02 g, 94% yield) as a brown oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.19 (s, 2H, H-2), 2.59 (t, 2H, H-3, J=7.4Hz), 1.54 (m, 2H, H-4), 1.31 
(m, 2H, H-5), 1.25 – 1.20 (m, 8H, H- 6, 7, 8 and 9), 0.81 (t, 3H, H-9, J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 175.66 (C-1), 33.50 (C-2), 32.85 (C-3), 31.80 (C-8), 29.15 (C-7), 
28.92 (C-4), 28.83 (C-5), 28.75 (C-6), 22.65 (C-9), 14.10 (C-9) 
IR (cm-1): 1703 (C=O stretch) 
HRMS: m/z calculated for C10H20O2SNa = 227.1076 [M+Na]
+; Found 227.1074 
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(9-Methlysulfanyl)-1-(pyrrole-2-yl)nonan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in pet ether) to give (9-methylsulfanyl)-1-(pyrrole-2-yl)nonan-1-one 
(787 mg, 49% yield) as a white solid. 
1H-NMR (CDCl3, 400 MHz): 9.42 (bs, 1H, H-N), 6.95 (m, 1H, H-1), 6.84 (m, 1H, H-3), 6.21 (m, 1H, 
H-2), 2.69 (t, 2H, H-6, J=7.2Hz), 2.41 (t, 2H, H-13, J=7.3Hz), 2.02 (s, 3H, H-14), 1.64 (m, 2H, 
H-7), 1.51 (m, 2H, H-8), 1.34 – 1.32 (m, 8H, H-9 to 12) 
13C-NMR (CDCl3, 100 MHz): 191.15 (C-5), 132.08 (C-4), 124. 32 (C-3), 115.98 (C-1), 110.56 (C-2), 
38.01 (C-6), 34.28 (C-13), 29.39, 29.34, 29.15, 29.10, 28.78, 25.24 (C-7), 15.56 (C-14) 
IR (cm-1): 3283 (N-H stretch), 1640 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1392 [M+Na]
+; Found 276.1390 
(8-Ethylsulfanyl)-1-(pyrrole-2-yl)octan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in pet ether) to give (8-ethylsulfanyl)-1-(pyrrole-2-yl)octan-1-one (2.68 g, 
89% yield) as a yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 6.95 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.75 (m, 1H, H-2), 2.69 (t, 2H, 
H-6, J=7.3Hz), 2.49 – 2.42 (m, 4H, H-12 and 13), 1.65 (m, 2H, H-7), 1.51 (m, 2H, H-11), 1.36 – 
1.29 (m, 6H, H-8 to 10), 1.18 (m, 3H, H-14) 
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13C-NMR (CDCl3, 100 MHz) δ: 191.07 (C-5), 132.10 (C-4), 124.31 (C-3), 117.69 (C-1), 115.94 
(C-2), 37.97 (C-6), 31.64 (C-12), 29.60, 29.33, 29.07, 28.78, 25.94 (C-13), 25.20 (C-7), 14.83 
(C-14) 
IR (cm-1): 1680 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1398 [M+Na]
+; Found 276.1396 
(7-Propylsulfanyl)-1-(pyrrol-2-yl)heptan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in hexane) to give (7-propylsulfanyl)-1-(pyrrol-2-yl)heptan-1-one (2.34 g, 
76% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.39 (bs, 1H, N-H), 6.94 (m, 1H, H-1), 6.84 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.69 (t, 2H, H-6, J=7.0Hz), 2.43 (m, 4H, H-11 and 12), 1.66 (m, 2H, H-7), 1.60 – 1.49 
(4H, m, H-10 and 13), 1.40 – 1.27 (m, 4H, H-8 and 9), 0.91 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 190.96 (C-5), 132.07 (C-4), 124.30 (C-3), 115.93 (C-1), 110.58 
(C-2), 37.89 (C-6), 34.24, 32.05, 29.58, 29.06, 28.73, 23.02, 25.11 (C-7), 13.55 (C-14) 
IR (cm-1): 3280 (N-H stretch), 1633 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1398 [M+Na]
+; Found 276.1396 
(6-Butylsulfanyl)-1-(pyrrol-2-yl)hexan-1-one 106 
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Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in hexane) to give (6-butylsulfanyl)-1-(pyrrol-2-yl)hexan-1-one (795 mg, 
81% yield) as a orange oil.   
1H-NMR (CDCl3, 400 MHz) δ: 9.61 (bs, 1H, N-H), 7.03 (m, 1H, H-3), 6.90 (m, 1H, H-1), 6.27 (m, 
1H, H-2), 2.77 (t, 2H, H-6, J=7.2Hz), 2.51 (m, 4H, H-10 and 11), 1.74 (m, 2H, H-7), 1.66 – 1.35 
(m, 8H, H- 8, 9, 12 and 13), 0.91 (t, 3H, H-14, J=7.0 Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 191.10 (C-5), 132.22 (C-4), 124.78 (C-3), 116.34 (C-1), 110.74 
(C-2), 37.76 (C-6), 32.16 (C-10), 32.06 (C-11), 32.01 (C-12), 29.74 (C-9), 28.91 (C-8), 25.01 (C-7), 
22.24 (C-13), 13.91 (C-14) 
IR (cm-1): 1679 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1398 [M+Na]
+; Found 276.1392 
(5-Pentylsulfanyl)-1-(pyrrol-2-yl)pentan-1-one 263 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in hexane) to give (5-pentylsulfanyl)-1-(pyrrol-2-yl)pentan-1-one 
(795 mg, 81% yield) as an orange oil.   
1H-NMR (CDCl3, 400 MHz) δ: 9.71 (bs, 1H, N-H), 6.96 (m, 1H, H-1), 6.85 (m, 1H, H-3), 6.20 (m, 
1H, H-2), 2.72 (t, 2H, H-6, J=7.3Hz), 2.49 – 2.40 (m, 4H, H-9 and 10), 1.76 (m, 2H, H-7), 1.59 (m, 
2H, H-8), 1.50 (m, 2H, H-11), 1.26 – 1.20 (m, 4H, H-11 and 12), 0.82 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 190.63 (C-5), 131.97 (C-4), 124.67 (C-3), 116.22 (C-1), 110.58 
(C-2), 37.44 (C-6), 32.16 (C-10), 31.86 (C-9), 31.12 (C-13), 29.40, 24.43 (C-7), 22.33 (C-12), 
14.01 (C-14). 1 signal missing. 
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IR (cm-1): 3285 (N-H), 1678 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1398 [M+Na]
+; Found 276.1393 
(4-Hexylsulfanyl)-1-(pyrrol-2-yl)butan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in hexane) to give (4-hexylsulfanyl)-1-(pyrrol-2-yl)butan-1-one (2.34 g, 
76% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.39 (bs, 1H, H-N), 6.96 (m, 1H, H-1), 6.88 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.84 (t, 2H, H-6, J=7.3Hz), 2.52 (t, 2H, H-8, J=7.4Hz), 2.44 (t, 2H, H-9, J=7.5Hz), 1.94 
(qu, 2H, H-7, J=7.4Hz), 1.50 (qu, 2H, H-10, J=7.3Hz), 1.30 – 1.18 (m, 6H, H-11 to 13), 0.81 (t, 
3H, H-14, J=7.1Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 189.91 (C-5), 131.92 (C-4), 124.44 (C-1), 116.18 (C-3), 110.69 
(C-2), 36.58 (C-6), 31.97 (C-9), 31.68 (C-8), 31.68, 29.63 (C-10), 28.63 (C-11), 24.64 (C-7), 22.58, 
14.08 (C-14) 
IR (cm-1): 3282 (N-H stretch), 1634 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1393 [M+ Na]
+; Found 276.1391 
(3-Heptylsulfanyl)-1-(pyrrol-2-yl)propan-1-one 
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Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in hexane) to give (3-heptylsulfanyl)-1-(pyrrol-2-yl)propan-1-one 
(794 mg, 60% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.34 (bs, 1H, N-H), 6.97 (m, 1H, H-1), 6.87 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.99 (t, 2H, H-6, J=7.4Hz), 2.82 (t, 2H, H-7, J=7.4Hz), 2.48 (t, 2H, H-8, J=7.5Hz), 1.52 
(m, 2H, H-9), 1.34 – 1.20 (m, 8H, H-10 to 13), 0.81 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 188.57 (C-5), 131.90 (C-4), 124.74 (C-3), 116.35 (C-1), 110.81 
(C-2), 38.23, 32.49, 31.75, 29.63, 28.92, 28.88, 26.97, 22.62, 14.09 (C-14) 
IR (cm-1): 3287 (N-H stretch), 1641 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1393 [M+ Na]
+; Found 276.1390 
(2-Octylsulfanyl)-1-(pyrrol-2-yl)ethan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in hexane) to give (2-octylsulfanyl)-1-(pyrrol-2-yl)ethan-1-one (128 mg, 
53% yield) as a dark yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 6.98 (m, 1H, H-3), 6.88 (m, 1H, H-1), 6.23 (m, 1H, H-2), 3.54 (s, 
2H, H-6), 2.54 (m, 2H, H-7), 1.51 (m, 2H, H-8), 1.29 (m, 2H, H-9), 1.22 – 1.17 (m, 8H, H-10 to 
13), 0.80 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 185.73 (C-5), 132.24 (C-4), 125.08 (C-3), 116.86 (C-1), 110.98 
(C-2), 36.75 (C-6), 32.72 (C-7), 31.80, 29.17, 29.10, 28.82, 22.65, 14.11 (C-14).  1 signal missing. 
IR (cm-1): 3283 (N-H stretch), 1640 (C=O stretch) 
HRMS: m/z calculated for C14H23NOSNa = 276.1393 [M+ Na]
+; Found 276.1391 
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2-(9-Methylsulfanylnonyl)-pyrrole 266 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 2-(9-methylsulfanylnonyl)-pyrrole (700 mg, 95% 
yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.84 (bs, 1H, N-H), 6.60 (m, 1H, H-1), 6.01 (m, H-2), 5.84 (m, 1H, 
H-3), 2.52 (t, 2H, H-5, J=7.6Hz), 2.42 (t, 2H, H-13, J=7.3Hz), 2.03 (s, 3H, H-14), 1.58 – 1.48 (m, 
4H, H-6 and 12), 1.32 – 1.19 (m, 10H, H-7 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 132.61 (C-4), 115.99 (C-1), 108.25 (C-2), 104.86 (C-3), 34.32 
(C-13), 29.67, 29.46, 29.39, 29.37, 29.25, 29.18, 28.83, 27.74 (C-5), 15.58 (C-14) 
IR (cm-1): 3371 (N-H stretch) 
HRMS: m/z calculated for C14H26NS = 240.1780 [M+H]
+; Found 240.1787 
2-(8-Ethylsulfanyloctyl)-pyrrole 267 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (7% EtOAc in pet ether) to give 2-(8-ethylsulfanyloctyl)-pyrrole (1.74 g, 69% yield) as 
a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.84 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.52 (t, 2H, H-5, J=7.5Hz), 2.47 – 2.42 (m, 4H, H-12 and 13), 1.58 – 1.47 (m, 4H, H-6 
and 11), 1.36 – 1.25 (m, 8H, H-7 to 10), 1.18 (t, 3H, H-14, J=7.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.71 (C-4), 115.98 (C-1), 108.88 (C-2), 104.88 (C-3), 31.68 
(C-12), 29.64, 29.31, 29.17, 28.92, 27.73 (C-5), 25.95 (C-13), 14.83 (C-14). 2 signals missing. 
177 
 
IR (cm-1): 3370 (N-H stretch) 
HRMS: m/z calculated for C14H26NS = 240.1780 [M+H]
+ and C14H25NSNa = 262.1605 [M+Na]
+; 
Found 240.1785 and 262.1605 
2-(7-Propylsulfanylheptyl)-pyrrole 268 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in pet ether) to give 2-(7-propylsulfanylheptyl)-pyrrole (730 mg, 80% yield) 
as a yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.95 (bs, 1H, N-H), 6.68 (m, 1H, H-1), 6.15 (m, 1H, H-3), 5.93 (m, 
1H, H-2), 2.62 (t, 2H, H-5, J=7.2Hz), 2.53 (4H, m, H-11 and 12), 1.68 – 1.56 (m, 6H, H-6, 9 and 
10), 1.47 – 1.38 (m, 6H, H-7, 8 and 13), 0.94 (t, 3H, H-14, J=7.1Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.66 (C-4), 116.02 (C-1), 108.26 (C-3), 104.92 (C-2), 32.12 
(C-11), 31.87 (C-12), 31.83 (C-7), 29.57 (C-10), 29.56 (C-6), 28.90 (C-7), 28.66 (C-8), 27.62 (C-5), 
22.06 (C-13), 13.73 (C-14) 
IR (cm-1): 3379 (N-H stretch) 
HRMS: m/z calculated for C14H26NS = 240.1780 [M+H]
+; Found 240.1783  
2-(6-Butylsulfanylhexyl)-pyrrole 101 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in hexane) to give 2-(6-butylsulfanylhexyl)-pyrrole (531 mg, 71% yield) as a 
yellow oil. 
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1H-NMR (CDCl3, 600 MHz) δ: 7.95 (bs, 1H, N-H), 6.68 (m, 1H, H-1), 6.15 (m, 1H, H-3), 5.93 (m, 
1H, H-2), 2.62 (t, 2H, H-5, J=7.2Hz), 2.53 (4H, m, H-10 and 11), 1.68 – 1.56 (m, 6H, H-6, 9 and 
12), 1.47 – 1.38 (m, 6H, H-7, 8 and 13), 0.94 (t, 3H, H-14, J=7.1Hz) 
13C-NMR (CDCl3, 150 MHz) δ: 132.66 (C-4), 116.02 (C-1), 108.26 (C-3), 104.92 (C-2), 32.12 
(C-11), 31.87 (C-10), 31.83 (C-7), 29.57 (C-12), 29.56 (C-6), 28.90 (C-7), 28.66 (C-8), 27.62 (C-5), 
22.06 (C-13), 13.73 (C-14) 
IR (cm-1): 3379 (N-H stretch) 
HRMS: m/z calculated for C14H26NS = 240.1780 [M+H]
+ and C14H25NSNa = 262.1605 [M+Na]
+; 
Found 240.1785 and 262.1605 
2-(5-Pentylsulphanylpentyl)-pyrrole 257 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in hexane) to give 2-(5-pentylsulphanylpentyl)-pyrrole (154 mg, 52% yield) 
as a yellow oil.  
1H-NMR (CDCl3, 400 MHz) δ: 7.85 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.54 (t, 2H, H-5, J=7.3Hz), 2.44 (m, 4H, H-9 and 10), 1.59 – 1.50 (m, 6H, H-6, 8 and 
11), 1.38 (m, 2H, H-7), 1.31 – 1.23 (m, 4H, H-12 and 13), 0.83 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.52 (C-4), 116.08 (C-1), 108.29 (C-2), 104.98 (C-3), 32.21 
(C-9), 32.08 (C-10), 31.15 (C-12), 29.49 (C-6), 29.44 (C-11), 29.32 (C-8), 28.60 (C-7), 27.61 (C-5), 
22.35 (C-13), 14.02 (C-14) 
IR (cm-1): 3384 (N-H stretch) 
HRMS: m/z calculated for C14H26NS = 240.1780 [M+H]
+ ; Found 240.1781 
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2-(4-Hexylsulphanylbutyl)-pyrrole 269 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in hexane) to give 2-(4-hexylsulphanylbutyl)-pyrrole (671 mg, 83% yield) as 
a yellow oil.  
1H-NMR (CDCl3, 400 MHz) δ: 7.87 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.85 (m, 
1H, H-3), 2.56 (t, 2H, H-5, J=7.3Hz), 2.47 – 2.40 (m, 4H, H-8 and 9), 1.70 – 1.46 (m, 6H, H-6, 7 
and 10), 1.34 – 1.19 (m, 6H, H-11, 12 and 13), 0.82 (t, 3H, H-14, J=7.0Hz)  
13C-NMR (CDCl3, 100 MHz) δ: 132.18 (C-4), 116.16 (C-1), 108.32 (C-2), 105.13 (C-3), 32.23 
(C-9), 31.48 (C-12), 29.69, 29.22, 28.79, 28.64, 27.32, 22.58, 14.06 (C-14). 1 signal missing. 
IR (cm-1): 3382 (N-H stretch) 
HRMS: m/z calculated for C14H26NSNa = 262.1600 [M+Na]
+ ; Found 262.1604 
2-(3-Heptylsulphanylpropyl)-pyrrole 270 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (7% EtOAc in hexane) to give 2-(3-heptylsulphanylpropyl)-pyrrole (474 mg, 63% yield) 
as a colourless oil.  
1H-NMR (CDCl3, 400 MHz) δ: 7.95 (bs, 1H, N-H), 6.60 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.86 (m, 
1H, H-3), 2.66 (t, 2H, H-5, J=6.9Hz), 2.53 – 2.39 (m, 4H, H-7 and 8), 1.84 (m, 2H, H-6), 1.50 (m, 
2H, H-9), 1.31 – 1.20 (m, 8H, H-10 to 13), 0.81 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.14 (C-4), 108.38 (C-2), 105.25 (C-3), 32.11 (C-8), 31.48 (C-7), 
31.76, 29.70, 29.39, 28.93, 26.50, 22.62, 14.10 (C-14). 2 signals missing. 
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IR (cm-1): 3380 (N-H stretch) 
HRMS: m/z calculated for C14H26NSNa = 262.1600 [M+Na]
+ ; Found 262.1600 
N-(5-Bromo-3-methoxy-pyrrol-2-ylidenemethyl)-diethylamine 80 
To a solution of diethyl formamide (1.63 ml, 14.59 mmol) in CH2Cl2 (10 ml), cooled to 0 
oC 
under argon, was added phosphorous oxybromide (4.18 g, 14.59 mmol) in CH2Cl2 (10 ml).  The 
resulting solution was stirred for 25 mins until a white precipitate formed to which 
4-methoxy-3-pyrolli-2-one (750 mg, 6.63 mmol) in CH2Cl2 (10 ml) was added and heated to 
40 oC for 6 hours.  Water (80 ml) was added, the pH adjusted to 8 with 2.35M NaOH before 
EtOAc (100 ml) was added and filtered through a pad of celite.  The aqueous layer was 
separated and extracted with EtOAc (2 x 75 ml).  The combined organics were washed with 
brine, dried (MgSO4) and concentrated under vacuum to give (1.26 g, 73% yield) as a brown 
oil. 
1H-NMR (CDCl3, 400 MHz): 6.99 (s, 1H, H-2), 5.58 (s, 1H, H-6), 4.11 (q, 2H H-7 or 7’, J=7.1Hz), 
3.75 (s, 3H, H-5), 3.39 (q, 2H, H-7 or 7’, 7.1Hz), 1.28 (m, 6H, Proton 8 and 8’) 
13C-NMR (CDCl3, 100 MHz) δ: 165.45 (C-3), 138.72 (C-2), 133.80 (C-4), 120.92 (C-1), 96.58 
(C-6), 58.11 (C-5), 51.23 (C-7 or 7’), 44.65 (C-7 or 7’), 14.72 (C-8 or 8’), 12.61 (C-8 or 8’) 
HRMS: m/z calculated for C10H16N2OBr = 259.0446 and 261.0426 [M+H]
+; Found 259.0434 and 
261.0416 
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N-Boc pyrrole-2-boronic acid 30 
To a solution of 2,2,6,6-tetramethyl piperidine (2.23 ml, 13.16 mmol) in THF (20 ml), cooled to 
-78 oC under argon, was added n-butyl lithium (9.77 ml, 14.95 mmol) cautiously and the 
resulting yellow solution allowed to warm to RT over 30 mins.  This solution was cooled back 
to -78 oC before N-Boc pyrrole (2.00 ml, 11.96 mmol) in THF (20 ml) was added and stirred for 
2 hours.  Trimethyl borate (35.88 mmol, 3.99 ml) in THF (20 ml) was added and the reaction 
mixture allowed to warm to RT overnight.  0.5M HCl (30 ml) was added to the reaction before 
the THF removed under vacuum.  Water (30 ml) was added and extracted with Et2O (4 x 20 
ml).  The combined organic were washed with brine, dried (MgSO4) and concentrated under 
vacuum until a white precipitate began to form.  This was cooled to -78 oC for 10 mins and the 
precipitate filtered off; this was repeated four times to give N-Boc pyrrole-2-boronic acid 
(1.36g, 54% yield) as an off-white solid. 
1H-NMR (CDCl3, 400 MHz): 7.72 (bs, 2H, H-8), 7.45 (dd, 1H, H-6, J1=3.1Hz, J2=1.7Hz), 7.12 (dd, 
1H, H-4, J1=3.3Hz, J2=1.7Hz ), 6.26 (t, 1H, H-5, J=3.2Hz), 1.62 (s, 9H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 152.48 (C-3), 128.94 (C-4), 127.21 (C-6), 112.24 (C-5), 85.75 
(C-2), 28.12 (C-1). 1 signal missing 
IR (cm-1): 3373 (H-O stretch), 1705 (C=O stretch) 
HRMS: m/z calculated for C9H14NO4Na = 234.0914 [M+Na]
+; Found 234.0902 
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3-Methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde125 
A suspension of palladium(II) acetate (68 mg, 0.30 mmol) and triphenyl phosphine (388 mg, 
1.48 mmol) in degassed toluene (4 ml), under argon, was heated to 70 oC for 20 mins.  To this 
was added N-(5-bromo-3-methoxy-pyrrol-2-ylidenemethyl)-diethyl-amine (767 mg, 
2.96 mmol) and N-Boc pyrrole-2-boronic acid (625 mg, 2.96 mmol) in degassed 10% 
water:1,4-dioxane (10 ml) and sodium carbonate (941 mg, 8.88 mmol).  The reaction was 
heated to 85 oC for a further 3 hours.  The reaction mixture was diluted with CH2Cl2 and water 
before 2M HCl was added to neutralise the mixture with vigorous stirring.  The aqueous layer 
was the separated and extracted several times with CH2Cl2.  The combined organics were 
dried (MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel 
(30% EtOAc in pet ether) to give 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-
carboxaldehyde (464 mg, 54% yield) as an orange solid. 
1H-NMR (d6-DMSO, 400 MHz δ: 10.65 (bs, 1H, N-H), 9.46 (s, 1H, H-9), 7.27 (m, 1H, H-1), 6.60 
(m, 1H, H-3), 6.18 (m, 1H, H-2), 6.00 (m, 1H, H-6), 3.82 (s, 3H, H-10), 1.54 (s, 9H, H-13) 
HRMS: m/z calculated for C15H18N2O4 = 291.1339 [M+H]
+; Found 291.1341 
2-[[5-(6-Butylsulfanylhexyl)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole 
hydrochloride salt47 102 
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To a solution of 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde (25 mg, 
0.09 mmol) and 2-(6-butylsulfanylhexyl)-pyrrole (23 mg, 0.10 mmol) in methanol (1.5 ml) was 
added 2M HCl in methanol (0.05 ml) and the resulting red solution stirred for 30 mins.  
Sodium methoxide (29 mg, 0.54 mmol) was added and the resulting yellow/brown solution 
stirred for a further 45 mins.  The reaction mixture was poured into water and the yellow 
colour extracted with EtOAc.  The combined organics were dried (MgSO4) and concentrated 
under vacuum.  The crude product was purified on reverse phase HPLC (Table 6.2).  The 
required fractions were combined and the methanol removed under vacuum.  The remaining 
solution was poured into sat NaHCO3 and the yellow colour extracted with EtOAc.  The 
combined organics were washed with 2M HCl, dried (MgSO4) and concentrated under vacuum 
to give 2-[[5-(6-butylsulfanylhexyl)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-
yl)pyrrole hydrochloride salt (14 mg, 38% yield) as a red solid. 
1H-NMR (CDCl3, 700 MHz δ: 12.63 (bs, 1H, N-H B), 12.55 (bs, 1H, N-H C), 12.45 (bs, 1H, N-H A), 
7.14 (m, 1H, H-1), 6.88 (s, 1H, H-6), 6.87 (s, 1H, H-6), 6.74 (m, 1H, H-12), 6.25 (m, 1H, H-2), 
6.10 (m, 1H, H-13), 6.00 (s, 1H, H-10), 3.92 (s, 3H, H-8), 2.86 (t, 2H, H-15), 2.41 (m, 4H, H-20 
and 21), 1.68 (m, 2H, H-16), 1.52 – 1.45 (m, 4H, H-19 and 22), 1.34 – 1.29 (m, 6H, H-17, 18 and 
23), 0.83 (t, 3H, H-24) 
13C-NMR (CDCl3, 125 MHz) δ: 165.32 (C-7), 151.72 (C-14), 147.93 (C-9), 128.17 (C-12), 126.72 
(C-1), 125.06 (C-11), 120.99 (C-4), 120.54 (C-5), 117.06 (C-3), 115.26 (C-6), 111.43 (C-13), 
111.01 (C-2), 92.16 (C-10), 57.85 (C-8), 31.09, 30.82, 28.64, 28.09, 27.91, 27.68, 27.29 (C-15), 
21.08, 12.69 (C-24).  1 signal missing. 
HRMS: m/z calculated for C24H34N3OS = 412.2417 [M+H]
+; Found 412.2420 
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2-[[5-(6-Butylhexylsulphoxide)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-
yl)pyrrole hydrochloride salt47,125 103 
To a solution of 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde (50 mg, 
0.17 mmol) and 2-(6-butylsulfanylhexyl)-pyrrole (45 mg, 0.19 mmol) in methanol (3 ml) was 
added 2M HCl in methanol (0.10 ml) and the resulting red solution stirred for 15 mins.  
3 Chloroperbenzoic acid (33 mg, 0.19 mmol) in methanol (1 ml) was added and stirred for a 
further 15 mins.  Sodium methoxide (55 mg, 1.02 mmol) was added and the resulting 
yellow/brown solution stirred for a further 45 mins.  The reaction mixture was poured into 
water and the yellow colour extracted with EtOAc.  The combined organics were dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on reverse phase 
HPLC (Table 6.3).  The required fractions were combined and the methanol removed under 
vacuum.  The remaining solution was poured into sat NaHCO3 and the yellow colour extracted 
with EtOAc.  The combined organics were washed with 2M HCl, dried (MgSO4) and 
concentrated under vacuum to give 2-[[5-(6-butylhexylsulphoxide)-1H-pyrrol-2-yl]methylene]-
3-methoxy-5-(1H-pyrrol-2-yl)pyrrole hydrochloride salt (42 mg, 58% yield) as a red solid and 2-
[[5-(6-Butylsulfanylhexyl)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole 
hydrochloride salt (23 mg, 33% yield). 
1H-NMR (CDCl3, 700 MHz) δ: 12.74 (bs, 1H, N-H B), 12.62 (bs, 1H, N-H C), 12.56 (bs, 1H, N-H A), 
7.23 (m, 1H, H-1), 6.99 (s, 1H, H-6), 6.95 (m, 1H, H-3), 6.83 (m, 1H, H-12), 6.35 (m, 1H, H-2), 
6.19 (m, 1H, H-13), 6.08 (s, 1H, H-10), 4.01 (s, 3H, H-8), 2.93 (t, 2H, H-15), 2.74 (m, 2H, H-20a 
and 21b), 2.64 (m, 2H, H-20b and 21b), 1.80 – 1.72 (m, 6H, H-16, 19 and 22), 1.55 – 1.42 (m, 
6H, H-17, 18 and 23), 0.94 (t, 3H, H-24, J=6.9Hz) 
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13C-NMR (CDCl3, 125 MHz) δ: 166.38 (C-7), 152.41 (C-14), 149.01 (C-9), 129.20 (C-12), 127.71 
(C-1), 126.03 (C-11), 122.03 (C-4), 121.58 (C-5), 112.03 (C-2), 118.10 (C-3), 116.35 (C-6), 112.52 
(C-13), 93.14 (C-10), 58.83 (C-8), 51.96, 51.87, 28.91, 28.59, 28.29, 28.19, 24.62, 22.35, 22.05,  
13.68 (C-24) 
HRMS: m/z calculated for C24H34N3O2S = 428.2366 [M+H]
+; Found 428.2365 
2-[[5-(6-Butylhexylsulphone)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-
yl)pyrrole hydrochloride salt47,125 256 
To a solution of 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde (50 mg, 
0.17 mmol) and 2-(6-butylsulfanylhexyl)-pyrrole (45 mg, 0.19 mmol) in methanol (3 ml) was 
added 2M HCl in methanol (0.10 ml) and the resulting red solution stirred for 15 mins.  Oxone 
(261 mg, 0.43 mmol) in methanol (1 ml) was added and stirred for a further 15 mins.  Sodium 
methoxide (64 mg, 1.19 mmol) was added and the resulting yellow/brown solution stirred for 
a further 45 mins.  The reaction mixture was poured into water and the yellow colour 
extracted with EtOAc.  The combined organics were dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on reverse phase HPLC (Table 6.3).  The required 
fractions were combined and the methanol removed under vacuum.  The remaining solution 
was poured into sat NaHCO3 and the yellow colour extracted with EtOAc.  The combined 
organics were washed with 2M HCl, dried (MgSO4) and concentrated under vacuum to give 2-
[[5-(6-butylhexylsulphone)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole 
hydrochloride salt (40 mg, 53% yield) as a red solid and 2-[[5-(6-butylhexylsulphoxide)-1H-
pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole hydrochloride salt (15 mg). 
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1H-NMR (CDCl3, 700 MHz δ: 12.87 (bs, 1H, N-H B), 12.71 (bs, 1H, N-H C), 12.66 (bs, 1H, N-H A), 
7.26 (m, 1H, H-1), 7.03 (s, 1H, H-6), 6.98 (m, 1H, H-3), 6.85 (m, 1H, H-12), 6.38 (m, 1H, H-2), 
6.21 (m, 1H, H-13), 6.11 (s, 1H, H-10), 4.04 (s, 3H, H-8), 2.98 – 2.94 (m, 4H, H-15, 20 and 21), 
1.87 – 1.79 (m, 6H, H-16, 19 and 22), 1.53 – 1.44 (m, 6H, H-17, 18 and 23), 0.96 (t, 3H, H-24) 
13C-NMR (CDCl3, 125 MHz) δ: 166.42 (C-7), 152.24 (C-14), 149.07 (C-9), 129.14 (C-12), 127.66 
(C-1), 126.04 (C-11), 122.09 (C-4), 121.63 (C-5), 118.07 (C-3), 116.39 (C-6), 112.52 (C-13), 
112.10 (C-2), 93.10 (C-10), 58.84 (C-8), 52.70, 52.41, 28.90, 28.52, 28.03, 23.88, 21.89, 21.77 
(C-15 to 19, 22 and 23), 13.53 (C-24).  1 signal missing. 
HRMS: m/z calculated for C24H34N3O3S = 444.2315 [M+H]
+; Found 444.2316 
 6.1.2 Synthesis of 2-UP 20 
1-(Pyrrol-2-yl)undecan-1-one 84 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (5% EtOAc in pet ether) to give 1-(pyrrol-2-yl)undecan-1-one (841 mg, 83% yield) as a 
white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 9.32 (bs, 1H, H-N), 6.94 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.1Hz), 1.64 (m, 2H, H-7), 1.59 – 1.30 (m, 14H, 6 to 14), 0.81 (t, 3H, 
H-15, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 191.19 (C-4), 124.18 (C-1), 115.86 (C-3), 110.55 (C-2), 38.06 
(C-6), 31.91, 22.69, 14.13 (C-15). 7 signals missing. 
IR (cm-1): 3282 (N-H stretch), 1642 (C=O stretch) 
HRMS: m/z calculated for C15H25NO = 258.1834 [M+Na]
+; Found 258.1832 
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2-Undecylpyrrole 20 
Following the general acyl ketone procedure, the crude product was purified on silica gel (5% 
EtOAc in pet ether) to give 2-undecylpyrrole (487 mg, 61% yield) as a white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 7.91 (bs, 1H, H-N), 6.68 (m, 1H, H-1), 6.14 (m, 1H, H-2), 5.93 (m, 
1H, H-3), 2.61 (t, 2H, H-5, J=7.1Hz), 1.63 (m, 2H, H-6), 1.38 – 1.28 (m, 16H, H-8 to 14), 0.90 (t, 
3H, H-15, J=6.7Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.90 (C-4), 115.95 (C-1), 108.24 (C-2), 104.84 (C-3), 31.93, 
22.70, 14.13 (C-15).  8 signals missing. 
IR (cm-1): 3365 (N-H stretch) 
HRMS: m/z calculated for C15H26DN = 223.2279 [M+H]
+; Found 223.2288 
 6.1.3 Synthesis of cyclopropane containing 2-UP analogues 
8-Nonyn-1-ol 123 
A suspension of sodium hydride (857 mg, 35.70 mmol) in ethylene diamine (25 ml), under 
argon, was heated to 60 oC for 45 mins, after which it turned purple.  3-Nonyn-1-ol (1.13 ml, 
7.14 mmol) was added and again heated to 60 oC for 2 hours.  The reaction mixture was 
cooled to 0 oC before 2M HCl (30 ml) was added cautiously followed by water (100 ml).  The 
aqueous layer was extracted with Et2O (3 x 30 ml).  The combined organic layers were washed 
with brine, dried (MgSO4) and concentrated under vacuum.  The crude product was purified 
on silica gel (15% EtOAc in hexane) to give 8-nonyn-1-ol (0.69 g, 67% yield) as a pale yellow oil. 
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1H-NMR (CDCl3, 700 MHz) δ: 3.64 (t, 2H, H-1, J=6.5Hz), 2.18 (td, 2H, H-7, J1=6.8Hz, J2=2.7Hz), 
1.94 (t, 1H, H-9, J=2.6Hz), 1.57 (m, 2H, H-2), 1.53 (m, 2H, H-6), 1.44 – 1.31 (m, 6H, H-3, 4 
and 5) 
13C-NMR (CDCl3, 175 MHz) δ: 84.67 (C-8), 68.13 (C-9), 62.95 (C-1), 32.68 (C-2), 28.86 (C-3), 
28.65 (C-5), 28.36 (C-6), 25.59 (C-4), 18.35 (C-7) 
IR (cm-1): 3300 (O-H stretch), 2114 (CΞC stretch) 
HRMS: m/z calculated for C9H16ONa = 163.1099 [M+Na]
+; Found 163.1096 
8-Nonyn-1-oxy(t-butyldimethylsilyl) 
To a solution of 8-nonyn-1-ol (3.22 g, 22.98 mmol) and t-butyldimethylsilylchloride (4.48 g, 
29.87 mmol) in CH2Cl2 (100 ml), cooled to 0 
oC under argon, was added imidazole (2.03 g, 
29.87 mmol) and the resulting solution stirred for 3 hours.  Water (150 ml) was added to 
dissolve the precipitate and the organics separated.  The organics were washed with brine, 
dried (MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel 
(5% EtOAc in hexane) to give 8-nonyn-1-oxy(t-butyldimethylsilyl) (5.48 g, 94% yield) as a pale 
yellow oil. 
1H-NMR (CDCl3, 700 MHz) δ: 3.60 (t, 2H, H-4, J=6.5Hz), 2.18 (td, 2H, H-10, J1=6.9Hz, J2=2.6Hz), 
1.94 (t, 1H, H-12, J=2.7Hz), 1.55 – 1.50 (m, 4H, H-5 and 9), 1.40 (m, 2H, H-6), 1.36 – 1.31 (m, 
4H, H-7 and 8), 0.90 (s, 9H, H-1), 0.05 (s, 6H, H-3) 
13C-NMR (CDCl3, 175 MHz) δ: 84.72 (C-11), 68.05 (C-12), 63.05 (C-4), 32.79 (C-9), 28.89 (C-8), 
28.72 (C-6), 28.43 (C-5), 27.94 (C-2), 25.97 (C-1), 25.67 (C-7), 18.37 (C-10), -5.28 (C-3) 
IR (cm-1): 3315 (C-H alkyne stretch), 2120 (CΞC stretch), 1254 (C-O stretch), 1098 (O-C stretch) 
HRMS: m/z calculated for C15H31OSi = 255.2144 [M+H]
+ ; Found 255.2135 
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1-(t-Butyldimethylsilyl)-oxy-undec-8-yne 124 
To a solution of 8-nonyn-1-oxy(t-butyldimethylsilyl) (1.00 g, 3.93 mmol) in THF (20 ml), cooled 
to -30 oC under argon, was added n-butyl lithium (3.45 ml, 5.11 mmol) and the resulting 
yellow solution stirred for 30 mins.  Ethyl iodide (1.5 ml, 18.87 mmol) in THF (10 ml) was 
added and stirred at RT for 24 hours.  A small amount of water was added to quench the 
reaction.  This was loaded directly onto silica gel and eluted with 10% EtOAc in hexane to give 
1-(t-butyldimethylsilyl)-oxy-undec-8-yne (0.97 g, 88% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.55 (t, 2H, H-4, J=6.5Hz), 2.14 – 2.07 (m, 4H, H-10 and 13), 1.48 
(m, 4H, H-5 and 9), 1.34 – 1.21 (m, 6H, H-6, 7 and 8), 1.07 (t, 3H, H-14, J=7.3Hz), 0.85 (s, 9H, 
H-1), 0.00 (s, 6H, H-3) 
13C-NMR (CDCl3, 100 MHz) δ: 81.46 (C-12), 79.43 (C-11), 63.30 (C-4), 32.84 (C-5), 29.12 (C-9), 
28.98 (C-6), 28.86 (C-8), 25.99 (C-1), 25.72 (C-7), 18.73 (C-10), 18.39 (C-2), 14.40 (C-14), 12.43 
(C-13), -5.25 (C-3) 
IR (cm-1): 2169 (CΞC stretch), 1253 (C-O stretch), 1099 (O-Si stretch) 
HRMS: m/z calculated for C17H34OSiNa = 305.2277 [M+Na]
+ ; Found 305.2271 
1-(t-Butyldimethylsilyl)-oxy-undec-8-(Z)-ene Z-125 
To a solution of 1-(t-butyldimethylsilyl)-oxy-undec-8-yne (1.00 g, 3.54 mmol) and quinoline 
(0.21 ml, 1.77 mmol) in THF (20 ml) was added Lindlar’s catalyst (20 mg) and the flask purged 
with hydrogen gas five times before being left to stir for 2 hours.  The reaction mixture was 
filtered through celite and concentrated under vacuum.  The crude material was purified on 
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silica gel (2% EtOAc in pet ether) to give 1-(t-butyldimethylsilyl)-oxy-undec-8-(Z)-ene (981 mg, 
98% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 5.38 – 5.24 (m, 2H, H-11 and 12), 3.55 (t, 2H, H-4, J=6.5Hz), 1.99 
(m, 4H, H-10 and 13), 1.46 (m, 2H, H-5), 1.30 – 1.25 (m, 8H, H-6, 7, 8 and 9), 0.97 (t, 3H, H-14, 
J=7.3Hz), 0.85 (s, 9H, H-1), 0.00 (s, 6H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 131.55 (C-12), 129.32 (C-11), 63.35 (C-4), 32.89 (C-5), 29.73, 
29.35, 29.27, 27.09 (C-10), 26.00 (C-1), 25.79, 20.52 (C-13), 18.71 (C-2), 14.40 (C-14), -5.24 
(C-3)  
IR (cm-1): 1253 (C-O stretch), 1098 (O-Si stretch) 
HRMS: m/z calculated for C17H36OSi = 285.2608 [M+H]
+ ; Found 285.2606 
1-(t-Butyldimethylsilyl)-oxy-undec-8-(E)-ene E-125 
Ammonia (100 ml) was condensed into a flask fitted with a dry ice/acetone condenser 
containing a solution of 1-(t-butyldimethylsilyl)-oxy-undec-8-yne (1.00 g, 3.54 mmol) in diethyl 
Et2O (10 ml) under argon.  Sodium (500 mg) was added in portions until the deep blue colour 
remained and allowed to stir for a further 5 hours.  Solid NH4Cl was cautiously added to 
quench the blue colour and the ammonia allowed to evaporate before water was added and 
extracted with Et2O.  The combined organics were dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (1% EtOAc in pet ether) to give 1-(t-
butyldimethylsilyl)-oxy-undec-8-(E)-ene (885 mg, 89% yield) as a yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 5.43 – 5.30 (m, 2H, H-11 and 12), 3.55 (t, 2H, H-4, J=6.6Hz), 1.99 
(m, 4H, H-10 and 13), 1.46 (m, 2H, H-5), 1.30 – 1.21 (m, 8H, H-6, 7, 8 and 9), 0.91 (t, 3H, H-14, 
J=7.4Hz), 0.85 (s, 9H, H-1), 0.00 (s, 6H, H-1) 
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13C-NMR (CDCl3, 100 MHz) δ: 131.90 (C-12), 129.36 (C-11), 63.35 (C-4), 32.89 (C-5), 32.55 
(C-10), 29.61, 29.32, 29.16, 26.00 (C-1), 25.77, 25.61, 18.71 (C-2), 14.42 (C-14), -5.25 (C-3) 
IR (cm-1): 1250 (C-O stretch), 1090 (O-Si stretch) 
HRMS: m/z calculated for C17H36OSi = 285.2608 [M+H
+] ; Found 285.2609 
7-(2-Ethylcyclopropyl)-(Z)-heptan-1-ol Z-126 
To a solution of 1-(t-butyldimethylsilyl)-oxy-undec-8-(Z)-ene (738 mg, 2.60 mmol) in CH2Cl2 
(45 ml), cooled to -20°C under argon in the dark, was added 1M diethyl zinc (12.98 ml, 12.98 
mmol).  Diiodomethane (1.04 ml, 12.98 mmol) was added dropwise and the reaction allowed 
to warm to RT over 24 hours.  Once GC-MS indicated the complete consumption of the 
starting material, 2.35M NaOH (12 ml) was cautiously added and the resulting white solid 
removed by filtration.  The combined organics were dried (MgSO4) and concentrated under 
vacuum. 
To a solution of this crude product in THF (15 ml), cooled to 0°C, was added 
tetrabutylammonium fluoride (946 mg, 7.80 mmol) and stirred for 5 hours.  The majority of 
the THF was removed under vacuum before the residual was loaded onto silica gel.  This was 
eluted with 20% EtOAc in pet ether to give 7-(2-ethylcyclopropyl)-(Z)-heptan-1-ol (425 mg, 
89% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 3.59 (t, 2H, H-1, J=6.4Hz), 1.52 (m, 2H, H-2), 1.38 – 1.28 (m, 10H, 
H-3 to 6, 7a and 11a), 1.18 – 1.07 (m, 2H, H-7b and 11b), 0.98 (t, 3H, H-12, J=7.3Hz) 0.60 (m, 
2H, 8 and 10), 0.52 (m, 1H, H-9a), -0.38 (m, 1H, H-9b) 
13C-NMR (CDCl3, 175 MHz) δ: 62.07 (C-1), 31.79 (C-2), 29.12, 28.58, 28.46, 27.56, 24.72, 20.90, 
16.67, 14.90, 13.45 (C-12), 9.66 (C-9) 
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IR (cm-1): 3319 (O-H stretch) 
HRMS: m/z calculated for C12H24ONa = 207.1719 [M+Na]
+; Found 207.1717  
7-(2-Ethylcyclopropyl)-(E)-heptan-1-ol E-126 
To a solution of 1-(t-butyldimethylsilyl)-oxy-undec-8-(E)-ene (485 mg, 1.71 mmol) in CH2Cl2 
(30 ml), cooled to -20°C under argon in the dark, was added 1M diethyl zinc (8.53 ml, 8.53 
mmol).  Diiodomethane (0.68 ml, 8.53 mmol) was added dropwise and the reaction allowed to 
warm to RT over 24 hours.  Once GC-MS indicated the complete consumption of the starting 
material, 2.35M NaOH (6 ml) was cautiously added and the resulting white solid removed by 
filtration.  The combined organics were dried (MgSO4) and concentrated under vacuum. 
To a solution of this crude product in THF (10 ml), cooled to 0°C, was added 
tetrabutylammonium fluoride (1.08 g, 3.42 mmol) and stirred for 5 hours.  The majority of the 
THF was removed under vacuum before the residual was loaded onto silica gel.  This was 
eluted with 15% EtOAc in pet ether to give 7-(2-ethylcyclopropyl)-(E)-heptan-1-ol (181 mg, 
58% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 3.57 (t, 2H, H-1, J=6.5Hz), 1.50 (m, 2H, H-2), 1.30 – 1.24 (m, 8H, 
H-3 to 6), 1.18 (m, 2H, H-7a and 11a), 1.09 (m, 1H, H-11b), 1.03 (m, 1H, H-7b), 0.87 (t, 3H, 
H-12, J=7.3Hz), 0.32 – 0.26 (m, 2H, H-8 and 10), 0.08 (m, 2H, H-9) 
13C-NMR (CDCl3, 175 MHz) δ: 63.11 (C-1), 34.29 (C-7), 32.81 (C-2), 29.62, 29.47, 29.44, 27.31 
(C-11), 25.74, 20.64 (C-10), 18.52 (C-8), 13.78 (C-12), 11.56 (C-9) 
IR (cm-1): 3320 (O-H stretch) 
HRMS: m/z calculated for C12H24ONa = 207.1719 [M+Na]
+; Found 207.1718 
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 7-(2-Ethylcyclopropyl)-(Z)-heptanal 
Following the general Swern procedure, the crude material was purified on silica gel (5% 
EtOAc in pet ether) to give 7-(2-ethylcyclopropyl)-(Z)-heptanal (693 mg, 87% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.70 (t, J=1.9Hz, 1H, H-1), 2.35 (td, 2H, H-2, J1=7.2Hz, J2=1.9Hz), 
1.57 (m, 2H, H-3), 1.34 – 1.27 (m, 8H, H-4 to 7a and 11b), 1.20 – 1.07 (m, 2H, 7b and 11b), 0.91 
(t, 3H, H-12, J=7.3Hz), 0.57 (m, 2H, H-8 and 10), 0.52 (m, 1H, H-9a), -0.40 (m, 1H, H-9b) 
13C-NMR (CDCl3, 100 MHz) δ: 203.04 (C-1), 43.95 (C-2), 30.00, 29.36, 29.23, 28.28, 22.12, 
21.94, 17.69, 15.88, 14.49 (C-12), 10.71 (C-9) 
IR (cm-1): 2713 (C(O)-H stretch), 1725 (C=O stetch) 
HRMS: m/z calculated for C12H22ONa = 205.1563 ; Found 205.1563  
7-(2-Ethylcyclopropyl)-(E)-heptanal 
Following the general Swern procedure, the crude material was purified on silica gel (5% 
EtOAc in pet ether) to give 7-(2-ethylcyclopropyl)-(E)-heptanal (300 mg, 70% yield) as a pale 
yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.62 (t, 1H, H-1, J=1.8Hz), 2.27 (td, 2H, H-2, J1=7.4Hz, J2=1.8Hz), 
1.49 (m, 2H, H-3), 1.19 (m, 6H, H-4, 5 and 6), 1.11 (m, 2H, 7a and 11a), 0.99 (m, 2H, H-7b and 
11b), 0.79 (t, 3H, H-12, J=7.4Hz), 0.20 (m, 2H, H-8 and 10), 0.00 (m, 2H, H-9) 
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13C-NMR (CDCl3, 100 MHz) δ: 202.96 (C-1), 43.93 (C-2), 34.22, 29.48, 29.22, 29.19, 27.31, 
22.10, 20.66, 18.52, 13.78 (C-12), 11.58 (C-9) 
IR (cm-1): 2710 (CO-H stretch), 1725 (C=O stretch) 
HRMS: m/z calculated for C12H23O = 183.1743, [M+H]
+; Found 183.1749 
7-(2-Ethylcyclopropyl)-(Z)-heptanoic acid Z-127 
Following the general Oxone procedure gave 7-(2-ethylcyclopropyl)-(Z)-heptanoic acid 
(632 mg, 91% yield) was a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.28 (t, 2H, H-2, J=7.6Hz), 1.57 (m, 2H, H-3), 1.34 – 1.28 (m, 8H, 
H-4, 5, 6, 7a and 11a), 1.19 – 1.07 (m, 2H, H-7b and 11b), 0.91 (t, 3H, H-12, J=7.6Hz), 0.56 – 
0.49 (m, 3H, H-8, 9a and 10), -0.40 (m, 1H, H-9b) 
13C-NMR (CDCl3, 100 MHz) δ: 179.48 (C-1), 33.95, 29.98, 29.23, 21.93, 29.11 (C-11), 28.52 
(C-7), 17.69, 15.88, 24.70 (C-2), 14.48 (C-12), 10.70 (C-9) 
IR (cm-1): 1706 (C=O stretch) 
HRMS: m/z calculated for C12H21O = 197.1547 [M-H]
-; Found 197.1552 
7-(2-Ethylcyclopropyl)-(E)-heptanoic acid E-127 
Following the general Oxone procedure gave 7-(2-ethylcyclopropyl)-(E)-heptanoic acid 
(310 mg, 95% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 2.21 (t, 2H, H-2, J=7.6Hz), 1.50 (m, 2H, H-3), 1.19 (m, 6H, H-4 to 
6), 1.09 (m, 2H, H-7a and 11a), 1.04 – 0.93 (m, 2H, H-7b to 11b), 0.79 (t, , 3H, H-12 J=7.6Hz), 
0.20 (m, 2H, H-8 and 10), 0.00 (m, 2H, H-9) 
13C-NMR (CDCl3, 100 MHz) δ: 179.59 (C-1), 34.23, 29.48, 29.11, 29.08, 27.31, 24.70, 20.65, 
18.55, 13.79 (C-12), 11.58 (C-9). 1 signal missing. 
IR (cm-1): 1707 (C=O stretch) 
HRMS: m/z calculated for C12H22ONa = 221.1512 [M+Na]
+; Found 221.1513 
7-(2-(Z)-Ethylcyclopropyl)-1-(pyrrol-2-yl)heptan-1-one Z-128 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 7-(2-(Z)-ethylcyclopropyl)-1-(pyrrol-2-yl)heptan-1-
one (548 mg, 69% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.29 (bs, 1H, N-H), 6.94 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.20 (m, 
1H, H-2), 2.96 (t, 2H, H-6, J=7.8Hz), 1.65 (m, 2H, H-7), 1.30 (m, 8H, H-8, 9, 10, 11a and 15a), 
1.12 (m, 2H, H-11b and 15b), 0.90 (t, 3H, H-16, J=7.1Hz), 0.58 (m, 2H, H-12 and 14), 0.50 (m, 
1H, H-13a), -0.40 (m, 1H, 13b) 
13C-NMR (CDCl3, 100 MHz) δ: 191.10 (C-5), 132.30 (C-4), 124.14 (C-3), 115.82 (C-1), 110.56 
(C-2), 38.05 (C-6), 30.06, 29.53, 29.45, 28.56, 25.31 (C-7), 21.93 14.48 (C-16), 10.70 (C-13, 
17.70, 15.91 
IR (cm-1): 3271 (N-H stretch), 1635 (C=O stretch) 
HRMS: m/z calculated for C16H25NO = 248.2009 [M+H]
+ and C16H25NONa = 270.1828 [M+Na]
+; 
Found 248.2007 and 270.1825 
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7-(2-(E)-Ethylcyclopropyl)-1-(pyrrol-2-yl)heptan-1-one E-128 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 7-(2-(E)-ethylcyclopropyl)-1-(pyrrol-2-yl)heptan-1-
one (169 mg, 44% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.26 (bs, 1H, N-H), 6.94 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.20 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.8Hz), 1.65 (m, 2H, H-7), 1.28 (m, 6H, H-6 to 8), 1.21 – 1.01 (m, 
4H, H-11 and 15), 0.86 (t, 3H, H-16, J=7.3Hz), 0.27 (m, 2H, H-12 and 14), 0.07 (m, 2H, H-13) 
13C-NMR (CDCl3, 100 MHz) δ: 192.20 (C-5), 128.47 (C-4), 124.14 (C-1), 115.82 (C-3), 110.56 
(C-2), 38.06 (C-6), 30.04, 29.50, 29.47, 28.56, 25.30 (C-7), 21.90, 20.66, 18.56, 13.80 (C-16), 
11.58 (C-13) 
IR (cm-1): 3270 (N-H stretch), 1630 (C=O stretch) 
HRMS: m/z calculated for C16H25NO = 248.2009 [M+H]
+; Found 248.2007 
2-[7-(2-(Z)-Ethylcyclopropyl)heptyl]-pyrrole Z-118 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (3% EtOAc in pet ether) to give 2-[7-(2-(Z)-ethylcyclopropyl)heptyl]-pyrrole (415 mg, 
60% yield) as a purple oil. 
1H-NMR (CDCl3, 700 MHz) δ: 7.90 (bs, 1H, N-H), 6.67 (m, 1H, H-1), 6.14 (m, 1H, H-2), 5.92 (m, 
1H, H-3), 2.61 (t, 2H, H-5, J=7.7Hz), 1.64 (m, 2H, H-6), 1.41 – 1.32 (m, 10H, H-7 to 10, 11a and 
15a), 1.24 – 1.14 (m, 2H, H-11b and 15b), 0.99 (t, 3H, H-16, J=7.3Hz), 0.65 (m, 2H, H-12 and 
14), 0.56 (m, 1H, H-13a), -0.31 (m, 1H, H-13b) 
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13C-NMR (CDCl3, 175 MHz) δ: 132.87 (C-4), 115.92 (C-1), 108.24 (C-2), 104.84 (C-3), 30.18, 
29.66, 29.55, 29.47, 29.38, 28.57, 27.73 (C-5), 21.91 (C-15), 17.69, 15.91, 14.45 (C-16), 10.68 
(C-13) 
IR (cm-1): 3380 (N-H stretch) 
HRMS: m/z calculated for and C16H27N = 234.2216 [M+H]
+; Found 234.2216 
2-[7-(2-(E)-Ethylcyclopropyl)heptyl]-pyrrole E-118 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (3% EtOAc in pet ether) to give 2-[7-(2-(E)-ethylcyclopropyl)heptyl]-pyrrole (103 mg, 
65% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 7.91 (bs, 1H, N-H), 6.68 (m, 1H, H-1), 6.14 (m, 1H, H-2), 6.14 (m, 
1H, H-3), 2.61 (t, 3H, H-5, J=7.6Hz), 1.64 (m, 2H, H-6), 1.43 – 1.22 (m, 10H, H-7 to 10, 11a and 
15a), 1.18 (m, 1H, H-15b), 1.11 (m, 1H, H-11b), 0.95 (t, 3H, H-16, J=7.4Hz), 0.38 (m, 2H, H-12 
and 14), 0.16 (m, 2H, H-13) 
13C-NMR (CDCl3, 175 MHz) δ: 132.89 (C-4), 115.94 (C-1), 108.24 (C-2), 104.84 (C-3), 34.31 
(C-11), 29.68, 29.57, 29.49, 29.42, 29.40, 27.74 (C-5), 27.33 (C-15), 20.65, 18.58, 13.80 (C-16), 
11.57 (C-13) 
IR (cm-1): 3376 (N-H stretch) 
HRMS: m/z calculated for and C16H27N = 234.2216 [M+H]
+; Found 234.2213 
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 6.1.4 Synthesis of branched methyl containing 2-UP analogues 
8-Benzyloxyoctan-1-ol 15475 
To a solution of octan-1,8-diol (3.00 g, 20.52 mmol) in CH2Cl2 (30 ml), under argon, was added 
silver (I) oxide (7.13 g, 30.78 mmol) and the resulting suspension stirred for 20 mins.  Benzyl 
bromide (0.90 ml, 7.52 mmol) was added and the reaction mixture stirred for 16 hours.  The 
reaction mixture was filtered and concentrated under vacuum.  The crude product was 
purified on silica gel (35% EtOAc in pet ether) to give 8-benzyloxyoctan-1-ol (3.61 g, 74% yield) 
as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.26 – 7.21 (m, 5H, H-1, 2 and 3), 4.43 (s, 2H, H-5), 3.56 (t, 2H, 
H-13, J=6.6Hz), 3.39 (t, 2H, H-6, J=6.6Hz), 1.58 – 1.45 (m, 4H, H-7 and 12), 1.31 – 1.25 (m, 8H, 
H-8 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 138.71 (C-4), 128.35, 127.64, 127.49, 72.88 (C-5), 70.49 (C-6), 
63.05 (C-13), 32.78 (C-12), 29.75 (C-7), 29.43, 29.36, 26.14, 25.68 
IR (cm-1): 3290 (H-O stretch) 
HRMS: m/z calculated for and C15H24O2Na = 259.1669 [M+Na]
+; Found 259.1676 
8-Benzyloxyoctyl 4-methylbenzenesulfonate 
To a solution of 8-benzyloxyoctan-1-ol (1.00 g, 4.23 mmol), 4-dimethylaminopyridine (155 mg, 
1.27 mmol) and triethylamine (1.29 ml, 10.58 mmol) in CH2Cl2 (15 ml), under argon, was 
added p-toluenesulfonyl chloride and the resulting mixture was stirred for 24 hours.  CH2Cl2 
was added to dilute the reaction mixture and was washed with 2M HCl, sat NaHCO3, dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (15% 
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EtOAc in pet ether) to give 8-benzyloxyoctyl 4-methylbenzenesulfonate (1.40 g, 85% yield) as 
a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.71 (m, 2H, H-15), 7.27 – 7.20 (m, 7H, H-1 to 3 and 16), 4.42 (s, 
2H, H-5), 3.94 (t, 2H, H-13, J=6.6Hz), 3.37 (t, 2H, H-6, J=6.4Hz), 2.37 (s, 3H, H-18), 1.59 – 1.47 
(m, 4H, H-7 and 12), 1.28 – 1.15 (m, 8H, H-8 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 144.63 (C-17), 138.68 (C-4), 133.26 (C-14), 129.81 (C-16), 128.36, 
127.90, 127.64, 127.50, 72.89 (C-5), 70.67 (C-13), 70.41 (C-6), 29.71, 29.21, 28.87, 28.80, 
26.06, 25.28, 21.69 (C-18) 
IR (cm-1): 1357 (S=O stretch) 
HRMS: m/z calculated for C22H30O4S = 413.1757 [M+H]
+; Found 413.1762 
8-Benzyloxy-1-iodooctane 189 
To a solution of 8-benzyloxyoctyl 4-methylbenzenesulfonate (1.40 g, 3.58 mmol) in acetone 
(20 ml), under argon, was added potassium iodide (11.90 g, 71.70 mmol) and the resulting 
suspension heated to 65 oC for 24 hours. The reaction mixture was poured into water and 
extracted with EtOAc.  The combined organics were dried (MgSO4) and concentrate under 
vacuum to give a mixture of 8-benzyloxy 1-iodooctane (1.07 g, 90% yield) and 8-benzyloxy 1-
chlorooctane (79 mg, 10% yield) as a yellow/brown oil; ratio estimated by 1H-NMR integration 
of triplets adjacent to the halogen. 
1H-NMR (CDCl3, 400 MHz) δ: 7.26 – 7.20 (m, 5H, H-1 to 3), 4.43 (s, 2H, H-5), 3.45 (t, 0.2H, H-13 
Cl, J=6.9Hz), 3.39 (t, 2H, H-6, J=6.5Hz), 3.11 (t, 1.8H, H-13 I, J=6.9Hz), 1.74 (m, 2H, H-12), 1.54 
(m, 2H, H-7), 1.33-1.24 (m, 8H, H-8 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 138.70 (C-4), 128.37, 127.64, 127.50 (C-1 to 3), 72.89 (C-5), 70.43 
(C-6), 45.34 (C-13 Cl), 33.54 (C-12), 30.45, 29.73, 29.25, 28.49, 26.12, 7.30 (C-13 I) 
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IR (cm-1): 1098 (C-O stretch) 
HRMS: m/z calculated for C15H23OI = 369.0686 [M+Na]
+; Found 369.0686 
1-Benzyloxy-9-methylundec-8-ene 190 
To a solution of 8-benzyloxy-1-iodooctane (1.03 g, 2.97 mmol) in toluene (20 ml) was added 
triphenyl phosphine (1.17 g, 4.46 mmol) and the resulting solution heated to 120 oC for 
48 hours.  The toluene was removed under vacuum before dissolving the residue in THF (40 
ml) under argon.  This was cooled to -78 oC before n-butyl lithium (2.23 ml, 3.56 mmol) was 
added and the bright orange solution stirred for 30 mins.  Butanone (0.40 ml, 4.46 mmol) was 
added and stirred for a further 16 hours while warming to RT.  The reaction was quenched 
with sat NH4Cl and extracted with Et2O.  The combined organics were dried (MgSO4) and 
concentrated under vacuum.  The crude product was purified on silica gel (3% Et2O in pet 
ether) to give 1-benzyloxy-9-methylundec-8-ene (600 mg*, 85% yield) as a colourless oil. 
*Product co-purified with Ph3PO so yield is based on 
1H-NMR intergrals. 
1H-NMR (CDCl3, 400 MHz) δ: 7.27 – 7.20 (m, H-1 to 3 plus Ph3PO), 5.01 (m, 1H, H-13), 4.43 (s, 
2H, H-5), 3.39 (t, 2H, H-6), 1.97 – 1.88 (m, 4H, H-12 and 16), 1.58 – 1.48 (m, 5H, H-7 and 15), 
1.30 – 1.18 (m, 8H, H-8 to 11), 0.89 (m, 3H, H-17) 
13C-NMR (CDCl3, 100 MHz) δ: * 
HRMS: * 
* No data due to triphenylphosphine oxide impurity 
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1-(4-Methoxybenzyloxy)hex-5-yne 178 
To a solution of 5-hexyn-1-ol (1.00 g, 10.19 mmol) in DMF (20 ml), cooled to 0 oC under argon, 
was added sodium hydride (240 mg, 12.23 mmol) and the suspension stirred for 30 mins.  
4-Methoxybenzyl chloride (1.66 ml, 12.23 mmol) was added and the reaction mixture heated 
to 60 oC for 16 hours.  The reaction mixture was poured into water and extracted with EtOAc.  
The combined organics were dried (MgSO4) and concentrated under vacuum.  The crude 
product was purified on silica gel (7% Et2O in pet ether) to give 1-(4-methoxybenzyloxy)hex-5-
yne (1.89 g, 95% yield) as a colourless oil.   
1H-NMR (CDCl3, 400 MHz) δ: 7.18 (d, 2H, H-4, J=8.6Hz), 6.80 (d, 2H, H-3, J=8.6Hz), 4.36 (s, 2H, 
H-6), 3.73 (s, 3H, H-1), 3.40 (t, 2H, H-7, J=6.2Hz), 2.14 (td, 2H, H-10, J=7.1, 2.6Hz), 1.87 (t, 1H, 
H-12, J=2.6Hz), 1.65 (m, 2H, H-8), 1.55 (m, 2H, H-9) 
13C-NMR (CDCl3, 100 MHz) δ: 159.30 (C-2), 130.68 (C-5), 129.23 (C-4), 113.78 (C-3), 84.40 
(C-12), 72.55 (C-6), 69.44 (C-7), 68.37 (C-11), 55.30 (C-1), 28.78 (C-8), 25.26 (C-9), 18.23 (C-10) 
IR (cm-1): 3290 (C-H alkyne stretch), 2935 (C-H stretch) 
HRMS: m/z calculated for and C14H18O2Na = 241.1199 [M+Na]
+; Found 241.1197 
3-Methylpentyl p-toluenesulphonate 
To a solution of 3-methylpentan-1-ol (2.00 g, 19.58 mmol), 4-dimethylaminopyridine (717 mg, 
5.87 mmol) and triethylamine (6.73 ml, 48.95 mmol) in CH2Cl2 (100 ml), under argon, was 
added p-toluenesulphonyl chloride (4.11 g, 21.54 mmol) and the resulting mixture stirred for 
4 hours.  The reaction mixture was poured into water and extracted with CH2Cl2.  The organics 
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were washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (10% EtOAc in pet ether) to give 
3-methylpentyl p-toluenesulphonate (4.50 g, 90% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.72 (d, 2H, H-4, J=8.3Hz), 7.27 (d, 2H, H-3, J=8.3Hz), 3.99 (m, 2H, 
H-6), 2.38 (s, 3H, H-1), 1.59 (m, 1H, H-7a), 1.37 (m, 2H, H-7b and 8), 1.20 (m, 1H, H-10a), 1.05 
(m, 1H, H-10b), 0.75 (t, 3H, H-11, J=7.4Hz), 0.72 (d, 3H, H-9, J=6.3Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 143.60 (C-5), 133.41 (C-2), 128.77 (C-3), 126.87 (C-4), 68.13 
(C-6), 34.29 (C-7), 29.69 (C-8), 28.11 (C-10), 20.62 (C-1), 17.65 (C-9), 10.06 (C-11) 
IR (cm-1): 1358 (S=O stretch) 
HRMS: m/z calculated for C13H20O3S = 279.1025 [M+Na]
+; Found 279.1027 
1-Iodo-3-methyl pentane 193 
To a solution of 3-methylpentyl p-toluenesulphonate (2.00 g, 7.80 mmol) in acetone (40 ml) 
was added potassium iodide (26.00 g, 156 mmol) and the reaction heated to 60 oC for 
48 hours.  The reaction mixture was poured into water and extracted with Et2O.  The 
combined organics were washed with sat NaHCO3, dried (MgSO4) and concentrated under 
vacuum to give 1-iodo-3-methyl pentane (1.40 g, 100% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.21 – 3.07 (m, 2H, H-1), 1.81 (m, 1H, H-2a), 1.58 (m, 1H, H-2b), 
1.42 (m, 1H, H-3), 1.28 (m, 1H, H-5a), 1.11 (m, 1H, H-5b), 0.83 – 0.79 (m, 6H, H-4 and 6) 
13C-NMR (CDCl3, 100 MHz) δ: 39.54 (C-2), 34.41 (C-3), 27.71 (C-5), 17.22 (C-4), 10.13 (C-6), 4.34 
(C-1) 
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1-(4-Methoxybenzyloxy)-9-methyl-undec-5-yne 194 
To a solution of 1-(4-methoxybenzyloxy)hex-5-yne (2.65 g, 12.16 mmol) in THF (40 ml), cooled 
to -78 oC under argon, was added n-butyl lithium (8.62 ml, 13.97 mmol) and the solution 
stirred for 15 mins.  1-Iodo-3-methyl pentane (1.72 g, 8.11 mmol) in THF (20 ml) was added 
and the reaction heated to 75 oC to 48 hours.  The reaction mixture was poured into water 
and extracted with EtOAc.  The combined organics were dried (MgSO4) and concentrated 
under vacuum.  The crude product was purified on silica gel (3% EtOAc in pet ether) to give 
1-(4-methoxybenzyloxy)-9-methyl-undec-5-yne (1.35 g, 75% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.20 (d, 2H, H-3, J=8.4Hz), 6.81 (d, 2H, H-4, J=8.2Hz), 4.36 (s, 2H, 
H-6), 3.73 (s, 3H, H-1), 3.39 (t, 2H, H-7, J=6.4Hz), 2.11 – 2.03 (m, 4H, H-10 and 13), 1.63 (m, 2H, 
H-8), 1.52 – 1.03 (m, 7H, H-9, 14, 15 and 17), 0.79 (m, 6H, H-16 and 18) 
13C-NMR (CDCl3, 100 MHz) δ: 159.41 (C-2), 130.76 (C-5), 129.21 (C-3), 113.77 (C-4), 72.51 
(C-6), 69.66 (C-7), 55.29 (C-1), 35.92, 33.60, 29.11, 28.89, 25.85, 18.59 (C-16), 16.54 (C-8), 
11.32 (C-18).  3 signals missing. 
HRMS: m/z calculated for C20H30O2Na = 325.2138 [M+Na]
+; Found 325.2137 
9-Methylundecan-1-ol 191 
From 1-benzyloxy-9-methylundec-8-ene:  To a solution of naphthalene (1.68 g, 13.14 mmol) in 
THF (13 ml), under argon, was added lithium (76 mg, 10.95 mmol) and the resulting mixture 
sonicated for 60 sec until a dark green solution appeared.  This was stirred for a further 
4 hours before 1-benzyloxy-9-methylundec-8-ene (600 mg, 2.19 mmol) in THF (7 ml) was 
added and heated to 50 oC for 48 hours.  Sat NH4Cl solution was cautiously added and 
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extracted with EtOAc.  The combined organics were washed with brine, dried (MgSO4) and 
concentrated under vacuum.  The crude product was purified on silica gel (15% EtOAc in pet 
ether). 
The purified material from the previous step was dissolved in THF (7 ml) before 10% palladium 
on carbon (50 mg) was added and flushed with hydrogen gas ten times.  The resulting mixture 
was allowed to stir for 16 hours before being filtered through celite and concentrated under 
vacuum to give 9-methylundecan-1-ol (393 mg, 96% yield) as a colourless oil. 
From 1-(4-methoxybenzyloxy)-9-methyl-undec-5-yne: To a solution of 1-(4-
methoxybenzyloxy)-9-methyl-undec-5-yne (1.35 g, 4.47 mmol) in THF (40 ml) was added 10% 
palladium on carbon (70 mg) and the flask flushed with hydrogen gas ten times and stirred for 
24 hours.  The reaction mixture was filtered through celite and concentrated under vacuum.  
The crude product was purified on silica gel (10% EtOAc in pet ether) to give 
9-methylundecan-1-ol (591 mg, 71% yield) as a colourless oil.  
1H-NMR (CDCl3, 400 MHz) δ: 3.57 (t, 2H, H-1, J=6.7Hz), 1.50 (m, 2H, H-2), 1.29 – 1.14 (m, 13H, 
H-3 to 7, 8a, 9 and 11a), 1.08 – 0.99 (m, 2H, H-8b and 11b), 0.81 – 0.77 (m, 6H, H-10 and 12) 
13C-NMR (CDCl3, 100 MHz) δ: 63.13 (C-1), 36.63, 34.41 (C-9), 32.83 (C-2), 29.95, 29.66, 29.51, 
29.46, 27.09, 25.76, 19.23 (C-10), 11.42 (C-12) 
IR (cm-1): 3349 (H-O stretch) 
HRMS: m/z calculated for and C12H26ONa = 209.1876 [M+Na]
+; Found 209.1873 
9-Methylundecanal 
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Following the general IBX procedure, the crude product was purified on silica gel (10% EtOAc 
in pet ether) to give 9-methylundecanal (437 mg, 73% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.70 (t, 1H, H-1, J=1.9Hz), 2.35 (td, 2H, H-2, J1=7.3Hz, J2=1.9Hz), 
1.56 (m, 2H, H-3), 1.30 – 1.15 (m, 10H, H-4 to 7, 8a, 9 and 11a), 1.08 – 0.99 (m, 2H, H-8b and 
11b), 0.78 (m, 6H, H-10 and 12) 
13C-NMR (CDCl3, 100 MHz) δ: 202.99 (C-1), 43.94 (C-2), 36.59, 34.39 (C-9), 29.78, 29.49, 29.41, 
29.19, 27.01, 19.22 (C-10), 11.42 (C-12).  1 signal missing. 
IR (cm-1): 2712 (OC-H stretch), 1725 (C=O stretch) 
HRMS: m/z calculated for and C12H24ONa = 207.1717 [M+Na]
+; Found 207.1715 
9-Methylundecanoic acid 188 
Following the general procedure gave 9-methylundecanoic acid (468 mg, 99% yield) as a pale 
yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.28 (t, 2H, H-2, J=7.5Hz), 1.57 (m, 2H, H-3), 1.28 – 1.15 (m, 11H, 
H-4 to 8a, 9 and 11a), 1.10 – 0.99 (m, 2H, H-8b and 11b), 0.80 – 0.76 (m, 6H, H-10 and 12) 
13C-NMR (CDCl3, 100 MHz) δ: 179.14 (C-1), 36.59, 34.39 (C-9), 33.80 (C-2), 29.78, 29.50, 29.28, 
29.07, 27.02, 24.70 (C-3), 19.22 (C-10), 11.42 (C-12) 
IR (cm-1): 1706 (C=O stretch) 
HRMS: m/z calculated for and C12H24O2Na = 223.1666 [M+Na]
+; Found 233.1669 
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9-Methyl-1-(1H-pyrrol-2-yl)undecan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was the purified 
on silica gel (7% EtOAc in pet ether) to give 9-methyl-1-(1H-pyrrol-2-yl)undecan-1-one 
(485 mg, 83% yield) as a pale yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.30 (bs, 1H, H-N), 6.94 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.12 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.2Hz), 1.65 (m, 2H, H-7), 1.27 – 1.19 (m, 11H, H-8 to 12a, 13 and 
15a), 1.08 – 0.98 (m, 2H, H-12b and 15b), 0.80 – 0.76 (m, 6H, H-14 and 16) 
13C-NMR (CDCl3, 100 MHz) δ: 191.16 (C-5), 132.00 (C-4), 124.16 (C-3), 115.83 (C-1), 110.55 
(C-2), 38.06 (C-6), 36.61, 34.39 (C-13), 29.85, 29.50, 27.06, 25.31 (C-7), 19.22 (C-14), 11.42 
(C-16).  2 signals missing. 
IR (cm-1): 3277 (N-H stretch), 1634 (C=O stretch) 
HRMS: m/z calculated for and C16H27NONa = 272.1985 [M+Na]
+; Found 272.1994 
2-(9-Methylundecyl)-1H-pyrrole 185 
Following the general acyl ketone reduction, the crude product was the purified on silica gel 
(5% EtOAc in pet ether) to give 2-(9-methylundecyl-)1H-pyrrole (298 mg, 66% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.82 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.52 (t, 2H, H-5, J=7.5Hz), 1.55 (m, 2H, H-6), 1.29 – 1.12 (m, 13H, H-7 to 11, 12a, 13 
and 15a), 1.08 – 1.01 (m, 2H, H-12b and 15b), 0.80 – 0.76 (m, 6H, H-14 and 16) 
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13C-NMR (CDCl3, 100 MHz) δ: 132.77 (C-4), 115.95 (C-1), 108.26 (C-2), 104.86 (C-3), 36.63, 
34.42 (C-13), 30.01, 29.69, 29.64, 29.52, 29.48, 29.42, 27.76 (C-5), 27.10, 19.24 (C-14), 11.43 
(C-16) 
IR (cm-1): 3383 (N-H stretch) 
HRMS: m/z calculated for and C16H29N = 236.2373 [M+H]
+; Found 236.2369 
8-Benzyloxyoctanal 155 
Following the general Swern oxidation procedure, the crude product was purified on silica gel 
(15% Et2O in pentane) to give 8-benzyloxyoctanal (910 mg, 81% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.69 (t, 1H, H-13, J=1.9Hz), 7.27 – 7.18 (m, 5H, H-1 to 3), 4.43 (s, 
2H, H-5), 3.39 (t, 2H, H-6, J=6.6Hz), 2.34 (td, 2H, H-12, J1=7.4Hz, J2=1.9Hz), 1.59 – 1.50 (m, 4H, 
H-7 and 11), 1.34 – 1.24 (m, 6H, H-8 to 10) 
13C-NMR (CDCl3, 100 MHz) δ: 202.87 (C-13), 138.68 (C-4), 128.36, 127.64, 127.50, 72.90 (C-5), 
70.38 (C-6), 43.89 (C-12), 29.69 (C-7), 29.19 (C-8), 29.10 (C-10), 26.01 (C-9), 22.02 (C-11) 
IR (cm-1): 2717 (OC-H stretch), 1722 (C=O stretch), 1621 and 1453 (benzene), 1097 (C-O 
stretch) 
HRMS: m/z calculated for and C15H22O2Na = 257.1512 [M+Na]
+; Found 257.1513 
11-Benzyloxyundecan-4-ol 151 
To a solution of 8-benzyloxyoctanal (3.19 g, 13.62 mmol) in THF (100 ml), cooled to -78 oC 
under argon, was added dropwise propylmagnesium chloride solution (10.22 ml 2M solution).  
The resulting solution was allowed to warm to RT over 16 hours before water was cautiously 
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added and extracted with EtOAc.  The combined organics were dried (MgSO4) and 
concentrated under vacuum.  The crude product was purified on silica gel (20% EtOAc in pet 
ether) to give 11-benzyloxyundecan-4-ol (3.46 g, 91% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.26 – 7.21 (m, 5H, H-1 to 3), 4.43 (s, 2H, H-5), 3.52 (m, 1H, H-13), 
3.39 (t, 2H, H-6, J=6.6Hz), 1.54 (m, 2H, H-7), 1.39 – 1.19 (m, 14H, H-8 to 12 and 14 to 15), 0.86 
(t, 3H, H-16, J=7.1Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 138.72 (C-4), 128.35, 127.63, 127.48, 72.88 (C-5), 71.72 (C-13), 
70.50 (C-6), 39.69, 37.49, 29.76, 29.65, 29.46, 26.16, 25.60, 18.85, 14.15 (C-16) 
IR (cm-1): 3342 (H-O stretch) 
HRMS: m/z calculated for and C18H30O2Na = 301.2138 [M+Na]
+; Found 301.2140 
11-Benzyloxyundecan-4-one 152 
Following the general Swern procedure, the crude product was purified on silica gel (7% 
EtOAc in pet ether) to give 11-benzyloxyundecan-4-one (761 mg, 82% yield) as a colourless oil.  
1H-NMR (CDCl3, 400 MHz) δ: 7.27 – 7.20 (m, 5H, H-1 to 3), 4.43 (s, 2H, H-5), 3.39 (t, 2H, H-6, 
J=6.6Hz), 2.29 (m, 4H, H-12 and 14), 1.57 – 1.45 (m, 6H, H-7, 11 and 15), 1.31 – 1.17 (m, 6H, 
H-8 to 10), 0.84 (t, 3H, H-16, J=7.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 210.14 (C-13), 138.73 (C-4), 128.35, 127.48, 127.48, 72.88 (C-5), 
70.44 (C-6), 44.73, 42.81, 29.71, 29.29, 29.21, 26.05, 23.80, 17.32, 13.79 (C-16) 
IR (cm-1): 1709 (C=O stretch) 
HRMS: m/z calculated for and C18H28O2Na = 299.1982 [M+Na]
+; Found 299.1980 
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Dimethyl titanocene126 
To a suspension of titanocene dichloride (5.00 g, 20.08 mmol) in toluene (100 ml), cooled to 
0 oC under argon, was added methylmagnesium chloride (14.7 ml 3M solution) dropwise over 
30 mins.  This was stirred for a further 10 mins before 1H-NMR showed the reaction was 
complete.  6% NH4Cl solution was added dropwise and the aqueous layer extracted with 
EtOAc.  The combined organics were washed with water and dried (MgSO4).  The remaining 
solution was concentrated to approximately 30 ml to give a bright orange solution (4.09 g, 
98% yield, ~0.5M in toluene and THF). 
4-Methylene-11-benzyloxyundecane127 
To a solution of 11-benzyloxyundecan-4-one (855 mg, 3.10 mmol) and titanocene dichloride 
(40 mg, 0.16 mmol) in THF (15 ml), under argon, was added dimethyl titanocene (15.5 ml 
~0.5M solution) and heated to 85 oC for 72 hours.  The THF was removed under vacuum 
before 5% EtOAc in pet ether (100 ml) was added and the precipitate filtered. This was 
concentrated under vacuum before being purified on silica gel (2% EtOAc in pet ether) to give 
4-methylene-11-benzyloxyundecane (646 mg, 76% yield) as a yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.26 – 7.20 (m, 5H, H-1 to 3), 4.62 (m, 2H, H-14), 4.43 (s, 2H, H-5), 
3.39 (t, 2H, H-6, J=6.6Hz), 1.91 (m, 4H, H-12 and 15), 1.55 (m, 2H, H-7), 1.12 – 1.19 (m, 10H, 
H-8 to 11 and 16), 0.83 (t, 3H, H-17, J=7.2Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 150.10 (C-13), 138.74 (C-4), 128.35, 127.47, 127.47, 72.88 (C-5), 
70.52 (C-6), 38.23, 36.03, 29.78, 29.40, 27.77, 26.19, 20.19, 13.91 (C-17).  2 signals missing. 
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HRMS: m/z calculated for and C19H30ONa = 297.2189 [M+Na]
+; Found 297.2193 
2-Methylpentyl p-toluenesulphonate 
To a solution of 2-methylpentan-1-ol (2.00 g, 19.58 mmol), 4-dimethylaminopyridine (717 mg, 
5.87 mmol) and triethyl amine (6.73 ml, 48.95 mmol) in CH2Cl2 (100 ml) was added 
p-toluenesulphonyl chloride (4.11 g, 21.54 mmol) and the reaction stirred for 4 hours.  The 
reaction mixture was diluted with CH2Cl2.  The organics were washed with water, 2M, HCl, sat 
NaHCO3, dried (MgSO4) and concentrated under vacuum.  The crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 2-methylpentyl p-toluenesulphonate (4.95 g, 98% 
yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.71 (d, 2H, H-4, J=8.3Hz), 7.27 (d, 2H, H-3, J=8.1Hz), 3.80 (dd, 1H, 
H-6a, J1=9.4, J2=5.7Hz), 3.72 (dd, 1H, H-6b, J1=9.4Hz, J2=6.5Hz), 2.38 (s, 3H, H-1), 1.71 (m, 1H, 
H-7), 1.27 – 0.97 (m, 4H, H-9 and 10), 0.82 (d, 3H, H-8, J=6.7Hz), 0.76 (t, 3H, H-11, J=7.2Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 144.62 (C-5), 133.19 (C-2), 129.79 (C-3), 127.90 (C-4), 75.19 
(C-6), 34.87 (C-9), 32.57 (C-7), 21.64 (C-1), 19.71 (C-10), 16.40 (C-8), 14.09 (C-11) 
IR (cm-1): 1355 (S=O stretch) 
HRMS: m/z calculated for and C13H20O3SNa = 279.1025 [M+Na]
+; Found 279.1024 
1-Iodo-2-methyl pentane 196 
To a solution of 2-methylpentyl p-toluenesulphonate (2.00 g, 7.80 mmol) in acetone (40 ml) 
was added potassium iodide (26.00 g, 156.00 mmol) and the reaction heated to 60 oC for 
48 hours.  The reaction mixture was poured into water and extracted with Et2O.  The 
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combined organics were washed with sat NaHCO3, dried (MgSO4) and concentrated under 
vacuum to give 1-iodo-2-methyl pentane (1.32 g, 80% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.15 (dd, 1H, H-1a, J1=9.6Hz, J2=4.6Hz), 3.09 (dd, 1H, H-1b, 
J1=9.3Hz, J2=6.1Hz), 1.39 (m, 1H, H-2), 1.31 – 1.19 (m, 3H, H-4a and 5), 1.13 (m, 1H, H-4b), 0.90 
(d, 3H, H-3, J=6.6Hz), 0.84 (t, 3H, H-6, J=7.1Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 38.68 (C-4), 34.48 (C-2), 20.59 (C-3), 20.09 (C-5), 18.11 (C-1), 
14.11 (C-6) 
1-(4-Methoxybenzyloxy)-8-methyl-undec-5-yne 197 
To a solution of 1-(4-methoxybenzyloxy)hex-5-yne (2.90 g,  13.30 mmol) in THF (40 ml), cooled 
to -78 oC under argon, was added n-butyl lithium (9.14 ml, 14.63 mmol) and the solution 
stirred for 15 mins.  1-Iodo-2-methyl pentane (1.41 g, 6.65 mmol) in THF (20 ml) was added 
and the reaction heated to 75 oC to 48 hours.  The reaction mixture was poured into water 
and extracted with EtOAc.  The combined organics were dried (MgSO4) and concentrated 
under vacuum.  The crude product was purified on silica gel (5% EtOAc in pet ether) to give 
1-(4-methoxybenzyloxy)-8-methyl-undec-5-yne (1.31 g, 65% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.19 (d, 2H, H-3, J=8.4Hz), 6.80 (d, 2H, H-4, J=8.3Hz), 4.36 (s, 2H, 
H-6), 3.74 (s, 3H, H-1), 3.39 (t, 2H, H-7, J=6.4Hz), 2.13 (m, 2H, H-10), 2.02 (m, 1H, H-13a), 1.95 
(m, 1H, H-13b), 1.64 (m, 2H, H-8), 1.55 – 1.40 (m, 3H, H-8 and 14), 1.32 – 1.04 (m, 4H, H-16 
and 17), 0.87 (d, 3H, H-15, J=6.7Hz), 0.82 (t, 3H, H-18, J=7.2Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 159.50 (C-2), 130.73 (C-5), 129.24 (C-4), 113.75 (C-3), 80.71, 
79.29, 72.51 (C-6), 69.65 (C-7), 55.30 (C-1), 38.38, 26.17, 25.89, 20.21, 32.59 (C-14), 28.90 
(C-8), 19.52 (C-15), 18.61 (C-10), 14.31 (C-18) 
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HRMS: m/z calculated for C20H30O2Na = 325.2138 [M+Na]
+; Found 325.2134 
8-Methylundecan-1-ol 198 
From 4-methylene-11-benzyloxyundecane: A solution of 4-methylene-11-benzyloxyundecane 
(646 mg, 2.36 mmol) and palladium on carbon (10%) was flushed with hydrogen gas five times 
and heated to 70 oC for 15 days.  The reaction mixture was filtered through celite and 
concentrated under vacuum.  The crude product was purified on silica gel (20% EtOAc in pet 
ether) to give 8-methylundecan-1-ol (345 mg, 79% yield) as a colourless oil.  The benzyl 
protected alcohol was also isolated in 15% yield. 
From 1-(4-methoxybenzyloxy)-8-methyl-undec-5-yne: To a solution of 1-(4-
methoxybenzyloxy)-8-methyl-undec-5-yne (489 mg, 1.62 mmol) in THF (10 ml) was added 10% 
palladium on carbon (30 mg) and the flask flushed with hydrogen gas ten times and stirred for 
24 hours.  The reaction mixture was filtered through celite and concentrated under vacuum.  
The crude product was purified on silica gel (20% EtOAc in pet ether) to give 
9 methylundecan-1-ol (143 mg, 48% yield) as a colourless oil.  
1H-NMR (CDCl3, 400 MHz) δ: 3.57 (t, 2H, H-1, J=6.7Hz), 1.50 (m, 2H, H-2), 1.32 – 1.14 and 1.00 
(m, 16H, H-3 to 8, 10 and 11), 0.81 (t, 3H, H-12, J=7.0Hz), 0.76 (d, 3H, H-9, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 63.13 (C-1), 39.43, 37.07, 32.84 (C-2), 32.48 (C-8), 29.98, 29.50, 
27.01, 25.77, 20.15, 19.68 (C-9), 14.42 (C-12) 
IR (cm-1): 3309 (H-O stretch) 
HRMS: m/z calculated for C12H26ONa = 209.1876 [M+Na]
+; Found 209.1877 
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8-Methylundecanal 
Following the general Swern procedure, the crude product was purified on silica gel (7% 
EtOAc in pet ether) to give 8-methylundecanal (338 mg, 68% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.70 (t, 1H, H-1, J=1.6Hz), 2.35 (td, 2H, H-2, J1=7.4Hz, J2=1.6Hz), 
1.56 (m, 2H, H-3), 1.38 – 1.17 (m, 12H, H-4 to 7a, 8, 10a and 11), 1.02 (m, 2H, H-7b and 10b), 
0.80 (t, 3H, H-12, J=6.7Hz), 0.77 (d, 3H, H-9, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 202.98 (C-1), 43.94 (C-2), 39.39, 36.98, 32.46 (C-8), 29.71, 29.22, 
27.64, 26.84, 22.12 (C-3), 19.65 (C-9), 14.41 (C-12) 
IR (cm-1): 2710 (OC-H stretch), 1726 (C=O stretch) 
HRMS: m/z calculated for and C12H24ONa = 207.1719 [M+Na]
+; Found 207.1727 
8-Methylundecanoic acid 199 
Following the general Oxone procedure gave 8-methylundecanoic acid (350 mg, 95% yield) as 
a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.28 (t, 2H, H-2, J=7.4Hz), 1.57 (m, 2H, H-3), 1.32 – 1.13 (m, 11H, 
H-4 to 7a, 8, 10a and 11), 1.02 (m, 2H, H-7b and 10b), 0.80 (t, 3H, H-12, J=6.8Hz), 0.76 (d, 3H, 
H-9, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.83 (C-1), 39.40, 36.99 (C-2), 33.86, 32.46 (C-8), 29.60, 29.12, 
26.85, 24.71 (C-3), 20.14, 19.66 (C-9), 14.42 (C-12) 
IR (cm-1): 1707 (C=O stretch) 
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HRMS: m/z calculated for C12H24O2Na = 223.1666 [M+Na]
+; Found 223.1670 
8-Methyl-1-(1H-pyrrol-2-yl)undecan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (7% EtOAc in pet ether) to give 8-methyl-1-(1H-pyrrol-2-yl)undecan-1-one (310 mg, 
71% yield) as a brown oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.30 (bs, 1H, N-H), 6.94 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.5Hz), 1.65 (m, 2H, H-7), 1.31 – 1.12 (m, 13H, H-8 to 11a, 12, 14a 
and 15), 0.99 (m, 2H, H-11b and 14b), 0.80 (t, 3H, H-16, J=6.9Hz), 0.76 (d, 3H, H-13, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 191.20 (C-5), 131.90 (C-4), 124.15 (C-1), 115.83 (C-3), 110.55 
(C-2), 38.06 (C-6), 36.68, 34.39, 32.47 (C-12), 29.50, 27.10, 25.31, 19.67 (C-13), 14.42 (C-16).  
2 signals missing 
IR (cm-1): 3274 (N-H stretch), 1635 (C=O stretch) 
HRMS: m/z calculated for and C16H27NONa = 272.1985 [M+Na]
+; Found 272.1984 
2-(8-Methylundecyl)-1H-pyrrole 180 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in pet ether) to give 2-(8-methylundecyl)-1H-pyrrole (171 mg, 59% yield) 
as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.82 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.52 (t, 2H, H-5, J=7.7Hz), 1.55 (m, 2H, H-6), 1.32 – 1.14 (m, 13H, H-7 to 11a, 12, 13a 
and 14), 1.02 (m, 2H, H-11b and 13b), 0.81 (t, 3H, H-16, J=6.9Hz), 0.76 (t, 3H, H-13, J=6.5Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 132.80 (C-4), 115.95 (C-1), 108.26 (C-2), 104.86 (C-3), 39.43, 
37.08, 32.48 (C-12), 29.93, 29.69, 29.51, 29.42, 27.75 (C-5), 27.06, 20.15, 19.68 (C-13), 14.43 
(C-16) 
IR (cm-1): 3384 (N-H stretch) 
HRMS: m/z calculated for and C16H29N = 236.2373 [M+H]
+; Found 236.2370 
 6.1.5 Synthesis of methy-substituted pyrrole containing 2-UP analogues 
1-(3-Methylpyrrolyl)undecan-1-one 206 
Following the general carboxylic acid coupling procedure with 3-methyl pyrrole, the crude 
product was purified on silica gel (10% EtOAc in pet ether) to give 1-(3-
methylpyrroyl)undecan-1-one (355 mg, 53% yield) as a while solid. 
1H-NMR (CDCl3, 400 MHz) δ: 9.28 (bs, 1H, N-H), 6.88 (t, 1H, H-1, J=2.7Hz), 6.10 (t, 1H, H-2, 
J=2.6Hz), 2.74 (t, 2H, H-7, J=7.4Hz), 2.41 (s, 3H, H-4), 1.71 (qu, 2H, H-8, J=7.5Hz), 1.39 – 1.27 
(m, 14H, H-6 to 12), 0.90 (t, 3H, H-13, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 190.80 (C-6), 129.49 (C-5), 126.23 (C-3), 122.55 (C-1), 113.56 
(C-2), 39.88 (C-7), 31.89, 29.58, 29.53, 29.32, 22.67, 14.44 (C-1), 14.10 (C-4). 3 signals missing. 
IR (cm-1): 3281 (N-H stretch), 1619 (C=O stretch) 
HRMS: m/z calculated for C16H27NO = 250.2165 [M+H]
+; Found 250.2164 
Melting point (oC): 39 – 40 
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3-Methyl-2-undecylpyrrole 207 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (5% EtOAc in pet ether) to give 3-methyl-2-undecylpyrrole (228 mg, 68% yield) as a 
brown oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.75 (bs 1H, N-H), 6.62 (t, 1H, H-1, J=2.6Hz), 6.01 (t, 1H, H-2, 
J=2.7Hz), 2.57 (t, 2H, H-6, J=7.5Hz), 2.08 (s, 3H, H-4), 1.59 (m, 2H, H-7), 1.34 – 1.30 (m, 16H, 
H-8 to 15), 0.93 (t, 3H, H-16, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 128.58 (C-5), 114.76 (C-1), 113.68 (C-3), 109.94 (C-2), 31.94, 
30.01, 29.74, 29.68, 29.66, 29.64, 29.51, 29.45, 25.84 (C-6), 22.72, 14.14 (C-16), 10.90 (C-4) 
IR (cm-1): 3382 (N-H stretch) 
HRMS: m/z calculated for C16H29N = 236.2373 [M+H]
+; Found 236.2373 
3-Benzyloxy-2-methyl propan-1-ol 
To a solution of 2-methyl-1,3-propandiol (500 mg, 5.55 mmol) in CH2Cl2 (30 ml), under argon, 
was added silver (I) oxide (1.91 g, 8.25 mmol) and the resulting suspension stirred for 30 mins.  
Benzyl bromide (0.73 ml, 6.16 mmol) was added and the reaction mixture allowed to stir for a 
further 16 hours.  The reaction mixture was filtered and concentrated under vacuum.  The 
crude product was purified on silica gel (60% Et2O in pentane) to give 3-benzyloxy-2-methyl-
propan-1-ol (902 mg, 90% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 7.26 (m, 5H, H-1 to 3), 4.45 (s, 2H, H-5), 3.56 (m, 2H, H-9), 3.49 
(dd, 1H, H-6a, J1=9.1Hz, J2=4.5Hz), 3.36 (m, 1H, H-6b), 2.00 (m, 1H, H-7), 0.81 (d, 3H, H-8, 
J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 138.05 (C-4), 128.48, 127.75, 127.63, 75.52 (C-6), 73.43 (C-5), 
67.95 (C-9), 35.60 (C-7), 13.47 (C-8) 
IR (cm-1): 3345 (H-O stretch) 
HRMS: m/z calculated for C11H16O2 = 203.1043 [M+Na]
+; Found 203.1047 
(3-Benzyloxy-2-methyl propyl) 4-methylbenzenesulfonate 
To a solution of 3-benzyloxy-2-methylpropan-1-ol (902 mg, 5.00 mmol), 4-dimethylamino 
pyridine (183 mg, 1.50 mmol) and triethylamine (1.53 ml, 12.50 mmol) in CH2Cl2 (20 ml), 
under argon, was added p-toluene sulfonylchloride (1.05 g, 5.50 mmol) and the resulting 
solution stirred for 24 hours.  The reaction mixture was diluted with CH2Cl2 and washed with 
2M HCl.  The organics were dried (MgSO4) and concentrated under vacuum to give 
(3-benzyloxy-2-methyl propyl) 4-methylbenzenesulfonate (1.59 g, 95% yield) as a yellow oil.  
1H-NMR (CDCl3, 400 MHz) δ: 7.70 (d, 2H, H-11, J=8.3Hz), 7.27 – 7.15 (m, 7H, H-1 to 3 and 12), 
4.32 (s, 2H, H-5), 3.95 (m, 2H, H-9), 3.26 (m, 2H, H-6), 2.35 (s, 3H, H-14), 2.03 (m, 1H, H-7), 
0.87 (d, 3H, H-8, J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 144.66 (C-10), 138.23 (C-4), 133.05 (C-13), 129.81, 128.35, 
127.59, 127.45, 127.93 (C-11), 73.08 (C-5), 72.25 (C-9), 71.11 (C-6), 33.70 (C-7), 21.64 (C-14), 
13.64 (C-8) 
HRMS: m/z calculated for C18H22O4Na = 357.1131 [M+Na]
+; Found 357.1135 
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3-Benzyloxy-2-methyl 1-bromopropane 214 
To a solution of (3-benzyloxy-2-methyl propyl) 4-methylbenzenesulfonate (3.51 g, 
10.49 mmol) in acetone (40 ml), under argon, was added lithium bromide (18.22 g, 
209.80 mmol) and the resulting suspension heated to 65 oC for 24 hours.  The reaction 
mixture was poured into water and extracted with EtOAc.  The combined organics were dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (7% 
EtOAc in pet ether) to give 3-benzyloxy-2-methyl 1-bromopropane (2.20 g, 87% yield) as a 
colourless oil.     
1H-NMR (CDCl3, 400 MHz) δ: 7.30 – 7.20 (m, 5H, H-1 to 3), 4.45 (s, 2H, H-5), 3.44 (m, 2H, H-9), 
3.34 (m, 2H, H-6), 2.07 (m, 1H, H-7), 0.96 (d, 3H, H-8, J=6.8Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 138.36 (C-4), 128.40, 127.60, 73.21 (C-5), 72.78 (C-6), 38.21 
(C-9), 35.68 (C-7), 15.89 (C-8).  1 signal missing. 
IR (cm-1): 1094 (C-O stretch), 696 (C-Br stretch) 
HRMS: m/z calculated for C11H15BrO = 265.0198 and 267.0178 [M+Na]
+; Found 265.0198 and 
267.0179 
1-Benzyloxy-2-methyl pentadecan-4-ol 
Magnesium turnings (93 mg, 3.86 mmol), under argon, was heated with a heat gun for 
10 mins before THF (5 ml) was added.  3-Benzyloxy-2-methyl 1-bromopropane (890 mg, 
3.68 mmol) in THF (2 ml) was added and heated to 50 oC for 3 hours.  The reaction mixture 
was allowed to cool to RT before dodecanal (690 mg, 4.05 mmol) in THF (2 ml) was added and 
stirred for a further 16 hours.  2M HCl was added cautiously and extracted with EtOAc.  The 
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combined organics were dried (MgSO4) and concentrated under vacuum.  The crude product 
was purified on silica gel (15% EtOAc in pet ether to give 1-benzyloxy-2-methyl pentadecan-4-
ol (733 mg, 60% yield) as a colourless oil.  
Note: the mixture of diastereoisomers was not separated 
1H-NMR (CDCl3, 400 MHz) δ: 7.30 – 7.21 (m, 5H, H-1 to 3), 4.46 (s, 2H, H-5), 3.67 – 3.55 (m, 1H, 
H-10), 3.33 – 3.19 (m, 2H, H-6), 2.00 – 1.87 (m, 1H, H-7), 1.45 – 1.19 (m, 22H, H-9 and 11 to 
20), 0.87 (d, 3H, H-8, J=6.9Hz), 0.81 (t, 3H, H-21, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 138.05 (C-4), 128.44, 127.74, 127.71, 76.64, 75.93 (C-6), 73.28, 
73.18 (C-5), 70.52, 69.23 (C-10), 43.46, 42.95, 37.55, 31.95, 31.79, 30.21, 29.77, 29.67, 29.39, 
25.86, 25.81, 22.72, 18.17, 18.07 (C-8), 14.16 (C-21) 
Note: multiple signals for several of the carbons due to the mixture of diastereoisomers 
IR (cm-1): 3398 (H-O stretch), 1092 (C-O stretch), 1072 (C-O stretch) 
HRMS: m/z calculated for C23H40O2Na = 371.2921 [M+Na]
+; Found 371.2925 
2-Methyl-pentadecane-1,4-diol 215 
To a solution of 1-benzyloxy-2-methyl pentadecan-4-ol (633 mg, 1.82 mmol) in THF (15 ml) 
was added 10% palladium on carbon and the flask flushed with hydrogen gas ten times before 
being allowed to stir for 16 hours.  The reaction mixture was filtered through celite and 
concentrated under vacuum to give 2-methyl-pentadecane-1,4-diol (417 mg, 89% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.72 – 3.63 (m, 1H, H-5), 3.54 – 3.32 (m, 2H, H-1), 1.91 – 1.73 (m, 
1H, H-2), 1.46 – 1.35 (m, 4H, H-4 and 6), 1.25 – 1.19 (m, 18H, H-7 to 15), 0.88 – 0.79 (m, 6H, 
H-3 and 16) 
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13C-NMR (CDCl3, 100 MHz) δ: 71.18, 69.47 (C-5), 68.95, 68.05 (C-1), 43.06, 41.84, 38.64, 37.63, 
34.57, 32.19 (C-2), 31.93, 29.07, 29.64, 29.36, 25.81, 25.69, 22.70, 18.01, 17.51 (C-3), 14.13 
(C-16).  2 signals missing. 
Note: multiple signals for several carbons due to mixture of several diastereoisomers 
IR (cm-1): 3300 (H-O stretch) 
HRMS: m/z calculated for C16H35O2 = 259.2632 [M+H]
+; Found 259.2630 
2-Methyl-4-oxo-pentadecanal 216 
To a solution of oxalyl chloride (0.31 ml, 3.54 mmol) in CH2Cl2 (2 ml), cooled to -78 
oC under 
argon, was added DMSO (0.50 ml, 7.08 mmol) and stirred for 15 mins.  2-Methylpentadecane-
1,4-diol (417 mg, 1.61 mmol) in CH2Cl2 (6 ml) was added and allowed to stir for a further 20 
mins.  Triethylamine (1.96 ml, 16.10 mmol) was added and stirred for 20 mins.  Water was 
added and extracted with CH2Cl2.  The combined organics were washed with 2M HCl, sat 
NaHCO3, brine, dried (MgSO4) and concentrated under vacuum.  The crude product was 
purified on silica gel (15% EtOAc on pet ether) to give 2-methyl-4-oxo-pentadecanal (306 mg, 
75% yield) as a waxy white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 9.62 (s, 1H, H-1), 2.91 – 2.77 (m, 2H, H-2 and 4a), 2.43 – 2.30 (m, 
3H, H-4b and 6), 1.51 (m, 2H, H-7), 1.25 – 1.14 (m, 16H, H-8 to 15), 1.08 (d, 3H, H-3, J=7.4Hz), 
0.81 (t, 3H, H-16, J=6.8Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 208.81 (C-5), 203.38 (C-1), 43.11, 41.56 (C-2), 31.91, 29.61, 
29.47, 29.40, 29.34, 29.20, 22.69, 23.82 (C-7), 14.13 (C-16), 13.54 (C-3).  2 signals missing. 
IR (cm-1): 2350 (C(O)-H stretch), 1694 (C=O stretch) 
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HRMS: m/z calculated for C16H31O2 = 255.2319 [M+H]
+; Found 255.2308 
Melting point (oC): 65 – 67 
1-Bromotridec-1-yne 223 
To a solution of 1-tridecyne (1.00 g, 5.55 mmol) in acetone (120 ml), in the dark under argon, 
was added silver nitrate (0.28 g, 1.67 mmol) followed by N-bromo succinimide (1.38 g, 
7.77 mmol) and the resulting mixture stirred for 6 hours.  Water was added and the acetone 
removed under vacuum. The aqueous layer was extracted with Et2O.  The combined organics 
were dried (MgSO4) and concentrated under vacuum.  The crude product was purified on 
silica gel (pet ether) to give 1-bromotridec-1yne (1.17 g, 82% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 2.13 (t, 2H, H-11, J=7.2Hz), 1.44 (m, 2H, H-10), 1.29 (m, 2H, H-9), 
1.23 – 1.19 (m, 14H, H-2 to 8), 0.81 (t, 3H, H-1, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 80.52 (C-12), 37.41, 31.92, 29.62, 29.50, 29.35, 29.09, 28.80, 
28.31, 22.70, 19.69 (C-11), 14.13 (C-1). 1 signal missing. 
HRMS: m/z calculated for C13H22Br = 257.0899 and 259.0879 [M-H]
-; Found 257.0895 and 
259.0874 
N-Allyl p-toluenesulfonylamide 221 
To a solution of p-toluenesulfonylamide (3.00 g, 17.52 mmol) in acetone (90 ml), under argon, 
was added potassium carbonate (2.66 g, 19.72 mmol) and the reaction mixture heated to 
60 oC for 3 hours.  Sodium iodide (0.26g g, 1.75 mmol) followed by allyl bromide (3.03 ml, 
35.04 mmol) in acetone (10 ml) was added and stirred at 60 oC for an additional 16 hours.  The 
reaction mixture was cooled to RT and water added.  The acetone was removed under 
vacuum and the residual aqueous extracted with EtOAc.  The combined organics were dried 
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(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (25% 
EtOAc in pet ether) to give N-allyl p-toluenesulfonylamide (1.15 g, 32% yield) as a white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 7.79 (d, 2H, H-4, J=8.4Hz), 7.24 (d, 2H, H-3, J=8.3Hz), 5.65 (m, 1H, 
H-7), 5.06 (m, 2H, H-8), 4.43 (t, 1H, N-H, J=5.9Hz), 3.52 (m, 2H, H-6), 2.36 (s, 3H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 143.54 (C-2), 136.97 (C-5), 133.00 (C-7), 129.75 (C-3), 127.17 
(C-4), 117.75 (C-8), 45.80 (C-6), 21.55 (C-1) 
HRMS: m/z calculated for C16H31O2 = 255.2319 [M+H]
+; Found 255.2308 
1-(p-Tolylsulfonyl)-2-undecyl-4-methyl pyrrole 225 
To a solution of 1-bromotridec-1-yne (1.17 g, 4.53 mmol) and N-allyl p-toulenesulfonylamide 
(1.91 g, 9.06 mmol) in DMF (10 ml), under argon, was added potassium phosphate tribasic 
(1.44 g, 6.80 mmol) and the reaction mixture heated to 120 oC for 2 hours. The reaction 
mixture was cooled to RT before n-tetrabutylammonium bromide (2.19 g, 6.80 mmol) was 
added and stirred for 10 mins.  Palladium(II) acetate (0.10 g, 0.45 mmol) was added and the 
mixture again heated to 120 oC for 3 hours.  After cooling to RT, the reaction was diluted with 
EtOAc and filtered through celite and the solvent removed under vacuum.  The crude product 
was purified on silica gel (4% EtOAc in pet ether) to give 1-(p-tolylsulfonyl)-2-undecyl-4-methyl 
pyrrole (525 mg, 30% yield) as a brown oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.55 (d, 2H, H-3, J=7.6Hz), 7.20 (d, 2H, H-4, J=7.5Hz), 6.92 (s, 1H, 
H-6), 5.76 (s, 1H, H-9), 2.54 (t, 2H, H-11, J=7.8Hz), 2.32 (s, 3H, H-1), 1.93 (s, 3H, H-8), 1.43 (m, 
2H, H-12), 1.23 – 1.18 (m, 16H, H-13 to 20), 0.81 (t, 3H, H-21, J=6.7Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 144.29 (C-2), 136.82 (C-5), 136.17 (C-10), 129.85 (C-4), 126.64 
(C-3), 121.90 (C-7), 119.03 (C-6), 114.27 (C-9), 29.65, 29.56, 29.43, 29.37, 29.31, 28.71, 27.21, 
26.42, 22.70, 21.59 (C-1), 14.14 (C-21), 11.84 (C-8).  1 signal missing. 
HRMS: m/z calculated for C23H36NO2S = 390.2461 [M+H]
+; Found 390.2462 
 6.1.6 Synthesis of fluorine containing 2-UP analogues 
1,3-Hexan-diol 
To a suspension of lithium aluminium hydride (1.44 g, 27.93 mmol) in THF (100 ml), under 
argon, was added ethyl 3-oxohexanoate (5.05 ml, 31.61 mmol) in THF (20 ml) and the 
resulting mixture heated to 70 oC for 48 hours.  The reaction mixture was cooled to 0 oC 
before water was cautiously added and filtered through celite.  The combined organics were 
dried (MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel 
(40% EtOAc in pet ether) to give 1,3-hexan-diol (2.77 g, 75% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.86 – 3.74 (m, 3H, H-1 and 3), 1.93 (bs, 2H, H-O), 1.70 – 1.56 (m, 
2H, H-2), 1.49 – 1.24 (m, 4H, H-4 and 5), 0.87 (t, 22H, H-6) 
13C-NMR (CDCl3, 100 MHz) δ: 72.17 (C-3), 61.98 (C-1), 40.04 (C-4), 38.31 (C-2), 18.70 (C-5), 
14.06 (C-6) 
IR (cm-1): 3316 (O-H stretch) 
HRMS: m/z calculated for C6H14O2Na = 141.0886 [M+Na]
+; Found 141.0888 
3-Hydroxyhexyl-2,2-dimethylpropanoate 
To a solution of 1,3-hexan-diol (1.31 g, 11.09 mmol) in pyridine (15 ml) and CH2Cl2 (8 ml), 
cooled to -20 oC under argon, was added trimethylacetyl chloride (1.78 ml, 14.42 mmol) 
224 
 
dropwise.  The resulting mixture was allowed to stir for 30 mins.  An additional 0.2 ml of 
trimethylacetyl chloride was required to complete the reaction after which EtOAc was added.  
The organics were washed with 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under 
pressure.  The crude product was purified on silica gel (15% EtOAc in pet ether). 
1H-NMR (CDCl3, 400 MHz) δ: 4.36 (m, 1H, H-4a), 4.14 (m, 1H, H-4b), 3.67 (m, 1H, H-6), 1.82 (m, 
1H, H-5a), 1.68 (m, 1H, H-5b), 1.50 – 1.43 (m, 3H, H-7a and 8), 1.37 (m, 1H, H-7b), 1.21 (s, 9H, 
H-1), 0.94 (t, 3H, H-9, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.95 (C-3), 68.47 (C-6), 61.69 (C-4), 39.55, 38.75 (C-2), 36.44 
(C-5), 27.18 (C-1), 18.78, 13.96 (C-9) 
HRMS: m/z calculated for C11H26O2SiNa = 241.1600 [M+Na]
+; Found 241.1596 
1-Bromopentan-2-one 175 
To a solution of butyryl chloride (0.97 ml, 9.39 mmol) in acetonitrile (20 ml), under argon, was 
added 2M trimethylsilyl diazomethane solution (4.90 ml, 9.80 mmol) dropwise over 15 mins 
and the resulting yellow solution stirred for 30 mins.  The reaction mixture was cooled to 
-20 oC and 33% hydrobromic acid in acetic acid (2.50 ml, 12.21 mmol) was added dropwise 
over 10 mins.  The resulting colourless solution was allowed to warm to RT over 16 hours.  The 
solvent was removed under vacuum and diluted with Et2O.  The combined organics were 
washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under pressure to 
give a mixture of 1-bromopentan-2-one and 1-chloropentan-2-one (Br: 69%, Cl 25%; 94% total 
yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.00 (s, 0.3H, H-5 Cl), 3.81 (s, 1.7H, H-5 Br), 2.57 (t, 1.7H, H-3 Br, 
J=7.3Hz), 2.51 (t, 0.3H, H-3 Cl, J=7.3Hz), 1.58 (m, 2H, H-2), 0.88 (t, 3H, H-1, J=7.4Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 201.95 (C-4), 48.23 (C-5 Cl), 41.71 (C-3 Br), 41.58 (C-3 Cl), 34.30 
(C-5 Br), 17.35 (C-2 Br), 17.11 (C-2 Cl), 13.57 (C-1) 
IR (cm-1): 1712 (C=O stretch) 
HRMS: m/z calculated for C5H10Br = 164.9910 and 166.9889 [M+H]
+; Found 164.9908 and 
166.9887. m/z calculated for C5H10Cl = 121.0415 and 123.0385 [M+H]
+; Found 121.0414 and 
123.0415 
1-Bromo-2,2-difluorpetane 176 
To a solution of 1-bromopentan-2-one and 1-chloropentan-2-one mixture (1.00 g, 6.34 mmol) 
in CH2Cl2 (10 ml), cooled to 0 
oC under argon, was added DAST (1.67 ml, 12.68 mmol) 
dropwise.  The reaction mixture was allowed to warm to RT over 16 hours.  A further 0.1 ml of 
DAST was required to complete the reaction.  The reaction mixture was poured in sat NaHCO3 
and extracted with Et2O.  The combined organics were washed with sat NaHCO3, 2M HCl, 
dried (MgSO4) and concentrated under vacuum without heating to give 1-bromo-2,2-
difuloropentane (490 mg, 42% yield) as a brown oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.44 (t, 2H, H-5, J=13.0Hz), 1.94 (m, 2H, H-3), 1.47 (m, 2H, H-2), 
0.92 (t, 3H, H-1, J=7.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 121.39 (C-4), 35.52 (C-3, t, J=24.1Hz), 30.35 (C-5, t, 34.4Hz), 
14.53 (C-2, t, 14.4Hz), 12.75 (C-1) 
19F-NMR (CDCl3, 300 MHz) δ: 99.03 
Methyl 6-hydroxyhexanoate 
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To a solution of ε-caprolactone (1.94 ml, 17.52 mmol) in methanol (60 ml), under argon, was 
added Dowex 50W-X8 (40 mg) and heated to 65 oC for 16 hours.  The reaction mixture was 
filtered and concentrated under vacuum to give methyl 6-hydroxyhexanoate (2.56 g, 100% 
yield) as a colourless oil.  
1H-NMR (CDCl3, 400 MHz) δ: 3.61 – 3.58 (m, 5H, H-1 and 7), 2.26 (t, 2H, H-3, J=7.0Hz), 1.60 (m, 
2H, H-4), 1.52 (m, 2H, H-6), 1.34 (m, 2H, H-5) 
13C-NMR (CDCl3, 100 MHz) δ: 174.08 (C-2), 61.65 (C-7), 50.50 (C-1), 32.96 (C-3), 31.30 (C-6), 
24.27 (C-5), 23.61 (C-4) 
HRMS: m/z calculated for C7H14O3Na = 169.0835 [M+Na]
+; Found 169.0832 
1-Benzyloxy-non-8-ene 171 
To a solution of 8-benzyloxyoctanal (2.82 g, 12.04 mmol) in THF (15 ml), under argon, was 
added titanocene dichloride (150 mg, 0.60 mmol) followed by dimethyl titanocene (49.4 ml, 
~0.5M solution) and the mixture heated to 85 oC for 72 hours.  The reaction mixture was 
cooled to RT and poured into 5% EtOAc in pet ether.  The precipitate was removed by 
filtration through celite and the solvent removed under vacuum.  The crude product was 
purified on silica gel (3% EtOAc in pet ether) to give 1-benzyloxy-non-8-ene (1.58 g, 57% yield) 
as a yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.27 – 7.20 (m, 5H, H-1 to 3), 5.79 – 5.69 (m, 1H, H-13), 4.94 – 
4.85 (m, 2H, H-14), 4.43 (s, 2H, H-5), 3.39 (t, 2H, H-6, J=6.0Hz), 1.95 (m, 2H, H-12), 1.54 (m, 2H, 
H-17), 1.32 – 1.21 (m, 8H, H-8 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 139.20 (C-13), 138.73 (C-4), 128.35, 127.47, 114.15 (C-14), 72.88 
(C-5), 70.51 (C-6), 33.79 (C-12), 29.77, 29.33, 29.08, 28.87, 26.16 (C-7 to 11).  1 signal missing. 
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1-Benzyloxy-non-8-ene oxide 168 
To a solution of 1-benzyloxy-non-8-ene (1.58 g, 6.81 mmol) in CH2Cl2 (60 ml), cooled to 0 
oC 
under argon, was added m-chloroperbenzoic acid (1.29 g, 7.49 mmol) and the reaction 
allowed to warm to RT over 16 hours.  A further 400 mg of m-chloroperbenzoic acid was 
required to complete the reaction.  The reaction mixture was poured into sat NaHCO3 and the 
organics separated.  The organic layer was dried (MgSO4) and concentrated under vacuum.  
The crude product was purified on silica gel (10% EtOAc in pet ether) to give 1-benzyloxy-8-
ene oxide (1.41 g, 84% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.28 – 7.20 (m, 5H, H-1 to 3), 4.43 (s, 2H, H-5), 3.93 (t, 2H, H-6, 
J=6.6Hz), 2.82 (m, 1H, H-13), 2.67 (dd, 1H, H-14a, J1=5.1Hz, J2=4.1Hz), 2.39 (dd, 1H, H-14b, 
J1=5.1Hz, J2=2.8Hz), 1.55 (m, 2H, H-7), 1.45 (m, 2H, H-12), 1.43 – 1.23 (m, 8H, H-8 to 11) 
13C-NMR (CDCl3, 100 MHz) δ: 139.10 (C-4), 128.35, 127.63, 127.45, 72.89 (C-5), 70.46 (C-6), 
52.40 (C-13), 47.14 (C-14), 32.48 (C-12), 29.74, 29.38, 26.11, 25.92.  1 signal missing. 
IR (cm-1): 3031 (C-H stretch epoxide), 1099 (C-O stretch ether) 
HRMS: m/z calculated for C16H24O2Na = 271.1669 [M+Na]
+; Found 271.1669 
9-Benzyloxy-2-fluoro-nonan-1-ol 172 
To pyridinium polyhydrofluoride (0.12 ml, 10eq), in a polypropylene tube cooled to 0 oC under 
argon, was added 1-benzyloxy-non-8-ene oxide (100 mg, 0.40 mmol) in CH2Cl2 (0.3 ml) and 
allowed to warm to RT over 16 hours.  The reaction mixture was poured into ice cold 2M 
ammonia and neutralised with conc ammonia.  The aqueous layer was extracted with EtOAc.  
The combined organics were washed with 2M HCl, dried (MgSO4) and concentrated under 
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vacuum.  The crude product was purified on silica gel (25% EtOAc in pet ether) to give 9-
benzyloxy-2-fluoro-nonan-1-ol (52 mg, 49% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.18 – 7.28 (m, 5H, H-1 to 3), 4.53 (m, 0.5H, H-13), 4.42 – 4.38 (m, 
2.5Hz, H-5 and 13), 3.66 – 3.51 (m, 2H, H-14), 3.39 (t, 2H, H-6, J=6.6Hz), 2.00 (bs, 1H, H-O), 
1.62 – 1.47 (m, 4H, H-7 and 12), 1.41 – 1.25 (m, 8H, H-8 and 11) 
13C-NMR (CDCl3, 100 MHz) δ: 138.67 (C-4); 128.37, 127.65, 95.60, 93.94 (C-13), 72.89 (C-5), 
70.44 (C-6), 65.14, 64.93 (C-14), 31.05, 30.84 (C-12), 29.72, 29.37, 29.28, 26.09, 24.90, 24.85 
(C-7 to 11) 
IR (cm-1): 3403 (H-O stretch), 1093 (C-O stretch) 
HRMS: m/z calculated for C16H26OFNa = 269.1911 [M+Na]
+; Found 269.1916 
(9-Benzyloxy-2-fluoro-nonyl)-4-methylbenzenesulphonate 173 
To a solution of 9-benzyloxy-2-fluoro-nonan-1-ol (1.28 g, 4.77 mmol), 4-dimethylamino 
pyridine (175 mg, 1.43 mmol) and triethylamine (0.87 ml, 7.16 mmol) in CH2Cl2 (15 ml), cooled 
to 0 oC under argon, was added p-toluenesulphonyl chloride (1.09 g, 5.73 mmol) and stirred 
for 16 hours.  The reaction mixture was poured into water and extracted with CH2Cl2.  The 
combined organics were washed with 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated 
under vacuum.  The crude product was purified on silica gel (10% EtOAc in pet ether) to give 
(9-benzyloxy-2-fluoro-nonyl)-4-methylbenzenesulphonate (1.18 g, 59 %yield). 
1H-NMR (CDCl3, 400 MHz) δ: 7.73 (d, 2H, H-17, J=8.4Hz), 7.29 – 7.20 (m, 7H, H-1 to 3 and 16), 
4.51 (dm, 1H, H-13, J=48.8Hz), 4.43 (s, 2H, H-5), 4.10 – 3.94 (m, 2H, H-14), 3.38 (t, 2H, H-6, 
J=6.6Hz), 2.38 (s, 3H, H-19), 1.52 (m, 4H, H-7 and 12), 1.36 – 1.18 (m, 8H, H-8 to 11) 
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13C-NMR (CDCl3, 100 MHz) δ: 145.05 (C-8), 138.68 (C-4), 129.92, 128.36, 127.99, 127.64, 127.5, 
91.38, 89.64 (C-13), 72.89 (C-5), 70.77, 70.54 (C-14), 70.38 (C-6), 30.99, 30.79 (C-12), 29.70, 
29.18, 26.06, 24.54, 24.50, 21.68 (C-19) 
HRMS: m/z calculated for C23H32O4F = 423.2000 [M+H]
+; Found 423.2004 
 6.1.7 Synthesis of ether containing 2-UP analogues 
1-(t-Butyldimethyl silyl)oxypentan-5-ol 
To a suspension of sodium hydride (460 mg, 19.20 mmol) in THF (30 ml), cooled to 0 oC under 
argon, was slowly added 1,5-pentadiol (2.01 ml, 19.20 mmol) in THF (10 ml) and the resulting 
white precipitate stirred for 30 mins.  t-Butyldimethylsilyl chloride (2.88 g, 19.20 mmol) in THF 
(10 ml) was slowly added over 10 mins and allowed to stir for a further 45 mins.  Water was 
cautiously added, the THF removed under vacuum and the aqueous layer extracted with 
EtOAc (3 x 40 ml).  The combined organics were washed with brine, dried (MgSO4) and 
concentrated under vacuum.  The crude product was purified on silica gel (20% EtOAc in 
hexane) to give 1-(t-butyldimethyl silyl)oxypentan-5-ol (2.93 g, 70% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.59 (m, 4H, H-4 and 8), 1.58 – 1.46 (m, 4H, H-5 and 7), 1.32 (m, 
2H, H-6), 0.85 (s, 9H, H-1), 0.00 (s, 6H, H-3) 
13C-NMR (CDCl3, 100 MHz) δ: 63.12 (C-4), 62.99 (C-8), 32.51 (C-5), 32.33 (C-7), 25.98 (C-1), 
22.04 (C-6), 18.39 (C-2), -5.27 (C-3) 
IR (cm-1): 3367 (H-O stretch), 1095 (O-Si stretch) 
HRMS: m/z calculated for C11H26O2SiNa = 241.1600 [M+Na]
+; Found 241.1596 
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1-(t-Butyldimethyl silyl)oxyheptan-7-ol 
To a solution of 1,7-heptandiol (3.00 g, 22.71 mmol) in THF (70 ml), cooled to 0 oC under 
argon, was added sodium hydride (572 mg, 23.85 mmol) and stirred for 15 mins.  
T-Butyldimethylsilyl chloride (3.40 g, 22.71 mmol) was added and stirred for a further 60 mins.  
The reaction was poured into water and extracted with EtOAc.  The combined organics were 
dried (MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel 
(20% EtOAc in pet ether) to give 1-(t-butyldimethyl silyl)oxyheptan-7-ol (2.23 g, 45% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 3.63 (t, 2H, H-10, J=6.6Hz), 3.60 (t, 2H, H-4, J=6.5Hz), 1.57 (m, 2H, 
H-9), 1.51 (m, 2H, H-5), 1.45 (bs, 1H, H-O), 1.37 – 1.33 (m, 6H, H-6 to 8), 0.90 (s, 9H, H-10), 
0.05 (s, 6H, H-8) 
13C-NMR (CDCl3, 175 MHz) δ: 63.28 (C-4), 62.99 (C-10), 32.80, 32.75, 29.25, 29.18, 25.80 (C-1), 
25.76, 18.38 (C-2), -5.26 (C-3) 
IR (cm-1): 3325 (H-O stretch), 1253 (C-O stretch), 1096 (O-Si stretch) 
HRMS: m/z calculated for C13H30O2SiNa = 269.1913 [M+Na]
+; Found 269.1907 
t-Butyldimethyl-(5-pentoxy-pentoxy)silane 93 
To a solution of 1-(t-butyldimethyl silyl)oxypentan-5-ol (2.93 g, 13.42 mmol) in DMF (50 ml), 
cooled to 0 oC under argon, was added sodium hydride (483 mg, 20.14 mmol) and allowed to 
stir for 30 mins.  1-Bromopentane (4.12 ml, 33.50 mmol) was added and allowed to warm to 
RT over 24 hours.  TLC showed the presence of 1-(t-butyldimethyl silyl)oxypentan-5-ol so 
another equivalent of sodium hydride and 1-bromopentane was added and stirred for a 
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further 16 hours.  Water was cautiously added and extracted with EtOAc (3 x 30 ml).  The 
combined organics were washed with brine, dried (MgSO4) and concentrated under vacuum.  
The crude product was purified on silica gel (3% EtOAc in pet ether) to give t-butyldimethyl-(5-
pentoxy-pentoxy)silane (3.09 g, 80% yield) as a colourless oil. 
1H-NMR (CDCl3, 600 MHz) δ: 3.46 (t, 2H, H-4, J=6.4Hz), 3.35 (m, 4H, H-8 and 9), 1.56 – 1.47 (m, 
6H, H-5, 7 and 10), 1.33 (m, 2H, H-6), 1.27 (m, 4H, H-11 and 12), 0.85 (m, 12H, H-1 and 13), 
0.00 (s, 6H, H-3) 
13C-NMR (CDCl3, 150 MHz) δ: 69.97 (C-9), 69.82 (C-8), 62.16 (C-4), 31.68 (C-5), 28.55 (C-7), 
28.46 (C-10), 27.37 (C-11), 24.96 (C-1), 21.55 (C-6), 21.44 (C-12), 17.35 (C-13), 13.03 (C-13),  
-6.37 (C-3) 
IR (cm-1): 1254 (C-O stretch), 1095 (O-Si stretch) 
HRMS: m/z calculated for C16H36O2SiNa = 311.2377 [M+Na]
+; Found 311.2375 
t-Butyldimethyl-(7-propoxy-heptanoxy)silane 96 
To a solution of 1-(t-butyldimethyl silyl)oxyheptan-7-ol (875 mg, 3.55 mmol) in DMF (15 ml), 
cooled to 0 oC under argon, was added sodium hydride (170 mg, 7.11 mmol) and stirred for 
20 mins.  1-Bromopropane (0.96 ml, 10.65 mmol) in DMF (5 ml) was added and stirred for a 
further 16 hours.  Water was added and extracted with EtOAc.  The combined organics were 
dried (MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel 
(5% EtOAc in pet ether) to give t-butyldimethyl-(7-propoxy-heptanoxy)silane (853 mg, 84% 
yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.55 (t, 2H, H-4, J=6.6Hz), 3.34 (m, 4H, H-10 and 11), 1.59 – 1.43 
(m, 6H, H-5, 9 and 12), 1.32 – 1.23 (m, 6H, H-6 to 8), 0.87 (t, 3H, H-13, J=7.4Hz), 0.85 (s, 9H, 
H-1), 0.00 (s, 6H, H-2) 
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13C-NMR (CDCl3, 100 MHz) δ: 72.57, 70.91, 63.31 (C-4), 32.84, 29.75, 29.33, 26.21, 25.80, 
22.95, 26.00 (C-1), 18.39 (C-2), 10.60 (C-13), -5.25 (C-3) 
IR (cm-1): 1096(O-Si stretch) 
HRMS: m/z calculated for C16H36O2SiNa = 311.2377 [M+Na]
+; Found 311.2370 
5-Pentoxypentan-1-ol 
To a solution of t-butyldimethyl-(5-pentoxy-pentoxy)silane (3.09 g, 10.72 mmol) in THF 
(40 ml), cooled to 0 oC, was added tetrabutylammonium fluoride (6.76 g, 21.44 mmol) and 
stirred for 2 hours.  The THF was removed under vacuum and the crude product purified on 
silica gel (15% EtOAc in pet ether) to give 5-pentoxypentan-1-ol (1.81 g, 97% yield) was a pale 
yellow oil. 
1H-NMR (CDCl3, 700 MHz) δ: 3.66 (t, 2H, H-1, J=6.3Hz), 3.41 (m, 4H, H-5 and 6), 1.63 – 1.56 (m, 
6H, H-2, 4 and 7), 1.44 (m, 2H, H-3), 1.32 (m, 4H, H-8 and 9), 0.90 (t, 3H, H-10, J=7.0Hz) 
13C-NMR (CDCl3, 175 MHz) δ: 71.04 (C-6), 70.74 (C-5), 62.87 (C-1), 32.50 (C-2), 29.69 (C-4), 
29.43 (C-7), 28.35 (C-8), 22.54 (C-9), 22.45 (C-3), 14.04 (C-10) 
IR (cm-1): 3386 (H-O stretch), 1113 (C-O stretch) 
HRMS: m/z calculated for C10H22O2Na = 197.1512 [M+Na]
+; Found 197.1515 
7-Propyloxyheptan-1-ol 
To a solution of t-butyldimethyl-(7-propoxy-heptanoxy)silane (1.60 g, 5.55 mmol) in THF 
(25 ml) was added tetrabutylammonium fluoride (3.51 g, 11.10 mmol) and stirred for 4 hours.  
TLC showed no starting material so the reaction was concentrated under vacuum.  The crude 
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product was purified on silica gel (20% EtOAc in pet ether) to give 7-propyloxyheptan-1-ol 
(900 mg, 93% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.54 (t, 2H, H-1, J=6.6Hz), 3.30 (t, 2H, H-7, J=6.7Hz), 3.26 (t, 2H, 
H-8, J=6.8Hz), 1.54 – 1.44 (m, 6H, H-2, 6 and 9), 1.28 – 1.23 (m, 6H, H-3 to 5), 0.82 (t, 3H, H-10, 
J=7.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 72.59 (C-8), 70.86 (C-7), 63.05 (C-1), 32.73 (C-2), 29.71, 29.28, 
26.19, 25.70, 22.95 (C-9), 10.61 (C-10) 
IR (cm-1): 3380 (H-O stretch), 1113 (C-O stretch) 
HRMS: m/z calculated for C10H22O2Na = 197.1512 [M+Na]
+; Found 197.1516 
5-Pentoxypentanal 
To a solution of 5-pentoxypentan-1-ol (1.00 g, 5.74 mmol) in DMSO (20 ml) was added IBX 
(2.41 g, 8.61 mmol) and the resulting solution stirred for 4 hours.  Water was added and the 
resulting white precipitate was filtered off and washed with Et2O (3 x 50 ml).  The combined 
organics were washed with NaHCO3, (3 x 20 ml), brine, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (10% EtOAc in pet ether) to give 
5-pentoxypentanal (0.79 g, 80% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.70 (t, 1H, H-1, J=1.8Hz), 3.43 (m, 4H, H-5 and 6), 2.40 (td, 2H, 
H-2, J1=7.1Hz, J2=1.7Hz), 1.66 (m, 2H, H-3), 1.57 – 1.46 (m, 4H, H-4 and 7), 1.25 (m, 4H, H-8 and 
9), 0.83 (t, 3H, H-10, J=6.7Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 202.62 (C-1), 71.08 (C-6), 70.23 (C-5), 43.66 (C-2), 29.44 (C-7), 
29.18 (C-4), 28.37 (C-8), 22.55 (C-9), 19.00 (C-3), 14.05 (C-10) 
IR (cm-1): 1725 (C=O stretch), 1112 (C-O stretch) 
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HRMS: m/z calculated for C10H20O2Na = 195.1356 [M+Na]
+; Found 195.1356 
7-Propyloxyheptananal 
To a solution of 7-propyloxyheptan-1-ol (900 mg, 5.17 mmol) in DMSO (10 ml) was added IBX 
(2.18 g, 7.78 mmol) and stirred for 16 hours.  The reaction mixture was diluted with EtOAc and 
filtered.  The organic layer was washed with water, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (10% EtOAc in pet ether) to give 
7-propyloxyheptanal (597 mg, 67% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.69 (t, 1H, H-1,J=1.8Hz), 3.33 (t, 2H, H-7, J=6.5Hz), 3.29 (t, 2H, 
H-8, J=6.7Hz), 2.36 (td, 2H, H-2, J1=7.3Hz, J2=1.9Hz), 1.59 (m 2H, H-3), 1.50 – 1.47 (m, 4H, H-6 
and 9), 1.30 (m, 4H, H-4 and 5), 0.85 (t, 3H, H-10, J=7.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 202.84 (C-1), 72.58 (C-8), 70.66 (C-7), 43.82 (C-2), 29.55, 29.00, 
25.98, 22.91, 22.03 (C-3), 14.19 (C-10) 
IR (cm-1): 2719 (C-H stretch aldehyde), 1724 (C=O stretch), 1112 (C-O stretch) 
HRMS: m/z calculated for C10H20O2Na = 195.1356 [M+Na]
+; Found 195.1353 
5-Pentoxypentanoic acid 90 
To a solution of 5-pentoxypentanal (785 mg, 4.56 mmol) in DMF (10 ml) was added Oxone 
(3.64 g, 5.93 mmol) and the resulting suspension stirred for 4 hours.  Water was added and 
acidified with 2M HCl before being extracted with EtOAc (3 x 40 ml).  The combined organics 
were dried (MgSO4) and concentrated under vacuum.  The crude product was left under high-
vacuum for 24 hours to give 5-pentoxypentanoic acid (0.75 g, 88% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 3.34 (m, 4H, H-5 and 6), 2.33 (t, 2H, H-2, J=7.0Hz), 1.65 (m, 2H, 
H-3), 1.56 (m, 2H, H-4), 1.50 (m, 2H, H-7), 1.28 – 1.21 (m, 4H, H-8 and 9), 0.83 (t, 3H, H-10, 
J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.69 (C-1), 71.10 (C-6), 70.28 (C-5), 33.67 (C-2), 29.41 (C-7), 
28.99 (C-4), 28.35 (C-8). 22.54 (C-9), 21.63 (C-3), 14.05 (C-10) 
IR (cm-1): 1703 (C=O stretch), 1110 (C-O stretch) 
HRMS: m/z calculated for C10H21O3 = 189.1485 [M+H]
+; Found 189.1484 
7-Propyloxyheptanoic acid 97 
To a solution of 7-propyloxyheptananal (597 mg, 3.47 mmol) in DMF (10 ml) was added Oxone 
(2.77 g, 4.51 mmol) and the resulting suspension stirred for 4 hours.  Water was added and 
acidified with 2M HCl before being extracted with EtOAc (3 x 40 ml).  The combined organics 
were dried (MgSO4) and concentrated under vacuum.  The crude product was left under high-
vacuum for 24 hours to give 7-propyloxyheptanoic acid (0.62 g, 94% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.31 (t, 2H, H-7, J=6.5Hz), 3.29 (t, 2H, H-8, J=6.7Hz), 2.28 (t, 2H, 
H-2, J=7.4Hz), 1.59 (m, 2H, H-3), 1.50 – 1.47 (m, 4H, H-6 and 9), 1.30 (m, 4H, H-5 and 5), 0.84 
(t, 3H, H-10, J=7.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 179.37 (C-1), 72.59 (C-8), 70.71 (C-7), 33.91 (C-2), 29.54 (C-6), 
28.90 (C-5), 25.86 (C-9), 24.65 (C-3), 22.90 (C-4), 10.58 (C-10) 
IR (cm-1): 1707 (C=O stretch), 1107 (C-O stretch) 
HRMS: m/z calculated for C10H20O3Na = 211.1305 [M+Na]
+; Found 211.1307 
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5-Pentyloxy-1-(1H-pyrrol-2-yl)-pentan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (20% EtOAc in hexane) to give 5-pentyloxy-1-(1H-pyrrol-2-yl)-pentan-1-one (384 mg, 
40% yield) as a pink oil.   
1H-NMR (CDCl3, 400 MHz) δ: 9.52 (bs, 1H, N-H), 7.01 (m, 1H, H-1), 6.91 (m, 1H, H-3), 6.27 (m, 
1H, H-2), 3.43 (t, 2H, H-9, J=6.4Hz), 3.39 (t, 2H, H-10, J=6.7Hz), 2.79 (t, 2H, H-6, J=7.1Hz), 1.79 
(m, 2H, H-7), 1.64 (m, 2H, H-8), 1.56 (m, 2H, H-11); 1.31 (m, 4H, H-12 and 13), 0.89 (t, 3H, 
H-14, J=6.8Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 190.94 (C-5), 132.31 (C-4), 124.43 (C-3), 116.12 (C-1), 110.67 
(C-2), 71.16 (C-10), 70.61 (C-9), 37.79 (C-6), 29.57 (C-8), 29.54 (C-11), 28.49 (C-12), 22.67 
(C-13), 22.10 (C-7), 14.16 (C-14) 
IR (cm-1): 3279 (N-H stretch), 1632 (C=O stretch), 1110 (C-O stretch) 
HRMS: m/z calculated for C14H23NO2Na = 260.1621 [M+Na]
+; Found 260.1626 
7-Propyloxy-1-(1H-pyrrol-2-yl)-heptan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (20% EtOAc in hexane) to give 7-propyloxy-1-(1H-pyrrol-2-yl)-heptan-1-one (384 mg, 
40% yield) as a pink oil.   
1H-NMR (CDCl3, 400 MHz) δ: 9.47 (bs, 1H, N-H), 6.95 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.20 (m, 
1H, H-2), 3.33 (t, 2H, H-11, J=6.7Hz), 3.29 (t, 2H, H-12, J=6.7Hz), 2.69 (t, 2H, H-6, J=7.6Hz), 1.68 
(m, 2H, H-7), 1.50 (m, 4H, H-10 and 13), 1.32 (m, 4H, H-8 and 9), 0.84 (t, 2H, H-14, J=7.4Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 191.09 (C-5), 132.23 (C-4), 124.33 (C-3), 115.97 (C-1), 110.54 
(C-2), 72.58 (C-12), 70.77 (C-11), 37.95 (C-6), 29.63 (C-10), 29.31 (C-8), 26.05 (C-9), 25.23 (C-7), 
22.94 (C-13), 10.60 (C-14) 
IR (cm-1): 3277 (N-H stretch), 1630 (C=O stretch), 1111 (C-O stretch) 
HRMS: m/z calculated for C14H23NO2Na = 260.1621 [M+Na]
+; Found 260.1618 
2-(5-Pentoxypentyl)-pyrrole 85 
Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 2-(5-pentoxypentyl)-pyrrole (206 mg, 85% yield) as a 
yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.90 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.05 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 3.33 (m, 4H, H-9 and 10), 2.54 (t, 2H, H-5, J=7.4Hz), 1.62 – 1.49 (m, 6H, H-6, 8 and 
11), 1.35 (m, 2H, H-7), 1.25 (m, 4H, H-12 and 13), 0.84 (t, 3H, H-14, J=6.8Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 116.03 (C-1), 108.25 (C-2), 104.94 (C-3), 71.05 (C-9), 70.77 
(C-10), 29.48, 28.39 (C-13), 27.58 (C-5), 25.88 (C-7), 22.57 (C-12), 14.07 (C-14).  1 signal 
missing) 
IR (cm-1): 3380 (N-H stretch), 1099 (C-O) stretch  
HRMS: m/z calculated for C14H26NO = 224.2009 [M+H]
+ and C14H25NONa = 246.1834 [M+Na]
+; 
Found 224.2006 and 246.1828 
2-(7-Propoxyheptyl)-pyrrole 86 
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Following the general acyl ketone reduction procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give 2-(7-propoxyheptyl)-pyrrole (206 mg, 85% yield) as a 
yellow oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.84 (bs, 1H, N-H), 6.59 (m, 1H, H-1), 6.08 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 3.34 – 3.27 (m, 4H, H-11 and 12), 2.52 (t, 2H, H-5, J=7.5Hz), 1.59 – 1.46 (m, 6H, H-6, 
10 and 13), 1.27 (m, 6H, H-7 to 9), 0.85 (t, 3H, H-14, J=7.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 132.24 (C-4), 115.98 (C-1), 108.26 (C-2), 104.88 (C-3), 72.60 
(C-12), 70.90 (C-11), 29.76 (C-10), 29.62 (C-6), 29.31, 27.71 (C-5), 26.15 (C-9), 22.96 (C-13), 
10.61 (C-14).  1 signal missing. 
IR (cm-1): 3382 (N-H stretch), 1097 (C-O stretch) 
HRMS: m/z calculated for C14H25NONa = 246.1828 [M+Na]
+; Found 246.1826 
2-[[5-(5-Pentoxypentyl)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole 
hydrochloride salt47 
To a solution of 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde (50 mg, 
0.17 mmol) and 2-(5-pentoxypentyl)-pyrrole (42 mg, 0.19 mmol) in methanol (3 ml)was added 
2M HCl in methanol (0.10 ml) and the resulting red solution stirred for 15 mins.  Sodium 
methoxide (55 mg, 1.02 mmol) was added and the resulting yellow/brown solution stirred for 
a further 45 mins.  The reaction mixture was poured into water and the yellow colour 
extracted with EtOAc.  The combined organics were washed with brine, dried (MgSO4) and 
concentrated under vacuum.  The crude product was purified via reverse phase HPLC 
(Table 6.2).  The required fractions were combined and the methanol removed under vacuum.  
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The remaining solution was the poured into sat NaHCO3 and the yellow colour extracted with 
EtOAc.  The combined organics were washed with 2M HCl, dried (MgSO4) and concentrated 
under vacuum to give 2-[[5-(5-pentoxypentyl)-1H-pyrrol-2-yl]methylene]-3-methoxy-5-(1H-
pyrrol-2-yl)pyrrole hydrochloride salt (58 mg, 87% yield) as a red solid. 
1H-NMR (CDCl3, 700 MHz) δ: 12.82 (bs, 1H, N-H B), 12.68 (bs, 1H, N-H C), 12.63 (bs, 1H, N-H A), 
7.22 (m, 1H, H-1), 6.96 (s, 1H, H-6), 6.93 (m, 1H, H-3), 6.82 (m, 1H, H-12), 6.34 (m, 1H, H-2), 
6.19 (m, 1H, H-13), (s, 1H, H-10), 3.99 (s, 3H, H-9), 3.41 (t, 2H, H-19, J=6.7Hz), 3.38 (t, 2H, H-20, 
J=6.7Hz), 2.94 (t, 2H, H-15, J=7.7Hz), 1.80 (m, 2H, H-16), 1.63 (m, 2H, H-18), 1.55 (m, 2H, H-21), 
1.46 (m, 2H, H-17), 1.33 – 1.29 (m, 4H, H-22 and 23), 0.88 (t, 3H, H-24, J=6.9Hz) 
13C-NMR (CDCl3, 125 MHz) δ: 166.29 (C-7), 152.64 (C-14), 148.86 (C-9), 129.14 (C-12), 127.48 
(C-1), 125.99 (C-11), 122.08 (C-4), 121.47 (C-5), 117.95 (C-3), 116.31 (C-6), 112.50 (C-13), 
112.00 (C-2), 93.09 (C-10), 70.94 (C-20), 70.70 (C-19), 58.85 (C-8), 29.47, 29.45, 29.07 (C-16), 
28.35 (C-15), 25.93, 22.54 (C-17), 14.05 (C-24).  1 signal missing. 
5-(t-Butyldimethylsilyl)oxypentanal 
Following the general Swern procedure, the crude product was purified on silica gel (10% 
EtOAc in pet ether) to give 5-(t-butyldimethylsilyl)oxypentanal (1.16 g, 79% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.72 (t, 1H, H-1, J=1.8Hz), 3.58 (t, 2H, H-5, J=6.2Hz), 2.41 (td, 2H, 
H-2, J1=7.3Hz, J2=1.8Hz), 1.66 (m, 2H, H-3), 1.51 (m, 2H, H-4), 0.84 (s, 9H, H-8), 0.00 (s, 6H, H-6) 
13C-NMR (CDCl3, 100 MHz) δ: 202.78 (C-1), 62.61 (C-5), 43.64 (C-2), 32.12 (C-4), 25.95 (C-8), 
18.63 (C-3), -5.33 (C-6).  1 signal missing. 
HRMS: m/z calculated for C11H24O2Si = 239.1443 [M+Na]
+; Found 239.1432 
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5-(t-Butyldimethylsilyl)oxypentanoic acid 
To a solution of 5-(t-butyldimethylsilyl)oxypentanal (1.02 g, 4.72 mmol) and 2-methyl-2-
butene (2 ml)in t-butanol (14 ml) was added sodium chlorite (642 mg, 7.09 mmol) and sodium 
dihydrophosphate (115 mg, 0.95 mmol) in water (4 ml) before being stirred for 60 mins.  The 
reaction mixture was poured into 1M HCl and extracted with EtOAc.  The combined organics 
were dried (MgSO4) and concentrated under vacuum.  The crude product was purified on 
silica gel (30% EtOAc in pet ether) to give 5-(t-butyldimethylsilyl)oxypentanoic acid (700 mg, 
64% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.59 (t, 2H, H-5, J=6.3Hz), 2.34 (t, 2H, H-2, J=7.3Hz), 1.65 (m, 2H, 
H-3), 1.54 (m, 2H, H-4), 0.84 (s, 9H, H-8), 0.00 (s, 6H, H-6) 
 13C-NMR (CDCl3, 100 MHz) δ: 178.55 (C-1), 62.66 (C-5), 33.60 (C-2), 31.97 (C-4), 25.95 (C-8), 
21.27 (C-3), 18.29 (C-7), -3.59 (C-6) 
IR (cm-1): 1708 (C=O stretch) 
HRMS: m/z calculated for C11H24O3Si = 231.1422 [M-H]
-; Found 231.1418 
5-(t-Butyldimethylsilyl)oxy-1-(1H-pyrrol-2-yl)pentan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (15% EtOAc in pet ether) to give 5-(t-butyldimethylsilyl)oxy-1-(1H-pyrrol-2-yl)pentan-
1-one (398 mg, 47% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 9.38 (bs, 1H, H-N), 6.97 (m, 1H, H-1), 6.86 (m, 1H, H-3), 6.62 (m, 
1H, H-2), 3.60 (t, 2H, H-9, J=6.4Hz), 2.74 (t, 2H, H-6, J=7.5Hz), 1.74 (m, 2H, H-7), 1.55 (m, 2H, 
H-8), 0.84 (s, 9H, H-12), 0.00 (s, 6H, H-10) 
 13C-NMR (CDCl3, 100 MHz) δ: 190.72 (C-5), 124.24 (C-1), 115.91 (C-3), 110.57 (C-2), 62.87 
(C-9), 37.71 (C-6), 32.47 (C-8), 25.98 (C-12), 21.66 (C-7), 18.33 (C-11), -5.28 (C-10).  1 signal 
missing. 
2-((5-t-Butyldimethylsilyl)oxypentyl)-pyrrole 
Following the general acyl ketone procedure, the crude product was purified on silica gel (10% 
EtOAc in pet ether) to give 2-((t-butyldimethylsilyl)oxypentyl)-pyrrole (338 mg, 90% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.88 (bs, 1H, H-N), 6.61 (m, 1H, H-1), 6.08 (m, 1H, H-2), 5.86 (m, 
1H, H-3), 3.56 (t, 2H, H-9, J=6.5Hz), 2.56 (t, 2H, H-5, J=7.5Hz), 1.59 (m, 2H, H-6), 1.50 (m, 2H, 
H-8), 1.35 (m, 2H, H-7), 0.85 (s, 9H, H-12), 0.00 (s, 6H, H-10) 
 13C-NMR (CDCl3, 100 MHz) δ: 116.03 (C-1), 108.27 (C-2), 104.95 (C-3), 63.16 (C-9), 32.59 (C-8), 
29.50 (C-6), 27.68 (C-5), 26.00 (C-12), 25.53 (C-7), 18.31 (C-11), -5.25 (C-10).  1 signal missing. 
2-(5-Hydroxypentyl)-pyrrole 
To a solution of 2-((5-t-butyldimethylsilyl)oxypentyl)-pyrrole (100 mg, 0.37 mmol) in THF 
(5 ml) was added tetrabutylammonium fluoride (177 mg, 0.56 mmol) and stirred for 16 hours.  
The THF was removed under vacuum and the residue loaded onto silica gel.  The product was 
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eluted with (55% EtOAc in pet ether) to give 2-(5-hydroxypentyl)-pyrrole (39 mg, 70% yield) as 
a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.87 (bs, 1H, H-N), 6.60 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.85 (m, 
1H, H-3), 3.58 (t, 2H, H-9, J=6.5Hz), 2.55 (t, 2H, H-5, J=7.6Hz), 1.60 (m, 2H, H-6), 1.54 (m, 2H, 
H-8), 1.36 (m, 2H, H-7) 
 13C-NMR (CDCl3, 100 MHz) δ: 116.09 (C-1), 108.30 (C-2), 105.00 (C-3), 62.90 (C-9), 32.49 (C-8), 
29.45 (C-6), 27.65 (C-5), 25.43 (C-7).  1 signal missing. 
2-[[5-(Pentan-1-ol)-1H-pyrrol-2-yl]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole hydrochloride salt47 
To a solution of 3-methoxy-5-(1-BOC-pyrrol-2-yl)-1H-pyrrole-2-carboxaldehyde (9 mg, 
0.03 mmol) and 2-(5-hydroxypentyl)-pyrrole (6 mg, 0.04 mmol) in methanol (1.5 ml) was 
added 2M HCl in methanol (0.10 ml) and the resulting red solution stirred for 15 mins.  
Sodium methoxide (10 mg, 0.18 mmol) was added and the resulting yellow/brown solution 
stirred for a further 45 mins.  The reaction mixture was poured into water and the yellow 
colour extracted with EtOAc.  The combined organics were washed with brine, dried (MgSO4) 
and concentrated under vacuum.  The crude product was purified via reverse phase HPLC, 
(Table 6.2).  The required fractions were combined and the methanol removed under vacuum.  
The remaining solution was the poured into sat NaHCO3 and the yellow colour extracted with 
EtOAc.  The combined organics were washed with 2M HCl, dried (MgSO4) and concentrated 
under vacuum to give 2-[[5-(Pentan-1-ol)-1H-pyrrol-2-yl]-3-methoxy-5-(1H-pyrrol-2-yl)pyrrole 
hydrochloride salt (8 mg, 80% yield) as a red solid. 
1H-NMR (CDCl3, 700 MHz) δ: 12.94 (bs, 1H, N-H B), 12.79 (bs, 1H, N-H C), 12.70 (bs, 1H, N-H A), 
7.19 (m, 1H, H-1), 6.94 (s, 1H, H-6), 6.89 (m, 1H, H-3), 6.77 (m, 1H, H-12), 6.29 (m, 1H, H-2), 
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6.14 (m, 1H, H-13), 6.02 (s, 1H, H-10), 3.95 (s, 3H, H-8), 3.60 (t, 2H, H-19, J=6.4Hz), 2.88 (t, 2H, 
H-15, J=7.7Hz), 1.77 (m, 2H, H-16), 1.59 (m, 2H, H-18), 1.43 (m, 2H, H-17) 
 13C-NMR (CDCl3, 125 MHz) δ: 166.55 (C-7), 152.80 (C-14), 149.17 (C-8), 129.40 (C-12), 127.89 
(C-1), 126.23 (C-11), 122.28 (C-4), 121.73 (C-5), 118.23 (C-3), 116.57 (C-6), 112.79 (C-13), 
112.26 (C-2), 93.40 (C-10), 62. 82 (C-11), 59.03 (C-9), 32.35 (C-18), 29.22 (C-16), 28.44 (C-18), 
25.44 (C-17) 
 6.1.8 Synthesis of stereoselectively deuterium-labelled 2-UP analogue 
Pent-4-ynyl-2,2-dimethylpropanoate 
To a solution of 4-pentyne-1-ol (2.00 g, 23.78 mmol), triethyl amine (4.38 ml, 30.91 mmol) and 
4-dimethylamino pyridine (140 mg, 1.19 mmol) in CH2Cl2 (40 ml), cooled to 0 
oC under argon, 
was added trimethylacetyl chloride (3.22 ml, 26.16 mmol) dropwise.  The reaction mixture 
was allowed to warm to RT over 16 hours.  The reaction mixture was diluted with CH2Cl2, 
washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under vacuum.  The 
crude product was purified on silica gel (5% EtOAc in pet ether) to give pent-4-ynyl-2,2-
dimethylpropanoate (3.86 g, 97% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 4.09 (t, 2H, H-4, J=6.3Hz), 2.22 (td, 2H, H-6, J1=7.1Hz, J2=2.6Hz), 
1.90 (t, 1H, H-8, J=2.6Hz), 1.80 (qu, 2H, H-5, J=6.7Hz), 1.13 (s, 9H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 178.50 (C-3), 82.98 (C-8), 68.93 (C-7), 62.84 (C-4), 27.63 (C-5), 
27.19 (C-1), 26.52 (C-2), 15.22 (C-6) 
HRMS: m/z calculated for C10H16O2 = 169.1223 [M+H]
+; Found 169.1223 
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4-Pentyn-1-oxy-(t-butyldimethylsilyl) 
To a solution of 4-pentyne-1-ol (3.00 g, 35.66 mmol) and t-butyldimethyl silyl chloride (6.99 g, 
46.36 mmol) in CH2Cl2 (150 ml), cooled to 0 
oC under argon, was added imidazole (3.16 g, 
46.36 mmol) and the reaction mixture allowed to stir for 2 hours.  TLC showed no starting 
material so the reaction mixture was diluted with CH2Cl2.  The organics were washed with 
water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under vacuum to give 4-pentyn-
1-oxy-(t-butyldimethylsilyl) (7.07 g, 100% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.64 (t, 2H, H-4, J=6.0Hz), 2.22 (td, 2H, H-6, J1=7.0Hz, J2=2.7Hz), 
1.87 (t, 1H, H-8, J=2.6Hz), 1.67 (qu, 2H, H-5, J=6.5Hz), 0.84 (s, 9H, H-1), 0.00 (s, 6H, H-3) 
 13C-NMR (CDCl3, 100 MHz) δ: 84.01 (C-7), 68.23 (C-8), 61.44 (C-4), 31.53 (C-5), 25.66 (C-1), 
18.41 (C-6), 14.85 (C-6), -5.36 (C-3) 
HRMS: m/z calculated for C11H23OSi = 199.1513 [M+H]
+; Found 199.1511 
1-(4-Methoxybenzyloxy)-pent-4-yne 240 
To a suspension of sodium hydride (1.71 g, 71.33 mmol) in DMF (70 ml), cooled to 0 oC under 
argon, was added 4-pentyn-1-ol (5.00 g, 59.44 mmol) in DMF (50 ml) and stirred for 30 mins.  
4-Methoxybenzyl chloride (9.67 ml, 71.33 mmol) was added and the reaction mixture heated 
to 70 oC for 24 hours.  The reaction mixture was poured into water and extracted with EtOAc.  
The combined organics were washed with water, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (7% Et2O in pet ether) to give 1-(4-
methoxybenzyloxy)-pent-4-yne (9.92 g, 83% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 7.19 (d, 2H, H-3, J=8.7Hz), 6.80 (d, 2H, H-4, J=8.6Hz), 4.38 (s, 2H, 
H-6), 3.73 (s, 3H, H-1), 3.47 (t, 2H, H-7, J=6.1Hz), 2.23 (td, 2H, H-9, J1=7.1, J2=2.7Hz), 1.86 (t, 
1H, H-11, J=2.6Hz), 1.80 (qu, 2H, H-8, J=6.4Hz) 
 13C-NMR (CDCl3, 100 MHz) δ: 159.18 (C-2), 130.58 (C-5), 129.58 (C-3), 113.79 (C-4), 84.03 
(C-10), 72.67 (C-6), 68.41 (C-7), 55.30 (C-1), 28.68 (C-8), 15.34 (C-9).  1 signal missing. 
HRMS: m/z calculated for C13H16O2Na = 227.1043 [M+H]
+; Found 227.1039 
(2S)-Oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) S-238 
To a solution of R-(+)-glycidol (1.00 g, 13.50 mmol), 4-dimethylamino pyridine (1.65 g, 
13.50 mmol) and triethylamine (3.76 ml, 27.00 mmol) in CH2Cl2 (40 ml), cooled to 0 
oC under 
argon, was added t-butyldimethylsilyl chloride (3.06 g, 20.30 mmol) dropwise over 60 mins.  
The reaction mixture was allowed to warm to RT over 16 hours.  TLC showed no starting 
material so the reaction mixture was washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) 
and concentrated under vacuum.  The crude product was the purified on silica gel (5% EtOAc 
in pet ether) to give (2S)-oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) (2.18 g, 86% yield) as a 
colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.77 (dd, 1H, H-4a, J1=11.8Hz, J2=3.2Hz), 3.58 (dd, 1H, H-4b, 
J1=11.8Hz , J2=4.8Hz), 3.01 (m, 1H, H-3), 2.69 (m, 1H, H-6a), 2.55 (1H, H-6b, J1=5.1Hz, J2=2.6Hz), 
0.83 (s, 9H, H-1), 0.00 (2, 6H, H-3) 
 13C-NMR (CDCl3, 100 MHz) δ: 63.76 (C-4), 52.44 (C-5), 44.49 (C-6), 25.88 (C-1), 0.05 (C-2), 
-5.29 (C-3) 
IR (cm-1): 1250 (C-O stretch) 
HRMS: m/z calculated for C9H20O2SiNa = 211.1125 [M+H]
+; Found 211.1126] 
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(2R)-Oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) R-238 
To a solution of S-(-)-glycidol (2.00 g, 26.99 mmol), 4-dimethylaminopyridine (4.95 g, 
40.50 mmol) and triethylamine (7.51 ml, 53.98 mmol) in CH2Cl2 (70 ml), cooled to 0 
oC under 
argon, was added t-butyldimethylsilyl chloride (6.10 g, 40.50 mmol) in CH2Cl2 (60 ml) dropwise 
over 60 mins.  The reaction was allowed to warm to RT over 4 hours.  TLC showed no starting 
material so the reaction was diluted with CH2Cl2 (100 ml).  The organics were washed with 
water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under vacuum.  The crude 
product was purified on silica gel (5% EtOAc in pet ether) to give (2R)-oxiran-2-yl-methoxy-1-
(t-butyldimethylsilyl) (4.62 g, 91% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.70 (dd, 1H, H-4a, J1=11.9Hz, J2=3.2 Hz), 3.61 (dd, 1H, H-4a, 
J1=11.9Hz, J2=4.9Hz), 3.01 (m, 1H, H-5), 2.69 (m, 1H, H-6b), 2.56 (m, 1H, H-6b, J1=5.2Hz, 
J2=2.5Hz), 0.83 (s, 9H, H-1), 0.00 (s, 6H, H-3) 
13C-NMR (CDCl3, 100 MHz) δ: 63.76 (C-4), 52.44 (C-5), 44.49 (C-6), 25.88 (C-1), 0.01 (C-2), -5.34 
(C-3) 
HRMS: m/z calculated for C9H20O2SiNa = 211.1125 [M+H]
+; Found 211.1120 
(2S)-1,8-bis((t-Butyldimethylsilyl)oxy)oct-4-yn-2-ol 
To a solution of 4-pentyn-1-oxy-(t-butyldimethylsilyl) (263 mg, 1.33 mmol) in THF (2 ml), 
cooled to -78 oC under argon, was added n-butyl lithium (0.79 ml, 1.17 mmol) dropwise and 
stirred for 30 mins.  Boron trifluoride diethyletherate (0.14 ml, 1.17 mmol) was added 
followed by (2S)-oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) (100 mg, 0.53 mmol) in THF 
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(1 ml) and stirred for a further 30 mins.  TLC showed no SM so the THF was removed under 
vacuum and loaded onto silica gel.  The product was eluted with 10% EtOAc in pet ether to 
give (2S)-1,8-bis((t-butyldimethylsilyl)oxy)oct-4-yn-2-ol (106 mg, 52% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.71 (m, 1H, H-10), 3.62 (t, 2H, H-4, J=6.1Hz), 3.53 (dd, 2H, H-11, 
J1=9.6Hz, J2=5.7Hz), 2.33 (m, 2H, H-9), 2.19 (tt, 2H, H-6, J1=7.1Hz, J2=2.4Hz), 1.63 (qu, 2H, H-5, 
J=6.5Hz), 0.86 (s, 9H, H-1 or 14), 0.84 (s, 9H, H-1 or 14), 0.03 (s, 6H, H-3 or 12), 0.00 (s, 6H, H-3 
or 12) 
 13C-NMR (CDCl3, 100 MHz) δ: 81.15 (C-7), 75.85 (C-8), 70.50 (C-10), 65.67 (C-11), 61.70 (C-4), 
32.03 (C-5), 25.94, 25.88, 23.44 (C-9), 18.34, 18.08, 15.18 (C-6), -5.31, -5.40 
IR (cm-1): 3450 (H-O stretch), 1252 (C-O stretch), 1103 (O-Si stretch) 
HRMS: m/z calculated for C20H42O3Si2H = 387.2745 [M+H]
+; Found 387.2746 
(2S)-1-(t-Butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-4-yn-2-ol S-241 
To a solution of 1-(4-methoxybenzyloxy)-pent-4-yne (6.11 g, 29.94 mmol) in THF (150 ml), 
cooled to -78oC under argon, was added n-butyl lithium (16.2 ml, 25.95 mmol) and stirred for 
15 mins.  (2S)-Oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) (3.76 g, 19.96 mmol) in THF (50 ml) 
followed by boron trifluoride diethyletherate (3.16 ml, 25.95 mmol) was added and stirred for 
a further 3 hours.  TLC showed no starting material so the reaction mixture was poured into 
water and extracted with EtOAc.  The combined organics were washed with water, dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (12% 
EtOAc in pet ether) to give (2S)-1-(t-butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-
4-yn-2-ol (7.00 g, 89% yield) as a colourless oil. 
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1H-NMR (CDCl3, 400 MHz) δ: 7.18 (d, 2H, H-4, J=8.6Hz), 6.79 (d, 2H, H-3, J=8.6Hz), 4.35 (s, 2H, 
H-6), 3.72 (s, 3H, H-1), 3.67 – 3.59 (m, 2H, H-13 and 14a), 3.50 (dd, 1H, H-14b, J1=9.6Hz, 
J2=5.7Hz), 3.44 (t, 2H, H-7, J=6.3Hz), 2.37 (m, 1H, H-12a), 2.29 (m, 1H, H-12b), 2.19 (m, 2H, 
H-9), 1.69 (qu, 2H, H-8, J=6.5Hz), 0.82 (s, 9H, H-17), 0.00 (s, 6H, H-15) 
13C-NMR (CDCl3, 100 MHz) δ: 159.10 (C-2), 130.60 (C-5), 129.23 (C-4), 113.78 (C-3), 81.91 
(C-10), 72.62 (C-6), 76.06 (C-11), 70.48 (C-13), 68.67 (C-7), 65.67 (C-14), 55.29 (C-1), 29.14 
(C-8), 25.88 (C-17), 23.45 (C-12), 18.54 (C-16), 15.67 (C-9), -5.91 (C-15) 
HRMS: m/z calculated for C22H36O4SiNa = 415.2275 [M+Na]
+; Found 415.2276 
(2R)-1-(t-Butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-4-yn-2-ol R-241 
To a solution of 1-(4-methoxybenzyloxy)-pent-4-yne (2.58 g, 12.66 mmol) in THF (80 ml), 
cooled to -78 oC under argon, was added n-butyl lithium (7.39 ml, 11.82 mmol) and stirred for 
15 mins.  (2R)-Oxiran-2-yl-methoxy-1-(t-butyldimethylsilyl) (1.59 g, 8.44 mmol) in THF (20 ml) 
followed by boron trifluoride diethyletherate (1.43 ml, 11.82 mmol) was added and stirred for 
a further 4 hours.  TLC showed no starting material so the reaction mixture was poured into 
water and extracted with EtOAc.  The combined organics were washed with water, dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (15% 
EtOAc in pet ether) to give (2R)-1-(t-butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-
4-yn-2-ol (2.09 g, 63% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.24 (d, 2H, H-4, J=8.6Hz), 6.85 (d, 2H, H-3, J=8.6Hz), 4.41 (s, 2H, 
H-6), 3.78 (s, 3H, H-1), 3.71 (m, 1H, H-13), 3.65 – 3.57 (m, 2H, H-14), 3.50 (t, 2H, H-7, J=6.2Hz), 
2.44 (m, 1H, H-12a), 2.34 (m, 1H, H-12b), 2.25 (tt, 2H, H-9, J1=7.1Hz, J2=2.4Hz), 1.75 (qu, 2H, 
H-8, J=6.8Hz), 0.88 (s, 9H, H-17), 0.06 (s, 6H, H-15) 
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13C-NMR (CDCl3, 100 MHz) δ: 159.09 (C-2), 130.61 (C-5), 129.23 (C-4), 113.77 (C-3), 81.91 
(C-10), 76.00 (C-11), 72.62 (C-6), 70.47 (C-13), 68.66 (C-7), 65.66 (C-14), 55.29 (C-1), 29.13 
(C-8), 25.89 (C-17), 23.44 (C-12), 18.40 (C-16), 15.67 (C-9), -5.89 (C-15) 
HRMS: m/z calculated for C22H36O4SiNa = 415.2275 [M+Na]
+; Found 415.2271 
(7S)-8-(t-Butyldimethylsilyl)oxyoctan-1,7-diol S-242 
To a solution of (2S)-1-(t-butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-4-yn-2-ol 
(7.00 g, 17.85 mmol) in THF (150 ml) was added 10% palladium on carbon (300 mg).  The 
reaction flask was flushed with hydrogen gas ten times before being allowed to stir for 24 
hours.  The reaction mixture was filtered through celite and concentrated under vaccum.  The 
crude product was purified on silica gel (45% EtOAc in pet ether) to give (7S)-8-(t-
butyldimethylsilyl)oxyocatn-1,7-diol (2.55 g, 52% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.58 – 3.53 (m, 3H, H-1, 7 and 8a), 3.31 (dd, 1H, H-8b, J1=10.1Hz, 
J2=8.5Hz), 1.61 (m, 2H, H-2), 1.47 – 1.18 (m, 8H, H-3 to 6), 0.83 (s, 9H, H-11), 0.00 (s, 6H, H-9) 
13C-NMR (CDCl3, 100 MHz) δ: 71.87 (C-7), 67.29 (C-8), 63.02 (C-1), 32.81, 32.70, 31.79, 29.40, 
25.90 (C-11), 25.56, 22.61 (C-10).  1 signal missing. 
HRMS: m/z calculated for C14H32O3SiNa = 299.2018 [M+Na]
+; Found 299.2010 
(7R)-8-(t-Butyldimethylsilyl)oxyoctan-1,7-diol R-242 
To a solution of (2R)-1-(t-butyldimethylsilyl)oxy-8-((4-methoxyphenyl)methoxy)oct-4-yn-2-ol 
(2.09 g, 5.33 mmol) in THF (40 ml) was added 10% palladium on carbon (100 mg).  The 
reaction flask was flushed with hydrogen gas ten times before being allowed to stir for 48 
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hours.  The reaction mixture was filtered through celite and concentrated under vacuum.  The 
crude product was purified on silica gel (45% EtOAc in pet ether) to give (7R)-8-(t-
butyldimethylsilyl)oxyoctan-1,7-diol (987 mg, 67% yield) as a colourless oil.   
1H-NMR (CDCl3, 400 MHz) δ: 3.57 (m, 4H, H-1, 7 and 8a), 3.31 (m, 1H, H-8b), 1.50 (m, 3H, H-2 
and 6a), 1.38 – 1.28 (m, 7H, H-3 to 6b), 0.83 (s, 9H, H-11), 0.00 (s, 6H, H-9) 
13C-NMR (CDCl3, 100 MHz) δ: 71.81 (C-7), 67.29 (C-8), 63.01 (C-1), 32.69 (C-6); 29.46, 25.65, 
25.56 (C-2 to 5); 32.69 (C-6), 25.90 (C-11).  2 signals missing. 
HRMS: m/z calculated for C14H32O3SiNa = 299.2018 [M+Na]
+; Found 299.2013 
((7S)-8-(t-Butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate 
To a solution of (7S)-8-(t-butyldimethylsilyl)oxyoctan-1,7-diol (2.55 g, 9.23 mmol) in pyridine 
(20 ml), cooled to -20 oC under argon, was added trimethylacetly chloride (1.50 ml, 
12.00 mmol) in CH2Cl2 (15 ml) and stirred for 60 mins.  TLC showed no starting material so the 
reaction was poured into water and extracted with CH2Cl2.  The combined organics were 
washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under vacuum.  The 
crude product was purified on silica gel (10% EtOAc in pet ether) to give ((7S)-8-(t-
butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate (2.56 g, 77%  yield) as a 
colourless oil.   
1H-NMR (CDCl3, 400 MHz) δ: 3.97 (t, 2H, H-4, J=6.6Hz), 3.55 (m, 2H, H-10 and 11a), 3.31 (dd, 
1H, H-11b, J1=10.1Hz, J2=8.4Hz), 2.34 (m, 1H, H-10), 1.55 (m, 2H, H-5), 1.44 – 1.24 (m, 8H, H-6 
to 9), 1.12 (s, 9H, H-1), 0.83 (s, 9H, H-14), 0.00 (s, 6H, H-12) 
13C-NMR (CDCl3, 100 MHz) δ: 178.56 (C-3), 71.78 (C-10), 67.28 (C-11), 64.39 (C-4), 38.80 (C-2), 
32.70, 29.34, 28.57 (C-5), 27.22 (C-1), 25.90 (C-14), 25.87, 25.50, 18.24 (C-13), -5.30 (C-12) 
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HRMS: m/z calculated for C19H39O4Si = 359.2623 [M+H]
+; Found = 359.2628 
((7R)-8-(t-Butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate 
To a solution of (7R)-8-(t-butyldimethylsilyl)oxyoctan-1,7-diol (1.05 g, 3.80 mmol) in pyridine 
(10 ml), cooled to -20 oC under argon, was added trimethylacetly chloride (0.61 ml, 
4.94 mmol) in CH2Cl2 (7 ml) and stirred for 60 mins.  TLC showed no starting material so the 
reaction was poured into water and extracted with CH2Cl2.  The combined organics were 
washed with water, 2M HCl, sat NaHCO3, dried (MgSO4) and concentrated under vacuum.  The 
crude product was purified on silica gel (10% EtOAc in pet ether) to give ((7R)-8-(t-
butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate (1.10 g, 80%  yield) as a 
colourless oil.   
1H-NMR (CDCl3, 400 MHz) δ: 4.05 (t, 2H, H-4, J=6.6Hz), 3.64 – 3.61 (m, 2H, H-10 and 11a), 3.39 
(dd, 1H, H-11b, J1=10.6Hz, J2=8.3Hz), 2.39 (bs, 1H, H-O), 1.60 (m, 2H, H-5), 1.45 – 1.36 (m, 8H, 
H-6 to 9), 1.20 (s, 9H, H-1), 0.91 (s, 9H, H-14), 0.07 (s, 6H, H-12) 
13C-NMR (CDCl3, 100 MHz) δ: 178.57 (C-3), 71.78 (C-10), 67.26 (C-11), 64.39 (C-4), 38.81 (C-2), 
32.76, 29.35, 28.54 (C-5), 27.23 (C-1), 25.91 (C-14), 25.88, 25.50, 18.25 (C-13), -5.28 (C-12) 
HRMS: m/z calculated for C19H39O4Si = 359.2623 [M+H]
+; Found = 359.2621 
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((7S)-8-(t-Butyldimethylsilyl)oxy-7-(p-tolylsulphonyloxy)octyl)-2,2-dimethylpropanoate 
S-243 
To a solution of ((7S)-8-(t-butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate 
(2.46 g, 6.83 mmol), 4-dimethylaminopyridine (250 mg, 2.05 mmol) and triethylamine 
(2.36 ml, 17.08 mmol) in chloroform (35 ml), under argon, was added p-toluenesulphonyl 
chloride (1.69 g, 8.88 mmol) and the reaction heated to 70 oC for 16 hours.  The reaction 
mixture was poured into water and extracted with CH2Cl2.  The combined organics were 
washed with water, 2M HCl, sat NaHCO3 and concentrated under vacuum.  The crude product 
was purified on silica gel (5% EtOAc in pet ether) to give ((7S)-8-(t-butyldimethylsilyl)oxy-7-(p-
tolylsulphonyloxy)octyl)-2,2-dimethylpropanoate (2.82 g, 81% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.80 (d, 2H, H-12, J=8.3Hz), 7.33 (dd, 2H, H-13, J=8.2Hz), 4.48 (m, 
1H, H-10), 4.02 (t, 2H, H-4, J=6.6Hz), 3.64 (dd, 2H, H-16, J1=10.9Hz, J2=4.7Hz), 2.45 (s, 3H, 
H-15), 1.72 – 1.52 (m, 4H, H-5 and 9), 1.30 – 1.15 (m, 15H, H-6 to 8 and 1), 0.85 (s, 9H, H-19), 
0.00 (s, 6H, H-17) 
13C-NMR (CDCl3, 100 MHz) δ: 178.57 (C-3), 144.47 (C-14), 134.47 (C-11), 129.67 (C-13), 127.82 
(C-12), 83.17 (C-10), 64.30 (C-4), 63.99 (C-16), 38.64 (C-2), 30.99 (C-9), 28.91 (C-5), 28.45, 
27.22 (C-1), 25.79 (C-19), 25.70, 24.54, 21.61 (C-15), -5.70 (C-17).  1 signal missing.  
HRMS: m/z calculated for C26H46O6SSi = 537.2677 [M+Na]
+; Found = 537.2678 
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((7R)-8-(t-Butyldimethylsilyl)oxy-7-(p-tolylsulphonyloxy)octyl)-2,2-dimethylpropanoate 
R-243 
To a solution of ((7R)-8-(t-butyldimethylsilyl)oxy-7-hydroxy-octyl)-2,2-dimethylpropanoate 
(1.96 g, 5.44 mmol), 4-dimethylaminopyridine (200 mg, 1.63 mmol) and triethylamine 
(1.90 ml, 13.60 mmol) in chloroform (35 ml), under argon, was added p-toluenesulphonyl 
chloride (1.35 g, 7.07 mmol) and the reaction heated to 70 oC for 16 hours.  The reaction 
mixture was poured into water and extracted with CH2Cl2.  The combined organics were 
washed with water, 2M HCl, sat NaHCO3 and concentrated under vacuum.  The crude product 
was purified on silica gel (5% EtOAc in pet ether) to give ((7R)-8-(t-butyldimethylsilyl)oxy-7-(p-
tolylsulphonyloxy)octyl)-2,2-dimethylpropanoate (2.19 g, 79% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.79 (d, 2H, H-12, J=8.4Hz), 7.31 (d, 2H, H-13, J=8.3Hz), 4.47 (m, 
1H, H-10), 4.02 (t, 2H, H-4, J=6.6Hz), 3.64 (m, 2H, H-16), 2.44 (s, 3H, H-15), 1.67 – 1.54 (m, 4H, 
H-5 and 9), 1.29 – 1.23 (m, 6H, H-6 to 8), 1.19 (s, 9H, H-1), 0.84 (s, 9H, H-19), 0.00 (s, 6H, H-17) 
13C-NMR (CDCl3, 100 MHz) δ: 178.54 (C-3), 144.47 (C-14), 134.47 (C-11), 129.67 (C-13), 127.82 
(C-12), 83.18 (C-10), 64.36 (C-4), 63.99 (C-16), 38.65 (C-2), 31.01 (C-9), 28.94 (C-5), 28.43, 
27.22 (C-1), 25.74 (C-19) ,25.71, 24.54, 21.62 (C-15), -5.69 (C-7).  1 signal missing. 
HRMS: m/z calculated for C26H46O6SSi = 537.2677 [M+Na]
+; Found = 537.2674 
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6-(2R)-Oxiranhexyl-2,2-dimethylpropanoate R-244 
To a solution of ((7S)-8-(t-butyldimethylsilyl)oxy-7-(p-tolylsulphonyloxy)octyl)-2,2-
dimethylpropanoate (2.82 g, 5.48 mmol) in THF (35 ml), under argon, was added 
tetrabutylammonium fluoride (2.08 g, 6.58 mmol) and stirred for 3 hours.  TLC showed no UV 
active spots and so the solvent was removed under vacuum.  The crude product was purified 
on silica gel (10% EtOAc in pet ether) to give 6-(2R)-oxiranhexyl-2,2-dimethylpropanoate 
(1.07 g, 86% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.95 (t, 2H, H-4, J=6.5Hz), 2.81 (m, 1H, H-10), 2.65 (dd, 1H, H-11a, 
J1=5.0Hz, J2=4.2Hz), 2.37 (dd, 1H, H-11b, J1=5.0Hz, J2=2.6Hz), 1.53 (m, 2H, H-5), 1.45 – 1.25 (m, 
8H, H-6 to 9), 1.10 (s, 9H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 178.46 (C-3), 64.33 (C-4), 52.31 (C-10), 47.10 (C-11), 38.73 (C-2), 
32.40 (C-9); 29.05, 28.53 (C-5), 27.22 (C-1), 25.87, 25.66  
IR (cm-1): 2930 (C-H stretch), 1725 (C=O stretch), 1152 (C-O epoxide stretch) 
HRMS: m/z calculated for C13H24O3Na = 251.1618 [M+Na]
+; Found = 251.1619 
6-(2S)-Oxiranhexyl-2,2-dimethylpropanoate S-244 
To a solution of ((7R)-8-(t-butyldimethylsilyl)oxy-7-(p-tolylsulphonyloxy)octyl)-2,2-
dimethylpropanoate (2.19 g, 4.26 mmol) in THF (30 ml), under argon, was added 
tetrabutylammonium fluoride (1.61 g, 5.11 mmol) and stirred for 3 hours.  TLC showed no UV 
active spots and so the solvent was removed under vacuum.  The crude product was purified 
on silica gel (10% EtOAc in pet ether) to give 6-(2R)-oxiranhexyl-2,2-dimethylpropanoate 
(696 mg, 72% yield) as a colourless oil. 
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 1H-NMR (CDCl3, 400 MHz) δ: 3.95 (t, 2H, H-4, J=6.7Hz), 2.81 (m, 1H, H-10), 2.65 (m, 1H, H-
11a), 2.36 (dd, 1H, H-11b, J1=5.0Hz, J2=2.7Hz), 1.53 (m, 2H, H-5), 1.45 – 1.27 (m, 8H, H-6 to 9), 
1.10 (s, 9H, H-1) 
13C-NMR (CDCl3, 100 MHz) δ: 178.59 (C-3), 64.33 (C-3), 52.31 (C-10), 47.11 (C-11), 38.75 (C-2), 
32.40, 29.05, 28.53, 27.22 (C-1), 25.87, 25.66  
IR (cm-1): 2932 (C-H stretch), 1726 (C=O stretch), 1152 (C-O epoxide stretch) 
HRMS: m/z calculated for C13H24O3Na = 251.1618 [M+Na]
+; Found = 251.1619 
n-Propyl lithium 
To a dried flask was added 25% lithium dispersion in mineral oil (19.45 g, 70.00 mmol) before 
the flask was flushed with argon.  The lithium suspension was washed with hexane (5 x 50 ml), 
each time allowing time for the lithium to rise to the surface before decanting off the 
washings.   
The clean lithium was the suspended in hexane (100 ml) and cooled to 0 oC.  To this solution 
was added 1-chloropropane (28.15 ml, 31.83 mmol) in hexane (25 ml) dropwise over a period 
of 60 mins.  The reaction mixture was stirred for 2 hours before being allowed to warm to RT 
and stirred for a further 3 hours.  After this time, the stirring was stopped and the mixture 
allowed to stand overnight.  The reaction mixture was filtered through a sintered glass funnel 
via a cannula and stored under argon at 4 oC for 3 days.  During this time, a fine white 
precipitate formed and so the mixture was again filtered through a sintered glass funnel and 
stored under argon.  The concentration of n-propyl lithium was determined using the method 
outlined above for n-butyl lithium. 
(7R)-7-Hydroxyundecyl-2,2-dimethylpropanoate R-247 
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To a suspension of copper(I) cyanide (467 mg, 5.22 mmol) in Et2O (50 ml), cooled to -78 
oC 
under argon, was added n-propyl lithium (2.44 ml, 6.26 mmol).  The reaction mixture was 
allowed to warm to 0 oC for 15 mins, ensuring that all the solid had dissolved.  This was cooled 
back to -78 oC before 6-(2R)-oxiranhexyl-2,2-dimethylpropanoate (596 mg, 2.61 mmol) in Et2O 
(20 ml) was added followed by boron trifluoride diethyletherate (0.35 ml, 2.87 mmol).  The 
resulting solution was stirred for 30 mins until TLC showed no starting material.  The reaction 
was quenched by addition of NH4Cl, poured into water and extracted with EtOAc.  The 
combined organics were washed with 2M HCl, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (15% EtOAc in pet ether) to give (7R)-7-
hydroxyundecyl-2,2-dimethylpropanoate (533 mg, 75% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.98 (t, 2H, H-4, J=6.6Hz), 3.52 (m, 1H, H-10), 1.56 (m, 2H, H-5), 
1.40 – 1.19 (m, 12H, H-7 to 9, 11 to 13), 1.13 (s, 9H, H-1), 0.84 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.54 (C-3), 71.96 (C-10), 64.40 (C-4), 37.37, 37.24, 29.30, 
28.58, 27.86, 27.23 (C-1), 25.92, 25.55, 22.77, 14.09 (C-14).  1 signal missing. 
IR (cm-1): 3415 (H-O stretch); 295, 2929, 2857 (C-H stretch); 1728 (C=O stretch) 
HRMS: m/z calculated for C16H32O3Na = 295.2244 [M+Na]
+; Found = 295.2251 
(7S)-7-Hydroxyundecyl-2,2-dimethylpropanoate S-247 
To a suspension of copper(I) cyanide (511 mg, 5.70 mmol) in Et2O (50 ml), cooled to -78 
oC 
under argon, was added n-propyl lithium (2.66 ml, 6.84 mmol).  The reaction mixture was 
allowed to warm to 0 oC for 15 mins, ensuring that all the solid had dissolved.  This was cooled 
back to -78 oC before 6-(2S)-oxiranhexyl-2,2-dimethylpropanoate (651 mg, 2.85 mmol) in Et2O 
(20 ml) was added followed by boron trifluoride diethyletherate (0.38 ml, 3.14 mmol).  The 
resulting solution was stirred for 30 mins until TLC showed no starting material.  The reaction 
257 
 
was quenched by addition of NH4Cl, poured into water and extracted with EtOAc.  The 
combined organics were washed with 2M HCl, dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified on silica gel (15% EtOAc in pet ether) to give (7S)-7-
hydroxyundecyl-2,2-dimethylpropanoate (387 mg, 50% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.98 (t, 2H, H-4, J=6.5Hz), 3.52 (m, 1H, H-10), 1.54 (m, 2H, H-5), 
140 – 1.19 (m, 14H, H-6 to 9, 11 to 13), 1.13 (s, 9H, H-1), 0.84 (t, 3H, H-14, J=6.9Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.52 (C-3), 71.96 (C-10), 64.41 (C-4), 37.37, 37.25, 29.32, 
28.58, 27.87, 27.24 (C-1), 25.93, 25.57, 22.79, 14.13 (C-14).  1 signal missing. 
IR (cm-1): 3410 (H-O stretch), 1730 (C=O stretch) 
HRMS: m/z calculated for C16H32O3Na = 295.2244 [M+Na]
+; Found = 295.2249 
((7R)-7-((2S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (R, S)-255 
To a solution of (S)-α-methoxy-α-trifluorophenylacetic acid (25 mg, 0.11 mmol) and 
dicyclohexylcarbodiimide (23 mg, 0.11 mmol) in chloroform (0.8 ml), under argon, was added 
dimethylaminopyridine (13 mg, 0.11 mmol) and stirred for 15 mins.  (7R)-7-Hydroxyundecyl-
2,2-dimethylpropanoate (10 mg, 0.037 mmol) in chloroform (0.2 ml) was added and heated to 
50 oC for 16 hours.  The reaction mixture was filtered through a plug of cotton wool and 
concentrated under vacuum.  The crude product was purified on silica gel (5% EtOAc in pet 
ether) to give ((7R)-7-((2S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (8 mg, 44% yield) as a colourless oil. 
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1H-NMR (CDCl3, 700 MHz) δ: 7.55, 7.39 (m, 5H, H-20 to 22), 5.08 (m, 1H, H-10), 4.02 (t, 2H, 
H-4, J=6.4Hz), 3.56 (s, 3H, H-18), 1.66 (m, 1H, H-11a), 1.60 – 1.52 (m, 5H, H-5, 9 and 11b), 
1.32 – 1.14 (m, 19H, H-1, 6 to 8, 12 and 13), 0.88 (t, 3H, H-14, J=6.9Hz) 
13C-NMR (CDCl3, 175 MHz) δ: 178.78 (C-3), 166.47 (C-15), 132.65 (C-19), 129.64, 128.44, 
127.47, 123.57 (C-17, qu, J=289.5Hz), 84.61 (C-16, qu, J=28.3Hz), 77.59 (C-10), 64.44 (C-4), 
55.57 (C-18), 38.87 (C-2), 33.58, 33.53, 29.08, 28.59 (C-5), 27.51 (C-12), 27.35 (C-1), 25.85, 
24.87, 22.63 (C-13), 14.06 (C-14) 
HRMS: m/z calculated for C26H39O5F3Na = 511.2642 [M+Na]
+; Found = 511.2661  
((7R)-7-((2R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (R, R)-255 
To a solution of (R)-α-methoxy-α-trifluorophenylacetic acid (25 mg, 0.11 mmol) and 
dicyclohexylcarbodiimide (23 mg, 0.11 mmol) in chloroform (0.8 ml), under argon, was added 
dimethylaminopyridine (13 mg, 0.11 mmol) and stirred for 15 mins.  (7R)-7-Hydroxyundecyl-
2,2-dimethylpropanoate (10 mg, 0.037 mmol) in chloroform (0.2 ml) was added and heated to 
50 oC for 16 hours.  The reaction mixture was filtered through a plug of cotton wool and 
concentrated under vacuum.  The crude product was purified on silica gel (5% EtOAc in pet 
ether) to give ((7R)-7-((2R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (9 mg, 50% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 7.54, 7.39 (m, 5H, H-20 to 22), 5.08 (m, 1H, H-10), 4.04 (t, 2H, 
H-4, J=6.6Hz), 3.55 (s, 3H, H-18), 1.65 (m, 1H, H-9a), 1.61 – 1.52 (m, 5H, H-5, 9b and 11), 1.33 
(m, 6H, H-6 to 8), 1.23 – 1.14 (m, 13H, H-1, 12 and 13), 0.82 (t, 3H, H-14, J=7.1Hz) 
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13C-NMR (CDCl3, 175 MHz) δ: 178.78 (C-3), 166.46 (C-15), 132.61 (C-19), 129.65, 128.45, 
127.49, 123.06 (C-17, qu, J=288.7Hz), 84.64 (C-16, qu, J=28.1Hz), 77.57 (C-10), 64.41 (C-4), 
55.58 (C-18), 38.88 (C-2), 33.81 (C-9), 33.31 (C-11), 29.17, 28.64 (C-5), 27.34 (C-1), 27.13 
(C-12), 25.91, 25.27 (C-8), 22.54 (C-13), 14.01 (C-14) 
HRMS: m/z calculated for C26H39O5F3Na = 511.2642 [M+Na]
+; Found = 511.2651 
((7S)-7-((2S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (S, S)-255 
To a solution of (S)-α-methoxy-α-trifluorophenylacetic acid (25 mg, 0.11 mmol) and 
dicyclohexylcarbodiimide (23 mg, 0.11 mmol) in chloroform (0.8 ml), under argon, was added 
4-dimethylaminopyridine (13 mg, 0.11 mmol) and stirred for 15 mins.  (7S)-7-Hydroxyundecyl-
2,2-dimethylpropanoate (10 mg, 0.037 mmol) in chloroform (0.2 ml) was added and heated to 
50 oC for 16 hours.  The reaction mixture was filtered through a plug of cotton wool and 
concentrated under vacuum.  The crude product was purified on silica gel (5% EtOAc in pet 
ether) to give ((7S)-7-((2S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (10 mg, 56% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 7.54, 7.34 (m, 5H, H-20 to 22), 5.09 (m, 1H, H-10), 4.04 (t, 2H, 
H-4, J=6.5Hz), 3.55 (s, 3H, H-18), 1.65 (m, 1H, H-9a), 1.60 – 1.53 (m, 5H, H-5, 9b and 11), 1.33 
(m, 6H, H-6 to 8), 1.25 – 1.14 (m, 13H, H-1, 12 and 13), 0.82 (t, 3H, H-14, J=7.3Hz) 
13C-NMR (CDCl3, 175 MHz) δ: 178.64 (C-3), 166.32 (C-15), 132.47 (C-19), 129.51, 128.31, 
127.35, 123.41 (qu, C-17, J=288.7Hz), 84.50 (qu, C-16, J=28.3Hz), 77.43 (C-10), 64.27 (C-4), 
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55.41 (C-18), 38.74 (C-2), 33.67 (C-9), 33.17 (C-11), 29.03, 28.50 (C-5), 27.21 (C-1), 26.99 
(C-12), 25.77, 25.13; 22.40 (C-13), 13.87 (C-13) 
HRMS: m/z calculated for C26H39F3O5 = 511.2642 [M+Na]
+; Found 511.2649 
((7S)-7-((2R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (S, R)-255 
To a solution of (R)-α-methoxy-α-trifluorophenylacetic acid (25 mg, 0.11 mmol) and 
dicyclohexylcarbodiimide (23 mg, 0.11 mmol) in chloroform (0.8 ml), under argon, was added 
4-dimethylaminopyridine (13 mg, 0.11 mmol) and stirred for 15 mins.  (7R)-7-Hydroxyundecyl-
2,2-dimethylpropanoate (10 mg, 0.037 mmol) in chloroform (0.2 ml) was added and heated to 
50 oC for 16 hours.  The reaction mixture was filtered through a plug of cotton wool and 
concentrated under vacuum.  The crude product was purified on silica gel (5% EtOAc in pet 
ether) to give ((7S)-7-((2R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propanoyl)undecyloxy)-2,2-
dimethylpropanoate (9 mg, 50% yield) as a colourless oil. 
1H-NMR (CDCl3, 700 MHz) δ: 7.54, 7.39 (m, 5H, H-20 to 22), 5.08 (m, 1H, H-10), 4.02 (t, 2H, H-
4, J=6.5Hz), 3.56 (s, 3H, H-18), 1.65 (m, 1H, H-11a), 1.59 – 1.54 (m, 5H, H-5, 9 and 11b), 1.31 – 
1.16 (m, 19H, H-1, 6 to 8, 12 and 13), 0.88 (t, 3H, H-14, J=7.0Hz) 
13C-NMR (CDCl3, 175 MHz) δ: 178.83 (C-3), 166.51 (C-15), 132.69 (C-19), 129.69, 128.49, 
127.51, 123.51 (qu, C-17, J=288.9Hz), 84.66 (qu, C-16, J=28.4Hz), 77.63, (C-10), 64.48 (C-4), 
55.62 (C-18), 33.62, 33.57, 29.13, 28.94 (C-2), 28.63 (C-5), 27.39 (C-1), 27.55 (C-12), 25.90, 
24.92 (C-6 to 8), 22.68 (C-13), 14.11 (C-14) 
HRMS: m/z calculated for C26H39F3O5 = 511.2642 [M+Na]
+; Found 511.2641 
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[(7S)-7-(p-Tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate S-248 
To a solution of (7S)-7-hydroxyundecyl-2,2-dimethylpropanoate (350 mg, 1.28 mmol) in 
chloroform (20 ml), under argon, was added 4-dimethylaminopyridine (46 mg, 0.38 mmol), 
triethylamine (0.45 ml, 3.20 mmol) followed by p-toluenesulphonyl chloride (316 mg, 
1.66 mmol) and heated to 70 oC for 16 hours.  The reaction was diluted with CH2Cl2 and 
poured into water.  The organic layer was separated, washed with 2M HCl, sat NaHCO3, dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (10% 
EtOAc in pet ether) to give [(7S)-7-(p-tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate (129 
mg, 24% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.72 (d, 2H, H-16, J=8.2Hz), 7.26 (d, 2H, H-17, J=8.3Hz), 4.47 (m, 
1H, H-10), 3.94 (t, 2H, H-4, J=6.6Hz), 2.37 (s, 3H, H-19), 1.49 (m, 6H, H-5, 9 and 11), 1.21 – 1.14 
(m, 8H, H-6 to 8, 12), 1.13 (s, 9H, H-1), 0.74 (t, 3H, H-14, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.57 (C-3), 144.37 (C-18), 134.74 (C-15), 129.65 (C-17), 127.73 
(C-16), 84.43 (C-10), 64.31 (C-4), 38.61 (C-2), 34.06, 33.84, 28.94, 28.47, 26.84, 25.73, 24.60, 
22.39, 21.63 (C-19), 13.87 (C-14).  1 signal missing. 
HRMS: m/z calculated for C23H38O5S = 449.2332 [M+Na]
+; Found 449.2328 
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[(7R)-7-(p-Tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate R-248 
To a solution of (7R)-7-hydroxyundecyl-2,2-dimethylpropanoate (533 mg, 1.96 mmol) in 
chloroform (30 ml), under argon, was added 4-dimethylaminopyridine (72 mg, 0.59 mmol), 
triethylamine (0.45 ml, 4.90 mmol) followed by p-toluenesulphonyl chloride (486 mg, 
2.55 mmol) and heated to 70 oC for 16 hours.  The reaction was diluted with CH2Cl2 and 
poured into water.  The organic layer was separated, washed with 2M HCl, sat NaHCO3, dried 
(MgSO4) and concentrated under vacuum.  The crude product was purified on silica gel (8% 
EtOAc in pet ether) to give [(7R)-7-(p-tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate (205 
mg, 25% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 7.73 (d, 2H, H-16, J=8.2Hz), 7.25 (d, 2H, H-17, J=8.3Hz), 4.48 (m, 
1H, H-10), 3.95 (t, 2H, H-4, J=6.4Hz), 2.37 (s, 3H, H-19), 1.49 (m, 6H, H-5, 9 and 11), 1.18 – 1.12 
(m, 17H, H-1, 6 to 8, 12 and 13), 0.74 (t, 3H, H-3, J=6.7Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 178.54 (C-3), 144.37 (C-18), 134.74 (C-15) 129.64 (C-17), 127.73 
(C-16), 84.42 (C-10), 64.32 (C-4), 38.61 (C-2), 34.07, 33.85, 28.93, 27.23 (C-1), 25.73, 24.60, 
21.42 (C-19), 13.85 (C-14) 
HRMS: m/z calculated for C23H38O5S = 449.2332 [M+Na]
+; Found 449.2332 
(7S)-7-Deuterioundecan-1-ol S-249 
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To a suspension of lithium aluminium deuteride (90 mg, 2.15 mmol) in THF (4 ml), cooled to 
0 oC under argon, was added [(7R)-7-(p-tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate 
(185 mg, 0.43 mmol) and allowed to warm to RT over 16 hours.  The reaction mixture was 
cooled back to 0 oC and quenched with water before being poured into 1M HCl and extracted 
with EtOAc.  The combined organics were dried (MgSO4) and concentrated under vacuum.  
The crude product was purified on silica gel (20% EtOAc in pet ether) to give (7S)-7-
deuterioundecan-1-ol (18 mg, 24% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.57 (m, 2H, H-1), 1.50 (m, 2H, H-2), 1.29 – 1.12 (m, 15H, H-3 to 
10), 0.81 (t, 3H, H-11, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 63.14 (C-1), 32.84 (C-2), 31.90, 29.71, 29.60, 29.51, 29.45, 29.25, 
25.75, 22.70, 14.13 (C-11) 
(7R)-7-Deuterioundecan-1-ol R-249 
To a suspension of lithium aluminium deuteride (88 mg, 2.10 mmol) in THF (4 ml), cooled to 
0 oC under argon, was added [(7S)-7-(p-tolylsulfonyloxy)undecyl]-2,2-dimethylpropanoate 
(179 mg, 0.42 mmol) and allowed to warm to RT over 16 hours.  The reaction mixture was 
ooled back to 0 oC and quenched with water before being poured into 1M HCl and extracted 
with EtOAc.  The combined organics were dried (MgSO4) and concentrated under vacuum.  
The crude product was purified on silica gel (20% EtOAc in pet ether) to give (7S)-7-
deuterioundecan-1-ol (41 mg, 56% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 3.57 (m, 2H, H-1), 1.50 (m, 2H, H-2), 1.29 – 1.13 (m, 15H, H-3 to 
10), 0.81 (t, 3H, H-11, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 63.14 (C-1), 32.89 (C-2), 31.90, 29.71, 29.60, 29.51, 29.46, 29.25, 
25.75, 22.70, 14.13 (C-11) 
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(7S)-7-Deuterioundecanal 
Following the general Swern procedure, the crude product was purified on silica gel (8% 
EtOAc in pet ether) to give (7S)-deuterioundecanal (10 mg, 59% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.74 (t, 1H, H-1, J=1.8Hz), 2.40 (td, 2H, H-2, J1=7.4Hz, J2=1.8Hz), 
1.61 (m, 2H, H-3), 1.27 – 1.23 (m, 13H, H-4 to 10), 0.86 (t, 3H, H-11, J=6.4Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 203.04 (C-1), 43.94 (C-2), 31.86, 29.34, 29.20, 22.61, 22.08 (C-3), 
14.14 (C-11).  3 signals missing. 
(7R)-7-Deuterioundecanal 
Following the general Swern procedure, the crude product was purified on silica gel (8% 
EtOAc in pet ether) to give (7R)-deuterioundecanal (26 mg, 67% yield) as a colourless oil. 
1H-NMR (CDCl3, 400 MHz) δ: 9.70 (t, 1H, H-1, J=1.4Hz), 2.35 (td, 2H, H-2, J1=7.4Hz, J2=1.4Hz), 
1.56 (m, 2H, H-3), 1.27 – 1.22 (m, 13H, H-10), 0.81 (t, 3H, H-11, J=6.6Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 203.02 (C-1), 43.94 (C-2), 31.87, 29.34, 29.19, 22.64, 22.11 (C-3), 
14.12 (C-11).  3 signals missing. 
(7S)-7-Deuterioundecanoic acid S-250 
Following the general Oxone procedure gave (7S)-7-deuterioundecanoic acid (8 mg, 74% yield) 
as a whit solid. 
1H-NMR (CDCl3, 400 MHz) δ: 2.28 (t, 2H, H-2, J=7.5Hz), 1.57 (m, 2H, H-3), 1.26 – 1.19 (m, 13H, 
H-4 to 10), 0.81 (t, 3H, H-11, J=6.5Hz) 
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13C-NMR (CDCl3, 100 MHz) δ: 177.74 (C-1), 33.68 (C-2), 31.87, 29.35, 29.21, 29.08, 24.73 (C-3), 
14.12 (C-11).  3 signals missing. 
HRMS: m/z calculated for C11H21DO2 = 186.1610 [M-H]
-; Found 186.1608 
(7R)-7-Deuterioundecanoic acid R-250 
Following the general Oxone procedure gave (7S)-7-deuterioundecanoic acid (21 mg, 75% 
yield) as a whit solid. 
1H-NMR (CDCl3, 400 MHz) δ: 2.28 (t, 2H, H-2, J=7.5Hz), 1.57 (m, 2H, H-3), 1.26 – 1.19 (m, 13H, 
H-4 to 10), 0.81 (t, 3H, H-11, J=6.5Hz) 
13C-NMR (CDCl3, 100 MHz) δ: 177.97 (C-1), 33.71 (C-2), 31.87, 29.34, 29.22, 29.08, 24.72 (C-3), 
14.12 (C-11).  3 signals missing. 
HRMS: m/z calculated for C11H21DO2 = 186.1610 [M-H]
-; Found 186.1610 
(7S)-7-Deuterio-1-(1H-pyrrol-2-yl)undecan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give (7S)-7-deuterio-1-(1H-pyrrol-2-yl)undecan-1-one 
(8 mg, 87% yield) as a white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 9.20 (bs, 1H, H-N), 6.90 (m, 1H, H-1), 6.85 (m, 1H, H-3), 6.23 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.4Hz), 1.64 (m, 2H, H-7), 1.26 – 1.13 (m, 13H, H-8 to 14), 0.81 (t, 
3H, H-15) 
13C-NMR (CDCl3, 100 MHz) δ: 188.00 (C-5), 131.80 (C-4), 124.31 (C-1), 116.69 (C-3), 110.69 
(C-2), 36.71 (C-6), 31.91, 22.69, 14.10 (C-15).  6 signals missing. 
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HRMS: m/z calculated for C15H24DNO = 237.2072 [M+H]
+; Found 237.2070 
(7R)-7-Deuterio-1-(1H-pyrrol-2-yl)undecan-1-one 
Following the general carboxylic acid coupling procedure, the crude product was purified on 
silica gel (10% EtOAc in pet ether) to give (7R)-7-deuterio-1-(1H-pyrrol-2-yl)undecan-1-one 
(16 mg, 63% yield) as a white solid. 
1H-NMR (CDCl3, 400 MHz) δ: 9.21 (bs, 1H, H-N), 6.92 (m, 1H, H-1), 6.83 (m, 1H, H-3), 6.21 (m, 
1H, H-2), 2.68 (t, 2H, H-6, J=7.5Hz), 1.65 (m, 2H, H-7), 1.28 – 1.15 (m, 13H, H-8 to 14), 0.80 (t, 
3H, H-15) 
13C-NMR (CDCl3, 100 MHz) δ: 188.01 (C-5), 131.83 (C-4), 124.31 (C-1), 116.69 (C-3), 110.67 
(C-2), 36.75 (C-6), 31.91, 22.69, 14.10 (C-15).  6 signals missing. 
HRMS: m/z calculated for C15H24DNO = 237.2072 [M+H]
+; Found 237.2067 
2-((7S))-7-Deuterioundecyl)-pyrrole S-232 
Following the general acyl ketone procedure, the crude product was purified on silica gel (10% 
EtOAc in pet ether) to give 2-((7S))-7-deuterioundecyl)-pyrrole (8 mg, 54% yield) as a white 
solid. 
1H-NMR (CDCl3, 700 MHz) δ: 7.83 (bs, 1H, H-N), 6.59 (m, 1H, H-1), 6.06 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.52 (t, 2H, H-5, J=7.6Hz), 1.55 (m, 2H, H-6), 1.26 (m, 2H, H-7), 1.22 – 1.19 (m, 13H, 
H-8 to 14), 0.81 (t, 3H, H-15, J=6.7Hz) 
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13C-NMR (CDCl3, 150 MHz) δ: 131.88 (C-4), 114.91 (C-1), 107.21 (C-2), 103.82 (C-3), 30.86, 
28.68, 28.65, 28.53, 28.44, 28.27, 28.34, 28.18 (t, C-11, J=19.3Hz), 26.71 (C-5), 13.10 (C-15) 
HRMS: m/z calculated for C15H26DN = 223.2279 [M+H]
+; Found 223.2288 
2-((7R))-7-Deuterioundecyl)-pyrrole R-232 
Following the general acyl ketone procedure, the crude product was purified on silica gel (10% 
EtOAc in pet ether) to give 2-((7R))-7-deuterioundecyl)-pyrrole (7 mg, 100% yield) as a white 
solid. 
1H-NMR (CDCl3, 700 MHz) δ: 7.85 (bs, 1H, H-N), 6.59 (m, 1H, H-1), 6.05 (m, 1H, H-2), 5.84 (m, 
1H, H-3), 2.52 (t, 2H, H-5, J=7.7Hz), 1.55 (m, 2H, H-6), 1.28 (m, 2H, H-7), 1.23 – 1.18 (m, 13H, 
H-8 to 14), 0.81 (t, 3H, H-15, J=7.0Hz) 
13C-NMR (CDCl3, 150 MHz) δ: 131.88 (C-4), 114.92 (C-1), 107.20 (C-2), 103.81 (C-3), 30.87, 
28.68, 28.66, 28.54, 28.44, 28.27, 28.34, 28.18, (t, C-11, J=19.4Hz), 21.67, 26.71 (C-5), 13.09 
(C-15) 
HRMS: m/z calculated for C15H26DN = 223.2279 [M+H]
+; Found 223.2276 
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6.2  Biology Experimental 
Electoporation was carried out using a BioRad GenePulser alongside a BioRad Pulse Controller 
Plus.  Centrifugation was conducted on Eppendorf models 5810R and 5424. 
Overlay membranes were purchased from Focus Packaging and Design Ltd and sterilised by 
autoclaving prior to use. 
Additional components of medium was sterilised by autoclaving prior to addition.  Trace 
elements solution was sterilised by filtration through a 0.2μm filter immediately prior to use. 
6.2.1 Media and antibiotics 
6.2.1.1 R5 medium 
Sucrose (103 g), potassium sulphate (0.25 g), magnesium chloride hexahydrate (10 g), glucose 
(10 g), Casamino acids (0.1 g), Bacto yeast extract (5 g), TES buffer (5 g) and Bacto agar (20 g) 
was dissolved in distilled water (1 l) and the resulting solution was sterilised by autoclaving.  
At the time of use, 0.5% potassium dihydrogen phosphate (10 ml; 5 g / l), 5M calcium chloride 
(4 ml; 732 g / l), 20% L-proline (15 ml; 200 g / l), 1M sodium hydroxide (7 ml; 40 g / l) and trace 
elements (2 ml; 40 mg zinc(II) chloride, 200 mg iron(III) chloride, 10 mg copper(II) chloride, 
10 mg manganese(II) chloride, 10 mg sodium tetraborate, 10 mg ammonium molybdate) was 
added. 
6.2.1.2 GYM medium118 
Starch (20 g), malt extract (10 g), glucose (4 g), Bacto yeast extract (4 g), calcium carbonate 
(2 g) and Bacto agar (15 g) were dissolved in distilled water (1 l) and the resulting solution 
wassterilised by autoclaving. 
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6.2.1.3 MP5 medium118 
MOPS (20.9 g), Bacto yeast extract (7 g), sodium chloride (5 g), sodium nitrate (1 g) and Bacto 
agar (15 g) were dissolved in distilled water (1 l) and the pH was adjusted to 7.2 using 2.35M 
NaOH.  The resulting solution was sterilised by autoclaving. 
6.2.1.4 Ossamycin production medium  
Dry distillate soluble (12.5 g), glucose (10 g), calcium carbonate (10 g) and Bacto agar (15 g) 
were suspended in distilled water (1 l) and the resulting suspension was sterilised by 
autoclaving. 
6.2.1.5 SMMS medium 
Casamino acids (2 g), TES buffer (5.67 g) and Bacto agar (15 g) were dissolved in distilled water 
(1 l) and the resulting solution was sterilised by autoclaving.  At time of use, 50 mM 
dipotassiumhydrogen phosphate and sodium dihydrogen phosphate (10 ml), 1M magnesium 
sulphate (5 ml), 50% w/v glucose (18 ml) and trace elements (2 ml; 40 mg zinc(II) chloride, 
200 mg iron(III) chloride, 10 mg copper(II) chloride, 10 mg manganese(II) chloride, 10 mg 
sodium tetraborate, 10 mg ammonium molybdate) were added. 
6.2.1.6 SFM medium 
Soy flour (20 g), D-mannitol (20 g) and Bacto agar (20 g) were suspended in tap water (1 l) and 
the resulting suspension was sterilised by autoclaving. 
6.2.1.7 LB medium 
Tryptone (10 g), Bacto yeast extract (5 g) and sodium chloride (10 g) were dissolved in distilled 
water (1 l) and the resulting solution was sterilised by autoclaving.  For LB plates, Bacto agar 
(15 g) was added prior to autoclaving. 
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6.2.1.8 Antibiotics 
Antibiotics stock solutions were made as described in Table 6.1 and filtered through a 0.2 μm 
filter. 
Antibiotic  Stock Solution Working Solutions 
Ampicillin  100 mg / 1 ml water 100 µg / 1 ml 
Kanamycin 50 mg / 1 ml water 25 µg / 1ml 
Chloramphenicol 25 mg / 1 ml water 25 µg / 1 ml 
Hygromycin 50 mg / 1 ml water 25 µg / 1 ml 
Nalidixic acid 25 mg / 1 ml 0.3M NaOH 25 µg / 1 ml 
Table 6.1: Antibiotic stock solutions 
6.2.2 Microbial Strains and Plasmids 
Bacterial strains used in this work: 
 E. coli ET12567/pUZ8002 – lab stock from Daniel Zabala 
 Streptomyces coelicolor A(3)2 ‘wild type’ M511 – lab stock from Paulina Sydor 
 Streptomyces coelicolor A(3)2 redL::oriT-apr + redHG W116 – lab stock from Paulina 
Sydor 
 Streptomyces coelicolor A(3)2 M511 ΔredG::scar – lab stock from Paulina Sydor 
 Streptomyces albus ‘wild type’ – lab stock from Paulina Sydor 
 Streptomyces albus + redH – this work 
 Streptomyces albus + redHG – this work 
Plasmids used in this work: 
 pOSV556 + redH – E. coli Streptomyces shuttle vector containing redH under control of 
the ermE* promoter, ampicillin and hygromycin resistance gene, oriT, the attP 
Streptomyces chromosomal integration site and the corresponding integrase 
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 pOSV556 + redHG – E. coli Streptomyces shuttle vector containing redHG under 
control of the ermE* promoter, ampicillin and hygromycin resistance gene, oriT, the 
attP Streptomyces chromosomal integration site and the corresponding integrase 
6.2.3 Preparation and Transformation of Electrocompetent E. coli ET12567/pUZ8002 
E. coli ET12567/pUZ8002, provided by Daniel Zabala, was inoculated into 10 ml of liquid LB, 
containing the appropriate antibiotics, and the resulting culture was grown at 37 oC overnight.  
100 μl of this preculture was used to inoculate 10 ml of fresh liquid LB and the resulting 
culture grown to an OD600 5-6 over 3-4 hours.  This culture was centrifuged at 3000 rpm and 
the supernatant was decanted.  The cell pellet was resuspended in 10% glycerol and washed 
twice more with 10 ml of fresh liquid LB.  The cell pellet was resuspended in 10% glycerol 
(100 μl). 
A solution of the appropriate plasmid (3 μl) was added to 100 μl of electrocompetent E. coli 
ET12567/pUZ8002 and the resulting suspension was transferred to an ice cold 0.3 cm 
electroporation cuvette.  Electroporation was performed using a BioRad GenePulser II set to 
1.8 kV, with a time constant recorded between 4.8 and 5.0 ms.  Ice cold liquid LB (1 ml) was 
added and the resulting mixture was transferred to a sterile 1.5 ml emicrocentrifuge tube, 
shaken at 180 rpm at 37 oC for 1 hour.  The resulting suspension was spread on LB agar 
containing chloramphenicol, kanamycin and ampicillin. 
6.2.4 Conjugation of plasmid with Streptomyces albus 
A single transformant of E. coli ET12567/pUZ8002, as prepared in Section 6.2.3, was used to 
inoculate 10 ml of liquid LB containing chloramphenicol, kanamycin and hygromycin and the 
resulting culture was grown at 37 oC overnight.  100 μl of this preculture was used to inoculate 
10 ml of fresh liquid LB containing chloramphenicol, kanamycin and hygromycin and the 
resulting culture was grown to an OD600 5-6 over 3-4 hours.  This culture was centrifuged at 
3000 rpm and the supernatant was decanted.  The resulting cell pellet was resuspended in LB 
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medium and washed twice more with 10 ml fresh liquid LB.  The final cell pellet was 
resuspended in 0.5 ml of liquid LB. 
15 μl of a Streptomyces albus spore stock was added to 0.5 ml of liquid LB and the resulting 
suspension was heat-shocked at 42 oC for 10 mins, left at 30 oC for 3 hours.  The spores were 
mixed with the E. coli cells and the mixture was briefly centrifudged to pellet the cells.  The 
supernatant was decanted and the resulting pellet was serially diluted with sterile water and 
spread on SFM agar medium containing 10 mM magnesium chloride.  After growing for 16 
hours, the plates were overlaid with 1 ml of water containing nalidixic acid and hygromycin to 
select for the desired transconjugants.  After a further 5 – 7 days growth at 30 oC, a single 
colony was picked and spread on SFM agar medium containing nalidixic acid and hygromycin.  
The resulting culture was gorwn for a further 7 days at 30 oC. 
6.2.5 General procedure for Streptomyces spore stock creation 
To mannitol-soy flour agar plates was added 20 µl of a spore stock suspension.  The spores 
were spread across the surface with an inoculation loop and the resulting culture incubated at 
30 oC for 7 days.  Sterile water (10 ml) was added to the surface of the plate and the spores 
were suspended in the water by agitation with a sterile inoculation loop.  The suspension was 
filtered through sterile glass wool into 15 ml sterile tubes and centrifuged at 3000 rpm for 
10 mins.  The liquid was decanted and the pelleted spores were suspended in 0.5 ml 
25% glycerol.  This spore suspension was stored at -20 oC. 
6.2.6 ‘Suspension’ feeding method to Streptomyces coelicolor  
Plates containing R5 agar medium plated were overlaid with sterile membranes (12 – 14 kDa 
molecular weight cut off).  7 μl of the appropriate Streptomyces strain spore stock were added 
to the sterile membrane and spread with an inoculation loop.  After 3 days incubation at 
30 oC, 3 mg of 2-UP or an analogue in 200 μl of methanol was diluted with 2 ml of water and 
the resulting suspension distributed around the plate as small droplets.  After a further 2 days 
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of incubation at 30 oC, the biomass was scrapped off the membrane into a glass vial using a 
scalpel.  5 ml of 0.1M HCl in methanol was added to the glass vial and the resulting suspension 
was sonicated for 5 min.  100 μl of this extract was diluted with 0.5 ml of methanol and the 
resulting suspension was filtered through a 0.2 μm spin filter.  Methanol was added to give a 
total volume of 1 ml and the sample was analysed by LC-MS. 
6.2.7 ‘Precipitation’ feeding method to Streptomyces coelicolor  
Plates containing R5 agar medium plated were overlaid with sterile membranes (12 – 14 kDa 
molecular weight cut off).  7 μl of the appropriate Streptomycesn strain spore stock was added 
to the sterile membrane and spread with an inoculation loop.  After 3 days incubation at 
30 oC, 2 ml of water was added to the culture followed by 3 mg of 2-UP or an analogue in 
200 μl of methanol.  After a further 2 days of incubation at 30 oC, the biomass was scrapped 
off the membrane into a glass vial using a scalpel.  5 ml of 0.1M HCl in methanol was added to 
the glass vial and the resulting suspension was sonicated for 5 min.  100 μl of this extract was 
diluted with 0.5 ml of methanol and the resulting suspension was filtered through a 0.2 μm 
spin filter.  Methanol was added to give a total volume of 1 ml and the sample was analysed 
by LC-MS. 
6.2.8 Feeding method to Streptomyces albus 
Plates containing R5 agar medium plated were overlaid with sterile membranes (12 – 14 kDa 
molecular weight cut off).  7 μl of the appropriate Streptomyces strain spore stock was added 
to the sterile membrane and spread with an inoculation loop.  After 2 days incubation at 
30 oC, 3 mg of 2-UP or an analogue in 100 μl of methanol and 3 mg of MBC in 100 μl of DMSO 
was mixed together and added to the plate as small droplets.   After a further 2 days 
incubation at 30 oC, the biomass was scrapped off into a glass vial using a scalpel.  5 ml of 
0.1M HCl in methanol was added to the glass vial and the resulting suspension was sonicated 
for 5 min.  100 μl of this extract was diluted with 0.5 ml of methanol and the resulting 
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suspension was filtered through a 0.2 μm spin filter.  Methanol was added to give a total 
volume of 1 ml and the sample was analysed by LC-MS. 
6.3  HPLC and LC-MS Experimental 
6.3.1 HPLC purification 
HPLC purification was performed on an Agilent 1200 HPLC instrument fitted with an Agilent 
Zorbax XDB-C18 column (21.2 x 150 mm, 5 µm, 25°C) with a flow rate of 20 ml / min.  Samples 
were monitored at 533 nm and collected using an automated fraction collector set to a 
threshold of 400 mAU. 
HPLC grade methanol and water was purchased from either Fisher Scientific or Sigma Aldrich.  
HPLC grade formic acid was purchased from Sigma Aldrich and used within one month of 
opening.   
HPLC grade formic acid (1 ml / l) was added to HPLC grade methanol and water and filtered 
through Nylon 0.2 µm membranes purchased from GE Healthcare immediately prior to use.   
Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 60 40 
5.00 60 40 
20.00 0 100 
25.00 0 100 
30.00 60 40 
 Table 6.2: HPLC conditions used for the purification of 76 and 102 
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Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 80 20 
5.00 80 20 
25.00 0 100 
30.00 0 100 
35.00 80 20 
Table 6.3: HPLC conditions used for the purification of 103 and 256 
6.3.2 LC-MS analysis 
Low resolution LC-MS analysis was performed on an Agilent 1100 HPLC instrument fitted with 
an Agilent Eclipse XDB-C18 column (4.6 x 150 mm, 5 µm, 25°C) connected to a Bruker HCT 
ultra mass spectrometer, using either of the elution profile shown in Table 6.4 or 6.5. 
Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 50 50 
3.00 50 50 
7.00 25 75 
24.00 20 80 
26.00 50 50 
Table 6.4: Elution profile for low resolution LC-MS analysis 
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Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 80 20 
3.00 80 20 
25.00 0 100 
27.00 0 100 
30.00 80 20 
Table 6.5: Alternative elution profile for low resolution LC-MS analysis 
High resolution LC-MS analysis was performed using a Dionex 3000 R5 UHPLC instrument 
fitted with  an Agilent Zorbax Eclipse Plus C18 600 Bar (2.1 x 100 mm, 1.8 µm, 25°C) connected 
to a Bruker Maxis Impact mass spectrometer, using the elution profile shown in Table 6.6. 
Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 95 5 
5.00 95 5 
17.00 0 100 
23.00 0 100 
25.00 95 5 
Table 6.6: Elution profile for high resolution LC-MS  
6.3.3 Homochiral stationary phase HPLC analysis of Mosher esters (S, R)-, (S, S)-, (R,R)- 
and (R, S)-255 
Liquid chromatography on a homochiral stationary phase was used to determine the 
enatiomeric mixture of the four Mosher diastereomeric esters.  Samples were prepared by 
dissolving 2 mg of Mosher ester in 150 µl hexane + 0.1% diethylamine.  Analysis was 
performed on an Agilent 1100 HPLC instrument fitted with a Chiral Technologies Europe 
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ChiralPak IA column (4.6 mm x 250 mm, 25 oC), using the elution profile shown in Table 6.7, 
with a flow rate of 1 ml/ min.  Peaks were collected into individual vials and injected directly 
into a Bruker Maxis mass spectrometer. 
Time (min) Hexane % 
(0.1% diethylamine) 
Isopropanol % 
(0.1% diethylamine) 
0.00 100 0 
5.00 100 0 
30.00 50 50 
35.00 50 50 
40.00 95 5 
Table 6.7: Elution profile for HPLC analysis of Mosher esters on a homochiral stationary phase 
6.3.3 Homochiral stationary phase HPLC analysis of streptorubin B deuterium analogues 
R5 media plated were overlaid with sterile membranes (12 – 14 kDa molecular weight cut off).  
7 μl of the S. albus + redHG spore stock was added to the sterile membrane and spread with 
an inoculation loop.  After 2 days incubation at 30 oC, 3 mg of S-232 or R-232 in 100 μl 
methanol and 3 mg of MBC in 100 μl DMSO was mixed together and added to the plate as 
small droplets.   After a further 2 days incubation at 30 oC, the biomass were scrapped off into 
plastic tube using a scalpel.  5 ml of 0.1M HCl in methanol was added to the plastic tube and 
sonicated for 5 mins.  The resulting suspension was centrifuged at 3000 rpm for 10 mins 
before the supernatant was decanted; this process was repeated twice more.  The combined 
organic extracts were concentrated under vacuum before resuspending in 200 µl CH2Cl2.  This 
red solution was loaded onto basic alumina and eluted with 5% EtOAc in hexane, collecting 
the yellow fractions.  The solvent was removed under vacuum and resuspended in 1 ml 0.1% 
HCl methanol.  HPLC purification using the elution profile shown in Table 6.8 provided the 
desired streptorubin B analogues.  The solvent from the combined fractions was removed 
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under vacuum and the resulting aqueous layer adjusted to pH 9 with sat NaHCO3.  The yellow 
pigment was extract with EtOAc, dried (MgSO4) and concentrated under vacuum. 
These streptorubin B free bases were analysed via HPLC using a homochiral stationary phase.  
Samples were prepared as the free bases and dissolved in 50 µl hexane / isopropanol (95:5) + 
0.1% diethylamine.  Analysis was performed on an Agilent 1100 HPLC instrument fitted with a 
Chiral Technologies Europe ChiralPak IA column (4.6 mm x 250 mm, 25 oC), using the elution 
profile shown in Table 6.9, with a flow rate of 1 ml/ min.  Peaks were collected into individual 
vials and injected directly into a Bruker Maxis mass spectrometer. 
Time (min) Water % 
(0.1% formic acid) 
Methanol % 
(0.1% formic acid) 
0.00 30 70 
5.00 30 70 
7.50 20 80 
10.00 0 100 
14.50 0 100 
15.00 30 70 
Table 6.8: HPLC conditions used for the purification of deuterium labelled streptorubin B 
analogues 
 
 
 
 
 
279 
 
Time (min) Hexane % 
(0.1% diethylamine) 
Isopropanol % 
(0.1% diethylamine) 
0.00 95 5 
20.00 95 5 
21.00 90 10 
50.00 90 10 
51.00 95 5 
60.00 95 5 
Table 6.9: Elution profile for HPLC analysis of deuterium labelled streptorubin B analogues on 
a homochiral stationary phase 
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Appendix 1.1: A comparison between 5.70 – 5.10 ppm and 2.20 – -0.50 ppm of the 1H-NMR 
spectrum in CDCl3 at 700 MHz of E- (top spectrum) and Z-118 (bottom spectrum) 
Appendix 1.2: The GC-MS chromatogram for E- (top spectra) and Z-118 (bottom spectra) 
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Appendix 1.3: A comparison of the 1H-NMR spectrum in CDCl3 at 400 MHz of titanocene 
dichloride (top spectrum) with the reaction of methylithium after 15 mins (middle spectrum) 
and after 45 mins (bottom spectrum).  The additional peaks observed in the spectra are due to 
the toluene and THF used as a solvent for this reaction 
Appendix 1.4: The 1H-NMR spectrum in CDCl3 at 700 MHz of 206 
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Appendix 1.5: A533 chromatogram (black) and extracted ion chromatograms at m/z = 412 
(red), m/z = 428 (blue), m/z = 444 (yellow) and m/z = 410 (green) from the LC-MS analysis of 
the mycelial extract of the redL mutant fed with 2-UP analogue 269 
Appendix 1.6: A533 chromatogram (black) and extracted ion chromatograms at m/z = 412 
(red), m/z = 428 (blue), m/z = 444 (yellow) and m/z = 410 (green) from the LC-MS analysis of 
the mycelial extract of the redL mutant fed with 2-UP analogue 270 
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Appendix 1.7: Extracted ion chromatograms at m/z = 410 from the LC-MS analysis of the 
mycelial extract of the redL mutant (green) and the redLG double mutant (purple) fed with 
2-UP analogue 270 
Appendix 1.8: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue), 
m/z = 444.23 (yellow) and m/z = 410.22 (green) from the LC-MS analysis of the mycelial 
extract of S. albus + redHG fed with 2-UP analogue 268 and MBC 19 
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Appendix 1.9: Extracted ion chromatograms at m/z = 412.24 (red), m/z = 428.23 (blue), 
m/z = 444.23 (yellow) and m/z = 410.22 (green) from the LC-MS analysis of the mycelial 
extract of S. albus + redHG fed with 2-UP analogue 267 and MBC 19 
Appendix 1.10: Extracted ion chromatograms at m/z = 396.26 (red) and m/z = 352.20 (blue) 
from the LC-MS analysis of the mycelial extract of S. albus + redHG fed with 2-UP analogue 86 
and MBC 19 
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Appendix 1.11: Extracted ion chromatograms at m/z = 406.28 (red), m/z = 404.27 (blue) and 
m/z = 422.28 (yellow) from the LC-MS analysis of the mycelial extract of S. albus + redHG fed 
with 2-UP analogue Z-118 and MBC 19 
Appendix 1.12: Extracted ion chromatograms at m/z = 406.28 (red), m/z = 404.27 (blue) and 
m/z = 422.28 (yellow) from the LC-MS analysis of the mycelial extract of S. albus + redHG fed 
with 2-UP analogue E-118 and MBC 19 
 
 
